PT J
AU Jokinen, R
   Battersby, BJ
AF Jokinen, Riikka
   Battersby, Brendan J.
TI Insight into mammalian mitochondrial DNA segregation
SO ANNALS OF MEDICINE
LA English
DT Article
DE Autophagy; disease; genetics; metabolism; mitochondria; mitochondrial DNA
ID mtdna copy number; transcription factor; skeletal-muscle; reticulocyte maturation; heteroplasmic mice; histocompatibility antigen; embryonic-development; rapid segregation; axonal-transport; point mutation
AB Mitochondrial DNA (mtDNA) is essential for aerobic energy production in eukaryotic cells, and mutations in this genome can lead to mitochondrial dysfunction. Human mtDNA mutations are typically heteroplasmic, a mix of mutant and wild-type genomes, which can present as a heterogeneous group of disorders ranging in severity from mild to fatal, and commonly affecting highly aerobic tissues such as heart, skeletal muscle, and neurons. During the 1990s, many research groups started to notice that mtDNA mutations could segregate depending upon the mutation and tissue. This segregation pattern can have a direct effect on the onset and severity of these mutations. However, these segregation patterns could not be easily explained by respiratory chain function, implying that there is regulation of mtDNA independent of its bioenergetic role. A lot of research on this topic has been largely descriptive, but over the last several years advances in mitochondrial biology have provided some mechanistic insight into the regulation of the organelle and its genome. This review addresses these advances with respect to somatic segregation of mtDNA in mammals.
C1 [Battersby, Brendan J.] Univ Helsinki, Biomedicum Helsinki, Res Programs Unit Mol Neurol, FIN-00290 Helsinki, Finland.
   Univ Helsinki, Biomedicum Helsinki, Inst Biomed, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki
RP Battersby, BJ (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Programs Unit Mol Neurol, R C524B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM brendan.battersby@helsinki.fi
FU Academy of Finland; Jane and Aatos Erkko Foundation; University of Helsinki; Biocentrum Helsinki; UMDF-USA; Helsinki Biomedical Graduate School
CR Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bogenhagen DF, 2011, BIOCH BIOPHYS ACTA, V0, P0
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jokinen R, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001161
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Ney PA, 2011, CURR OPIN HEMATOL, V18, P152, DOI 10.1097/MOH.0b013e328345213e
   Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015
   Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107
   SHOUBRIDGE EA, 1995, BIOCHEM BIOPH RES CO, V213, P189, DOI 10.1006/bbrc.1995.2115
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2
   Takeda K, 2000, GENETICS, V155, P777
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   tHart LM, 1996, HUM MUTAT, V7, P193
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046
   Weber K, 1997, AM J HUM GENET, V60, P373
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957
   Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 98
TC 18
Z9 19
U1 0
U2 31
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 0785-3890
EI 
J9 ANN MED
JI Ann. Med.
PD MAR 15
PY 2013
VL 45
IS 2
BP 149
EP 155
DI 10.3109/07853890.2012.693190
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 084GX
UT WOS:000314527800007
PM 22775146
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Tran, GT
   Schwarzlmüller, T
   Specht, K
   Haugarvoll, K
   Balafkan, N
   Lilleng, PK
   Miletic, H
   Biermann, M
   Bindoff, LA
AF Tzoulis, Charalampos
   Gia Tuong Tran
   Schwarzlmuller, Thomas
   Specht, Karsten
   Haugarvoll, Kristoffer
   Balafkan, Novin
   Lilleng, Peer K.
   Miletic, Hrvoje
   Biermann, Martin
   Bindoff, Laurence A.
TI Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations
SO BRAIN
LA English
DT Article
DE substantia nigra; POLG; mitochondria; neurodegenerative disease; Parkinson's disease
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; charlevoix-saguenay arsacs; substantia-nigra neurons; recessive spastic ataxia; disease; deletions; dysfunction; polg
AB The role of mitochondria in the pathogenesis of neurodegeneration is an area of intense study. It is known that defects in proteins involved in mitochondrial quality control can cause Parkinson's disease, and there is increasing evidence linking mitochondrial dysfunction, and particularly mitochondrial DNA abnormalities, to neuronal loss in the substantia nigra. Mutations in the catalytic subunit of polymerase gamma are among the most common causes of mitochondrial disease and owing to its role in mitochondrial DNA homeostasis, polymerase gamma defects are often considered a paradigm for mitochondrial diseases generally. Yet, despite this, parkinsonism is uncommon with polymerase gamma defects. In this study, we investigated structural and functional changes in the substantia nigra of 11 patients with polymerase gamma encephalopathy. We characterized the mitochondrial DNA abnormalities and examined the respiratory chain in neurons of the substantia nigra. We also investigated nigrostriatal integrity and function using a combination of post-mortem and in vivo functional studies with dopamine transporter imaging and positron emission tomography. At the cellular level, dopaminergic nigral neurons of patients with polymerase gamma encephalopathy contained a significantly lower copy number of mitochondrial DNA (depletion) and higher levels of deletions than normal control subjects. A selective and progressive complex I deficiency was seen and this was associated with a severe and progressive loss of the dopaminergic neurons of the pars compacta. Dopamine transporter imaging and positron emission tomography showed that the degree of nigral neuronal loss and nigrostriatal depletion were severe and appeared greater even than that seen in idiopathic Parkinson's disease. Despite this, however, none of our patients showed any signs of parkinsonism. The additional presence of both thalamic and cerebellar dysfunction in our patients suggested that these may play a role in counteracting the effects of basal ganglia dysfunction and prevent the development of clinical parkinsonism.
C1 [Tzoulis, Charalampos; Haugarvoll, Kristoffer; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, Charalampos; Gia Tuong Tran; Haugarvoll, Kristoffer; Balafkan, Novin; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Schwarzlmuller, Thomas; Biermann, Martin] Haukeland Hosp, Dept Radiol, Ctr Nucl Med PET, N-5021 Bergen, Norway.
   [Schwarzlmuller, Thomas; Biermann, Martin] Univ Bergen, Inst Surg Sci, Bergen, Norway.
   [Specht, Karsten] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.
   [Specht, Karsten] Haukeland Hosp, Dept Med Engn, N-5021 Bergen, Norway.
   [Lilleng, Peer K.; Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Lilleng, Peer K.] Univ Bergen, Gade Inst, Sect Pathol, Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
FU Western Norway Health Trust; University of Bergen; Meltzer Foundation
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   BOUCHARD RW, 1979, CAN J NEUROL SCI, V6, P191, DOI 10.1017/S0317167100119626
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dickson DW, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009258
   Dickson JC, 2012, EUR J NUCL MED MOL I, V39, P188, DOI 10.1007/s00259-011-1884-z
   Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085
   Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lim SM, 2009, J NUCL MED, V50, P1638, DOI 10.2967/jnumed.109.065870
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Machado A, 2006, MOVEMENT DISORD, V21, PS247, DOI 10.1002/mds.20959
   Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033
   Mills EM, 1999, TOXICOL APPL PHARM, V156, P6, DOI 10.1006/taap.1999.8630
   MINOSHIMA S, 1995, J NUCL MED, V36, P1238
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   Pifl C, 2012, MOVEMENT DISORD, V27, P1618, DOI 10.1002/mds.25109
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Reeve AK, 2012, MITOCHONDRIAL DYSFUNCTION IN NEURODEGENERATIVE DISORDERS, V0, P0
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   TOTH S, 1961, J NEUROL NEUROSUR PS, V24, P143, DOI 10.1136/jnnp.24.2.143
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Varrone A, 2004, ANN NEUROL, V55, P426, DOI 10.1002/ana.20054
NR 42
TC 71
Z9 72
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 
J9 BRAIN
JI Brain
PD AUG 15
PY 2013
VL 136
IS 
BP 2393
EP 2404
DI 10.1093/brain/awt103
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 190KG
UT WOS:000322338000013
PM 23625061
DA 2024-11-01
ER

PT J
AU Milone, M
   Klassen, BT
   Landsverk, ML
   Haas, RH
   Wong, LJ
AF Milone, Margherita
   Klassen, Bryan T.
   Landsverk, Megan L.
   Haas, Richard H.
   Wong, Lee-Jun
TI Orthostatic Tremor, Progressive External Ophthalmoplegia, and Twinkle
SO JAMA NEUROLOGY
LA English
DT Article
ID parkinsonism; mutations; spectrum; disease
AB IMPORTANCE Orthostatic tremor (OT) is a high-frequency (13-18 Hz) leg tremor occurring in standing position. Orthostatic tremor has an unknown pathophysiologic mechanism. It is thought to be sporadic but siblings with OT from 3 unrelated families were reported. No mutations have been reported in OT. We describe a patient with OT carrying a C10orf2 TWINKLE mutation to highlight the possible association of OT with mitochondrial dysfunction and mutations in the mitochondrial replicative helicase Twinkle. OBSERVATIONS A man in his late 60s had ptosis and tremor on standing for 30 years, followed by development of progressive external ophthalmoplegia. Polygraphic recordings revealed an orthostatic synchronic tremor with 17.5-Hz frequency. Electromyography/nerve conduction studies showed evidence for a mild myopathy and associated mild axonal sensorimotor peripheral neuropathy. Muscle biopsy revealed ragged red fibers; mild cerebral atrophy was evident by magnetic resonance imaging. Molecular analysis revealed a novel heterozygous missense mutation at an evolutionarily conserved residue of the C10orf2 TWINKLE gene. CONCLUSIONS AND RELEVANCE Although the incidental association of OT and C10orf2 TWINKLE mutation is possible, the simultaneous onset of OT and eyelid ptosis at a much younger age than usually observed for OT raises the possibility of mitochondrial dysfunction and loss of mitochondrial DNA integrity in the pathogenesis of OT.
C1 [Milone, Margherita; Klassen, Bryan T.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
   [Landsverk, Megan L.; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Haas, Richard H.] Univ Calif San Diego, Dept Neurosci & Pediat, San Diego, CA 92103 USA.
C3 Mayo Clinic; Baylor College of Medicine; University of California System; University of California San Diego
RP Milone, M (corresponding author), Mayo Clin, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.
EM milone.margherita@mayo.edu
FU Mayo Clinic Center for Translational Science Activities from the National Institutes of Health National Center for Research Resources [UL1 RR024150]
CR Baker M, 2009, MOVEMENT DISORD, V24, P1550, DOI 10.1002/mds.22630
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Contarino MF, 2006, NEUROLOGY, V66, P1600, DOI 10.1212/01.wnl.0000216263.23642.db
   Fischer M, 2007, J NEUROL, V254, P1759, DOI 10.1007/s00415-007-0647-z
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gerschlager W, 2004, MOVEMENT DISORD, V19, P788, DOI 10.1002/mds.20132
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HEILMAN KM, 1984, ARCH NEUROL-CHICAGO, V41, P880, DOI 10.1001/archneur.1984.04050190086020
   Katzenschlager R, 2003, ANN NEUROL, V53, P489, DOI 10.1002/ana.10475
   Leu-Semenescu S, 2007, MOVEMENT DISORD, V22, P2063, DOI 10.1002/mds.21651
   Piboolnurak P, 2005, MOVEMENT DISORD, V20, P1455, DOI 10.1002/mds.20588
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Virmani T, 2012, NEUROLOGY, V79, P288, DOI 10.1212/WNL.0b013e31825fdfb3
   Wegner F, 2008, J NEUROL, V255, P1840, DOI 10.1007/s00415-008-0023-7
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
NR 16
TC 10
Z9 12
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD NOV 15
PY 2013
VL 70
IS 11
BP 1429
EP 1431
DI 10.1001/jamaneurol.2013.3521
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA 295LG
UT WOS:000330117000014
PM 24061067
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Mahjoub, SZ
AF Finsterer, J.
   Mahjoub, S. Zarrouk
TI Mitochondrial epilepsy in pediatric and adult patients
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Review
DE mitochondrial disorder; epilepsy; seizure; electroencephalography; central nervous system involvement; antiepileptic drugs
ID complex-i-deficiency; c-oxidase deficiency; alpers-huttenlocher-syndrome; ragged-red fibers; progressive external ophthalmoplegia; onset spinocerebellar ataxia; partial status epilepticus; respiratory-chain defects; kearns-sayre-syndrome; stroke-like episodes
AB Few data are available about the difference between epilepsy in pediatric mitochondrial disorders (MIDs) and adult MIDs. This review focuses on the differences between pediatric and adult mitochondrial epilepsy with regard to seizure type, seizure frequency, and underlying MID. A literature search via Pubmed using the keywords 'mitochondrial', 'epilepsy', 'seizures', 'adult', 'pediatric', and all MID acronyms, was carried out. Frequency of mitochondrial epilepsy strongly depends on the type of MID included and is higher in pediatric compared to adult patients. In pediatric patients, mitochondrial epilepsy is more frequent due to mutations in nDNA-located than mtDNA-located genes and vice versa in adults. In pediatric patients, mitochondrial epilepsy is associated with a syndromic phenotype in half of the patients and in adults more frequently with a non-syndromic phenotype. In pediatric patients, focal seizures are more frequent than generalized seizures and vice versa in adults. Electro-clinical syndromes are more frequent in pediatric MIDs compared to adult MIDs. Differences between pediatric and adult mitochondrial epilepsy concern the onset of epilepsy, frequency of epilepsy, seizure type, type of electro-clinical syndrome, frequency of syndromic versus non-syndromic MIDs, and the outcome. To optimize management of mitochondrial epilepsy, it is essential to differentiate between early and late-onset forms.
C1 [Finsterer, J.] Krankenanstalt Rudolfstiftung Wien, A-1180 Vienna, Austria.
   [Mahjoub, S. Zarrouk] Fac Med Monastir, UR Human Nutr & Metab Disorders, Lab Biochem, Monastir, Tunisia.
C3 Rudolfstiftung Hospital; Universite de Monastir
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Agapitos Emmanuel, 1997, GENERAL AND DIAGNOSTIC PATHOLOGY, V142, P335
   Ahadi AM, 2008, NEUROL NEUROCHIR POL, V42, P263
   [Anonymous], 2010, GENEREVIEWS, V0, P0
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Arthur TM, 2007, MITOCHONDRION, V7, P279, DOI 10.1016/j.mito.2007.04.003
   Barghuti F, 2008, MOL GENET METAB, V94, P78, DOI 10.1016/j.ymgme.2007.11.013
   Barnerias C, 2010, DEV MED CHILD NEUROL, V52, Pe1, DOI 10.1111/j.1469-8749.2009.03541.x
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Burglen L, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-18
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Cardaioli E, 2011, J NEUROL SCI, V303, P142, DOI 10.1016/j.jns.2010.12.020
   Castro-Gago M, 1999, REV NEUROLOGIA, V29, P912, DOI 10.33588/rn.2910.99062
   Chen Yung-Nien, 2004, CHANG GUNG MED J, V27, P66
   Cheng J, 2011, AM J HUM GENET, V89, P56, DOI 10.1016/j.ajhg.2011.05.027
   Chou HF, 2008, PEDIATR NEUROL, V38, P143, DOI 10.1016/j.pediatrneurol.2007.09.015
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   El-Hattab AW, 2012, GENEREVIEWS, V0, P0
   Elia M, 1996, BRAIN DEV-JPN, V18, P207, DOI 10.1016/0387-7604(95)00126-3
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ezugha H, 2010, J CHILD NEUROL, V25, P1232, DOI 10.1177/0883073809361165
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Finsterer J, 2012, SEIZURE, V22, P119
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Finsterer J, 2010, EPILEPTIC DISORD, V12, P330, DOI 10.1684/epd.2010.0338
   Frye RE, 2011, J CHILD NEUROL, V26, P782, DOI 10.1177/0883073810391531
   Furuya H, 1997, RINSHO SHINKEIGAKU, V37, P680
   Gal A, 2010, ACTA NEUROL SCAND, V122, P252, DOI 10.1111/j.1600-0404.2009.01297.x
   Gati Istvan, 2011, ACTA MYOL, V30, P188
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Glamuzina E, 2012, J INHERIT METAB DIS, V35, P459, DOI 10.1007/s10545-011-9413-6
   Gordon N, 2006, DEV MED CHILD NEUROL, V48, P1001, DOI 10.1017/S0012162206002209
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Gramstad A, 2009, EPILEPSY BEHAV, V16, P172, DOI 10.1016/j.yebeh.2009.01.014
   Grazina MM, 2007, EUR J PAEDIATR NEURO, V11, P115, DOI 10.1016/j.ejpn.2006.11.015
   Gribaa M, 2007, BRAIN, V130, P1921, DOI 10.1093/brain/awm078
   Guerriero S, 2011, MIDDLE EAST AFR J OP, V18, P67, DOI 10.4103/0974-9233.75892
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen Anna H, 2010, DUODECIM, V126, P1552
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Horvath R, 2012, J NEUROL NEUROSUR PS, V83, P174, DOI 10.1136/jnnp-2011-301258
   HOWARD RS, 1995, QJM-INT J MED, V88, P197
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10
   Kang HC, 2007, CHILD NERV SYST, V23, P1301, DOI 10.1007/s00381-007-0369-7
   Kang HC, 2006, PEDIATR NEUROL, V35, P158, DOI 10.1016/j.pediatrneurol.2006.01.012
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Keränen T, 2006, EPILEPTIC DISORD, V8, P200
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06
   Kirches E, 1999, PATHOBIOLOGY, V67, P214, DOI 10.1159/000028075
   Koga Y, 2012, BRAIN DEV-JPN, V34, P87, DOI 10.1016/j.braindev.2011.03.003
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Lee HF, 2011, PEDIATR NEUROL, V45, P169, DOI 10.1016/j.pediatrneurol.2011.04.008
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Lindberg C, 2008, ACTA NEUROL SCAND, V117, P128, DOI 10.1111/j.1600-0404.2007.00913.x
   Liu Yu-Peng, 2012, ZHONGGUO DANG DAI ER KE ZA ZHI, V14, P561
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lupashko S, 2011, CHILD NERV SYST, V27, P1321, DOI 10.1007/s00381-011-1495-9
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mayr JA, 2011, AM J HUM GENET, V89, P792, DOI 10.1016/j.ajhg.2011.11.011
   Mccoy B, 2011, EUR J PAEDIATR NEURO, V15, P558, DOI 10.1016/j.ejpn.2011.05.012
   Melberg A, 1996, ACTA NEUROL SCAND, V94, P233, DOI 10.1111/j.1600-0404.1996.tb07058.x
   Molinari F, 2009, CLIN GENET, V76, P188, DOI 10.1111/j.1399-0004.2009.01236.x
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Munakata K, 2007, MUTAT RES-FUND MOL M, V617, P119, DOI 10.1016/j.mrfmmm.2007.01.006
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Niehusmann P, 2011, EPILEPSY BEHAV, V20, P38, DOI 10.1016/j.yebeh.2010.11.008
   Nikali K, 2009, GENEREVIEWS, V0, P1993
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nolte KW, 2013, NEUROPATHOLOGY, V33, P59, DOI 10.1111/j.1440-1789.2012.01317.x
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagon, 2010, GENEREVIEWS, V0, P0
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Parikh S, 2008, PEDIATR NEUROL, V38, P191, DOI 10.1016/j.pediatrneurol.2007.10.011
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pronicka E, 2011, MED SCI MONITOR, V17, PCR203, DOI 10.12659/MSM.881716
   Pronicki M, 2010, EUR J PAEDIATR NEURO, V14, P253, DOI 10.1016/j.ejpn.2009.09.008
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Ramelli GP, 2006, J CHILD NEUROL, V21, P253, DOI 10.2310/7010.2006.00047
   Reddy GS, 2011, INDIAN J CLIN BIOCHE, V26, P312, DOI 10.1007/s12291-011-0139-x
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Rinalduzzi S, 2012, NEUROL SCI, V33, P419, DOI 10.1007/s10072-011-0755-5
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saitsu H, 2012, EPILEPSIA, V53, P1441, DOI 10.1111/j.1528-1167.2012.03548.x
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   Seaver LH, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027348
   Seo JH, 2010, BRAIN DEV-JPN, V32, P253, DOI 10.1016/j.braindev.2008.12.020
   Shrikhande DY, 2010, ITAL J PEDIATR, V36, P0, DOI 10.1186/1824-7288-36-62
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Sudo A, 2011, J LARYNGOL OTOL, V125, P1282, DOI 10.1017/S0022215111002453
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Thorns C, 1998, EXP CLIN ENDOCR DIAB, V106, P384, DOI 10.1055/s-0029-1212003
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   Toribe Yasuhisa, 2007, NO TO HATTATSU, V39, P38
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Tsao CY, 1997, CLIN ELECTROENCEPHAL, V28, P214, DOI 10.1177/155005949702800405
   Tsuji M, 2003, BRAIN DEV-JPN, V25, P245, DOI 10.1016/S0387-7604(02)00220-6
   Tuppen HAL, 2012, EUR J HUM GENET, V20, P897, DOI 10.1038/ejhg.2012.44
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   vanDomburg PHMF, 1996, BRAIN, V119, P997, DOI 10.1093/brain/119.3.997
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
   YOSHINAGA H, 1993, J CHILD NEUROL, V8, P129, DOI 10.1177/088307389300800204
   Zhao Han-Yue, 2008, YICHUAN, V30, P1557, DOI 10.3724/SP.J.1005.2008.01557
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
NR 153
TC 16
Z9 17
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD SEP 15
PY 2013
VL 128
IS 3
BP 141
EP 152
DI 10.1111/ane.12122
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA 201OY
UT WOS:000323152600004
PM 23480231
DA 2024-11-01
ER

PT J
AU Woodbridge, P
   Liang, C
   Davis, RL
   Vandebona, H
   Sue, CM
AF Woodbridge, P.
   Liang, C.
   Davis, R. L.
   Vandebona, H.
   Sue, C. M.
TI POLG mutations in Australian patients with mitochondrial disease
SO INTERNAL MEDICINE JOURNAL
LA English
DT Article
DE mitochondrial disease; POLG; DNA polymerase gamma; mitochondria; mitochondrial DNA
ID dna-polymerase-gamma; accessory subunit; ophthalmoplegia; neuropathy; depletion; defects; family
AB Background/Aim The nuclear POLG gene encodes the catalytic subunit of DNA polymerase gamma (pol), the only polymerase involved in the replication and proofreading of mitochondrial DNA. As a consequence, POLG mutations can cause disease through impaired replication of mitochondrial DNA. To date, over 150 different mutations have been identified, with a growing number of associated phenotypes described. The aim of this study was to determine the prevalence of POLG mutations in an adult population of Australian patients with mitochondrial disease, displaying symptoms commonly associated with POLG-related diseases. Methods The clinical presentations of 322 patients from a specialist adult mitochondrial disease clinic were reviewed. Nineteen exhibited a cluster of three or more predefined clinical manifestations suggestive of POLG-related disease: progressive external ophthalmoplegia, seizures and/or an abnormal electroencephalogram, neuropathy, ataxia, liver function abnormalities, migraine or dysphagia/dysarthria. Patients were screened for mutations by direct nucleotide sequencing of the coding and exon-flanking intronic regions of POLG. Results Five of the 19 patients (26%) displaying a phenotype suggestive of POLG-related disease were found to have informative POLG coding mutations (p.T851A, p.N468D, p.Y831C, p.G517V and novel p.P163S variant). Literature and analysis of these mutations revealed that two of these patients had pathogenic mutations known to cause POLG-related disease (patient #1: p.T851A and p.P163S; patient #2: p.T851A and p.N468D). Conclusions We conclude that the prevalence of pathogenic POLG mutations in our selected adult Australian cohort with suggestive clinical manifestations was 10%. A further 16% of patients had POLG variants but are unlikely to be responsible for causing their disease.
C1 [Woodbridge, P.; Liang, C.; Davis, R. L.; Vandebona, H.; Sue, C. M.] Kolling Inst Med Res, Dept Neurogenet, Sydney, NSW, Australia.
   [Woodbridge, P.; Liang, C.; Davis, R. L.; Vandebona, H.; Sue, C. M.] Univ Sydney, Sydney, NSW 2006, Australia.
   [Liang, C.; Sue, C. M.] Royal N Shore Hosp, Dept Neurol, Sydney, NSW, Australia.
C3 University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney; Royal North Shore Hospital
RP Sue, CM (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Reserve Rd, St Leonards, NSW 2065, Australia.
EM carolyn.sue@sydney.edu.au
FU Australian Mitochondrial Disease Foundation
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Barthélémy C, 2002, HUM GENET, V110, P479, DOI 10.1007/s00439-002-0708-4
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chinnery Patrick F, 2008, NEUROMUSCUL DISORD, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Schwabe MJ, 1997, PEDIATR NEUROL, V16, P337, DOI 10.1016/S0887-8994(97)00030-1
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stopinska K, 2006, ACTA BIOCHIM POL, V53, P591
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 36
TC 24
Z9 24
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-0903
EI 1445-5994
J9 INTERN MED J
JI Intern. Med. J.
PD FEB 15
PY 2013
VL 43
IS 2
BP 150
EP 156
DI 10.1111/j.1445-5994.2012.02847.x
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 090MY
UT WOS:000314984400008
PM 22647225
DA 2024-11-01
ER

PT J
AU Stringer, HAJ
   Sohi, GK
   Maguire, JA
   Côté, HCF
AF Stringer, Henry A. J.
   Sohi, Gurmeet K.
   Maguire, John A.
   Cote, Helene C. F.
TI Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Statin; Statin-induced myopathy; Mitochondrial DNA; Mitochondria; HMG-CoA reductase inhibitors; Skeletal muscle
ID high-dose simvastatin; slco1b1 polymorphism; deletion mutations; creatine-kinase; melas-syndrome; pharmacokinetics; toxicity; rhabdomyolysis; pravastatin; metabolism
AB Statins are widely used to treat hyperlipidemia and lower cardiovascular disease risk. While statins are generally well tolerated, some patients experience statin-induced myopathy (SIM). Statin treatment has been associated with mitochondrial dysfunction and mitochondrial DNA (mtDNA) depletion. In this retrospective study, skeletal muscle biopsies from patients diagnosed with SIM were studied. These were compared with biopsies from patients clinically assessed as having statin-unrelated myopathy but whose biopsy showed no or negligible pathology. For each biopsy sample, mtDNA was quantified relative to nuclear DNA (mtDNA content) by qPCR, mtDNA deletions were investigated by long-template PCR followed by gel densitometty, and mtDNA oxidative damage was quantified using a qPCR-based assay. For a subset of matched samples, mtDNA heteroplasmy and mutations were investigated by cloning/sequencing. Skeletal muscle mtDNA content was significantly lower in SIM patients (N=23, mean +/- SD, 2036 +/- 1146) than in comparators (N=24, 3220 +/- 1594), p=0.006. There was no difference in mtDNA deletion score or oxidative mtDNA damage between the two groups, and no evidence of increased mtDNA heteroplasmy or somatic mutations was detected. The significant difference in skeletal muscle mtDNA suggests that SIM or statin treatments are associated with depletion of skeletal muscle mtDNA or that patients with an underlying predisposition to SIM have lower mtDNA levels. If statins induce mtDNA depletion, this would likely reflect decreased mitochondria biogenesis and/or increased mitochondria autophagy. Further work is necessary to distinguish between the lower mtDNA as a predisposition to SIM or an effect of SIM or statin treatment. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Stringer, Henry A. J.; Sohi, Gurmeet K.; Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.
   [Maguire, John A.] Univ British Columbia, Vancouver Gen Hosp, Dept Pathol & Lab Med, Dept Anat Pathol, Vancouver, BC V5Z 4E3, Canada.
C3 University of British Columbia; University of British Columbia
RP Côté, HCF (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, G227-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.
EM hstring@interchange.ubc.ca; gurmeet.sohi@gmail.com; john.maguire@vch.ca; helene.cote@ubc.ca
FU Michael Smith Foundation; Canadian Foundation
CR Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8
   Bouitbir J, 2011, EUR HEART J, V0, P0
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Camerino GM, 2011, BIOCHEM PHARMACOL, V81, P1054, DOI 10.1016/j.bcp.2011.01.022
   CHARIOT P, 1993, AM J MED, V94, P109, DOI 10.1016/0002-9343(93)90129-D
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   de Mendoza C, 2004, AIDS REV, V6, P169
   Diaczok BJ, 2003, SOUTH MED J, V96, P318, DOI 10.1097/01.SMJ.0000061501.81880.83
   Echaniz-Laguna A, 2010, NEW ENGL J MED, V362, P564, DOI 10.1056/NEJMc0908215
   Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689
   ENGLAND JDF, 1995, AUST NZ J MED, V25, P374, DOI 10.1111/j.1445-5994.1995.tb01912.x
   Fernandez Genaro, 2011, CLEVE CLIN J MED, V78, P393, DOI 10.3949/ccjm.78a.10073
   Gambelli S, 2004, JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, V36, P85
   Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004
   Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585
   Guis S, 2006, ARTHRIT RHEUM-ARTHR, V55, P551, DOI 10.1002/art.22100
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Jacobson TA, 2008, MAYO CLIN PROC, V83, P687, DOI 10.4065/83.6.687
   Jitratkosol MHJ, 2012, AIDS, V26, P675, DOI 10.1097/QAD.0b013e32835142eb
   Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009
   Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890
   Knauer MJ, 2010, CIRC RES, V106, P297, DOI 10.1161/CIRCRESAHA.109.203596
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936
   Miller Nancy Houston, 1997, AMERICAN JOURNAL OF MEDICINE, V102, P43, DOI 10.1016/S0002-9343(97)00467-1
   Mohaupt MG, 2009, CAN MED ASSOC J, V181, PE11, DOI 10.1503/cmaj.081785
   Neale R, 2004, J CLIN PATHOL, V57, P989, DOI 10.1136/jcp.2004.015958
   Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010
   Päivä H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006
   Pasanen MK, 2007, CLIN PHARMACOL THER, V82, P726, DOI 10.1038/sj.clpt.6100220
   Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   Romaine SPR, 2010, PHARMACOGENOMICS J, V10, P1, DOI 10.1038/tpj.2009.54
   Santos Janine H, 2002, METHODS MOL BIOL, V197, P159, DOI 10.1385/1-59259-284-8:159
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   Thomas JE, 2007, EUR NEUROL, V57, P232, DOI 10.1159/000101287
   Westermeyer C, 2007, FEMS YEAST RES, V7, P436, DOI 10.1111/j.1567-1364.2006.00194.x
   Wikhe K, 2007, BIOCHEM SOC T, V35, P1529, DOI 10.1042/BST0351529
NR 37
TC 58
Z9 62
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD FEB 15
PY 2013
VL 325
IS 1-2
BP 142
EP 147
DI 10.1016/j.jns.2012.12.023
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 095GP
UT WOS:000315323000026
PM 23312852
DA 2024-11-01
ER

PT J
AU Chinnery, PF
   Hudson, G
AF Chinnery, Patrick Francis
   Hudson, Gavin
TI Mitochondrial genetics
SO BRITISH MEDICAL BULLETIN
LA English
DT Article
DE mitochondria; genetics; mitochondrial DNA; mitochondrial disease; mtDNA
ID cytochrome-c-oxidase; complex-iii deficiency; respiratory-chain disorders; progressive external ophthalmoplegia; hereditary optic neuropathy; transfer-rna mutations; large-scale deletion; dna copy number; i deficiency; lactic-acidosis
AB In the last 10 years the field of mitochondrial genetics has widened, shifting the focus from rare sporadic, metabolic disease to the effects of mitochondrial DNA (mtDNA) variation in a growing spectrum of human disease. The aim of this review is to guide the reader through some key concepts regarding mitochondria before introducing both classic and emerging mitochondrial disorders. In this article, a review of the current mitochondrial genetics literature was conducted using PubMed (). In addition, this review makes use of a growing number of publically available databases including MITOMAP, a human mitochondrial genome database (), the Human DNA polymerase Gamma Mutation Database () and PhyloTree.org (), a repository of global mtDNA variation. The disruption in cellular energy, resulting from defects in mtDNA or defects in the nuclear-encoded genes responsible for mitochondrial maintenance, manifests in a growing number of human diseases. The exact mechanisms which govern the inheritance of mtDNA are hotly debated. Although still in the early stages, the development of in vitro genetic manipulation could see an end to the inheritance of the most severe mtDNA disease.
C1 [Chinnery, Patrick Francis; Hudson, Gavin] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK
RP Hudson, G (corresponding author), Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM gavin.hudson@ncl.ac.uk
FU Wellcome Trust; MRC [MR/K000608/1] Funding Source: UKRI
CR Abu-Amero K, 2009, BR J OPHTHALMOL, V0, P0
   Achilli A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042242
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   CARVALHO MRS, 1992, HUM HERED, V42, P316, DOI 10.1159/000154089
   Casey JP, 2012, MOL GENET METAB, V106, P351, DOI 10.1016/j.ymgme.2012.04.017
   CHEN JD, 1989, HUM GENET, V82, P203, DOI 10.1007/BF00291154
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Christian B, 2009, MOL CELL, V35, P400, DOI 10.1016/j.molcel.2009.08.003
   Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003
   Gerards M, 2010, J MED GENET, V47, P507, DOI 10.1136/jmg.2009.067553
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Hammarsund M, 2001, HUM GENET, V109, P542, DOI 10.1007/s00439-001-0610-5
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Hegde ML, 2012, MECH AGEING DEV, V133, P157, DOI 10.1016/j.mad.2012.01.005
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirst Judy, 2011, BIOCHEM J, V437, Pe1, DOI 10.1042/BJ20110918
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HOWELL N, 1983, SOMAT CELL GENET, V9, P1, DOI 10.1007/BF01544045
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Lin DDM, 2003, AM J NEURORADIOL, V24, P33
   Ling MF, 1997, GENE, V197, P325, DOI 10.1016/S0378-1119(97)00279-5
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   MA JH, 1995, BBA-GENE STRUCT EXPR, V1261, P321, DOI 10.1016/0167-4781(95)00041-E
   Magner M, 2011, EUR J PAEDIATR NEURO, V15, P101, DOI 10.1016/j.ejpn.2010.10.001
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003
   McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   MITOMAP, 2000, HUM MIT GEN DAT, V0, P0
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2012, BRAIN, V135, P1695, DOI 10.1093/brain/aws102
   Phasukkijwatana N, 2010, HUM GENET, V0, P0
   Pierson TM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002325
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   Poulton J, 2012, BRIT MED J, V345, P0, DOI 10.1136/bmj.e6651
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Prokisch H, 2006, NUCLEIC ACIDS RES, V34, PD705, DOI 10.1093/nar/gkj127
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ridge PG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045134
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santoro A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012037
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674
   Thorburn DR, 2009, MOL GENET METAB, V98, P5
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Torroni A, 1996, GENETICS, V144, P1835
   Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001
   Vissing JSaM, 2002, NEW ENGL J MED, V0, P2081
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Weber K, 1997, AM J HUM GENET, V60, P373
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   WOLF A, 1954, RES PUBL ASSOC RES N, V34, P199
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
   Zvulunov A, 1998, BRIT J DERMATOL, V138, P1046
NR 167
TC 274
Z9 318
U1 1
U2 67
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
EI 1471-8391
J9 BRIT MED BULL
JI Br. Med. Bull.
PD JUN 15
PY 2013
VL 106
IS 1
BP 135
EP 159
DI 10.1093/bmb/ldt017
PG 25
WC Medicine, General & Internal
SC General & Internal Medicine
GA 160JE
UT WOS:000320114900008
PM 23704099
DA 2024-11-01
ER

PT J
AU Mukai, M
   Sugaya, K
   Yabe, I
   Goto, YI
   Yokochi, F
   Miyamoto, K
   Cai, H
   Sasaki, H
   Matsubara, S
AF Mukai, Masako
   Sugaya, Keizo
   Yabe, Ichiro
   Goto, Yu-ichi
   Yokochi, Fusako
   Miyamoto, Kazuhito
   Cai, Huaying
   Sasaki, Hidenao
   Matsubara, Shiro
TI Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a Y955C mutation in <i>POLG1</i>
SO PARKINSONISM & RELATED DISORDERS
LA English
DT Article
DE Progressive external ophthalmoplegia; Parkinsonism; POLG1; Neuromelanin imaging; Mitochondrial DNA
ID substantia-nigra; dna; neuropathology; deletions; gene
AB Background: Progressive external ophthalmoplegia (PEO) and parkinsonism can be caused by genetic mutations that affect mitochondrial DNA (mtDNA) maintenance. We characterized parkinsonism in a family with dominantly inherited PEO. Methods: We conducted clinical, histological and genetic analyses on two affected members suffering from PEO and parkinsonism, and reviewed the cases in the literature. To clarify parkinsonism related to multiple mtDNA deletions, we used 3-T neuromelanin magnetic resonance imaging (MRI) to assess signal changes in the substantia nigra (SN) and locus ceruleus (LC) in our patients, and compared the results to those observed in idiopathic Parkinson's disease (iPD) (n = 35). Results: We report the first case of a Japanese family harboring a heterozygous p.Y955C mutation in POLG1. The clinical features of parkinsonism related to the Y955C mutation in a total of 16 patients, including our two cases, are indistinguishable from iPD. However, neuromelanin MRI showed a distinct pattern in our cases compared to iPD. The neuromelanin imaging results were consistent with the neuropathological findings reported in cases of POLG1 mutations, in which neurons of the SN were profoundly affected while those in the LC were preserved. Conclusions: Our results suggest that 3-T neuromelanin MRI may be useful for differentiating POLG1 mutation-associated parkinsonism from iPD, and that POLG1 mutations may cause selective neuronal loss in the SN via a mechanism different from that of iPD. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Mukai, Masako; Sugaya, Keizo; Yokochi, Fusako; Miyamoto, Kazuhito; Matsubara, Shiro] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan.
   [Yabe, Ichiro; Cai, Huaying; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Div Mental Retardat & Birth Defect Res, Kodaira, Tokyo 187, Japan.
C3 Tokyo Metropolitan Institute for Neuroscience; Hokkaido University; National Center for Neurology & Psychiatry - Japan
RP Sugaya, K (corresponding author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.
EM keizo_sugaya@member.metro.tokyo.jp
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Elstner M, 2011, MOL BRAIN, V4, P0, DOI 10.1186/1756-6606-4-43
   Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612
   Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Ohtsuka C, 2013, NEUROSCI LETT, V541, P93, DOI 10.1016/j.neulet.2013.02.012
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Schwarz ST, 2011, MOVEMENT DISORD, V26, P1633, DOI 10.1002/mds.23722
   Shibata Eri, 2006, MAGN RESON MED SCI, V5, P197, DOI 10.2463/mrms.5.197
NR 12
TC 15
Z9 16
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8020
EI 1873-5126
J9 PARKINSONISM RELAT D
JI Parkinsonism Relat. Disord.
PD SEP 15
PY 2013
VL 19
IS 9
BP 821
EP 824
DI 10.1016/j.parkreldis.2013.04.011
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 204WH
UT WOS:000323401500009
PM 23673011
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Orngreen, MC
   Van Hall, G
   Vissing, J
AF Jeppesen, Tina D.
   Orngreen, Mette C.
   Van Hall, Gerrit
   Vissing, John
TI Lactate metabolism during exercise in patients with mitochondrial myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial myopathy; Lactate kinetics; Lactate acidosis; Premature fatigue
ID skeletal-muscle; triacylglycerol infusion; dichloroacetate; endurance; capacity; acclimatization; performance; disposal; mutation; kinetics
AB Patients with mitochondrial DNA mutations often have elevated plasma lactate at rest and during exercise, but it is unknown whether the high lactate levels are caused by a high production, an impaired oxidation or a combination. We studied lactate kinetics in 10 patients with mtDNA mutations and 10 matched healthy control subjects at rest and during cycle exercise with a combination of femoral arterio-venous differences of lactate, and lactate tracer dilution methodology. During exercise, lactate concentration and production rates were several-fold higher in patients, but despite mitochondrial dysfunction, lactate was oxidized in muscle to the same extent as in healthy control subjects. This surprisingly high ability to burn lactate in working muscle with defective mitochondria, probably relates to the variability of oxidative capacity among muscle fibers. The data suggests that lactate is not solely an indicator of impaired oxidative capacity, but an important fuel for oxidative metabolism, even in muscle with severely impaired mitochondrial function. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Jeppesen, Tina D.; Orngreen, Mette C.; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit,Sect 3342, DK-2100 Copenhagen, Denmark.
   [Van Hall, Gerrit] Univ Copenhagen, Rigshosp, Dept Biomed Sci, DK-2100 Copenhagen, Denmark.
C3 Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Sect 3342, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Tina@Dysgaard.dk
CR Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, PR899, DOI 10.1152/ajpregu.2000.279.3.R899
   Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684
   BORG G, 1970, SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE, V2, P92
   BROOKS GA, 1992, J APPL PHYSIOL, V72, P2435, DOI 10.1152/jappl.1992.72.6.2435
   CONSOLI A, 1990, J CLIN INVEST, V86, P2038, DOI 10.1172/JCI114940
   CONSOLI A, 1990, AM J PHYSIOL, V259, PE677, DOI 10.1152/ajpendo.1990.259.5.E677
   de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8
   Dengler R, 1996, MUSCLE NERVE, V19, P456, DOI 10.1002/(SICI)1097-4598(199604)19:4<456::AID-MUS5>3.0.CO;2-B
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   Finsterer J, 1998, J NEUROL SCI, V159, P176, DOI 10.1016/S0022-510X(98)00170-1
   Gladden LB, 2000, MED SCI SPORT EXER, V32, P753, DOI 10.1097/00005768-200004000-00006
   Grassi B, 2005, MED SCI SPORT EXER, V37, P1567, DOI 10.1249/01.mss.0000177472.67419.0a
   Haas Richard H, 1998, BIOFACTORS, V7, P259
   Hammans SR, 2004, MITOCHONDRIAL DISORD, V0, P49
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203
   Krustrup P, 2004, J PHYSIOL-LONDON, V559, P335, DOI 10.1113/jphysiol.2004.062232
   Lamb GD, 2006, J APPL PHYSIOL, V100, P1410, DOI 10.1152/japplphysiol.00023.2006
   LUDVIK B, 1993, PFLUG ARCH EUR J PHY, V423, P251, DOI 10.1007/BF00374403
   MAZZEO RS, 1986, J APPL PHYSIOL, V60, P232, DOI 10.1152/jappl.1986.60.1.232
   Roef MJ, 2002, AM J CLIN NUTR, V75, P228, DOI 10.1093/ajcn/75.2.228
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   van Hall G, 2003, AM J PHYSIOL-ENDOC M, V284, PE193, DOI 10.1152/ajpendo.00273.2002
   Van Hall G, 2002, AM J PHYSIOL-ENDOC M, V283, PE1203, DOI 10.1152/ajpendo.00134.2001
   van Hall G, 2001, AM J PHYSIOL-ENDOC M, V283, P1203
   van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wolfe RR, 1992, RADIOACTIVE STABLE I, V0, P0
NR 35
TC 18
Z9 18
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD AUG 15
PY 2013
VL 23
IS 8
BP 629
EP 636
DI 10.1016/j.nmd.2013.05.007
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 232QU
UT WOS:000325509900004
PM 23838278
DA 2024-11-01
ER

PT J
AU Schaffer, SW
   Jong, CJ
   Warner, D
   Ito, T
   Azuma, J
AF Schaffer, Stephen W.
   Jong, Chian Ju
   Warner, Danielle
   Ito, Takashi
   Azuma, Junichi
TI Taurine Deficiency and MELAS Are Closely Related Syndromes
SO TAURINE 8, VOL 2: NUTRITION AND METABOLISM, PROTECTIVE ROLE, AND ROLE IN REPRODUCTION, DEVELOPMENT, AND DIFFERENTIATION
LA English
DT Article; Proceedings Paper
ID stroke-like episodes; mitochondrial-dna; retinal degeneration; transporter knockout; lactic-acidosis; myocardial failure; insulin-resistance; depletion; gene; rats
AB MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) is a mitochondrial disease caused by one or more mutations of tRNA(Leu(UUR)). These mutations reduce both the aminoacylation of tRNA(Leu(UUR)) and a posttranslational modification in the wobble position of tRNA(Leu(UUR)). Both changes result in reduced transcription of mitochondria-encoded proteins; however, reduced aminoacylation affects the decoding of both UUG and UUA while the wobble defect specifically diminishes UUG decoding. Because 12 out of the 13 mitochondria-encoded proteins are more dependent on UUA decoding than UUG decoding, the aminoacylation defect should have a more profound effect on protein synthesis than the wobble defect, which more specifically alters the expression of one mitochondria-encoded protein, ND6. Taurine serves as a substrate in the formation of 5-taurinomethyluridine-tRNA(Leu(UUR)); therefore, taurine deficiency should mimic 5-taurinomethyluridine-tRNA(Leu(UUR)) deficiency. Hence, the wobble hypothesis predicts that the symptoms of MELAS mimic those of taurine deficiency, provided that the dominant defect in MELAS is wobble modification deficiency. On the other hand, if the aminoacylation defect dominates, significant differences should exist between taurine deficiency and MELAS. The present review tests this hypothesis by comparing the symptoms of MELAS and taurine deficiency.
C1 [Schaffer, Stephen W.; Jong, Chian Ju; Warner, Danielle] Univ S Alabama, Sch Med, Dept Pharmacol, Mobile, AL 36688 USA.
   [Ito, Takashi; Azuma, Junichi] Hyogo Univ Hlth Sci, Sch Pharm, Kobe, Hyogo, Japan.
C3 University of South Alabama
RP Schaffer, SW (corresponding author), Univ S Alabama, Sch Med, Dept Pharmacol, Mobile, AL 36688 USA.
EM sschaffe@jaguar1.usouthal.edu
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANDERSON PA, 1979, J ANIM SCI, V49, P1227, DOI 10.2527/jas1979.4951227x
   Arakawa K, 2010, CIRC J, V74, P2702, DOI 10.1253/circj.CJ-10-0044
   AZUMA J, 1983, CURR THER RES CLIN E, V34, P543
   BAGLEY PJ, 1995, J NUTR, V125, P933
   BLONDEL O, 1990, METABOLISM, V39, P787, DOI 10.1016/0026-0495(90)90120-2
   Chang KJ, 2000, ADV EXP MED BIOL, V483, P571
   Chiang Lin-Mei, 1995, JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, V94, P42
   DAVIES WE, 1994, ADV EXP MED BIOL, V359, P393
   GAULL GE, 1986, J AM COLL NUTR, V5, P121
   GEGGEL HS, 1985, NEW ENGL J MED, V312, P142, DOI 10.1056/NEJM198501173120302
   Golubnitschaja O, 2003, BIOCHEM PHARMACOL, V66, P511, DOI 10.1016/S0006-2952(03)00285-5
   Han XB, 2012, AMINO ACIDS, V43, P2249, DOI 10.1007/s00726-012-1314-y
   Hansen SH, 2001, DIABETES-METAB RES, V17, P330, DOI 10.1002/dmrr.229
   Harris NG, 1997, J NEUROCHEM, V68, P305
   HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364
   HAYES KC, 1980, J NUTR, V110, P2058, DOI 10.1093/jn/110.10.2058
   Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje
   Hilton G, 1995, J NEUROSCI NURS, V27, P278
   Hirano M, 2002, INTERNAL MED, V41, P113, DOI 10.2169/internalmedicine.41.113
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   IMAKI H, 1987, J NEUROSCI RES, V18, P602, DOI 10.1002/jnr.490180414
   Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001
   JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424
   Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   LAKE N, 1988, VISION RES, V28, P1071, DOI 10.1016/0042-6989(88)90133-2
   LAKE N, 1987, LIFE SCI, V40, P997, DOI 10.1016/0024-3205(87)90322-5
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Maassen JA, 2006, BIOCHEM SOC T, V34, P819, DOI 10.1042/BST0340819
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Mozaffari M, 2006, KIDNEY INT, V70, P329, DOI 10.1038/sj.ki.5001503
   MOZAFFARI MS, 1986, BIOCHEM PHARMACOL, V35, P985, DOI 10.1016/0006-2952(86)90087-0
   NOVOTNY MJ, 1994, CAN J VET RES, V58, P6
   NOVOTNY MJ, 1991, AM J PHYSIOL, V261, PH121, DOI 10.1152/ajpheart.1991.261.1.H121
   Oermann E, 2005, ANAT EMBRYOL, V210, P363, DOI 10.1007/s00429-005-0024-6
   PASANTESMORALES H, 1987, NEUROPHARMACOLOGY, V26, P1721, DOI 10.1016/0028-3908(87)90123-7
   PION PD, 1987, SCIENCE, V237, P764, DOI 10.1126/science.3616607
   PION PD, 1992, J AM VET MED ASSOC, V201, P267
   Roysommuti S, 2009, ADV EXP MED BIOL, V643, P135, DOI 10.1007/978-0-387-75681-3_14
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   SCHAFFER SW, 1993, DIABETOLOGIA, V36, P195, DOI 10.1007/BF00399949
   SCHMIDT SY, 1977, INVEST OPHTH VIS SCI, V16, P673
   Sergeeva OA, 2007, J PHYSIOL-LONDON, V585, P539, DOI 10.1113/jphysiol.2007.141432
   Silbert L, 1996, J STROKE CEREBROVASC DIS, V6, P67, DOI 10.1016/S1052-3057(96)80005-X
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   TRACHTMAN H, 1992, AM J PHYSIOL, V262, PF117, DOI 10.1152/ajprenal.1992.262.1.F117
   TRACHTMAN H, 1988, PEDIATR RES, V23, P35, DOI 10.1203/00006450-198801000-00008
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   TYSON JE, 1989, PEDIATRICS, V83, P406
   VALLECALLESANDOVAL MH, 1991, INT J DEV NEUROSCI, V9, P571, DOI 10.1016/0736-5748(91)90018-H
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VINTON NE, 1990, AM J CLIN NUTR, V52, P895, DOI 10.1093/ajcn/52.5.895
   VIONNET N, 1993, LANCET, V342, P1429, DOI 10.1016/0140-6736(93)92792-R
   Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje
   Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje
   Weisz C, 2009, NATURE, V461, P1126, DOI 10.1038/nature08487
   WEN GY, 1979, INVEST OPHTH VIS SCI, V18, P1200
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yatabe Yoshihisa, 2003, J ORTHOP SCI, V8, P415, DOI 10.1007/s10776-002-0636-1
NR 66
TC 13
Z9 14
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0065-2598
EI 2214-8019
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PD JUN 15
PY 2013
VL 776
IS 
BP 153
EP 165
DI 10.1007/978-1-4614-6093-0_16
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Medicine, Research & Experimental; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Research & Experimental Medicine; Nutrition & Dietetics
GA BA5XW
UT WOS:000337057500016
PM 23392880
DA 2024-11-01
ER

PT J
AU Zhang, SB
   Maguire, D
   Zhang, M
   Zhang, ZH
   Zhang, A
   Yin, LJ
   Zhang, LR
   Huang, LQ
   Vidyasagar, S
   Swarts, S
   Okunieff, P
AF Zhang, Steven B.
   Maguire, David
   Zhang, Mei
   Zhang, Zhenhuan
   Zhang, Amy
   Yin, Liangjie
   Zhang, Lurong
   Huang, Luquiang
   Vidyasagar, Sadasivan
   Swarts, Steven
   Okunieff, Paul
TI The Murine Common Deletion: Mitochondrial DNA 3,860-bp Deletion after Irradiation
SO RADIATION RESEARCH
LA English
DT Article
ID human skeletal-muscle; copy number; oxidative stress; bp deletion; cancer; age; cells; radiation; increase; disease
AB This study demonstrates that mice, similar to humans, have a common mitochondrial DNA deletion (3,860 bp) that encodes 5 transfer RNA genes and 5 polypeptide genes that is related to aging, tissue type and radiotoxicity. Our research indicates that the deletion ratio in the liver was significantly higher than in the brain and gut tissues of 8-month-old mice, as compared to 8-week-old mice. Our results also demonstrate that tissue type, oxidative metabolic capacity and radiosensitivity influence the 3,860-bp deletion level. Therefore, this 3,860-bp deletion content may serve as a biomarker of aging and oxidative damage in mice. (C) 2013 by Radiation Research Society
C1 [Zhang, Steven B.; Maguire, David; Zhang, Mei; Zhang, Zhenhuan; Zhang, Amy; Yin, Liangjie; Zhang, Lurong; Huang, Luquiang; Vidyasagar, Sadasivan; Swarts, Steven; Okunieff, Paul] Univ Florida, Dept Radiat Oncol, Gainesville, FL 32610 USA.
C3 State University System of Florida; University of Florida
RP Zhang, SB (corresponding author), Univ Florida, Canc & Genet Res Complex,2033 Mowry Rd,POB 103633, Gainesville, FL 32610 USA.
EM bszhang@ufl.edu
CR Anderson RF, 2001, CARCINOGENESIS, V22, P1189, DOI 10.1093/carcin/22.8.1189
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bianchini F, 2001, CARCINOGENESIS, V22, P885, DOI 10.1093/carcin/22.6.885
   Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767
   BURNET NG, 1994, RADIOTHER ONCOL, V33, P228, DOI 10.1016/0167-8140(94)90358-1
   BYRNE E, 1991, AUST NZ J MED, V21, P837, DOI 10.1111/j.1445-5994.1991.tb01404.x
   Carew JS, 2004, LEUKEMIA, V18, P1934, DOI 10.1038/sj.leu.2403545
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Fang HZ, 2010, BMC CANCER, V10, P0, DOI 10.1186/1471-2407-10-421
   FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010
   Kubota N, 1997, RADIAT RES, V148, P395, DOI 10.2307/3579525
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342
   Lott MT, 2013, MITOMAP: A HUMAN MITOCHONDRIAL GENOME DATABASE, V0, P0
   Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826
   Romano Antonino D, 2010, J NEPHROL, V23 Suppl 15, P0
   SCOTTO AW, 1983, ARCH BIOCHEM BIOPHYS, V222, P150, DOI 10.1016/0003-9861(83)90512-X
   Shen LJ, 2010, ANN NY ACAD SCI, V1201, P26, DOI 10.1111/j.1749-6632.2010.05635.x
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Soong N W, 1996, METHODS ENZYMOL, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F
   Suliman HB, 2002, FREE RADICAL BIO MED, V32, P246, DOI 10.1016/S0891-5849(01)00797-3
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Zhang HS, 2009, ADV EXP MED BIOL, V645, P43, DOI 10.1007/978-0-387-85998-9_7
   Zhang L, 2010, BRIT J RADIOL, V83, P694, DOI 10.1259/bjr/49886569
   Zhang SB, 2012, ADV EXP MED BIOL, V737, P139, DOI 10.1007/978-1-4614-1566-4_21
NR 52
TC 9
Z9 11
U1 0
U2 3
PU RADIATION RESEARCH SOC
PI LAWRENCE
PA 810 E TENTH STREET, LAWRENCE, KS 66044 USA
SN 0033-7587
EI 1938-5404
J9 RADIAT RES
JI Radiat. Res.
PD OCT 15
PY 2013
VL 180
IS 4
BP 407
EP 413
DI 10.1667/RR3373.1
PG 7
WC Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging
SC Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging
GA AA3KS
UT WOS:000330991900009
PM 24059680
DA 2024-11-01
ER

PT J
AU Sanaker, PS
   Bindoff, LA
AF Sanaker, Petter Schandl
   Bindoff, Laurence A.
TI MT-ND5 Mutation Causing Exercise Intolerance Displays Intercellular Heteroplasmy and Rapid Shifts Between Generations
SO HUMAN MUTATION
LA English
DT Article
DE mitochondrial DNA; mitochondrial myopathy; inheritance; heteroplasmy
ID red fibers merrf; mitochondrial-dna; skeletal-muscle; prenatal-diagnosis; mtdna; gene; expression; myopathy; segregation; deletions
AB We studied the inheritance and cellular segregation of a maternally inherited, heteroplasmic MT-ND5 mutation, m.13271T>C, previously shown to cause only exercise intolerance despite being present in multiple tissues. The mutation was present at low levels in early passage, bulk muscle culture, but on subcloning, only homoplasmic clones were found. Studies of transmission showed that the mutation expanded from very low levels in the patient's mother to higher levels in the patient, particularly skeletal muscle, but was not found in the placenta and umbilical cord blood of her child. Our study suggests that the m.13271T>C is either already strictly segregated (intercellular heteroplasmy), or moves rapidly to this state in cultured cells. Transmission studies suggest that intercellular heteroplasmy may also be present in the patient's germline. Although rapid shifts in heteroplasmic mitochondrial DNA mutations reflect a bottleneck in the female germline, complete segregation will accentuate the effects of this and further complicate genetic counseling.
C1 [Sanaker, Petter Schandl; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Sanaker, Petter Schandl; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen
RP Bindoff, LA (corresponding author), Univ Bergen, Haukeland Univ Hosp, IKM, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@helse-bergen.no
FU Research Council of Norway; Western Norway Regional Health Authority
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 2011, MITOMAP HUM MIT GEN, V0, P0
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BOUZIDI MF, 1993, NEUROMUSCULAR DISORD, V3, P599
   Chinnery PF, 2000, GENE REV, V0, P0
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Horváth R, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.015024
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Weber K, 1997, AM J HUM GENET, V60, P373
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
NR 23
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 
J9 HUM MUTAT
JI Hum. Mutat.
PD FEB 15
PY 2013
VL 34
IS 2
BP 292
EP 295
DI 10.1002/humu.22238
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 083PP
UT WOS:000314477700005
PM 23065728
DA 2024-11-01
ER

PT J
AU D'Aco, KE
   Manno, M
   Clarke, C
   Ganesh, J
   Meyers, KEC
   Sondheimer, N
AF D'Aco, Kristin E.
   Manno, Megan
   Clarke, Colleen
   Ganesh, Jaya
   Meyers, Kevin E. C.
   Sondheimer, Neal
TI Mitochondrial tRNA<SUP>Phe</SUP> mutation as a cause of end-stage renal disease in childhood
SO PEDIATRIC NEPHROLOGY
LA English
DT Article
DE Mitochondrial DNA; Mitochondrial tRNA; Mitochondrial disease; Heteroplasmy
ID lactic-acidosis; encephalopathy
AB We identified a mitochondrial tRNA mutation (m.586 G > A) in a patient with renal failure and symptoms consistent with a mitochondrial cytopathy. This mutation was of unclear significance due to the absence of consistent reports of linkage to specific disease phenotypes and any data pertaining to its effects on mitochondrial function. A 16-month-old girl with failure-to-thrive, developmental regression, persistent lactic acidosis, hypotonia, gastrointestinal dysmotility, adrenal insufficiency, and hematologic abnormalities developed hypertension and renal impairment with chronic tubulointerstitial fibrosis, progressing to renal failure with the need for peritoneal dialysis. Evaluation of her muscle and blood led to the identification of a mutation of the mitochondrial tRNA for phenylalanine, m.586 G > A. The m.586 G > A mutation is pathogenic and a cause of end-stage renal disease in childhood. The mutation interferes with the stability of tRNA(Phe) and affects the translation of mitochondrial proteins and the stability of the electron transport chain.
C1 [D'Aco, Kristin E.] Univ Rochester, Div Genet, Dept Pediat, Sch Med & Dent, Rochester, NY 14623 USA.
   [Manno, Megan; Clarke, Colleen; Ganesh, Jaya; Sondheimer, Neal] Childrens Hosp Philadelphia, Sect Biochem Genet, Philadelphia, PA 19104 USA.
   [Meyers, Kevin E. C.] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA.
   [Ganesh, Jaya; Meyers, Kevin E. C.; Sondheimer, Neal] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.
C3 University of Rochester; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania
RP Sondheimer, N (corresponding author), Childrens Hosp Philadelphia, Sect Biochem Genet, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM sondheimer@email.chop.edu
FU NIH [HD58022]
CR Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Au KM, 2007, PEDIATR NEPHROL, V22, P136, DOI 10.1007/s00467-006-0288-y
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Finsterer J, 2006, NETH J MED, V64, P61
   Fujii H, 2008, CLIN EXP NEPHROL, V12, P159, DOI 10.1007/s10157-007-0022-5
   Glatz C, 2011, MITOCHONDRION, V11, P615, DOI 10.1016/j.mito.2011.04.003
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Massin P, 2008, DIABETOLOGIA, V51, P1664, DOI 10.1007/s00125-008-1073-1
   Piccoli GB, 2012, BMC NEPHROL, V13, P0, DOI 10.1186/1471-2369-13-9
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Young TM, 2010, ARCH NEUROL-CHICAGO, V67, P1399, DOI 10.1001/archneurol.2010.283
NR 14
TC 27
Z9 30
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD MAR 15
PY 2013
VL 28
IS 3
BP 515
EP 519
DI 10.1007/s00467-012-2354-y
PG 5
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA 077OW
UT WOS:000314038000021
PM 23135609
DA 2024-11-01
ER

PT J
AU Zhou, XS
   Kannisto, K
   Curbo, S
   von Döbeln, U
   Hultenby, K
   Isetun, S
   Gåfvels, M
   Karlsson, A
AF Zhou, Xiaoshan
   Kannisto, Kristina
   Curbo, Sophie
   von Dobeln, Ulrika
   Hultenby, Kjell
   Isetun, Sindra
   Gafvels, Mats
   Karlsson, Anna
TI Thymidine Kinase 2 Deficiency-Induced mtDNA Depletion in Mouse Liver Leads to Defect β-Oxidation
SO PLOS ONE
LA English
DT Article
ID mitochondrial-dna depletion; tandem mass-spectrometry; deoxyguanosine kinase; tk2 deficiency; myopathy; mutations; gene; mice; compensation; metabolism
AB Thymidine kinase 2 (TK2) deficiency in humans causes mitochondrial DNA (mtDNA) depletion syndrome. To study the molecular mechanisms underlying the disease and search for treatment options, we previously generated and described a TK2 deficient mouse strain (TK2(-/-)) that progressively loses its mtDNA. The TK2(-/-) mouse model displays symptoms similar to humans harboring TK2 deficient infantile fatal encephalomyopathy. Here, we have studied the TK2(-/-) mouse model to clarify the pathological role of progressive mtDNA depletion in liver for the severe outcome of TK2 deficiency. We observed that a gradual depletion of mtDNA in the liver of the TK2(-/-) mice was accompanied by increasingly hypertrophic mitochondria and accumulation of fat vesicles in the liver cells. The levels of cholesterol and nonesterified fatty acids were elevated and there was accumulation of long chain acylcarnitines in plasma of the TK2(-/-) mice. In mice with hepatic mtDNA levels below 20%, the blood sugar and the ketone levels dropped. These mice also exhibited reduced mitochondrial beta-oxidation due to decreased transport of long chain acylcarnitines into the mitochondria. The gradual loss of mtDNA in the liver of the TK2(-/-) mice causes impaired mitochondrial function that leads to defect beta-oxidation and, as a result, insufficient production of ketone bodies and glucose. This study provides insight into the mechanism of encephalomyopathy caused by TK2 deficiency-induced mtDNA depletion that may be used to explore novel therapeutic strategies.
C1 [Zhou, Xiaoshan; Curbo, Sophie; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol F68, Huddinge, Sweden.
   [Kannisto, Kristina; Gafvels, Mats] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Chem, Huddinge, Sweden.
   [von Dobeln, Ulrika; Isetun, Sindra] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Metab Dis, Huddinge, Sweden.
   [Hultenby, Kjell] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Res Ctr, Huddinge, Sweden.
   [Gafvels, Mats] Lund Univ, Dept Lab Med, Div Clin Chem, Lund, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University
RP Curbo, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol F68, Huddinge, Sweden.
EM Sophie.Curbo@ki.se
FU Swedish Research Council [2010-2828]; Medical Faculty of Karolinska Institutet
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178
   Chace DH, 2001, CLIN CHEM, V47, P1166
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Ghoshal AK, 2005, CLIN CHIM ACTA, V358, P104, DOI 10.1016/j.cccn.2005.02.011
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Müller-Höcker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y
   Rao JN, 2011, J BIOL CHEM, V286, P42545, DOI 10.1074/jbc.M111.306951
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada Ann, 2009, BIOCHEM J, V422, Pe3, DOI 10.1042/BJ20091194
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Villarroya J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029691
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Weibel E, 1979, STEREOLOGICAL METHOD, V1, P91
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 39
TC 11
Z9 13
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2013
VL 8
IS 3
BP 
EP 
DI 10.1371/journal.pone.0058843
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 136BN
UT WOS:000318334500129
PM 23505564
DA 2024-11-01
ER

PT J
AU Campbell, GR
   Pallack, ZT
   Spector, SA
AF Campbell, Grant R.
   Pallack, Zachary T.
   Spector, Stephen A.
TI Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion
SO AIDS
LA English
DT Article
DE HIV; mitochondrial toxicity; mother-to-child transmission; nucleoside reverse transcriptase inhibitor; paediatrics; skeletal muscle; vitamin D
ID 1,25-dihydroxyvitamin d-3; disease progression; hiv; deficiency; association; infection; toxicity; autophagy; receptor; impact
AB Objective: To evaluate the impact of the active metabolite of vitamin D, 1 alpha, 25-dihydroxycholecalciferol (1,25D3), on nucleoside reverse transcriptase inhibitor (NRTI) induced mitochondrial DNA (mtDNA) depletion in human skeletal muscle myoblasts and myotubes. Design: mtDNA was quantified in human skeletal muscle myoblasts and myotubes following 1,25D3 and NRTI treatment using real-time PCR. Methods: Human skeletal muscle myoblasts and myotubes were treated with didanosine (ddI), stavudine (d4T), zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) alone or in combination either in the presence or absence of 1,25D3 for 5 days. Cells were harvested, DNA extracted and mtDNA quantified. Results: ddI and ddI-d4T significantly decreased both myoblast and myotube mtDNA in the absence of 1,25D3 compared with untreated controls (P <= 0.029). In addition, the ZDV-3TC combination resulted in a 47% decrease in myotube mtDNA (P = 0.005). 1,25D3 increased myotube mtDNA levels in ddI, ZDV, 3TC, ABC, ddI-d4T, d4T-3TC, ZDV-3TC, ZDV-ABC and ZDV-3TC-ABC-containing regimens and myoblast mtDNA levels in ddI, d4T, ZDV, 3TC, ddI-d4T, ZDV-3TC and ZDV-ABC-containing regimens. Of note, 1,25D3 protected against myotube mtDNA depletion following ZDV-3TC treatment, rendering them similar to 1,25D3 untreated controls (P = 0.62), and increased both myotube and myoblast mtDNA two to three-fold in ddI-containing regimens (P < 0.05). Conclusion: 1,25D3 confers a protective effect against NRTI-induced mitochondrial toxicity in skeletal muscle myoblasts and myotubes. These findings support a protective role for vitamin D in preventing mitochondrial toxicity and suggest that supplemental vitamin D may protect against NRTI-associated mitochondrial toxicity. (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
C1 [Campbell, Grant R.; Pallack, Zachary T.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA.
   [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA USA.
C3 University of California System; University of California San Diego; Rady Childrens Hospital San Diego
RP Spector, SA (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM saspector@ucsd.edu
FU National Institute of Allergy and Infectious Diseases (NIAID), NIH [AI084573]; International Maternal Perinatal Adolescent AIDS Clinical Trials (IMPAACT) Network; NIAID [U01 AI068632]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH) [AI068632]; Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases [5 U01 AI41110]; Pediatric AIDS Clinical Trials Group (PACTG); IMPAACT Group [U01 AI068616]; NICHD [N01-DK-9-001/HHSN267200800001C]
CR Alyaarubi S, 2005, J PEDIATR ENDOCR MET, V18, P719
   Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844
   Campbell GR, 2012, PLOS PATHOG, V8, P0, DOI 10.1371/journal.ppat.1003017
   Campbell GR, 2012, PLOS PATHOG, V8, P0, DOI 10.1371/journal.ppat.1002689
   Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110
   Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Dardenne O, 2003, J BONE MINER RES, V18, P637, DOI 10.1359/jbmr.2003.18.4.637
   Divi RL, 2007, TOXICOL SCI, V99, P203, DOI 10.1093/toxsci/kfm143
   El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436
   Faridi MMA, 2010, INDIAN PEDIATR, V47, P624, DOI 10.1007/s13312-010-0121-3
   Feeney ER, 2010, CURR PHARM DESIGN, V16, P3339, DOI 10.2174/138161210793563482
   Fluss J, 2014, BRAIN DEV-JPN, V36, P84, DOI 10.1016/j.braindev.2012.11.014
   Foo LH, 2009, J NUTR, V139, P1002, DOI 10.3945/jn.108.102053
   Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012
   Haug CJ, 1998, J CLIN ENDOCR METAB, V83, P3832, DOI 10.1210/jc.83.11.3832
   Hazell TJ, 2012, NUTR REV, V70, P520, DOI 10.1111/j.1753-4887.2012.00510.x
   Lake Jordan E, 2011, CURR HIV/AIDS REP, V8, P133, DOI 10.1007/s11904-011-0082-8
   Mehta S, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0008770
   Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699
   Mueller NJ, 2010, AIDS, V24, P1127, DOI 10.1097/QAD.0b013e328337b161
   PAUZA CD, 1993, J LEUKOCYTE BIOL, V53, P157, DOI 10.1002/jlb.53.2.157
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Saitoh A, 2008, ANTIMICROB AGENTS CH, V52, P2825, DOI 10.1128/AAC.00434-08
   Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x
   SIMPSON RU, 1985, J BIOL CHEM, V260, P8882
   Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7
   Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Wang YJ, 2011, ENDOCRINOLOGY, V152, P354, DOI 10.1210/en.2010-1109
   Ward KA, 2010, J CLIN ENDOCR METAB, V95, P4643, DOI 10.1210/jc.2009-2725
   Ward KA, 2009, J CLIN ENDOCR METAB, V94, P559, DOI 10.1210/jc.2008-1284
NR 33
TC 7
Z9 7
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JUN 1
PY 2013
VL 27
IS 9
BP 1397
EP 1401
DI 10.1097/QAD.0b013e32836010dd
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 301FV
UT WOS:000330519100005
PM 23435299
DA 2024-11-01
ER

PT J
AU Milenkovic, D
   Matic, S
   Kühl, I
   Ruzzenente, B
   Freyer, C
   Jemt, E
   Park, CB
   Falkenberg, M
   Larsson, NG
AF Milenkovic, Dusanka
   Matic, Stanka
   Kuhl, Inge
   Ruzzenente, Benedetta
   Freyer, Christoph
   Jemt, Elisabeth
   Park, Chan Bae
   Falkenberg, Maria
   Larsson, Nils-Goran
TI TWINKLE is an essential mitochondrial helicase required for synthesis of nascent D-loop strands and complete mtDNA replication
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; transcription factor-a; dna helicase; rna-polymerase; copy number; mutations; maintenance; expression; deletions; nucleoids
AB Replication of the mammalian mitochondrial DNA (mtDNA) is dependent on the minimal replisome, consisting of the heterotrimeric mtDNA polymerase (POLG), the hexameric DNA helicase TWINKLE and the tetrameric single-stranded DNA-binding protein (mtSSB). TWINKLE has been shown to unwind DNA during the replication process and many disease-causing mutations have been mapped to its gene. Patients carrying Twinkle mutations develop multiple deletions of mtDNA, deficient respiratory chain function and neuromuscular symptoms. Despite its importance in human disease, it has been unclear whether TWINKLE is the only replicative DNA helicase in mammalian mitochondria. Furthermore, a substantial portion of mtDNA replication events is prematurely terminated at the end of mitochondrial control region (D-loop) and it is unknown whether TWINKLE also has a role in this abortive replication. Here, we present a conditional mouse knockout for Twinkle and demonstrate that TWINKLE is essential for mouse embryonic development and thus is the only replicative DNA helicase in mammalian mitochondria. Conditional knockout of Twinkle results in severe and rapid mtDNA depletion in heart and skeletal muscle. No replication intermediates or deleted mtDNA molecules are observed after Twinkle knockout, suggesting that TWINKLE once loaded is very processive. We also demonstrate that TWINKLE is essential for nascent H-strand synthesis in the D-loop, thus showing that there is no separate DNA helicase responsible for replication of this region. Our data thus suggest that the relative levels of abortive D-loop synthesis versus complete mtDNA replication are regulated and may provide a mechanism to control progression to complete mtDNA replication.
C1 [Milenkovic, Dusanka; Matic, Stanka; Kuhl, Inge; Ruzzenente, Benedetta; Park, Chan Bae; Falkenberg, Maria; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
   [Freyer, Christoph; Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   [Jemt, Elisabeth; Falkenberg, Maria] Univ Gothenburg, Dept Biochem & Cell Biol, Gothenburg, Sweden.
   [Park, Chan Bae] Ajou Univ, Inst Med Sci, Sch Med, Suwon 443721, South Korea.
C3 Max Planck Society; Karolinska Institutet; University of Gothenburg; Ajou University
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Robert Koch Str 21, D-50931 Cologne, Germany.
EM larsson@age.mpg.de
FU European Research Council; Swedish Research Council; Swedish Cancer Foundation; Max-Planck Society
CR Bratic A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002324
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Goffart S, 2009, METHODS MOL BIOL, V554, P103, DOI 10.1007/978-1-59745-521-3_7
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Liu BY, 2009, MOL CELL, V35, P490, DOI 10.1016/j.molcel.2009.07.004
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Polosa PL, 2005, NUCLEIC ACIDS RES, V33, P3812, DOI 10.1093/nar/gki693
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Sanchez-Martinez A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043954
   Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   TERSCHEGGET J, 1971, BIOCHIM BIOPHYS ACTA, V254, P1
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wanrooij S, 2012, EMBO REP, V0, P0, DOI DOI 10.1038/embor.2012.161
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
NR 50
TC 118
Z9 136
U1 2
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2013
VL 22
IS 10
BP 1983
EP 1993
DI 10.1093/hmg/ddt051
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 139CL
UT WOS:000318559000007
PM 23393161
DA 2024-11-01
ER

PT J
AU Nesbitt, V
   Pitceathly, RDS
   Turnbull, DM
   Taylor, RW
   Sweeney, MG
   Mudanohwo, EE
   Rahman, S
   Hanna, MG
   McFarland, R
AF Nesbitt, Victoria
   Pitceathly, Robert D. S.
   Turnbull, Doug M.
   Taylor, Robert W.
   Sweeney, Mary G.
   Mudanohwo, Ese E.
   Rahman, Shamima
   Hanna, Michael G.
   McFarland, Robert
TI The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A&gt;G mutation-implications for diagnosis and management
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID dna mutations; melas; population; myopathy
AB Background Population-based studies suggest the m.3243A>G mutation in MTTL1 is the most common disease-causing mtDNA mutation, with a carrier rate of 1 in 400 people. The m.3243A>G mutation is associated with several clinical syndromes including mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS), maternally inherited deafness and diabetes (MIDD) and progressive external ophthalmoplegia (PEO). Many patients affected by this mutation exhibit a clinical phenotype that does not fall within accepted criteria for the currently recognised classical mitochondria! syndromes. Methods We have defined the phenotypic spectrum associated with the m.3243A>G mtDNA mutation in 129 patients, from 83 unrelated families, recruited to the Mitochondria! Disease Patient Cohort Study UK. Results 10% of patients exhibited a classical MELAS phenotype, 30% had MIDD, 6% MELAS/MIDD, 2% MELAS/chronic PEO (CPEO) and 5% MIDD/CPEO overlap syndromes. 6% had PEO and other features of mitochondrial disease not consistent with another recognised syndrome. Isolated sensorineural hearing loss occurred in 3%. 28% of patients demonstrated a panoply of clinical features, which were not consistent with any of the classical syndromes associated with the m.3243A>G mutation. 9% of individuals harbouring the mutation were clinically asymptomatic. Conclusion Following this study we propose guidelines for screening and for the management of confirmed cases.
C1 [Nesbitt, Victoria; Turnbull, Doug M.; Taylor, Robert W.; McFarland, Robert] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Pitceathly, Robert D. S.; Rahman, Shamima; Hanna, Michael G.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Pitceathly, Robert D. S.; Rahman, Shamima; Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Sweeney, Mary G.; Mudanohwo, Ese E.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
C3 Newcastle University - UK; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP McFarland, R (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
FU Medical Research Council Centre for Translational Research in Neuromuscular Diseases [RES/0211/7552]; MRC [MR/K000608/1, G0700718, G0800674] Funding Source: UKRI
CR Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
NR 10
TC 156
Z9 166
U1 1
U2 17
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD AUG 15
PY 2013
VL 84
IS 8
BP 936
EP 938
DI 10.1136/jnnp-2012-303528
PG 3
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA 292NP
UT WOS:000329909200024
PM 23355809
DA 2024-11-01
ER

PT J
AU Ishiyama, A
   Komaki, H
   Saito, T
   Saito, Y
   Nakagawa, E
   Sugai, K
   Itagaki, Y
   Matsuzaki, K
   Nakura, M
   Nishino, I
   Goto, Y
   Sasaki, M
AF Ishiyama, Akihiko
   Komaki, Hirofumi
   Saito, Takashi
   Saito, Yoshiaki
   Nakagawa, Eiji
   Sugai, Kenji
   Itagaki, Yusuke
   Matsuzaki, Koji
   Nakura, Michiaki
   Nishino, Ichizo
   Goto, Yu-ichi
   Sasaki, Masayuki
TI Unusual exocrine complication of pancreatitis in mitochondrial disease
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Mitochondrial disease; Pancreatitis; CPEO; MELAS
ID progressive external ophthalmoplegia; ragged-red fibers; lactic-acidosis; recurrent pancreatitis; trna(leu(uur)) gene; tissue distribution; diabetes-mellitus; a3243g mutation; episodes melas; dna
AB No association between mitochondrial disease and pancreatitis has yet been established, although diabetes mellitus and diseases caused by exocrine insufficiency, such as Pearson syndrome, are the commonest pancreatic complications of mitochondrial diseases. Here, we report 2 cases of mitochondrial disease complicated by pancreatitis as an unusual pancreatic exocrine manifestation. One patient was a 10-year-old girl with mild retardation of psychomotor development who had experienced recurrent pancreatitis since the age of 4 years. Chronic progressive external ophthalmoplegia (CPEO) due to m.8344A>G mutation was diagnosed when the patient was 10 years old. The other patient was a 28-year-old woman who was diagnosed with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) due to m.3243A>G mutation at 10 years of age. She had experienced regular recurrent vomiting since the age of 16 and suffered an episode of critical pancreatitis at 23 years. In both cases, no possible etiological, morphological, or genetic factors for pancreatitis were identified, including anomalous pancreaticobiliary duct. A combination therapy of the standard treatment for chronic pancreatitis and supportive therapy for mitochondrial energy production may be beneficial to prevent the recurrence of acute pancreatitis complicating mitochondrial diseases. The pathophysiological mechanism of pancreatitis in mitochondrial disease has not been adequately established; however, our observations suggest that pancreatitis should be included in the list of pancreatic complications of mitochondrial disease. (C) 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Ishiyama, Akihiko; Komaki, Hirofumi; Saito, Takashi; Saito, Yoshiaki; Nakagawa, Eiji; Sugai, Kenji; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Child Neurol, Kodaira, Tokyo 1878551, Japan.
   [Itagaki, Yusuke; Matsuzaki, Koji] Suita Municipal Hosp, Dept Pediat, Osaka, Japan.
   [Nakura, Michiaki] Japanese Red Cross Mito Hosp, Dept Pediat, Ibaraki, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878551, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878551, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Komaki, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Child Neurol, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.
EM komakih@ncnp.go.jp
FU Ministry of Health, Labour and Welfare of Japan [24-Y7, 23-6]
CR Abe K, 1999, J NEUROL SCI, V162, P65, DOI 10.1016/S0022-510X(98)00296-2
   Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1
   Chang YJ, 2011, ACTA PAEDIATR, V100, P740, DOI 10.1111/j.1651-2227.2011.02158.x
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   CHINNERY PF, 1999, LANCET S1, V354, P17
   Debray FG, 2006, AM J MED GENET A, V140A, P2330, DOI 10.1002/ajmg.a.31457
   DOUGHERTY FE, 1994, J PEDIATR-US, V125, P758, DOI 10.1016/S0022-3476(94)70073-7
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Hom XB, 2004, MITOCHONDRION, V4, P601
   KAHLER SG, 1994, J PEDIATR-US, V124, P239, DOI 10.1016/S0022-3476(94)70311-6
   KATO S, 1990, J PEDIATR GASTR NUTR, V11, P549, DOI 10.1097/00005176-199011000-00018
   Kishnani PS, 1996, EUR J PEDIATR, V155, P898
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lal A, 2010, PEDIATR SURG INT, V26, P1193, DOI 10.1007/s00383-010-2684-4
   Maassen JA, 2002, AM J MED GENET, V115, P66, DOI 10.1002/ajmg.10346
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   Mukheriee R, 2008, CELL CALCIUM, V44, P14, DOI 10.1016/j.ceca.2007.11.013
   Oexle K, 1996, EXP CLIN ENDOCR DIAB, V104, P212, DOI 10.1055/s-0029-1211445
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Remes AM, 2002, NEUROLOGY, V59, P1275, DOI 10.1212/WNL.59.8.1275
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   TANNO Y, 1993, NEUROLOGY, V43, P1198, DOI 10.1212/WNL.43.6.1198
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Tsai K, 1998, GUT, V42, P850, DOI 10.1136/gut.42.6.850
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
NR 27
TC 5
Z9 6
U1 0
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 
J9 BRAIN DEV-JPN
JI Brain Dev.
PD AUG 15
PY 2013
VL 35
IS 7
BP 654
EP 659
DI 10.1016/j.braindev.2012.10.015
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 184IG
UT WOS:000321882700008
PM 23182449
DA 2024-11-01
ER

PT J
AU Ferdinandusse, S
   Waterham, HR
   Heales, SJR
   Brown, GK
   Hargreaves, IP
   Taanman, JW
   Gunny, R
   Abulhoul, L
   Wanders, RJA
   Clayton, PT
   Leonard, JV
   Rahman, S
AF Ferdinandusse, Sacha
   Waterham, Hans R.
   Heales, Simon J. R.
   Brown, Garry K.
   Hargreaves, Iain P.
   Taanman, Jan-Willem
   Gunny, Roxana
   Abulhoul, Lara
   Wanders, Ronald J. A.
   Clayton, Peter T.
   Leonard, James V.
   Rahman, Shamima
TI HIBCH mutations can cause Leigh-like disease with combined deficiency of multiple mitochondrial respiratory chain enzymes and pyruvate dehydrogenase
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Mitochondrial disease; Multiple respiratory chain enzyme deficiencies; Pyruvate dehydrogenase deficiency; 3-hydroxy-isobutyryl-CoA hydrolase; HIBCH; Acylcarnitines; Multiple mitochondrial dysfunctions syndrome; Valine catabolism; Organic aciduria
ID aciduria type-i; dna depletion; glutathione deficiency; ethylmalonic encephalopathy; methylmalonic aciduria; propionic aciduria; thiol status; coa; neurodegeneration; abnormality
AB Background: Deficiency of 3-hydroxy-isobutyryl-CoA hydrolase (HIBCH) caused by HIBCH mutations is a rare cerebral organic aciduria caused by disturbance of valine catabolism. Multiple mitochondrial respiratory chain (RC) enzyme deficiencies can arise from a number of mechanisms, including defective maintenance or expression of mitochondrial DNA. Impaired biosynthesis of iron-sulphur clusters and lipoic acid can lead to pyruvate dehydrogenase complex (PDHc) deficiency in addition to multiple RC deficiencies, known as the multiple mitochondrial dysfunctions syndrome. Methods: Two brothers born to distantly related Pakistani parents presenting in early infancy with a progressive neurodegenerative disorder, associated with basal ganglia changes on brain magnetic resonance imaging, were investigated for suspected Leigh-like mitochondrial disease. The index case had deficiencies of multiple RC enzymes and PDHc in skeletal muscle and fibroblasts respectively, but these were normal in his younger brother. The observation of persistently elevated hydroxy-C4-carnitine levels in the younger brother led to suspicion of HIBCH deficiency, which was investigated by biochemical assay in cultured skin fibroblasts and molecular genetic analysis. Results: Specific spectrophotometric enzyme assay revealed HIBCH activity to be below detectable limits in cultured skin fibroblasts from both brothers. Direct Sanger sequence analysis demonstrated a novel homozygous pathogenic missense mutation c.950G>A; p.Gly317Glu in the HIBCH gene, which segregated with infantile-onset neurodegeneration within the family. Conclusions: HIBCH deficiency, a disorder of valine catabolism, is a novel cause of the multiple mitochondrial dysfunctions syndrome, and should be considered in the differential diagnosis of patients presenting with multiple RC deficiencies and/or pyruvate dehydrogenase deficiency.
C1 [Ferdinandusse, Sacha; Waterham, Hans R.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
   [Heales, Simon J. R.; Gunny, Roxana] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England.
   [Abulhoul, Lara; Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England.
   [Heales, Simon J. R.; Hargreaves, Iain P.] Natl Hosp Neurol, Neurometab Unit, London, England.
   [Heales, Simon J. R.; Clayton, Peter T.; Leonard, James V.; Rahman, Shamima] UCL Inst Child Hlth, Clin & Mol Genet Unit, Mitochondrial Res Grp, London WC1N 1EH, England.
   [Brown, Garry K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.
   [Taanman, Jan-Willem] UCL Inst Neurol, Dept Clin Neurosci, London, England.
C3 University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Oxford; University of London; University College London
RP Rahman, S (corresponding author), Great Ormond St Hosp Sick Children, Metab Unit, Great Ormond St, London WC1N 3JH, England.
EM shamima.rahman@ucl.ac.uk
FU Great Ormond Street Hospital Children's Charity
CR ALI MS, 1993, J BIOL CHEM, V268, P22353
   BROWN GK, 1982, PEDIATRICS, V70, P532
   Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Chen Y, 2006, TOXICOL APPL PHARM, V216, P256, DOI 10.1016/j.taap.2006.05.006
   Chrzanowska-Lightowlers Z M A, 2011, NEUROMUSCUL DISORD, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   COOPERSTEIN SJ, 1963, J BIOL CHEM, V238, P3606
   Danielson SR, 2011, J BIOL CHEM, V286, P7601, DOI 10.1074/jbc.M110.190108
   de Keyzer Y, 2009, PEDIATR RES, V66, P91, DOI 10.1203/PDR.0b013e3181a7c270
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Haack TB, 2012, J INHERIT METAB DIS, V0, P0
   Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Harting I, 2008, J INHERIT METAB DIS, V31, P368, DOI 10.1007/s10545-008-0801-5
   Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112
   HAYASAKA K, 1989, J INHERIT METAB DIS, V12, P247, DOI 10.1007/BF01799214
   KHAILOVA LS, 1989, ANN NY ACAD SCI, V573, P36, DOI 10.1111/j.1749-6632.1989.tb14985.x
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lehnert W, 2005, MED HYPOTHESES, V65, P330, DOI 10.1016/j.mehy.2005.02.021
   Loupatty FJ, 2007, AM J HUM GENET, V80, P195, DOI 10.1086/510725
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Okun JG, 2002, J BIOL CHEM, V277, P14674, DOI 10.1074/jbc.M200997200
   PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Salmi H, 2012, ACTA PAEDIATR, V101, Pe505, DOI 10.1111/j.1651-2227.2012.02799.x
   Salmi H, 2012, SCAND J CLIN LAB INV, V72, P152, DOI 10.3109/00365513.2011.646299
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schwab MA, 2006, BIOCHEM J, V398, P107, DOI 10.1042/BJ20060221
   SCHWARTZ ER, 1970, J BIOL CHEM, V245, P183
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Treacy E, 1996, J PEDIATR-US, V129, P445, DOI 10.1016/S0022-3476(96)70080-X
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   WICKING CA, 1986, BIOCHEM J, V239, P89, DOI 10.1042/bj2390089
NR 39
TC 60
Z9 66
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-1172
EI 
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD DEC 4
PY 2013
VL 8
IS 
BP 
EP 
DI 10.1186/1750-1172-8-188
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA AB8BW
UT WOS:000332016100001
PM 24299452
DA 2024-11-01
ER

PT J
AU Kiferle, L
   Orsucci, D
   Mancuso, M
   Lo Gerfo, A
   Petrozzi, L
   Siciliano, G
   Ceravolo, R
   Bonuccelli, U
AF Kiferle, Lorenzo
   Orsucci, Daniele
   Mancuso, Michelangelo
   Lo Gerfo, Annalisa
   Petrozzi, Lucia
   Siciliano, Gabriele
   Ceravolo, Roberto
   Bonuccelli, Ubaldo
TI Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: A case report and an update on the state of art
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Parkinsonism; PEO1; Twinkle; Ohthalmoplegia
ID mtdna deletions; disease; polg
AB The objective is to describe the clinical phenotype and genetic basis of a family with autosomal dominant progressive external ophthalmoplegia and parkinsonism with a Twinkle mutation. The proband, an 82 years old female, reported since childhood bilateral eyelid ptosis, ophthalmoplegia, sensorineural hypoacusis, mild depression since she was 45, with a positive familiar anamnesis of eyelid ptosis (father, two sisters and a son). She developed mild bilateral parkinsonism with a moderate clinical response to levodopa. The I-123-FP-CIT SCAN evidenced a marked bilateral putaminal reduction and moderate caudate uptake reduction. Her 79 years old sister reported eyelid ptosis since she was 45 with ophthalmoplegia and developed a mild bilateral rest and postural tremor with moderate right arm plastic hypertonia when she was 76. The parkinsonism was confirmed with I-123-FP-CIT SCAN. One of the two sons presented eyelid ptosis since he was 30 years old, with peripheral neuropathy with biopsy evidence of myopathy. We identified a G1750A mutation in the c10orf2 gene in the three patients. Mitochondrial dysfunction has been implicated in the pathogenesis of sporadic, idiopathic Parkinson disease (PD). In some cases, mitochondrial DNA primary genetic abnormalities or more commonly secondary rearrangements due to polymerase gamma (POLG) gene mutation can directly cause parkinsonism. Parkinsonism has been reported as a rare symptom associated to Twinkle (c10orf2). Parkinsonism has to be investigated in patients with PEO with analysis of Twinkle mutation. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Kiferle, Lorenzo; Orsucci, Daniele; Mancuso, Michelangelo; Lo Gerfo, Annalisa; Petrozzi, Lucia; Siciliano, Gabriele; Ceravolo, Roberto; Bonuccelli, Ubaldo] Univ Pisa, Dept Clin & Pathol Med, Neurol Sect, I-56126 Pisa, Italy.
C3 University of Pisa
RP Kiferle, L (corresponding author), Univ Pisa, Dept Clin & Pathol Med, Neurol Sect, Via Roma 67, I-56126 Pisa, Italy.
EM l.kiferle@virgilio.it
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Greenwood SM, 2010, J NEUROCHEM, V113, P1471, DOI 10.1111/j.1471-4159.2010.06737.x
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Um JW, 2010, J NEUROSCI, V30, P11805, DOI 10.1523/JNEUROSCI.2862-09.2010
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 12
TC 29
Z9 29
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD NOV 27
PY 2013
VL 556
IS 
BP 1
EP 4
DI 10.1016/j.neulet.2013.09.034
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 273FP
UT WOS:000328520900001
PM 24076137
DA 2024-11-01
ER

PT J
AU Wang, M
   Zhou, XL
   Liu, RJ
   Fang, ZP
   Zhou, M
   Eriani, G
   Wang, ED
AF Wang, Meng
   Zhou, Xiao-Long
   Liu, Ru-Juan
   Fang, Zhi-Peng
   Zhou, Mi
   Eriani, Gilbert
   Wang, En-Duo
TI Multilevel functional and structural defects induced by two pathogenic mitochondrial tRNA mutations
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE CCA-adding modification; elongation factor Tu (EF-Tu); mitochondria; pathogenicity; tRNA
ID t-stem; crystal-structure; sporadic patient; mtdna mutation; amino-acids; aminoacylation; maturation; myopathy; dynamics; binding
AB Point mutations in hmtRNAs (human mitochondrial tRNAs) can cause various disorders, such as CPEO (chronic progressive external ophthalmoplegia) and MM (mitochondrial myopathy). Mitochondrial tRNA(Leu), especially the UUR codon isoacceptor, is recognized as a hot spot for pathogenic mtDNA point mutations. Thus far, 40 mutations have been reported in hmtRNAs(Leu). In the present paper, we describe the wide range of effects of two substitutions found in the T Psi C arms of two hmtRNAs(Leu) isoacceptors. The G52A substitution, corresponding to the pathogenic G12315A mutation in tRNA(Leu) (CUN), and G3283A in tRNA(Leu) (UUR) exhibited structural changes in the outer corner of the tRNA shape as shown by RNase probing. These mutations also induced reductions in aminoacylation, 3'-end processing and base modification processes. The main effects of the A57G substitution, corresponding to mutations Al2320G in tRNA(Leu)(CUN) and A3288G in tRNA(Leu)(UUR), were observed on the aminoacylation activity and binding to hmEF-Tu (human mitochondrial elongation factor Tu). These observations suggest that the wide range of effects may amplify the deleterious impact on mitochondrial protein synthesis in vivo. The findings also emphasize that an exact understanding of tRNA dysfunction is critical for the future development of therapies for mitochondrial diseases.
C1 [Wang, Meng; Zhou, Xiao-Long; Liu, Ru-Juan; Fang, Zhi-Peng; Zhou, Mi; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Ctr RNA Res,State Key Lab Mol Biol, Shanghai 200031, Peoples R China.
   [Wang, Meng; Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France.
C3 Chinese Academy of Sciences; Center for Excellence in Molecular Cell Science, CAS; Centre National de la Recherche Scientifique (CNRS); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg
RP Eriani, G (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France.
EM g.eriani@ibmc-cnrs.unistra.fr; edwang@sibcb.ac.cn
FU National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [30930022, 31000355, 31130064]; Committee of Science and Technology in Shanghai [12JC1409700]; Centre National de la Recherche Scientific (CNRS); Chinese Academy of Sciences [2011T2S10]; Chinese Academy of Sciences (Sino-France)
CR Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Brulé H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q
   Brunel C, 2000, METHOD ENZYMOL, V318, P3
   Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763
   Chimnaronk S, 2009, BIOCHEMISTRY-US, V48, P5057, DOI 10.1021/bi900337d
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010
   COLE PE, 1972, BIOCHEMISTRY-US, V11, P4358, DOI 10.1021/bi00773a024
   Du X, 2003, NUCLEIC ACIDS RES, V31, P2865, DOI 10.1093/nar/gkg382
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   ERICSON JU, 1991, J MOL BIOL, V218, P509, DOI 10.1016/0022-2836(91)90697-5
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   Hunter Senyene Eyo, 2004, RNA BIOL, V1, P95, DOI 10.4161/rna.1.2.1034
   Jühling F, 2009, NUCLEIC ACIDS RES, V37, PD159, DOI 10.1093/nar/gkn772
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Kelley SO, 2001, J BIOL CHEM, V276, P10607, DOI 10.1074/jbc.M008320200
   LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Li Y, 1999, PROTEIN EXPRES PURIF, V16, P355, DOI 10.1006/prep.1999.1083
   Maeso E, 2007, NEUROMUSCULAR DISORD, V17, P415, DOI 10.1016/j.nmd.2007.01.015
   MANS RJ, 1960, BIOCHEM BIOPH RES CO, V3, P540, DOI 10.1016/0006-291X(60)90171-6
   MORL M, 1995, NUCLEIC ACIDS RES, V23, P3380, DOI 10.1093/nar/23.17.3380
   Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200
   NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317
   PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0
   PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Seif E, 2009, J BIOL CHEM, V284, P6600, DOI 10.1074/jbc.C800235200
   Silberklang M, 1979, METHODS ENZYMOL, V59, P58
   Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Tomita K, 2006, NATURE, V443, P956, DOI 10.1038/nature05204
   Valente L, 2009, BBA-MOL BASIS DIS, V1792, P791, DOI 10.1016/j.bbadis.2009.06.002
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711
   Yao YN, 2003, PROTEIN EXPRES PURIF, V30, P112, DOI 10.1016/S1046-5928(03)00097-4
   YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1
   Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423
NR 57
TC 10
Z9 11
U1 0
U2 9
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD AUG 1
PY 2013
VL 453
IS 
BP 455
EP 465
DI 10.1042/BJ20130294
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 190RU
UT WOS:000322358700014
PM 23631826
DA 2024-11-01
ER

PT J
AU Zhao, DH
   Wang, ZX
   Hong, DJ
   Zhang, W
   Yuan, Y
AF Zhao, Danhua
   Wang, Zhaoxia
   Hong, Daojun
   Zhang, Wei
   Yuan, Yun
TI Chronic progressive external ophthalmoplegia coexistent with motor neuron disease in a patient with a novel large-scale mitochondrial DNA deletion
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Chronic progressive external; ophthalmoplegia; Motor neuron disease; Mitochondrial DNA; Large-scale deletion
ID mutation; point; gene
C1 [Zhao, Danhua; Wang, Zhaoxia; Hong, Daojun; Zhang, Wei; Yuan, Yun] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
C3 Peking University
RP Wang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
EM drwangzx@yahoo.com.cn
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Borthwick Gillian M, 2006, ANN NEUROL, V59, P570, DOI 10.1002/ana.20758
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Cozzolino M, 2012, MOL CELLULAR NEUROSC, V0, P0
   Hanna MG, 1997, J NEUROL NEUROSUR PS, V62, P544, DOI 10.1136/jnnp.62.5.544
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Shi P, 2010, J ALZHEIMERS DIS, V20, PS311, DOI 10.3233/JAD-2010-100366
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 10
TC 7
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
EI 
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD AUG 15
PY 2013
VL 115
IS 8
BP 1490
EP 1492
DI 10.1016/j.clineuro.2012.11.011
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 198NJ
UT WOS:000322929300056
PM 23266267
DA 2024-11-01
ER

PT J
AU Dai, Y
   Kiselak, T
   Clark, J
   Clore, E
   Zheng, KN
   Cheng, A
   Kujoth, GC
   Prolla, TA
   Maratos-Flier, E
   Simon, DK
AF Dai, Ying
   Kiselak, Tomas
   Clark, Joanne
   Clore, Elizabeth
   Zheng, Kangni
   Cheng, Allen
   Kujoth, Gregory C.
   Prolla, Tomas A.
   Maratos-Flier, Eleftheria
   Simon, David K.
TI Behavioral and metabolic characterization of heterozygous and homozygous <i>POLG</i> mutator mice
SO MITOCHONDRION
LA English
DT Article
DE mtDNA polymerase gamma; mtDNA mutation; Parkinson's disease; Dopamine; Behavioral deficits; Metabolic deficits
ID mitochondrial-dna mutations; progressive external ophthalmoplegia; human substantia-nigra; parkinsons-disease; dopaminergic-neurons; point mutations; mtdna mutations; complex-i; deletions; abnormality
AB The mitochondrial DNA (mtDNA) polymerase (POLG) mutator mice provide the first experimental evidence that high levels of somatic mtDNA mutations can be functionally significant. Here we report that older homozygous, but not heterozygous, POLG mice show significant reductions in striatal dopaminergic terminals as well as deficits in motor function. However, resting oxygen consumption, heat production, mtDNA content and mitochondrial electron transport chain activities are significantly decreased at older ages in both homozygous and heterozygous mice. These results indicate that high levels of somatic mtDNA mutations can contribute to dopaminergic dysfunction and to behavioral and metabolic deficits. (c) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Dai, Ying; Kiselak, Tomas; Clark, Joanne; Clore, Elizabeth; Zheng, Kangni; Simon, David K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Neurol, Sch Med, Boston, MA 02215 USA.
   [Cheng, Allen] Harvard Univ, Sch Med, MD PhD Program, Boston, MA 02115 USA.
   [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.
   [Maratos-Flier, Eleftheria] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med,Med Sch, Boston, MA 02215 USA.
C3 Harvard University; Harvard Medical School; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Beth Israel Deaconess Medical Center
RP Dai, Y (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Room CLS 628, Brookline, MA 02445 USA.
EM ydai@bidmc.harvard.edu; tomas.kiselak@gmail.com; jclark3@bidmc.harvard.edu; eclore@gmail.com; kzheng@caregroup.harvard.edu; allen_cheng@hms.harvard.edu; gckujoth@wisc.edu; taprolla@wisc.edu; emaratos@bidmc.harvard.edu; dsimon1@bidmc.harvard.edu
FU National Institute on Aging [1R03AG035223-01]; National Institute of Neurological Disorders and Stroke [1R21NS077758]
CR Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BURNS RS, 1985, NEW ENGL J MED, V312, P1418, DOI 10.1056/NEJM198505303122203
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Clark J, 2011, PARKINSONS DIS-US, V2011, P0, DOI 10.4061/2011/659694
   Clark J, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012333
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CRUZSANCHEZ FF, 1995, J NEUROPATH EXP NEUR, V54, P74, DOI 10.1097/00005072-199501000-00009
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Emborg ME, 1998, J COMP NEUROL, V401, P253
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006
   Guttman M, 1997, NEUROLOGY, V48, P1578, DOI 10.1212/WNL.48.6.1578
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kokkotou E, 2005, AM J PHYSIOL-REG I, V289, PR117, DOI 10.1152/ajpregu.00861.2004
   Koprich JB, 2008, J NEUROINFLAMM, V5, P0, DOI 10.1186/1742-2094-5-8
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Ma SY, 1999, NEUROPATH APPL NEURO, V25, P394
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   PAKKENBERG B, 1991, J NEUROL NEUROSUR PS, V54, P30, DOI 10.1136/jnnp.54.1.30
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SEVERSON JA, 1982, J NEUROCHEM, V39, P1623, DOI 10.1111/j.1471-4159.1982.tb07996.x
   Siddiqi ZA, 1999, J NEUROPATH EXP NEUR, V58, P903, DOI 10.1097/00005072-199909000-00002
   TATTON WG, 1991, NEUROBIOL AGING, V12, P543, DOI 10.1016/0197-4580(91)90086-Y
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 48
TC 26
Z9 32
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2013
VL 13
IS 4
BP 282
EP 291
DI 10.1016/j.mito.2013.03.006
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 162VR
UT WOS:000320294600004
PM 23542163
DA 2024-11-01
ER

PT J
AU Battigelli, A
   Russier, J
   Venturelli, E
   Fabbro, C
   Petronilli, V
   Bernardi, P
   Da Ros, T
   Prato, M
   Bianco, A
AF Battigelli, Alessia
   Russier, Julie
   Venturelli, Enrica
   Fabbro, Chiara
   Petronilli, Valeria
   Bernardi, Paolo
   Da Ros, Tatiana
   Prato, Maurizio
   Bianco, Alberto
TI Peptide-based carbon nanotubes for mitochondrial targeting
SO NANOSCALE
LA English
DT Article
ID protein import; drug-delivery; gene-therapy; plasmid dna; functionalization; diseases; cells; translocation; system; muscle
AB In the present study, we report the design and synthesis of peptide-based-multi-walled carbon nanotubes (MWCNTs) to target mitochondria. Targeting these intracellular organelles might open the way to develop alternative systems to address diseases related to genetic mutations in mitochondrial (mt)-DNA, by delivering therapeutic oligonucleotides. The first step towards mitochondrial delivery of this type of nucleic acid was to target MWCNTs to mitochondria by covalent functionalization with a well-known endogenous mitochondrial targeting sequence (MTS). The subcellular localization of the conjugates, which were fluorescently labeled, in murine RAW 264.7 macrophages and human HeLa cells was then studied using different microscopy techniques, such as wide-field epifluorescence microscopy, confocal laser scanning microscopy (CLSM) and transmission electron microscopy (TEM). The localization of the MTS-MWCNT conjugates into mitochondria was further confirmed by analyzing the isolated organelles using TEM.
C1 [Battigelli, Alessia; Fabbro, Chiara; Da Ros, Tatiana; Prato, Maurizio] Univ Trieste, Dept Chem & Pharmaceut Sci, I-34127 Trieste, Italy.
   [Battigelli, Alessia; Russier, Julie; Venturelli, Enrica; Bianco, Alberto] CNRS, Inst Biol Mol & Cellulaire, Lab Immunopathol & Chim Therapeut, UPR 3572, F-67000 Strasbourg, France.
   [Fabbro, Chiara] Univ Venice, Dept Mol Sci & Nanosyst, I-30123 Venice, Italy.
   [Petronilli, Valeria; Bernardi, Paolo] Univ Padua, CNR Inst Neurosci, I-35121 Padua, Italy.
   [Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy.
C3 University of Trieste; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Padua; University of Padua
RP Prato, M (corresponding author), Univ Trieste, Dept Chem & Pharmaceut Sci, Piazzale Europa 1, I-34127 Trieste, Italy.
EM prato@units.it; a.bianco@ibmc-cnrs.unistra.fr
FU CNRS (PICS Program); University of Trieste; Italian Ministry of Education MIUR [2010N3T9M4, Firb RBAP11C58Y]; Biotechnology and Biological Sciences Research Council [BB/J008656/1]; AIRC [12214]; Universita italo-francese/Universite franco-italienne; BBSRC [BB/J008656/1] Funding Source: UKRI
CR Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108
   Ali-Boucetta H, 2013, ANGEW CHEM INT EDIT, V52, P2274, DOI 10.1002/anie.201207664
   Britz DA, 2006, CHEM SOC REV, V35, P637, DOI 10.1039/b507451g
   Cheung W, 2010, ADV DRUG DELIVER REV, V62, P633, DOI 10.1016/j.addr.2010.03.007
   DSouza GGM, 2005, MITOCHONDRION, V5, P352, DOI 10.1016/j.mito.2005.07.001
   DSouza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Delogu LG, 2010, J NANOSCI NANOTECHNO, V10, P5293, DOI 10.1166/jnn.2010.3083
   Delogu LG, 2009, BIOCONJUGATE CHEM, V20, P427, DOI 10.1021/bc800540j
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895
   Gaillard C, 2009, ADV MATER, V21, P2903, DOI 10.1002/adma.200900050
   Georgakilas V, 2002, CHEM COMMUN, V0, PP3050, DOI 10.1039/b209843a
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kagawa Y, 2001, ADV DRUG DELIVER REV, V49, P107, DOI 10.1016/S0169-409X(01)00129-6
   Karousis N, 2010, CHEM REV, V110, P5366, DOI 10.1021/cr100018g
   Kordatos K, 2001, J ORG CHEM, V66, P4915, DOI 10.1021/jo015608k
   Lacerda L, 2012, BIOMATERIALS, V33, P3334, DOI 10.1016/j.biomaterials.2012.01.024
   Lamanna G, 2012, NANOTECHNOL REV, V1, P17, DOI 10.1515/ntrev-2011-0002
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Ma XW, 2012, ACS NANO, V6, P10486, DOI 10.1021/nn302457v
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mukhopadhyay A, 2007, ADV DRUG DELIVER REV, V59, P729, DOI 10.1016/j.addr.2007.06.004
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r
   Pastorin G, 2006, CHEM COMMUN, V0, PP1182, DOI 10.1039/b516309a
   Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572
   RIZZUTO R, 1989, J BIOL CHEM, V264, P10595
   Samorì C, 2010, CARBON, V48, P2447, DOI 10.1016/j.carbon.2010.03.015
   Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763
   SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10
   Singh P, 2009, CHEM SOC REV, V38, P2214, DOI 10.1039/b518111a
   Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vashist SK, 2011, CARBON, V49, P4077, DOI 10.1016/j.carbon.2011.05.049
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weissig V, 2001, J CONTROL RELEASE, V75, P401, DOI 10.1016/S0168-3659(01)00392-3
   Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016
   Zhou FF, 2012, SMALL, V8, P1543, DOI 10.1002/smll.201101892
   Zhou FF, 2011, SMALL, V7, P2727, DOI 10.1002/smll.201100669
   Zhou FF, 2010, NANO LETT, V10, P1677, DOI 10.1021/nl100004m
NR 44
TC 53
Z9 59
U1 0
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2040-3364
EI 
J9 NANOSCALE
JI Nanoscale
PD JUN 15
PY 2013
VL 5
IS 19
BP 9110
EP 9117
DI 10.1039/c3nr02694a
PG 8
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science; Physics
GA 219JA
UT WOS:000324500900046
PM 23903095
DA 2024-11-01
ER

PT J
AU Goldstein, A
   Wolfe, LA
AF Goldstein, Amy
   Wolfe, Lynne A.
TI The Elusive Magic Pill: Finding Effective Therapies for Mitochondrial Disorders
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondria; ATP; mtDNA; nDNA; Respiratory chain; OXPHOS
ID fatty-acid oxidation; lipoic acid; exercise; metabolism; disease; dna; dichloroacetate; phosphorylation; mutations; myopathy
AB The incidence of mitochondrial diseases has been estimated at 11.5/100,000 (1:8500) worldwide. In the USA up to 4000 newborns annually are expected to develop a mitochondrial disease. More than 50 million adults in the USA also suffer from diseases in which primary or secondary mitochondrial dysfunction is involved. Mitochondrial dysfunction has been identified in cancer, infertility, diabetes, heart diseases, blindness, deafness, kidney disease, liver disease, stroke, migraine, dwarfism, and resulting from numerous medication toxicities. Mitochondrial dysfunction is also involved in normal aging and age-related neurodegenerative diseases, such as Parkinson and Alzheimer diseases. Yet most treatments available are based on empiric data and clinician experience because of the lack of randomized controlled clinical trials to provide evidence-based treatments for these disorders. Here we explore the current state of research for the treatment of mitochondrial disorders.
C1 [Goldstein, Amy] UPMC, Childrens Hosp Pittsburgh, Div Child Neurol, Pittsburgh, PA USA.
   [Wolfe, Lynne A.] NIH, Undiagnosed Dis Program, Bethesda, MD 20892 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA
RP Wolfe, LA (corresponding author), NIH, Undiagnosed Dis Program, 10 Ctr DR,MSC 1205,RM 3-2551, Bethesda, MD 20892 USA.
EM lynne.wolfe@nih.gov
CR Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281
   Alavian KN, 2012, BRAIN RES, V1446, P1, DOI 10.1016/j.brainres.2012.01.046
   Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Enns GM, 2000, J PEDIAT, V136, P1
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene S, 2011, MITOCHONDRIAL MED CL, V0, P0
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kossoff EH, 2009, J CHILD NEUROL, V24, P979, DOI 10.1177/0883073809337162
   Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Matsubara K, 2008, INT J MOL MED, V22, P381, DOI 10.3892/ijmm_00000034
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nasser M, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD006659.pub3
   Packer L, 2011, J CLIN BIOCHEM NUTR, V48, P26, DOI 10.3164/jcbn.11-005FR
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
NR 44
TC 11
Z9 14
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD APR 15
PY 2013
VL 10
IS 2
BP 320
EP 328
DI 10.1007/s13311-012-0175-0
PG 9
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 127EC
UT WOS:000317677900012
PM 23355364
DA 2024-11-01
ER

PT J
AU Campbell, GR
   Reeve, A
   Ziabreva, I
   Polvikoski, TM
   Taylor, RW
   Reynolds, R
   Turnbull, DM
   Mahad, DJ
AF Campbell, G. R.
   Reeve, A.
   Ziabreva, I.
   Polvikoski, T. M.
   Taylor, R. W.
   Reynolds, R.
   Turnbull, D. M.
   Mahad, D. J.
TI Mitochondrial DNA deletions and depletion within paraspinal muscles
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Article
DE ageing; mitochondrial DNA deletion; paraspinal muscle
ID real-time pcr; skeletal-muscle; paravertebral muscles; clonal expansion; individual cells; mutations; disease; camptocormia; mechanisms; accumulate
AB G. R. Campbell, A. Reeve, I. Ziabreva, T. M. Polvikoski, R. W. Taylor, R. Reynolds, D. M. Turnbull and D. J. Mahad (2013) Neuropathology and Applied Neurobiology39, 377389 Mitochondrial DNA deletions and depletion within paraspinal muscles Aims: Although mitochondrial abnormalities have been reported within paraspinal muscles in patients with axial weakness and neuromuscular disease as well as with ageing, the basis of respiratory deficiency in paraspinal muscles is not known. This study aimed to determine the extent and basis of respiratory deficiency in paraspinal muscles from cases undergoing surgery for degenerative spinal disease and post mortem cases without a history of spinal disease, where age-related histopathological changes were previously reported. Methods: Cervical and lumbar paraspinal muscles were obtained peri-operatively from 13 patients and from six post mortem control cases (age range 1882 years) without a neurological disease. Sequential COX/SDH (mitochondrial respiratory chain complex IV/complex II) histochemistry was performed to identify respiratory-deficient muscle fibres (lacking complex IV with intact complex II activity). Real-time polymerase chain reaction, long-range polymerase chain reaction and sequencing were used to identify and characterize mitochondrial DNA (mtDNA) deletions and determine mtDNA copy number status. Mitochondrial respiratory chain complex subunits were detected by immunohistochemistry. Results: The density of respiratory-deficient fibres increased with age. On average, 3.96% of fibres in paraspinal muscles were respiratory-deficient (range 010.26). Respiratory deficiency in 36.8% of paraspinal muscle fibres was due to clonally expanded mtDNA deletions. MtDNA depletion accounted for further 13.5% of respiratory deficiency. The profile of immunohistochemically detected subunits of complexes was similar in respiratory-deficient fibres with and without mtDNA deletions or mtDNA depletion. Conclusions: Paraspinal muscles appeared to be particularly susceptible to age-related mitochondrial respiratory chain defects. Clonally expanded mtDNA deletions and focal mtDNA depletion may contribute towards the development of age-related postural abnormalities.
C1 [Campbell, G. R.; Reeve, A.; Ziabreva, I.; Taylor, R. W.; Turnbull, D. M.; Mahad, D. J.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Polvikoski, T. M.] Newcastle Univ, Wolfson Res Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Reynolds, R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wolfson Neurosci Labs, London, England.
C3 Newcastle University - UK; Newcastle University - UK; Imperial College London
RP Mahad, DJ (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM mahadd@doctors.org.uk
FU Wellcome Trust (Intermediate Clinical Fellowship); Newcastle Healthcare Charity; Wellcome Trust Centre for Mitochondrial Research; Newcastle University Centre for Brain Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council as part of the cross-council Lifelong Health and Wellbeing Initiative [G0700718]; MRC [G0700718, MR/K000608/1, G0900652, G0502157, G0400074, G1100540, MR/L016451/1] Funding Source: UKRI
CR Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   DELISLE MB, 1993, NEUROMUSCULAR DISORD, V3, P579, DOI 10.1016/0960-8966(93)90120-9
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HUND E, 1995, NEUROLOGY, V45, P993, DOI 10.1212/WNL.45.5.993
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   KEYNES RJ, 1988, DEVELOPMENT, V103, P413
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   ORDAHL CP, 1992, DEVELOPMENT, V114, P339
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Ramsbacher J, 2001, SPINE, V26, P2180, DOI 10.1097/00007632-200110150-00003
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Regev GJ, 2010, SPINE, V35, P1265, DOI 10.1097/BRS.0b013e3181bfcd98
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   Schäbitz WR, 2003, MOVEMENT DISORD, V18, P408, DOI 10.1002/mds.10385
   Serratrice G, 1996, J NEUROL NEUROSUR PS, V60, P51, DOI 10.1136/jnnp.60.1.51
   Serratrice G, 2007, ACTA MYOL, V26, P11
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Wakata N, 2007, INTERNAL MED, V46, P747, DOI 10.2169/internalmedicine.46.6400
   Wharton SB, 1996, J NEUROL NEUROSUR PS, V61, P461, DOI 10.1136/jnnp.61.5.461
   Yoshiyama Y, 1999, J NEUROL SCI, V167, P22, DOI 10.1016/S0022-510X(99)00129-X
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 33
TC 17
Z9 18
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD JUN 15
PY 2013
VL 39
IS 4
BP 377
EP 389
DI 10.1111/j.1365-2990.2012.01290.x
PG 13
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 137HI
UT WOS:000318425900005
PM 22762368
DA 2024-11-01
ER

PT J
AU Malfatti, E
   Laforêt, P
   Jardel, C
   Stojkovic, T
   Behin, A
   Eymard, B
   Lombès, A
   Benmalek, A
   Bécane, HM
   Berber, N
   Meune, C
   Duboc, D
   Wahbi, K
AF Malfatti, Edoardo
   Laforet, Pascal
   Jardel, Claude
   Stojkovic, Tanya
   Behin, Anthony
   Eymard, Bruno
   Lombes, Anne
   Benmalek, Amria
   Becane, Henri-Marc
   Berber, Nawal
   Meune, Christophe
   Duboc, Denis
   Wahbi, Karim
TI High risk of severe cardiac adverse events in patients with mitochondrial m.3243A&gt;G mutation
SO NEUROLOGY
LA English
DT Article
ID left-ventricular hypertrophy; lactic-acidosis; clinical-features; episodes melas; follow-up; encephalopathy; involvement; myopathy; dna; dysfunction
AB Objectives: To determine the long-term incidence of cardiac life-threatening complications and death in patients with the m.3243A>G mutation, and to identify cardiac prognostic factors. Methods: We retrospectively included patients carrying the m.3243A>G mutation who were admitted to the Neuromuscular Disease Clinic of Pitie Salpetriere Hospital between January 1992 and December 2010. We collected information relative to their yearly neurologic and cardiac investigations, their mutation load in blood, urine, and muscle at initial admission, and the occurrence of cardiac life-threatening adverse events and death during follow-up. Results: Forty-one patients (median age 5 47 years [36-55 years], men 5 13) were included, of whom 38 had clinical manifestations of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and 3 were asymptomatic. One patient had a personal history of cardiac transplantation. Cardiac investigations displayed left ventricular hypertrophy, left ventricular dysfunction, or both abnormalities in 18 patients, along with Wolff-Parkinson-White syndrome in 7, conduction system disease in 4, and atrial fibrillation in 1. Over a median 5-year (3-9 years) follow-up period, 11 patients died, including 3 due to heart failure; 7 had life-threatening adverse events, including 6 hospitalizations for severe heart failure and 1 resuscitated cardiac arrest. By multivariate analysis, left ventricular hypertrophy was the only parameter independently associated with occurrence of cardiac adverse events. Conclusion: Patients with the m.3243A>G mutation have a high incidence of cardiac death and life-threatening adverse events. Left ventricular hypertrophy was the only parameter independently associated with occurrence of these events. Neurology (R) 2013;80:100-105
C1 [Malfatti, Edoardo; Laforet, Pascal; Stojkovic, Tanya; Behin, Anthony; Eymard, Bruno; Benmalek, Amria; Becane, Henri-Marc; Berber, Nawal; Wahbi, Karim] Hop La Pitie Salpetriere, AP HP, Reference Ctr Muscle Dis Paris Est, Myol Inst, Paris, France.
   [Malfatti, Edoardo] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Jardel, Claude] Hop La Pitie Salpetriere, AP HP, Dept Biochem, Paris, France.
   [Meune, Christophe; Duboc, Denis] Paris Descartes Univ, Dept Cardiol, Cochin Hosp, AP HP, Paris, France.
   [Lombes, Anne] UMRS 975 Cochin Hosp, APHP, INSERM, Paris, France.
   [Meune, Christophe; Duboc, Denis] Sorbonne Paris Cite Univ, Paris, France.
   [Wahbi, Karim] Univ Paris 06, Myol Inst, Hop La Pitie Salpetriere, Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; University of Siena; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite
RP Wahbi, K (corresponding author), Hop La Pitie Salpetriere, AP HP, Reference Ctr Muscle Dis Paris Est, Myol Inst, Paris, France.
EM karim.wahbi@psl.aphp.fr
FU AFM (Association Francaise contre les Myopathies)
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   DEVIVO DC, 1990, BIOL NEONATE, V58, P54
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Momiyama Y, 2001, DIABETES CARE, V24, P604, DOI 10.2337/diacare.24.3.604
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366
   SATO W, 1994, AM HEART J, V128, P733, DOI 10.1016/0002-8703(94)90272-0
   SCHUMANN GB, 1981, ACTA CYTOL, V25, P147
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Verdecchia P, 2001, CIRCULATION, V104, P2039, DOI 10.1161/hc4201.097944
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
NR 28
TC 51
Z9 54
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JAN 15
PY 2013
VL 80
IS 1
BP 100
EP 105
DI 10.1212/WNL.0b013e31827b1a2f
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 061ZT
UT WOS:000312889600020
PM 23243073
DA 2024-11-01
ER

PT J
AU Villar, P
   Bretón, B
   García-Pavía, P
   González-Páramos, C
   Blázquez, A
   Gómez-Bueno, M
   García-Silva, T
   García-Consuegra, I
   Martín, MA
   Garesse, R
   Bornstein, B
   Gallardo, ME
AF Villar, Pedro
   Breton, Begona
   Garcia-Pavia, Pablo
   Gonzalez-Paramos, Cristina
   Blazquez, Alberto
   Gomez-Bueno, Manuel
   Garcia-Silva, Teresa
   Garcia-Consuegra, Ines
   Angel Martin, Miguel
   Garesse, Rafael
   Bornstein, Belen
   Esther Gallardo, M.
TI Cardiac Dysfunction in Mitochondrial Disease - Clinical and Molecular Features
SO CIRCULATION JOURNAL
LA English
DT Article
DE Cardiomyopathy; Cybrid; Mitochondrial disease; Mitochondrial DNA; mtDNA
ID trna(val) gene mutation; hypertrophic cardiomyopathy; complex-i; neurological presentation; pediatric-patients; point mutation; dna mutation; deficiency; myopathy; spectrum
AB Background: Mitochondrial disorders (MD) are multisystem diseases that arise as a result of dysfunction of the oxidative phosphorylation System. The predominance of neuromuscular manifestations in MD could mask the presence of other clinical phenotypes such as cardiac dysfunction. Reported here is a retrospective study, the main objective of which was to characterize the clinical and molecular features of a cohort of patients with cardiomyopathy and MD. Methods and Results: Hospital charts of 2,520 patients, evaluated for presumed MD were reviewed. The clinical criterion for inclusion in this study was the presence of a cardiac disturbance accompanied by a mitochondrial dysfunction. Only 71 patients met this criterion. The mitochondrial genome (mtDNA) could be sequenced only in 45 and the pathogenicity of 2 of the found changes was investigated using transmitochondrial cybrids. Three nucleotide changes in mtDNA that may be relevant and 3 with confirmed pathogenicity were identified but no mutations were found in the 13 nuclear genes analyzed. Conclusions: The mtDNA should be sequenced in patients with cardiac dysfunction accompanied by symptoms suggestive of MD; databases should be carefully and periodically screened to discard mitochondrial variants that could be associated with MD; functional assays are necessary to classify mitochondrial variants as pathogenic or polymorphic; and additional efforts must be made in order to identify nuclear genes that can explain some as yet uncharacterized molecular features of mitochondria! cardiomyopathy.
C1 [Gonzalez-Paramos, Cristina; Garesse, Rafael; Bornstein, Belen; Esther Gallardo, M.] UAM CSIC, Coll Med, Biomed Res Inst Alberto Sols, Dept Biochem, Madrid 28029, Spain.
   [Blazquez, Alberto; Angel Martin, Miguel; Garesse, Rafael; Bornstein, Belen; Esther Gallardo, M.] Rare Dis Biomed Res Ctr CIBERER, Madrid, Spain.
   [Blazquez, Alberto; Garcia-Silva, Teresa; Garcia-Consuegra, Ines; Angel Martin, Miguel; Garesse, Rafael; Bornstein, Belen; Esther Gallardo, M.] Hosp 12 Octubre I 12, Hlth Res Inst, Madrid, Spain.
   [Villar, Pedro; Breton, Begona; Bornstein, Belen] Hosp Univ Puerta de Hieno, Biochem Unit, Madrid, Spain.
   [Garcia-Pavia, Pablo; Gomez-Bueno, Manuel] Hosp Univ Puerta de Hieno, Cardiol Unit, Madrid, Spain.
   [Garcia-Pavia, Pablo; Gomez-Bueno, Manuel] Net Clin & Basic Res Heart Failure REDINSCOR, Madrid, Spain.
   [Blazquez, Alberto; Garcia-Consuegra, Ines; Angel Martin, Miguel] Res Ctr, Lab Mitochondrial Dis, Madrid, Spain.
   [Garcia-Silva, Teresa] Hosp Univ 12 Octubre, Pediat Unit, Madrid, Spain.
   [Villar, Pedro; Breton, Begona; Garcia-Pavia, Pablo; Gomez-Bueno, Manuel; Bornstein, Belen] Res Inst Puerta de Hierro Majadahonda IDIPHIM, Madrid, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre
RP Gallardo, ME (corresponding author), UAM CSIC, Coll Med, Biomed Res Inst Alberto Sols, Dept Biochem, Avda Arzobispo Morcillo S-N, Madrid 28029, Spain.
EM belen.bornstein@uam.es; egallardo@iib.uam.es
FU Instituto de Salud Carlos III [PI 07/0167, PI 10/0703, PI 09/00941, PI 06/0205, PI060547]; Comunidad de Madrid [GEN-0269/2006]; Instituto de Salud Carlos III-Ministerio de Ciencia e Innovacion (CIII-MICIN); Agencia Lain Entralgo (Comunidad de Madrid); Centre for Biomedical Research on Rare Diseases (CIBERER); Instituto de Investigacion Puerta de Hierro Majadahonda (IDIPHIM)
CR Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Apte SM, 2006, J TRANSL MED, V4, P0, DOI 10.1186/1479-5876-4-16
   Arredondo JJ, 2012, MITOCHONDRION, V12, P357, DOI 10.1016/j.mito.2011.09.010
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Kimura A, 2011, CIRC J, V75, P1756, DOI 10.1253/circj.CJ-11-0368
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Paterick TE, 2012, CIRC J, V76, P1556, DOI 10.1253/circj.CJ-12-0666
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   van Oven M, 2012, J HUM GENET, V57, P65, DOI 10.1038/jhg.2011.120
   Verhoeven WMA, 2011, NEUROPSYCH DIS TREAT, V7, P293, DOI 10.2147/NDT.S20153
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 50
TC 6
Z9 6
U1 0
U2 8
PU JAPANESE CIRCULATION SOC
PI TOYKO
PA 18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN
SN 1346-9843
EI 1347-4820
J9 CIRC J
JI Circ. J.
PD NOV 15
PY 2013
VL 77
IS 11
BP 2799
EP 2806
DI 10.1253/circj.CJ-13-0557
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 243LJ
UT WOS:000326317600026
PM 23965802
DA 2024-11-01
ER

PT J
AU Montero, R
   Grazina, M
   López-Gallardo, E
   Montoya, J
   Briones, P
   Navarro-Sastre, A
   Land, JM
   Hargreaves, IP
   Artuch, R
   O'Callaghan, MD
   Jou, C
   Jimenez, C
   Buján, N
   Pineda, M
   García-Cazorla, A
   Nascimento, A
   Perez-Dueñas, B
   Ruiz-Pesini, E
   Fratter, C
   Salviati, L
   Simoes, M
   Mendes, C
   Santos, MJ
   Diogo, L
   Garcia, P
   Navas, P
AF Montero, Raquel
   Grazina, Manuela
   Lopez-Gallardo, Ester
   Montoya, Julio
   Briones, Paz
   Navarro-Sastre, Aleix
   Land, John M.
   Hargreaves, Iain P.
   Artuch, Rafael
   del Mar O'Callaghan, Maria
   Jou, Cristina
   Jimenez, Cecilia
   Bujan, Nuria
   Pineda, Merce
   Garcia-Cazorla, Angels
   Nascimento, Andres
   Perez-Duenas, Belen
   Ruiz-Pesini, Eduardo
   Fratter, Carl
   Salviati, Leonardo
   Simoes, Marta
   Mendes, Candida
   Santos, Maria Joao
   Diogo, Luisa
   Garcia, Paula
   Navas, Placido
TI Coenzyme Q<sub>10</sub> deficiency in mitochondrial DNA depletion syndromes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA depletion syndrome; Coenzyme Q(10) deficiency; Mitochondrial disorders
ID respiratory-chain disorders; skeletal-muscle; mutations; diagnosis; humans; children; genes; cells; form
AB We evaluated coenzyme Q(10) (CoQ) levels in patients studied under suspicion of mitochondrial DNA depletion syndromes (MDS) (n = 39). CoQ levels were quantified by HPLC, and the percentage of mtDNA depletion by quantitative real-time PCR. A high percentage of MDS patients presented with CoQ deficiency as compared to other mitochondrial patients (Mann-Whitney-U test: p = 0.001). Our findings suggest that MDS are frequently associated with CoQ deficiency, as a possible secondary consequence of disease pathophysiology. Assessment of muscle CoQ status seems advisable in MDS patients since the possibility of CoQ supplementation may then be considered as a candidate therapy. (c) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Montero, Raquel; Artuch, Rafael; del Mar O'Callaghan, Maria; Jou, Cristina; Jimenez, Cecilia; Pineda, Merce; Garcia-Cazorla, Angels; Nascimento, Andres; Perez-Duenas, Belen] Hosp St Joan de Deu, Dept Clin Chem, Barcelona 08950, Spain.
   [Montero, Raquel; Artuch, Rafael; del Mar O'Callaghan, Maria; Jou, Cristina; Jimenez, Cecilia; Pineda, Merce; Garcia-Cazorla, Angels; Nascimento, Andres; Perez-Duenas, Belen] Hosp St Joan de Deu, Dept Pathol, Barcelona 08950, Spain.
   [Montero, Raquel; Artuch, Rafael; del Mar O'Callaghan, Maria; Jou, Cristina; Jimenez, Cecilia; Pineda, Merce; Garcia-Cazorla, Angels; Nascimento, Andres; Perez-Duenas, Belen] Hosp St Joan de Deu, Dept Neurol, Barcelona 08950, Spain.
   [Montero, Raquel; Lopez-Gallardo, Ester; Montoya, Julio; Briones, Paz; Navarro-Sastre, Aleix; Artuch, Rafael; Pineda, Merce; Garcia-Cazorla, Angels; Navas, Placido] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [Grazina, Manuela] Univ Coimbra, Fac Med, P-3000 Coimbra, Portugal.
   [Grazina, Manuela; Simoes, Marta; Mendes, Candida; Santos, Maria Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, Lab Biochem Genet, P-3000 Coimbra, Portugal.
   [Lopez-Gallardo, Ester; Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50009 Zaragoza, Spain.
   [Briones, Paz; Navarro-Sastre, Aleix; Bujan, Nuria] Hosp Clin Barcelona, IBC Seccio Errors Congenits Metab, Serv Bioquim & Genet Mol, Barcelona, Spain.
   [Briones, Paz] CSIC, Barcelona, Spain.
   [Land, John M.; Hargreaves, Iain P.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Fratter, Carl] Churchill Hosp, Oxford Med Genet Labs, Oxford OX3 7LJ, England.
   [Salviati, Leonardo] Univ Padua, Serv Genet Clin & Epidemiol, Dept Pediat, I-35100 Padua, Italy.
   [Diogo, Luisa; Garcia, Paula] Ctr Hosp, Hosp Pediat Coimbra, Coimbra, Portugal.
   [Diogo, Luisa; Garcia, Paula] Univ Coimbra, P-3000 Coimbra, Portugal.
   [Navas, Placido] Univ Pablo de Olavide CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.
C3 University of Barcelona; University of Barcelona; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Coimbra; Universidade de Coimbra; University of Zaragoza; University of Barcelona; Hospital Clinic de Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Oxford; University of Padua; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)
RP Artuch, R (corresponding author), Hosp St Joan de Deu, Dept Clin Biochem, Passeig St Joan de Deu 2, Barcelona 08950, Spain.
EM rartuch@hsjdbcn.org
FU Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Spain (FIS) [PI11/00078, PI10/00662, PI11/01301, PI08/0307, PI08/0663, PI07/00184]; The Centro de Investigaciones Biomedicas en Red de Enfermedades Raras (CIBERER) by Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon y Fondo Social Europeo (Grupo B33); Asociacion de Enfermos de Patologia Mitocondrial (AEPMI); Department of Health's NIHR Biomedical Research Centres
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Grazina MM, 2012, METHODS MOL BIOL, V837, P73, DOI 10.1007/978-1-61779-504-6_6
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   López-Martín JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nogueira C, 2011, J CHILD NEUROL, V26, P866, DOI 10.1177/0883073811402072
   OCallaghan M, 2012, NEUROGENETICS, V26, P0
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tavares MV, 2013, J INHERIT METAB DIS, V36, P805, DOI 10.1007/s10545-012-9567-x
   Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528
   Yen HC, 2011, J BIOCHEM MOL TOXIC, V25, P280, DOI 10.1002/jbt.20387
NR 36
TC 44
Z9 48
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2013
VL 13
IS 4
BP 337
EP 341
DI 10.1016/j.mito.2013.04.001
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 162VR
UT WOS:000320294600010
PM 23583954
DA 2024-11-01
ER

PT J
AU Krag, TO
   Hauerslev, S
   Jeppesen, TD
   Duno, M
   Vissing, J
AF Krag, T. O.
   Hauerslev, S.
   Jeppesen, T. D.
   Duno, M.
   Vissing, J.
TI Muscle regeneration in mitochondrial myopathies
SO MITOCHONDRION
LA English
DT Article
DE Mitochondria; Muscle regeneration; Mitochondrial myopathy; mtDNA; Neonatal myosin heavy chain
ID progressive external ophthalmoplegia; dna deletions; point mutation; late-onset; gene; twinkle; alpha-7-beta-1; expression; phenotype; integrin
AB Mitochondrial myopathies cover a diverse group of disorders in which ragged red and COX-negative fibers are common findings on muscle morphology. In contrast, muscle degeneration and regeneration, typically found in muscular dystrophies, are not considered characteristic features of mitochondrial myopathies. We investigated regeneration in muscle biopsies from 61 genetically well-defined patients affected by mitochondrial myopathy. Our results show that the perturbed energy metabolism in mitochondrial myopathies causes ongoing muscle regeneration in a majority of patients, and some were even affected by a dystrophic morphology. The results add to the complexity of the pathogenesis underlying mitochondrial myopathies, and expand the knowledge about the impact of energy deficiency on another aspect of muscle structure and function. (C) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Krag, T. O.; Hauerslev, S.; Jeppesen, T. D.; Vissing, J.] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark.
   [Duno, M.] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.
C3 Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen
RP Krag, TO (corresponding author), Rigshosp, Neuromuscular Res Unit, Sect 3342, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM thomas.krag@rh.dk
FU Danish Medical Research Council; Lundbeck Foundation; Novo Nordisk Foundation; AP Moller Foundations
CR Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dubec SJ, 2008, REJUV RES, V11, P611, DOI 10.1089/rej.2007.0617
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, P0, DOI 10.1186/1471-2474-13-43
   Hodges BL, 1997, J CELL SCI, V110, P2873
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Krag TO, 2011, SKELET MUSCLE, V1, P0, DOI 10.1186/2044-5040-1-31
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Marsh DR, 1997, J APPL PHYSIOL, V83, P1270, DOI 10.1152/jappl.1997.83.4.1270
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   SARTORE S, 1982, NATURE, V298, P294, DOI 10.1038/298294a0
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
NR 30
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2013
VL 13
IS 2
BP 63
EP 70
DI 10.1016/j.mito.2013.01.009
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 125NW
UT WOS:000317547500001
PM 23376095
DA 2024-11-01
ER

PT J
AU Chen, WT
   Huo, JH
   Ma, AQ
   Bai, L
   Liu, P
AF Chen, Wenting
   Huo, Jianhua
   Ma, Aiqun
   Bai, Ling
   Liu, Ping
TI A novel mutation of the <i>LMNA</i> gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE Family dilated cardiomyopathy; Genetics; Mutation; LMNA
ID dreifuss muscular-dystrophy; lamin a/c mutation; cause autosomal-dominant; mitochondrial-dna; architecture; phenotypes; proteins; cells; risk
AB The LMNA gene, which encodes the nuclear envelope protein lamin A/C, is considered to be the most common autosomal disease gene associated with familial dilated cardiomyopathy. To date, each mutation of the LMNA gene has been associated with a specific disease phenotype. Clinical data, family histories, and blood samples were collected from 27 biological members of a family with dilated cardiomyopathy, prominently occurring as heart failure and conduction system disease with a high incidence of sudden cardiac death in young females. Twelve exons of the LMNA gene were screened for nucleotide alterations. A novel insertion mutation (nucleotide 1526insA, amino acid T510Y) in exon nine of the LMNA gene was identified in seven subjects (7/27, 25.9 %). This reveals that the LMNA gene insertion mutation (T510Y frameshift mutation) can cause dilated cardiomyopathy, conduction system disease, and sudden cardiac death without skeletal myopathy, clinically manifested with early onset, severe symptoms, and poor prognosis.
C1 [Chen, Wenting; Huo, Jianhua; Ma, Aiqun; Bai, Ling; Liu, Ping] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Cardiovasc Med, Xian 710061, Shaanxi, Peoples R China.
   [Chen, Wenting] Suzhou Municipal Hosp, Dept Cardiovasc Med, Suzhou, Peoples R China.
C3 Xi'an Jiaotong University
RP Liu, P (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Cardiovasc Med, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.
EM pingdoctor@163.com
CR Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2
   Bécane HM, 2000, PACE, V23, P1661, DOI 10.1046/j.1460-9592.2000.01661.x
   Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109
   Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906
   Chandar S, 2010, CIRC RES, V106, P573, DOI 10.1161/CIRCRESAHA.109.204388
   Crispell KA, 2002, J AM COLL CARDIOL, V39, P1503, DOI 10.1016/S0735-1097(02)01788-6
   De Backer J, 2010, INT J CARDIOL, V138, P97, DOI 10.1016/j.ijcard.2008.06.008
   DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52
   di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869
   Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302
   FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450
   Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101
   Grünig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Hershberger RE, 2002, AM HEART J, V144, P1081, DOI 10.1067/mhj.2002.126737
   Hutchison CJ, 2001, J CELL SCI, V114, P9
   Jakobs PM, 2001, J CARD FAIL, V7, P249, DOI 10.1054/jcaf.2001.26339
   Kärkkäinen S, 2007, ANN MED, V39, P91, DOI 10.1080/07853890601145821
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8
   OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434
   Quarta G, 2012, EUR HEART J, V33, P1128, DOI 10.1093/eurheartj/ehr451
   Seliem MA, 2000, PEDIATR RES, V48, P770, DOI 10.1203/00006450-200012000-00012
   Siu CW, 2012, AGING-US, V4, P803, DOI 10.18632/aging.100503
   SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3
   TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854
   van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1
   Wydner KL, 1996, GENOMICS, V32, P474, DOI 10.1006/geno.1996.0146
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 33
TC 9
Z9 9
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD OCT 15
PY 2013
VL 382
IS 1-2
BP 307
EP 311
DI 10.1007/s11010-013-1734-3
PG 5
WC Cell Biology
SC Cell Biology
GA 216AT
UT WOS:000324253900031
PM 23793583
DA 2024-11-01
ER

PT J
AU Yorns, WR
   Hardison, HH
AF Yorns, William R., Jr.
   Hardison, H. Huntley
TI Mitochondrial Dysfunction in Migraine
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID magnetic-resonance-spectroscopy; brain energy-metabolism; thioctic acid; astrocytes; headache; coenzyme-q10; riboflavin; topiramate; deficiency; mechanism
AB Migraine is the most frequent type of headache in children. In the 1980s, scientists first hypothesized a connection between migraine and mitochondrial (mt) disorders. More recent studies have suggested that at least some subtypes of migraine may be related to a mt defect. Different types of evidence support a relationship between mitochondria (mt) and migraine: (1) Biochemical evidence: Abnormal mt function translates into high intracellular penetration of Ca2+, excessive production of free radicals, and deficient oxidative phosphorylation, which ultimately causes energy failure in neurons and astrocytes, thus triggering migraine mechanisms, including spreading depression. The mt markers of these events are low activity of superoxide dismutase, activation of cytochrome-c oxidase and nitric oxide, high levels of lactate and pyruvate, and low ratios of phosphocreatine-inorganic phosphate and N-acetylaspartate-choline. (2) Morphologic evidence: mt abnormalities have been shown in migraine sufferers, the most characteristic ones being direct observation in muscle biopsy of ragged red and cytochrome-c oxidase-negative fibers, accumulation of subsarcolemmal mt, and demonstration of giant mt with paracrystalline inclusions. (3) Genetic evidence: Recent studies have identified specific mutations responsible for migraine susceptibility. However, the investigation of the mtDNA mutations found in classic mt disorders (mt encephalomyopathy with lactic acidosis and stroke-like episodes, myoclonus epilepsy with ragged red fibers, Kearns-Sayre syndrome, and Leber hereditary optic neuropathy) has not demonstrated any association. Recently, 2 common mtDNA polymorphisms (16519C -> T and 3010G -> A) have been associated with pediatric cyclic vomiting syndrome and migraine. Also, POLG mutations (eg, p.T851 A, p.N468D, p.Y831C, p.G517V, and p.P163S) can cause disease through impaired replication of mtDNA, including migraine. Further studies to investigate the relationship between mtDNA and migraine will require very large sample sizes to obtain statistically significant results. (4) Therapeutic evidence: Several agents that have a positive effect on mt metabolism have shown to be effective in the treatment of migraines. The agents include riboflavin (B2), coenzyme 910, magnesium, niacin, carnitine, topiramate, and lipoic acid. Further study is warranted to learn how mt interact with other factors to cause migraines. This will facilitate the development of new and more specific treatments that will reduce the frequency or severity or both of this disease. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Yorns, William R., Jr.; Hardison, H. Huntley] St Christophers Hosp Children, Neurol Sect, Philadelphia, PA 19134 USA.
   [Yorns, William R., Jr.; Hardison, H. Huntley] Drexel Univ, Coll Med, Dept Pediat, Philadelphia, PA 19104 USA.
   [Yorns, William R., Jr.; Hardison, H. Huntley] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.
C3 Drexel University; Drexel University
RP Hardison, HH (corresponding author), St Christophers Hosp Children, Neurol Sect, 3601 A St, Philadelphia, PA 19134 USA.
EM hhardiso@drexelmed.edu
FU St. Christopher's Foundation (St. Christopher's Hospital for Children); PHEC (Philadelphia Health Education Corporation; DUCOM (Drexel University College of Medicine), Philadelphia, Pennsylvania
CR Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676
   ARTS WFM, 1983, LANCET, V2, P581
   Balbi T, 2005, J FORENSIC SCI, V50, P630
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   BARBIROLI B, 1995, J NEUROL, V242, P472, DOI 10.1007/BF00873552
   Boehnke C, 2004, EUR J NEUROL, V11, P475, DOI 10.1111/j.1468-1331.2004.00813.x
   BRESOLIN N, 1991, J NEUROL SCI, V104, P182, DOI 10.1016/0022-510X(91)90308-T
   Chan A, 1998, J NEUROL, V245, P681, DOI 10.1007/s004150050267
   Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C
   Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321
   CODERRE TJ, 1992, J NEUROSCI, V12, P3671
   Crane FL, 1997, MOL ASPECTS MED, V18, P0
   Cruz M, 2009, CLIN PEDIAT NEUROSCI, V0, P303
   Cruz MJ, 2009, PEDIATR NEUROL, V41, P167, DOI 10.1016/j.pediatrneurol.2009.04.020
   Cutrer FM, 2013, HEADACHE, V53, P401, DOI 10.1111/head.12024
   DAndrea G, 2006, CEPHALALGIA, V26, P968, DOI 10.1111/j.1468-2982.2006.01141.x
   de Tommaso M, 2012, J HEADACHE PAIN, V13, P389, DOI 10.1007/s10194-012-0448-3
   DEVOTO M, 1986, CEPHALALGIA, V6, P101, DOI 10.1046/j.1468-2982.1986.0602101.x
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Goadsby PJ, 2008, WOLFFS HEADACHE AND OTHER HEAD PAIN, V8th, P105
   Gu T, 2008, NEUROL RES, V30, P229, DOI 10.1179/016164107X235473
   HAUGAARD N, 1970, BIOCHIM BIOPHYS ACTA, V222, P583, DOI 10.1016/0304-4165(70)90183-2
   Kabbouche MA, 2003, HEADACHE, V43, P490, DOI 10.1046/j.1526-4610.2003.03095.x
   Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008
   Kudin AP, 2004, EPILEPSIA, V45, P1478, DOI 10.1111/j.0013-9580.2004.13504.x
   LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409
   Lemos C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050626
   Lian XY, 2004, EUR J NEUROSCI, V19, P2446, DOI 10.1111/j.0953-816X.2004.03289.x
   LITTLEWOOD J, 1984, J NEUROL NEUROSUR PS, V47, P338, DOI 10.1136/jnnp.47.4.338
   Lodi R, 2001, BRAIN RES BULL, V54, P437, DOI 10.1016/S0361-9230(01)00440-3
   MAESAKA H, 1976, EUR J PEDIATR, V122, P159, DOI 10.1007/BF00466274
   Magis D, 2007, HEADACHE, V47, P52, DOI 10.1111/j.1526-4610.2006.00626.x
   Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X
   Majamaa K, 1996, LIFE SCI, V58, P691, DOI 10.1016/0024-3205(95)02338-0
   Markley HG, 2012, HEADACHE, V52, P81, DOI 10.1111/j.1526-4610.2012.02233.x
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Mauskop A, 2012, J NEURAL TRANSM, V119, P575, DOI 10.1007/s00702-012-0790-2
   Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   MONTAGNA P, 1994, CEPHALALGIA, V14, P184, DOI 10.1046/j.1468-2982.1994.014003184.x
   Montagna P, 1997, NEUROLOGY, V48, P113, DOI 10.1212/WNL.48.1.113
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Prousky J, 2005, NUTR J, V4, P0, DOI 10.1186/1475-2891-4-3
   Rosen N, 2008, HEADACHE, V48, P733, DOI 10.1111/j.1526-4610.2008.01118.x
   Rozen TD, 2002, CEPHALALGIA, V22, P137, DOI 10.1046/j.1468-2982.2002.00335.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Sarchielli P, 2005, NEUROIMAGE, V24, P1025, DOI 10.1016/j.neuroimage.2004.11.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seibel P, 1996, J NEUROL, V243, P305, DOI 10.1007/BF00868402
   Shanker G, 2001, BRAIN RES, V902, P156, DOI 10.1016/S0006-8993(01)02342-3
   SHIMOMURA T, 1994, CEPHALALGIA, V14, P215, DOI 10.1046/j.1468-2982.1994.014003215.x
   SHIMOMURA T, 1994, LANCET, V344, P625, DOI 10.1016/S0140-6736(94)92015-X
   Silberstein S, 2013, HEADACHE, V0, P0
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   Wanic-Kossowska M, 1997, POL ARCH MED WEWN, V97, P534
   Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x
   WELCH KMA, 1995, J NEUROL SCI, V134, P9, DOI 10.1016/0022-510X(95)00196-1
   WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Zaki E A, 2009, CEPHALALGIA, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x
NR 65
TC 87
Z9 89
U1 0
U2 29
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD SEP 15
PY 2013
VL 20
IS 3
BP 188
EP 193
DI 10.1016/j.spen.2013.09.002
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 269SK
UT WOS:000328262000004
PM 24331360
DA 2024-11-01
ER

PT J
AU Tarnopoisky, M
   Meaney, B
   Robinson, B
   Sheidon, K
   Boles, RG
AF Tarnopoisky, Mark
   Meaney, Brandon
   Robinson, Brian
   Sheidon, Katherine
   Boles, Richard G.
TI Severe Infantile Leigh Syndrome Associated With a Rare Mitochondrial <i>ND</i>6 Mutation, m.14487T&gt;C
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE Leigh disease; deep sequencing; homoplasmy; mitochondrial disease
ID prenatal-diagnosis; mtdna
AB We describe a case of severe infantile-onset complex I deficiency in association with an apparent de novo near-homoplasmic mutation (m.14487T>C) in the mitochondrial ND6 gene, which was previously associated with Leigh syndrome and other neurological disorders. The mutation was near-homoplasmic in muscle by NextGen sequencing (99.4% mutant), homoplasmic in muscle by Sanger sequencing, and it was associated with a severe complex I deficiency in both muscle and fibroblasts. This supports previous data regarding Leigh syndrome being on the severe end of a phenotypic spectrum including progressive myoclonic epilepsy, childhood-onset dystonia, bilateral striatal necrosis, and optic atrophy, depending on the proportion of mutant heteroplasmy. While the mother in all previously reported cases was heteroplasmic, the mother and brother of this case were homoplasmic for the wild-type, m.14487T. Importantly, the current data demonstrate the potential for cases of mutations that were previously reported to be homoplasmic by Sanger sequencing to be less homoplasmic by NextGen sequencing. This case underscores the importance of considering mitochondrial DNA mutations in families with a negative family history, even in offspring of those who have tested negative for a specific mtDNA mutation. Copyright (C) 2013 Wiley Periodicals, Inc.
C1 [Tarnopoisky, Mark; Meaney, Brandon] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Robinson, Brian] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1X8, Canada.
   [Sheidon, Katherine; Boles, Richard G.] Courtagen Diagnost Lab, Woburn, MA USA.
C3 McMaster University; University of Toronto; Hospital for Sick Children (SickKids)
RP Tarnopoisky, M (corresponding author), McMaster Univ, Dept Pediat, 1200 Main St W,HSC 2H26, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
FU Warren Lammert and Family; Dan Wright and family; MitoCanada
CR Christodoulou J, 1992, AM J HUM GENET, V50, P852
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Robinson BH, 2001, SEMIN NEUROL, V21, P269, DOI 10.1055/s-2001-17944
   ROBINSON BH, 1994, J BIOENERG BIOMEMBR, V26, P311, DOI 10.1007/BF00763102
   Safdar A, 2010, PLOS ONE, V5, P0
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
NR 12
TC 19
Z9 21
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD AUG 15
PY 2013
VL 161
IS 8
BP 2020
EP 2023
DI 10.1002/ajmg.a.36000
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 263EM
UT WOS:000327789600026
PM 23813926
DA 2024-11-01
ER

PT J
AU Paradas, C
   Camaño, P
   Otaegui, D
   Oz, O
   Emmanuele, V
   DiMauro, S
   Hirano, M
AF Paradas, Carmen
   Camano, Pilar
   Otaegui, David
   Oz, Oguzhan
   Emmanuele, Valentina
   DiMauro, Salvatore
   Hirano, Michio
TI Longitudinal Clinical Follow-up of a Large Family With the R357P Twinkle Mutation
SO JAMA NEUROLOGY
LA English
DT Article
ID progressive external ophthalmoplegia; mitochondrial-dna depletion; helicase; deletions
AB IMPORTANCE Autosomal dominant progressive external ophthalmoplegia due to PEO1 mutations is considered relatively benign, but no data about long-term progression of this disease have been reported. The aim of this study was to provide a 16-year clinical follow-up of autosomal dominant progressive external ophthalmoplegia due to the p. R357P gene mutation in PEO1. OBSERVATIONS Twenty-two members of an Irish-American family were examined in 1996, when PEO1 sequencing revealed a c. 1071G>C/p. R357P mutation in 9 of them. We reexamined the family in 2012 using a standardized clinical protocol. Autosomal dominant progressive external ophthalmoplegia due to the p. R357P PEO1 mutation is a late-onset ocular myopathy beginning with ptosis and progressing slowly. Ophthalmoparesis, if present, is mild and evident only by neurological examination. CONCLUSIONS AND RELEVANCE Our results are important for prognosis and genetic counseling.
C1 [Paradas, Carmen] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,Serv Neurol,Unidad Enfermedad, Seville, Spain.
   [Paradas, Carmen; Camano, Pilar] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Minist Econ & Competitiveness, Madrid, Spain.
   [Paradas, Carmen; Camano, Pilar; Otaegui, David; Oz, Oguzhan; Emmanuele, Valentina; DiMauro, Salvatore; Hirano, Michio] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   [Camano, Pilar] Ilundain Haritz Berri Fundazioa, Valle De Aranguren, Spain.
   [Camano, Pilar; Otaegui, David] Donostia Hosp, BioDonostia Hlth Res Inst, Dept Neurosci, San Sebastian, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Instituto de Salud Carlos III; Spanish Ministry of Economy & Competitiveness; CIBERNED; Columbia University; Instituto de Investigacion Sanitaria Biogipuzkoa; University Hospital Donostia
RP Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St,Room 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD32062, R01 HD057543, R01 HD056103]; National Institute of Neurological Disorders and Stroke [U54NS078059]; Marriott Mitochondrial Disorder Clinical Research Fund; Office of Dietary Supplements; Muscular Dystrophy Association; Spanish government, Health Institute Carlos III, Ministerio de Economia y Competitividad. [BA12/0097]
CR Allen RC, 2012, BRIT J OPHTHALMOL, V96, P841, DOI 10.1136/bjophthalmol-2011-300667
   Bladen JC, 2012, ORBIT, V31, P114, DOI 10.3109/01676830.2011.648805
   Bohlega S, 2009, NEUROMUSCULAR DISORD, V19, P845, DOI 10.1016/j.nmd.2009.10.002
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Johnson JA, 1998, PHARMACOECONOMICS, V13, P421, DOI 10.2165/00019053-199813040-00005
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
NR 15
TC 3
Z9 3
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD NOV 15
PY 2013
VL 70
IS 11
BP 1425
EP 1428
DI 10.1001/jamaneurol.2013.3185
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 295LG
UT WOS:000330117000013
PM 24018892
DA 2024-11-01
ER

PT J
AU Sohl, CD
   Kasiviswanathan, R
   Copeland, WC
   Anderson, KS
AF Sohl, Christal D.
   Kasiviswanathan, Rajesh
   Copeland, William C.
   Anderson, Karen S.
TI Mutations in human DNA polymerase γ confer unique mechanisms of catalytic deficiency that mirror the disease severity in mitochondrial disorder patients
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; reverse-transcriptase; autosomal-dominant; polg1 mutations; toxicity; replication; defects; subunit; discrimination; parkinsonism
AB Human mitochondrial DNA polymerase gamma (pol gamma) is solely responsible for the replication and repair of the mitochondrial genome. Unsurprisingly, alterations in pol gamma activity have been associated with mitochondrial diseases such as Alpers syndrome and progressive external ophthalmoplegia. Thus far, predicting the severity of mitochondrial disease based the magnitude of deficiency in pol gamma activity has been difficult. In order to understand the relationship between disease severity in patients and enzymatic defects in vitro, we characterized the molecular mechanisms of four pol gamma mutations, A957P, A957S, R1096C and R1096H, which have been found in patients suffering from aggressive Alpers syndrome to mild progressive external ophthalmoplegia. The A957P mutant showed the most striking deficiencies in the incorporation efficiency of a correct deoxyribonucleotide triphosphate (dNTP) relative to wild-type pol gamma, with less, but still significant incorporation efficiency defects seen in R1096H and R1096C, and only a small decrease in incorporation efficiency observed for A957S. Importantly, this trend matches the disease severity observed in patients very well (approximated as A957P >> R1096C >= R1096H >> A957S, from most severe disease to least severe). Further, the A957P mutation conferred a two orders of magnitude loss of fidelity relative to wild-type pol gamma, indicating that a buildup of mitochondrial genomic mutations may contribute to the death in infancy seen with these patients. We conclude that characterizing the unique molecular mechanisms of pol gamma deficiency for physiologically important mutant enzymes is important for understanding mitochondrial disease and for predicting disease severity.
C1 [Sohl, Christal D.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.
   [Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA.
C3 Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.
EM karen.anderson@yale.edu
FU National Institutes of Health [GM049551, GM099289, ES 065080]
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bailey CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1213, DOI 10.1016/j.bbapap.2010.01.007
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rajender S, 2010, MITOCHONDRION, V10, P419, DOI 10.1016/j.mito.2010.05.015
   Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Sohl CD, 2012, MOL PHARMACOL, V82, P125, DOI 10.1124/mol.112.078758
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 46
TC 13
Z9 15
U1 0
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAR 15
PY 2013
VL 22
IS 6
BP 1074
EP 1085
DI 10.1093/hmg/dds509
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 108MD
UT WOS:000316296600002
PM 23208208
DA 2024-11-01
ER

PT J
AU Fam, HK
   Chowdhury, MK
   Walton, C
   Choi, K
   Boerkoel, CF
   Hendson, G
AF Fam, Hok Khim
   Chowdhury, Miraj K.
   Walton, Cheryl
   Choi, Kunho
   Boerkoel, Cornelius F.
   Hendson, Glenda
TI Expression profile and mitochondrial colocalization of Tdp1 in peripheral human tissues
SO JOURNAL OF MOLECULAR HISTOLOGY
LA English
DT Article
DE Tdp1; Cytoplasmic localization; Nuclear localization; Oxidative stress; Mitochondrial localization
ID tyrosyl-dna phosphodiesterase; strand break repair; spinocerebellar ataxia; topoisomerase-i; axonal neuropathy; mouse-liver; human-cells; damage; disease; mutation
AB Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a DNA repair enzyme that processes blocked 3' ends of DNA breaks. Functional loss of Tdp1 causes spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1). Based on the prominent cytoplasmic expression of Tdp1 in the neurons presumably affected in SCAN1, we hypothesized that Tdp1 participates in the repair of mitochondrial DNA. As a step toward testing this hypothesis, we profiled Tdp1 expression in different human tissues by immunohistochemistry and immunofluorescence respectively and determined whether Tdp1 was expressed in the cytoplasm of tissues other than the neurons. We found that Tdp1 was ubiquitously expressed and present in the cytoplasm of many cell types. Within human skeletal muscle and multiple mouse tissues, Tdp1 partially colocalized with the mitochondria. In cultured human dermal fibroblasts, Tdp1 redistributed to the cytoplasm and partially colocalized with mitochondria following oxidative stress. These studies suggest that one role of cytoplasmic Tdp1 is the repair of mitochondrial DNA lesions arising from oxidative stress.
C1 [Fam, Hok Khim; Chowdhury, Miraj K.; Walton, Cheryl; Choi, Kunho; Boerkoel, Cornelius F.] Univ British Columbia, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada.
   [Fam, Hok Khim; Chowdhury, Miraj K.; Walton, Cheryl; Choi, Kunho; Boerkoel, Cornelius F.] Rare Dis Fdn, Vancouver, BC, Canada.
   [Boerkoel, Cornelius F.] Univ British Columbia, Prov Med Genet Program, Dept Med Genet, Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC V6H 3N1, Canada.
   [Hendson, Glenda] Univ British Columbia, Childrens & Womens Hlth Ctr British Columbia, Dept Anat Pathol, Vancouver, BC V6H 3N1, Canada.
C3 Child & Family Research Institute; University of British Columbia; University of British Columbia; BC Women's Hospital & Health Centre; BC Women's Hospital & Health Centre; University of British Columbia
RP Boerkoel, CF (corresponding author), Univ British Columbia, Prov Med Genet Program, Dept Med Genet, Childrens & Womens Hlth Ctr British Columbia, 4500 Oak St,Room C234, Vancouver, BC V6H 3N1, Canada.
EM nboerkoel@cfri.ca
FU United Mitochondrial Disease Foundation; Child & Family Research Institute; Canadian Institutes of Health Research [248178]; Michael Cuccione Studentship for Oncology Research
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Chiang SC, 2010, CELL CYCLE, V9, P588, DOI 10.4161/cc.9.3.10598
   Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107
   Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4
   Dexheimer TS, 2010, NUCLEIC ACIDS RES, V38, P2444, DOI 10.1093/nar/gkp1206
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   El-Khamisy SF, 2007, DNA REPAIR, V6, P1485, DOI 10.1016/j.dnarep.2007.04.015
   El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002
   Fam A, 2012, SPINOCEREBE IN PRESS, V0, P0
   GRAHAM J, 1994, ANAL BIOCHEM, V220, P367, DOI 10.1006/abio.1994.1351
   Hafezparast M, 2002, LANCET NEUROL, V1, P215, DOI 10.1016/S1474-4422(02)00100-X
   Hawkins AJ, 2009, DNA REPAIR, V8, P654, DOI 10.1016/j.dnarep.2008.12.012
   Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Hudson JJR, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1739
   Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200
   Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kamenisch Y, 2010, J EXP MED, V207, P379, DOI 10.1084/jem.20091834
   Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869
   Koene S, 2011, MITOCHONDRIAL MED CL, V0, P0
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Liu CY, 2004, DNA REPAIR, V3, P593, DOI 10.1016/j.dnarep.2004.03.030
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101
   Ogata T, 1997, ANAT REC, V248, P214
   Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552
   Raymond AC, 2005, J BIOL CHEM, V280, P22029, DOI 10.1074/jbc.M502148200
   Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5
   SILHAVY TJ, 1983, MICROBIOL REV, V47, P313, DOI 10.1128/MMBR.47.3.313-344.1983
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Walton C, 2009, DNA REPAIR MUTAGENES, V0, P0
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170
   Zhou WH, 2001, HEPATOLOGY, V33, P902, DOI 10.1053/jhep.2001.23073
NR 40
TC 15
Z9 16
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1567-2379
EI 
J9 J MOL HISTOL
JI J. Mol. Histol.
PD AUG 15
PY 2013
VL 44
IS 4
BP 481
EP 494
DI 10.1007/s10735-013-9496-5
PG 14
WC Cell Biology
SC Cell Biology
GA 190JL
UT WOS:000322335700012
PM 23536040
DA 2024-11-01
ER

PT J
AU Cheldi, A
   Ronchi, D
   Bordoni, A
   Bordo, B
   Lanfranconi, S
   Bellotti, MG
   Corti, S
   Lucchini, V
   Sciacco, M
   Moggio, M
   Baron, P
   Comi, GP
   Colombo, A
   Bersano, A
AF Cheldi, Antonella
   Ronchi, Dario
   Bordoni, Andreina
   Bordo, Bianca
   Lanfranconi, Silvia
   Bellotti, Maria Grazia
   Corti, Stefania
   Lucchini, Valeria
   Sciacco, Monica
   Moggio, Maurizio
   Baron, Pierluigi
   Comi, Giacomo Pietro
   Colombo, Antonio
   Bersano, Anna
TI POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome
SO BMC NEUROLOGY
LA English
DT Article
DE POLG1; MELAS; Red-ragged fibers; Stroke-like
ID progressive external ophthalmoplegia; mitochondrial-dna deletions; polymerase gamma-a; gene; disease; encephalopathy; population; spectrum
AB Background: POLG1 mutations have been associated with MELAS-like phenotypes. However given several clinical differences it is unknown whether POLG1 mutations are possible causes of MELAS or give raise to a distinct clinical and genetic entity, named POLG1-associated encephalopathy. Case presentation: We describe a 74 years old man carrying POLG1 mutations presenting with strokes, myopathy and ragged red fibers with some atypical aspects for MELAS such as late onset, lack of cerebral calcification and presence of frontal and occipital MRI lesions better consistent with the POLG associated-encephalopathy spectrum. Conclusion: The lack of available data hampers a definite diagnosis in our patient as well as makes it difficult to compare MELAS, which is a clearly defined clinical syndrome, with POLG1-associated encephalopathy, which is so far a purely molecularly defined syndrome with a quite heterogeneous clinical picture. However, the present report contributes to expand the phenotypic spectrum of POLG1 mutations underlining the importance of searching POLG1 mutations in patients with mitochondrial signs and MELAS like phenotypes but negative for common mtDNA mutations.
C1 [Cheldi, Antonella; Bordo, Bianca; Bellotti, Maria Grazia; Colombo, Antonio] Azienda Osped Desio & Vimercate, Osped Desio, Neurol Unit, Monza, Italy.
   [Ronchi, Dario; Bordoni, Andreina; Lanfranconi, Silvia; Corti, Stefania; Baron, Pierluigi; Comi, Giacomo Pietro] Univ Milan, Dept Pathophysiol & Transplantat DEPT, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr,Neurol Unit,Neurosci Sect, I-20122 Milan, Italy.
   [Lucchini, Valeria; Sciacco, Monica; Moggio, Maurizio] Univ Milan, Neuromuscular Unit, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Bersano, Anna] IRCCS Fdn Neurol Inst C Besta, Cerebrovasc Unit, I-20135 Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Bersano, A (corresponding author), IRCCS Fdn Neurol Inst C Besta, Cerebrovasc Unit, Via Celoria 23, I-20135 Milan, Italy.
EM anna.bersano@gmail.com
FU 'LOMBARDIA GENS' network; Associazione Amici del Centro Dino Ferrari; University of Milan; Telethon project [GTB07001]; Eurobiobank project [QLTR-2001-02769]; Criobanca Automatizzata di Materiale Biologico [R.F. 02.187]
CR Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tzoulis C, 2008, NEUROLOGY, V70, P1054, DOI 10.1212/01.wnl.0000307661.98694.c3
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 23
TC 25
Z9 28
U1 1
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2377
EI 
J9 BMC NEUROL
JI BMC Neurol.
PD JAN 15
PY 2013
VL 13
IS 
BP 
EP 
DI 10.1186/1471-2377-13-8
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 088LL
UT WOS:000314835800001
PM 23324391
DA 2024-11-01
ER

PT J
AU Yuan, JH
   Sakiyama, Y
   Higuchi, I
   Inamori, Y
   Higuchi, Y
   Hashiguchi, A
   Higashi, K
   Yoshimura, A
   Takashima, H
AF Yuan, Jun-Hui
   Sakiyama, Yusuke
   Higuchi, Itsuro
   Inamori, Yukie
   Higuchi, Yujiro
   Hashiguchi, Akihiro
   Higashi, Keiko
   Yoshimura, Akiko
   Takashima, Hiroshi
TI Mitochondrial myopathy with autophagic vacuoles in patients with the m.8344A&gt;G mutation
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID ragged-red fibers; clinical-features; myoclonic epilepsy; dna mutation; a8344g merrf; heteroplasmy; expression; trna(lys); disease; abnormality
AB Background and aims In mitochondrial myopathy, autophagy is presumed to play an important role in mitochondrial dysfunction. Rimmed vacuoles (RVs), a sign of autophagy, can be seen as a secondary phenomenon in muscle ragged-red fibres (RRFs), whereas the uncommon presentation is that some fibres contain RVs, but without any mitochondrial abnormalities. To investigate the pathogenesis beneath this pathological phenomenon. Methods We reviewed 783 skeletal muscle specimens and selected five obtained from patients with suspected mitochondrial myopathy, characterised by clearly visible autophagic vacuoles in non-RRFs, besides the coexistence of RRFs and cytochrome oxidase-negative fibres. Immunohistochemical staining with LC-3, and electron microscopy studies were performed. Using resequencing microarray and a next-generation sequencing system, the mitochondrial DNA was screened for mutations and the heteroplasmic level was measured in skeletal muscle and blood. Results Muscle fibres with RVs and RRFs, as well as some morphologically normal fibres, stained strongly for LC-3. Electron microscopy disclosed significant abnormal mitochondrial proliferation and existence of autophagic vacuoles. After mutation screening, m.8344A>G in the tRNA(Lys) gene was detected in two patients. The heteroplasmy of mutated G was 45.1% in skeletal muscle and 17.8% in blood in patient 1; patient 2 exhibited 80.3% mutated G in skeletal muscle and 25.2% in blood. Conclusions These findings demonstrate a new pathological phenotype for the m.8344A>G mutation- related disease and also provide pathological evidence of a correlation between mitochondrial abnormalities and autophagy.
C1 [Yuan, Jun-Hui; Sakiyama, Yusuke; Higuchi, Itsuro; Inamori, Yukie; Higuchi, Yujiro; Hashiguchi, Akihiro; Higashi, Keiko; Yoshimura, Akiko; Takashima, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 8908520, Japan.
C3 Kagoshima University
RP Takashima, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.
EM thiroshi@m3.kufm.kagoshima-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan [21591095, 21591094]; intramural research grant for neurological and psychiatric disorders of the National Center of Neurology and Psychiatry [21B-1]; Nervous and Mental Disorders and Research Committee for Charcot-Marie-Tooth disease, neuropathy, ataxic disease; Ministry of Health, Labour and Welfare of Japan [23300201]; Ministry of Health, Welfare and Labour, Japan; Grants-in-Aid for Scientific Research [23300201, 21591094, 21591095] Funding Source: KAKEN
CR Chen CY, 2011, MITOCHONDRION, V11, P739, DOI 10.1016/j.mito.2011.05.014
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Higuchi I, 1999, ACTA NEUROPATHOL, V98, P313, DOI 10.1007/s004010051086
   Holland MM, 2011, CROAT MED J, V52, P299, DOI 10.3325/cmj.2011.52.299
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012
   Kumamoto T, 2004, ACTA NEUROPATHOL, V107, P59, DOI 10.1007/s00401-003-0774-2
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Masucci JP, 1997, MOL CELL BIOCHEM, V174, P215, DOI 10.1023/A:1006808524536
   Mithani SK, 2007, CLIN CANCER RES, V13, P7335, DOI 10.1158/1078-0432.CCR-07-0220
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Niiyama T, 2002, ACTA NEUROPATHOL, V104, P67, DOI 10.1007/s00401-002-0522-z
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 32
TC 11
Z9 12
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
EI 
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD AUG 15
PY 2013
VL 66
IS 8
BP 659
EP 664
DI 10.1136/jclinpath-2012-201431
PG 6
WC Pathology
SC Pathology
GA 201SL
UT WOS:000323163200006
PM 23559353
DA 2024-11-01
ER

PT J
AU Roos, S
   Macao, B
   Fusté, JM
   Lindberg, C
   Jemt, E
   Holme, E
   Moslemi, AR
   Oldfors, A
   Falkenberg, M
AF Roos, Sara
   Macao, Bertil
   Fuste, Javier Miralles
   Lindberg, Christopher
   Jemt, Elisabeth
   Holme, Elisabeth
   Moslemi, Ali-Reza
   Oldfors, Anders
   Falkenberg, Maria
TI Subnormal levels of POLγA cause inefficient initiation of light-strand DNA synthesis and lead to mitochondrial DNA deletions and autosomal dominant progressive external ophthalmoplegia
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID polymerase-gamma; replication bubble; rna-polymerase; mutations; origin
AB The POLG1 gene encodes the catalytic subunit of mitochondrial DNA (mtDNA) polymerase gamma (POL gamma). We here describe a sibling pair with adult-onset progressive external ophthalmoplegia, cognitive impairment and mitochondrial myopathy characterized by DNA depletion and multiple mtDNA deletions. The phenotype is due to compound heterozygous POLG1 mutations, T914P and the intron mutation c.3104 1 3A > T. The mutant genes produce POL gamma isoforms with heterozygous phenotypes that fail to synthesize longer DNA products in vitro. However, exon skipping in the c.3104 + 3A > T mutant is not complete, and the presence of low levels of wild-type POL gamma explains patient survival. To better understand the underlying pathogenic mechanisms, we characterized the effects of POL gamma depletion in vitro and found that leading-strand DNA synthesis is relatively undisturbed. In contrast, initiation of lagging-strand DNA synthesis is ineffective at lower POL gamma concentrations that uncouples leading strand from lagging-strand DNA synthesis. In vivo, this effect leads to prolonged exposure of the heavy strand in its single-stranded conformation that in turn can cause the mtDNA deletions observed in our patients. Our findings, thus, suggest a molecular mechanism explaining how POL gamma mutations can cause mtDNA deletions in vivo.
C1 [Roos, Sara; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Macao, Bertil; Fuste, Javier Miralles; Jemt, Elisabeth; Falkenberg, Maria] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Lindberg, Christopher] Sahlgrens Univ Hosp, Dept Neurol, Neuromuscular Ctr, Gothenburg, Sweden.
   [Holme, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, Gula Straket 8, SE-41345 Gothenburg, Sweden.
EM sara.roos@gu.se
FU Swedish Research Council [2010-3545, 07122]; Swedish Cancer Society [2007/1216]; Swedish Strategic Foundation [FFL-3]; European Research Council [261248]; European Research Council (ERC) [261248] Funding Source: European Research Council (ERC)
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kokoska RJ, 2000, MOL CELL BIOL, V20, P7490, DOI 10.1128/MCB.20.20.7490-7504.2000
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
   Viguera E, 2001, J MOL BIOL, V312, P323, DOI 10.1006/jmbi.2001.4943
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   WONG TW, 1986, CELL, V45, P817, DOI 10.1016/0092-8674(86)90556-8
   WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0
NR 36
TC 19
Z9 19
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUN 15
PY 2013
VL 22
IS 12
BP 2411
EP 2422
DI 10.1093/hmg/ddt094
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 151AK
UT WOS:000319432800008
PM 23446635
DA 2024-11-01
ER

PT J
AU Aliev, G
   Obrenovich, ME
   Tabrez, S
   Jabir, NR
   Reddy, VP
   Li, Y
   Burnstock, G
   Cacabelos, R
   Kamal, MA
AF Aliev, Gjumrakch
   Obrenovich, Mark E.
   Tabrez, Shams
   Jabir, Nasimudeen R.
   Reddy, V. Prakash
   Li, Yi
   Burnstock, Geoffrey
   Cacabelos, Ramon
   Kamal, Mohammad Amjad
TI Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Review
ID amyloid precursor protein; coupled receptor kinase-2; glycogen-synthase kinase-3; hypoxia-inducible factor; cell-cycle regulators; tau-protein; smooth-muscle; neurofibrillary tangles; signal-transduction; growth-factor
AB Nitric oxide- (NO-) dependent oxidative stress results in mitochondrial ultrastructural alterations and DNA damage in cases of Alzheimer disease (AD). However, little is known about these pathways in human cancers, especially during the development as well as the progression of primary brain tumors and metastatic colorectal cancer. One of the key features of tumors is the deficiency in tissue energy that accompanies mitochondrial lesions and formation of the hypoxic smaller sized mitochondria with ultrastructural abnormalities. We speculate that mitochondrial involvement may play a significant role in the etiopathogenesis of cancer. Recent studies also demonstrate a potential link between AD and cancer, and anticancer drugs are being explored for the inhibition of AD-like pathology in transgenic mice. Severity of the cancer growth, metastasis, and brain pathology in AD (in animal models that mimic human AD) correlate with the degree of mitochondrial ultrastructural abnormalities. Recent advances in the cell-cycle reentry of the terminally differentiated neuronal cells indicate that NO-dependent mitochondrial abnormal activities and mitotic cell division are not the only important pathogenic factors in pathogenesis of cancer and AD, but open a new window for the development of novel treatment strategies for these devastating diseases.
C1 [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA.
   [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Atlanta, GA 30360 USA.
   [Obrenovich, Mark E.] Cleveland State Univ, Dept Chem, Cleveland, OH 44106 USA.
   [Obrenovich, Mark E.] Cleveland State Univ, Dept Biol, Cleveland, OH 44106 USA.
   [Tabrez, Shams; Jabir, Nasimudeen R.; Kamal, Mohammad Amjad] King Abdulaziz Univ, King Fahd Med Res Ctr, Fundamental & Appl Biol Grp, Metabol & Enzymol Unit, Jeddah 21589, Saudi Arabia.
   [Reddy, V. Prakash] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA.
   [Li, Yi] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA.
   [Burnstock, Geoffrey] Royal Free Hosp, Sch Med, Auton Neurosci Inst, London NW3 2PF, England.
   [Burnstock, Geoffrey] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia.
   [Cacabelos, Ramon] Inst CNS Disorders & Genom Med, EuroEspes Biomed Res Ctr, La Coruna 15165, Bergondo, Spain.
   [Cacabelos, Ramon] Camilo Jose Cela Univ, La Coruna 15165, Bergondo, Spain.
C3 Gally International Biomedical Research & Consulting LLC; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; King Abdulaziz University; University of Missouri System; Missouri University of Science & Technology; Yale University; University of London; University College London; UCL Medical School; Royal Free London NHS Foundation Trust; University of Melbourne; Camilo Jose Cela University
RP Aliev, G (corresponding author), GALLY Int Biomed Res Consulting LLC, 7733 Louis Pasteur Dr,328, San Antonio, TX 78229 USA.
EM aliev03@gmail.com
FU British Heart Foundation; "GALLY" International Biomedical Research Consulting LLC., San Antonio, TX, USA
CR Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797
   Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018
   Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159
   Aliev G, 2002, JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, V34, P37
   Aliev G, 2002, BRAIN PATHOL, V12, P21
   Aliev Gjumrakch, 2011, RECENT PAT CARDIOVASC DRUG DISCOV, V6, P222
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aliev G, 2009, NEUROTOX RES, V16, P293, DOI 10.1007/s12640-009-9066-5
   Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040
   Aliyev A, 2004, NEUROL RES, V26, P547, DOI 10.1179/01610425017613
   Allard S, 2012, J NEUROSCI, V32, P2002, DOI 10.1523/JNEUROSCI.1144-11.2012
   ANDERSON AJ, 1994, EXP NEUROL, V125, P286, DOI 10.1006/exnr.1994.1031
   Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8
   Anggrahini DW, 2009, CARDIOVASC RES, V82, P143, DOI 10.1093/cvr/cvp026
   ARENDT T, 1995, NEUROSCIENCE, V68, P5, DOI 10.1016/0306-4522(95)00146-A
   Arendt T, 1998, J NEURAL TRANSM, V105, P949, DOI 10.1007/s007020050104
   Bagnato A, 1997, CANCER RES, V57, P1306
   Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398
   BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P
   Beltrán B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602
   Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1
   Bliziotes M, 2000, BONE, V27, P367, DOI 10.1016/S8756-3282(00)00338-0
   Borzacchiello G, 2010, REPROD DOMEST ANIM, V45, Pe465, DOI 10.1111/j.1439-0531.2010.01580.x
   Buga GM, 2000, BIOL PATHOBIOLOGY, V0, P895
   Busser J, 1998, J NEUROSCI, V18, P2801
   Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4
   CHOPP M, 1993, CURR OPIN NEUROL NEU, V6, P6
   Clementi E, 1999, P NATL ACAD SCI USA, V96, P1559, DOI 10.1073/pnas.96.4.1559
   Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631
   Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697
   Dao HH, 2006, CARDIOVASC RES, V71, P61, DOI 10.1016/j.cardiores.2006.02.029
   de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057
   delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7
   Ding XL, 2000, AM J PATHOL, V157, P1983, DOI 10.1016/S0002-9440(10)64837-7
   DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T
   DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x
   Evans NJ, 2008, BIOPHYS J, V95, P483, DOI 10.1529/biophysj.107.119206
   Fang FC, 2002, AM J PHYSIOL-LUNG C, V282, PL941, DOI 10.1152/ajplung.00017.2002
   Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7
   Fukuda K, 1996, KIDNEY INT, V49, P1320, DOI 10.1038/ki.1996.188
   Galea E, 1999, FASEB J, V13, P2125, DOI 10.1096/fasebj.13.15.2125
   Gantier R, 2000, NEUROSCI LETT, V283, P217, DOI 10.1016/S0304-3940(00)00949-6
   GARTNER U, 1995, NEUROREPORT, V6, P1441
   Garver TD, 1996, J NEUROSCI RES, V44, P12, DOI 10.1002/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L
   Giachini FRC, 2009, AM J PHYSIOL-HEART C, V296, PH489, DOI 10.1152/ajpheart.00251.2008
   Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011
   Grant K, 2007, BRIT J SURG, V94, P106, DOI 10.1002/bjs.5536
   Grant K, 2003, BRIT J CANCER, V88, P163, DOI 10.1038/sj.bjc.6700750
   Greferath U, 2000, EUR J NEUROSCI, V12, P885, DOI 10.1046/j.1460-9568.2000.00976.x
   Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057
   Grimshaw MJ, 2002, MOL CANCER THER, V1, P1273
   Guo JM, 2009, CELL SIGNAL, V21, P899, DOI 10.1016/j.cellsig.2009.01.037
   Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200
   Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x
   Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794
   Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543
   Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9
   Janicki SM, 1999, AM J PATHOL, V155, P135, DOI 10.1016/S0002-9440(10)65108-5
   Janicki SM, 2000, NEUROBIOL AGING, V21, P829, DOI 10.1016/S0197-4580(00)00222-0
   Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106
   Jiménez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399
   Kashfi K, 2002, J PHARMACOL EXP THER, V303, P1273, DOI 10.1124/jpet.102.042754
   Kawamata T, 1998, J NEUROSCI, V18, P7402
   Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851
   Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002
   Kihiko ME, 1999, J NEUROCHEM, V73, P2609, DOI 10.1046/j.1471-4159.1999.0732609.x
   Kohno M, 1998, J CARDIOVASC PHARM, V31, PS84, DOI 10.1097/00005344-199800001-00027
   Kozawa O, 2000, CELL SIGNAL, V12, P375, DOI 10.1016/S0898-6568(00)00061-9
   Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lanius RA, 1997, BRAIN RES, V764, P75, DOI 10.1016/S0006-8993(97)00422-8
   Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2
   LEDESMA MD, 1992, FEBS LETT, V308, P218, DOI 10.1016/0014-5793(92)81278-T
   Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7
   Lipinski B, 2011, OXID MED CELL LONGEV, V2011, P0, DOI 10.1155/2011/809696
   Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289
   LU Q, 1993, J NEUROSCI RES, V35, P439, DOI 10.1002/jnr.490350411
   Luedecking EK, 2000, HUM GENET, V106, P565, DOI 10.1007/s004390050026
   Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153
   Lüth HJ, 2000, BRAIN RES, V852, P45, DOI 10.1016/S0006-8993(99)02178-2
   Marambaud P, 1999, BRIT J PHARMACOL, V126, P1186, DOI 10.1038/sj.bjp.0702406
   Marcus DL, 1998, NEUROBIOL AGING, V19, P393, DOI 10.1016/S0197-4580(98)00077-3
   MASLIAH E, 1993, LAB INVEST, V69, P562
   MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x
   McShea A, 1997, AM J PATHOL, V150, P1933
   McShea A, 1999, BRAIN RES, V815, P237, DOI 10.1016/S0006-8993(98)01135-4
   MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205
   Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06
   Métayé T, 2002, J CLIN ENDOCR METAB, V87, P3279, DOI 10.1210/jc.87.7.3279
   Métayé T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562
   Mills J, 1997, J NEUROSCI, V17, P9415
   MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6
   Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762
   Morris CD, 2005, BRIT J CANCER, V92, P2148, DOI 10.1038/sj.bjc.6602676
   Morris GE, 2010, CARDIOVASC RES, V85, P424, DOI 10.1093/cvr/cvp310
   Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007
   Mullol J, 2000, CLIN EXP ALLERGY, V30, P172
   Nagy Z, 1997, ACTA NEUROPATHOL, V93, P294, DOI 10.1007/s004010050617
   Nagy Z, 2000, NEUROBIOL AGING, V21, P761, DOI 10.1016/S0197-4580(00)00223-2
   Nakai M, 1998, NEUROREPORT, V9, P3467, DOI 10.1097/00001756-199810260-00024
   Nelson JB, 2005, NEOPLASIA, V7, P631, DOI 10.1593/neo.04787
   Neve RL, 2007, BBA-MOL BASIS DIS, V1772, P430, DOI 10.1016/j.bbadis.2006.10.008
   Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599
   North S, 2000, ONCOGENE, V19, P1206, DOI 10.1038/sj.onc.1203413
   Obrenovich ME, 2006, NEUROTOX RES, V10, P43, DOI 10.1007/BF03033333
   Obrenovich ME, 2011, CNS NEUROL DISORD-DR, V10, P192
   Obrenovich ME, 2009, J CELL MOL MED, V13, P853, DOI 10.1111/j.1582-4934.2008.00512.x
   Obrenovich ME, 2009, CARDIOVASC PSYCHIAT, V2009, P327360, DOI 10.1155/2009/327360
   Ong WY, 2005, J ALZHEIMERS DIS, V8, P183
   Özdogan O, 2002, HEPATOL RES, V24, P114, DOI 10.1016/S1386-6346(02)00082-7
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7
   Park DS, 1997, J NEUROSCI, V17, P8975
   Pasquier E, 2004, MOL CANCER THER, V3, P1301
   Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007
   Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0
   Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x
   Peppel K, 2000, CIRCULATION, V102, P793, DOI 10.1161/01.CIR.102.7.793
   Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035
   Piazza A, 2009, BIOCHEM SOC T, V37, P303, DOI 10.1042/BST0370303
   Prowatke I, 2007, BRIT J CANCER, V96, P82, DOI 10.1038/sj.bjc.6603490
   Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x
   Rosano L, 2006, MOL CANCER THER, V5, P833, DOI 10.1158/1535-7163.MCT-05-0523
   Rosanò L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123
   Rosenblatt R, 2009, ANAL QUANT CYTOL, V31, P137
   Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351
   SCHUBERT D, 1989, BIOCHEM BIOPH RES CO, V162, P83, DOI 10.1016/0006-291X(89)91965-7
   Shankar A, 1998, BRIT J SURG, V85, P502
   SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1
   Shichiri M, 1998, MOL ENDOCRINOL, V12, P172, DOI 10.1210/me.12.2.172
   Shimohama S, 1999, INT J MOL MED, V3, P597
   SHIRAZI SK, 1993, NEUROREPORT, V4, P435, DOI 10.1097/00001756-199304000-00024
   Sieradzki A, 2011, CNS NEUROL DISORD-DR, V10, P175, DOI 10.2174/187152711794480410
   Singh TJ, 1996, MOL CELL BIOCHEM, V154, P143, DOI 10.1007/BF00226782
   SINGH TJ, 1995, FEBS LETT, V358, P267, DOI 10.1016/0014-5793(94)01445-7
   Smith MZ, 1999, NEUROSCI LETT, V271, P45, DOI 10.1016/S0304-3940(99)00509-1
   Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629
   Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490
   Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785
   STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x
   SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x
   Takahashi M, 2000, J NEUROL SCI, V172, P63, DOI 10.1016/S0022-510X(99)00291-9
   Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9
   Tanaka T, 2000, ALZ DIS ASSOC DIS, V14, PS18, DOI 10.1097/00002093-200000001-00004
   TREJO J, 1994, J BIOL CHEM, V269, P21682
   Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5
   Tsujioka Y, 1999, DEMENT GERIATR COGN, V10, P192, DOI 10.1159/000017119
   Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741
   Van Gassen G, 2000, MOL MED, V6, P570, DOI 10.1007/BF03401795
   Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008
   Veng LM, 2003, PHYSIOL BEHAV, V80, P27, DOI 10.1016/S0031-9384(03)00219-1
   Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413
   Vincent I, 1997, J NEUROSCI, V17, P3588
   Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373
   Wan KF, 2003, J BIOL CHEM, V278, P18658, DOI 10.1074/jbc.M212103200
   Wang JZ, 1998, FEBS LETT, V436, P28, DOI 10.1016/S0014-5793(98)01090-4
   Webber KM, 2006, CURR PHARM DESIGN, V12, P691, DOI 10.2174/138161206775474305
   Wiesmann F, 2009, BREAST CANCER RES, V11, P0, DOI 10.1186/bcr2319
   Xu J, 1997, CLIN EXP ALLERGY, V27, P568, DOI 10.1046/j.1365-2222.1997.d01-530.x
   Yagihashi N, 2000, VIRCHOWS ARCH, V436, P109, DOI 10.1007/PL00008208
   Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
   Zhang WM, 2008, LIFE SCI, V82, P764, DOI 10.1016/j.lfs.2008.01.008
   Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880
   Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x
   Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6
   Zubenko GS, 1999, BIOL PSYCHIAT, V45, P731, DOI 10.1016/S0006-3223(98)00073-0
NR 167
TC 53
Z9 56
U1 0
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD JUN 15
PY 2013
VL 2013
IS 
BP 
EP 
DI 10.1155/2013/962984
PG 19
WC Cell Biology
SC Cell Biology
GA 125AW
UT WOS:000317511500001
PM 23691268
DA 2024-11-01
ER

PT J
AU Maresca, A
   la Morgia, C
   Caporali, L
   Valentino, ML
   Carelli, V
AF Maresca, Alessandra
   la Morgia, Chiara
   Caporali, Leonardo
   Valentino, Maria Lucia
   Carelli, Valerio
TI The optic nerve: A "mito-window" on mitochondrial neurodegeneration
SO MOLECULAR AND CELLULAR NEUROSCIENCE
LA English
DT Review
DE Mitochondrial disease; Optic atrophy; Mitochondrial functions; LHON; DOA; Retinal ganglion cells
ID dynamin-related protein; complex-i deficiency; functional retinal impairment; lhon/melas overlap syndrome; mild cognitive impairment; fiber layer evaluation; cytochrome-c release; splice-site mutation; alzheimers-disease; skeletal-muscle
AB Retinal ganglion cells (RGCs) project their long axons, composing the optic nerve, to the brain, transmitting the visual information gathered by the retina, ultimately leading to formed vision in the visual cortex. The RGC cellular system, representing the anterior part of the visual pathway, is vulnerable to mitochondrial dysfunction and optic atrophy is a very frequent feature of mitochondrial and neurodegenerative diseases. The start of the molecular era of mitochondrial medicine, the year 1988, was marked by the identification of a matemally inherited form of optic atrophy, Leber's hereditary optic neuropathy, as the first disease due to mitochondrial DNA point mutations. The field of mitochondrial medicine has expanded enormously over the last two decades and many neurodegenerative diseases are now known to have a primary mitochondrial etiology or mitochondrial dysfunction plays a relevant role in their pathogenic mechanism. Recent technical advancements in neuro-ophthalmology, such as optical coherence tomography, prompted a still ongoing systematic re-investigation of retinal and optic nerve involvement in neurodegenerative disorders. In addition to inherited optic neuropathies, such as Leber's hereditary optic neuropathy and dominant optic atrophy, and in addition to the syndromic mitochondrial encephalomyopathies or mitochondrial neurodegenerative disorders such as some spinocerebellar ataxias or familial spastic paraparesis and other disorders, we draw attention to the involvement of the optic nerve in classic age-related neurodegenerative disorders such as Parkinson and Alzheimer disease. We here provide an overview of optic nerve pathology in these different clinical settings, and we review the possible mechanisms involved in the pathogenesis of optic atrophy. This may be a model of general value for the field of neurodegeneration. This article is part of a Special Issue entitled 'Mitochondrial function and dysfunction in neurodegeneration'. (C) 2012 Elsevier Inc. All rights reserved.
C1 Univ Bologna, IRCCS Ist Sci Neurol Bologna, I-40123 Bologna, Italy.
   Univ Bologna, Dept Neurol Sci, I-40123 Bologna, Italy.
C3 University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna
RP Carelli, V (corresponding author), Univ Bologna, Dept Neurol Sci, IRCCS Inst Neurol Sci Bologna, Via Ugo Foscolo 7, I-40123 Bologna, Italy.
EM valerio.carelli@unibo.it
FU Telethon - Italy [GGP06233, GGP11182, GPP10005]; Fondazione Gino Galletti; e-RARE project on inherited optic neuropathies ERMION grant [JTC2009]
CR Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   ALBANO E, 1991, BIOCHIM BIOPHYS ACTA, V1091, P310, DOI 10.1016/0167-4889(91)90194-3
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010
   Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961
   Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105
   Angebault Claire, 2011, BMC RES NOTES, V4, P557, DOI 10.1186/1756-0500-4-557
   Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Archibald NK, 2009, BRAIN, V132, P1128, DOI 10.1093/brain/awp068
   Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222
   Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884
   Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709
   Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Barbet F, 2006, ADV EXP MED BIOL, V572, P21
   Barbet F, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.025502
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   Barboni P, 2011, OPHTHALMOLOGY, V118, P2076, DOI 10.1016/j.ophtha.2011.02.027
   Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Barnils N, 2007, ARCH SOC ESP OFTALMOL, V82, P377
   Barrett TG, 2000, J MED GENET, V37, P463, DOI 10.1136/jmg.37.6.463
   Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976
   Benard G, 2006, AM J PHYSIOL-CELL PH, V291, PC1172, DOI 10.1152/ajpcell.00195.2006
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029
   Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Blanks JC, 1996, NEUROBIOL AGING, V17, P385, DOI 10.1016/0197-4580(96)00009-7
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z
   BODISWOLLNER I, 1987, BRAIN, V110, P1675, DOI 10.1093/brain/110.6.1675
   BODISWOLLNER I, 1978, BRAIN, V101, P661, DOI 10.1093/brain/101.4.661
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   BRUYN GW, 1964, J NEUROL SCI, V1, P59, DOI 10.1016/0022-510X(64)90054-1
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Büeler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006
   BUNDEY S, 1993, LANCET, V342, P1059
   Burbulla LF, 2010, EUR J CLIN INVEST, V40, P1048, DOI 10.1111/j.1365-2362.2010.02354.x
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.3.CO;2-C
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 1998, J NEUROL SCI, V160, P183, DOI 10.1016/S0022-510X(98)00239-1
   Carelli V, 2008, NEUROLOGY, V70, P1075, DOI 10.1212/01.wnl.0000307668.75233.35
   Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Carelli V, 2011, HUM MOL GENET, V20, P1893, DOI 10.1093/hmg/ddr071
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Chadderton N, 2012, EUR J HUM GENET, V0, P0
   CHAU CMA, 1992, J BIOL CHEM, V267, P6999
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726
   Cordeiro MF, 2010, CELL DEATH DIS, V1, P0, DOI 10.1038/cddis.2009.3
   Cornille K, 2008, ANN NEUROL, V63, P667, DOI 10.1002/ana.21376
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Duchen Michael R, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P365, DOI 10.1016/j.mam.2004.03.001
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023
   Fortuna F, 2009, BRAIN, V132, P116, DOI 10.1093/brain/awn269
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X
   Galluzzi L, 2007, NAT CELL BIOL, V9, P487, DOI 10.1038/ncb0507-487
   Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287
   Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gray R E, 1996, METHODS ENZYMOL, V264, P369, DOI 10.1016/S0076-6879(96)64035-X
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Guo L, 2010, CURR ALZHEIMER RES, V7, P3, DOI 10.2174/156720510790274491
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Haefeli RH, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017963
   Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106
   Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123
   Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009
   Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Iyer S, 2012, HUM GENE THER, V23, P647, DOI 10.1089/hum.2011.177
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Ji YL, 2010, MOL VIS, V16, P416
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   JONES RD, 1992, MOVEMENT DISORD, V7, P232, DOI 10.1002/mds.870070308
   Jourdain A, 2009, INT J BIOCHEM CELL B, V41, P1884, DOI 10.1016/j.biocel.2009.05.001
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kanki T, 2009, CELL RES, V19, P922, DOI 10.1038/cr.2009.94
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014
   Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   Kleta R, 2002, MOL GENET METAB, V76, P201, DOI 10.1016/S1096-7192(02)00047-1
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141
   Koopman Werner J H, 2010, ANTIOXID REDOX SIGNAL, V12, P1431, DOI 10.1089/ars.2009.2743
   Lam BL, 2010, ARCH OPHTHALMOL-CHIC, V128, P1129, DOI 10.1001/archophthalmol.2010.201
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Lenaz G, 2012, ADV EXP MED BIOL, V942, P93, DOI 10.1007/978-94-007-2869-1_5
   Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lodi R, 1997, ANN NEUROL, V42, P573, DOI 10.1002/ana.410420407
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086
   Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006
   Magrané J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012
   Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Marella M, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011472
   Marelli C, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awq306
   Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017
   Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006
   MASHIMA Y, 1992, LANCET, V340, P368, DOI 10.1016/0140-6736(92)91442-B
   Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   MITOMAP, 2011, HUM MIT GEN DAT, V0, P0
   Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1001379
   Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318
   Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367
   Nakada K, 2011, EXP ANIM TOKYO, V60, P421
   Newman NJ, 2011, BRAIN, V134, P2447, DOI 10.1093/brain/awr192
   Nishioka T, 2004, J HUM GENET, V49, P701, DOI 10.1007/s10038-004-0209-5
   NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102
   Pretegiani E, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr101
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426
   Ramos CDF, 2009, INVEST OPHTH VIS SCI, V50, P1666, DOI 10.1167/iovs.08-2695
   Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011
   Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027
   Rendtorff ND, 2011, AM J MED GENET A, V155A, P1298, DOI 10.1002/ajmg.a.33970
   Reynier P, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016576
   Rojo M, 2002, J CELL SCI, V115, P1663
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z
   Sabet-Peyman EJ, 2012, J NEURO-OPHTHALMOL, V32, P54, DOI 10.1097/WNO.0b013e318241da45
   Sadun A A, 2000, TRANS AM OPHTHALMOL SOC, V98, P223
   SADUN AA, 1987, AM J OPHTHALMOL, V104, P113, DOI 10.1016/0002-9394(87)90001-8
   SADUN AA, 1990, OPHTHALMOLOGY, V97, P9
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Sadun AA, 2011, CURR TREAT OPTION NE, V13, P109, DOI 10.1007/s11940-010-0100-y
   Santel A, 2001, J CELL SCI, V114, P867
   Sartucci F, 2010, BRAIN RES BULL, V82, P169, DOI 10.1016/j.brainresbull.2010.04.001
   Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schaaf CP, 2011, MOL GENET METAB, V103, P383, DOI 10.1016/j.ymgme.2011.04.018
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Schon EA, 2010, J ALZHEIMERS DIS, V20, PS281, DOI 10.3233/JAD-2010-100495
   Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   Silva MF, 2005, BRAIN, V128, P2260, DOI 10.1093/brain/awh581
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679
   Stricker S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023024
   Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021
   Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002
   Tang S, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004492
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Taylor RW, 1996, ANN NEUROL, V39, P224, DOI 10.1002/ana.410390212
   Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312
   Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415
   Tondera D, 2004, J BIOL CHEM, V279, P31544, DOI 10.1074/jbc.M404704200
   Tranebjaerg L, 2001, OPHTHALMIC GENET, V22, P207
   Trounce IA, 2009, ARVO ANN M, V0, P0
   Valentino ML, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.037507
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Verny C, 2005, REV NEUROL-FRANCE, V161, P451, DOI 10.1016/S0035-3787(05)85075-1
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002
   VORA AJ, 1993, LANCET, V342, P1059, DOI 10.1016/0140-6736(93)92918-J
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Williams PA, 2011, VISION RES, V51, P229, DOI 10.1016/j.visres.2010.08.031
   Williams PA, 2012, BRAIN, V135, P493, DOI 10.1093/brain/awr330
   Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218
   Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Yarosh W, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.0040006
   Yavas GF, 2007, EUR J OPHTHALMOL, V17, P812, DOI 10.1177/112067210701700520
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Yen MY, 1996, BRIT J OPHTHALMOL, V80, P78, DOI 10.1136/bjo.80.1.78
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zhang AM, 2012, J TRANSL MED, V10, P0, DOI 10.1186/1479-5876-10-43
   Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922
   Zhang X, 2002, NEUROSCI LETT, V326, P97, DOI 10.1016/S0304-3940(02)00327-0
   ZHANG Y, 1990, J BIOL CHEM, V265, P16330
   Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104
   Zhao FX, 2009, BIOCHEM BIOPH RES CO, V389, P466, DOI 10.1016/j.bbrc.2009.08.168
   Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 271
TC 74
Z9 85
U1 0
U2 60
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1044-7431
EI 1095-9327
J9 MOL CELL NEUROSCI
JI Mol. Cell. Neurosci.
PD JUL 15
PY 2013
VL 55
IS 
BP 62
EP 76
DI 10.1016/j.mcn.2012.08.004
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 131MZ
UT WOS:000317999100008
PM 22960139
DA 2024-11-01
ER

PT J
AU Mezghani, N
   Mnif, M
   Mkaouar-Rebai, E
   Kallel, N
   Charfi, N
   Abid, M
   Fakhfakh, F
AF Mezghani, Najla
   Mnif, Mouna
   Mkaouar-Rebai, Emna
   Kallel, Nozha
   Charfi, Nadia
   Abid, Mohamed
   Fakhfakh, Faiza
TI A maternally inherited diabetes and deafness patient with the 12S rRNA m.1555A&gt;G and the ND1 m.3308T&gt;C mutations associated with multiple mitochondrial deletions
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE MIDD; m.1555A > G; m.3308T > C; Mitochondrial deletions
ID a3243g mutation; sensorineural deafness; tunisian patients; wolfram-syndrome; a1555g mutation; dna mutation; mellitus; family; gene; prevalence
AB Maternally inherited diabetes and deafness (MIDD) is a mitochondrial syndrome characterized by the onset of sensorineural hearing loss and diabetes in adults. Some patients may have other additional clinical features common in mitochondrial disorders such as pigmentary retinopathy, ptosis, cardiomyopathy, myopathy and renal affections. We report a 40-year-old Tunisian patient presenting maternally inherited type 2 diabetes and deafness (MIDD). A molecular genetic analysis was conducted in the patient and his twin sister, but no reported mutations in the tRNA(Leu(UUR)) and tRNA(Glu) genes were found, especially the two mitochondrial m.3243A>G and the m.14709T>C mutations in muscle and blood leukocytes. The results showed the presence of the mitochondrial NADH deshydrogenase 1 (ND1) homoplasmic m.3308T>C mutation the 2 tested tissues (blood leukocytes and skeletal muscle) of the proband and in the patient's sister blood leukocytes. In addition, we identified the mitochondrial 12S rRNA m.1555A>G mutation in muscle and blood leukocytes. The Long-range PCR amplification revealed the presence of multiple deletions of the mitochondrial DNA extracted from the patient's skeletal muscle removing several tRNA and protein-coding genes. Our study reported a Tunisian patient with clinical features of MIDD in whom we detected the 12S rRNA m.1555A>G and the ND1 m.3308T>C mutations with mitochondrial multiple deletions. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Mezghani, Najla; Mkaouar-Rebai, Emna; Fakhfakh, Faiza] Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Sfax 3029, Tunisia.
   [Mnif, Mouna; Kallel, Nozha; Charfi, Nadia; Abid, Mohamed] CHU Habib Bourguiba Sfax, Serv Endocrinol, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Habib Bourguiba; Hopital Hedi Chaker
RP Mezghani, N (corresponding author), Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Ave Magida Boulila, Sfax 3029, Tunisia.
EM najla.mezghani1980@gmail.com; faiza.fakh-fakh@gmail.com
CR Akbari M, 2004, SCAND J CLIN LAB INV, V64, P86, DOI 10.1080/00365510410004209
   Alkowari MK, 2012, INT J AUDIOL, V51, P181, DOI 10.3109/14992027.2011.625983
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Campos Y, 1997, BIOCHEM BIOPH RES CO, V238, P323, DOI 10.1006/bbrc.1997.7166
   Cao YY, 2010, MITOCHONDRION, V10, P330, DOI 10.1016/j.mito.2010.01.008
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Cheng Zu-jian, 2009, ZHONGHUA YI XUE ZA ZHI, V89, P2536
   Deng GH, 2009, ZHONGHUA YI XUE ZA Z, V40, P2822
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W
   Fukao T, 2009, MOL MED REP, V2, P69, DOI 10.3892/mmr_00000063
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Li MZ, 2008, CHINESE MED J-PEKING, V121, P682, DOI 10.1097/00029330-200804020-00004
   Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226
   Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1
   Malik SG, 2003, J HUM GENET, V48, P480, DOI 10.1007/s10038-003-0056-9
   Maseda E, 2008, ACTA OTORRINOLAR ESP, V59, P472, DOI 10.1016/S0001-6519(08)75121-5
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   Mkaouar-Rebai E, 2006, BIOCHEM BIOPH RES CO, V340, P1251, DOI 10.1016/j.bbrc.2005.12.123
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rigoli L, 1999, ACTA DIABETOL, V36, P163, DOI 10.1007/s005920050161
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   Sudoyo H, 2003, ADV EXP MED BIOL, V531, P19
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Suzuki Y, 2003, DIABETES CARE, V26, P1315, DOI 10.2337/diacare.26.4.1315
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Vilarinho L, 1999, J NEUROL SCI, V163, P168, DOI 10.1016/S0022-510X(99)00030-1
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Zhang AM, 2008, BIOCHEM BIOPH RES CO, V376, P221, DOI 10.1016/j.bbrc.2008.08.128
NR 42
TC 12
Z9 14
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 22
PY 2013
VL 431
IS 4
BP 670
EP 674
DI 10.1016/j.bbrc.2013.01.063
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 103QZ
UT WOS:000315935300005
PM 23357420
DA 2024-11-01
ER

PT J
AU Honzik, T
   Tesarova, M
   Vinsova, K
   Hansikova, H
   Magner, M
   Kratochvilova, H
   Zamecnik, J
   Zeman, J
   Jesina, P
AF Honzik, Tomas
   Tesarova, Marketa
   Vinsova, Kamila
   Hansikova, Hana
   Magner, Martin
   Kratochvilova, Hana
   Zamecnik, Josef
   Zeman, Jiri
   Jesina, Pavel
TI Different laboratory and muscle biopsy findings in a family with an m.8851T&gt;C mutation in the mitochondrial <i>MTATP6</i> gene
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Leigh syndrome; ATP synthase; Mitochondrial DNA m.8851T > C mutation
ID leigh-syndrome; atp synthase; point mutation; atpase-6 gene; dna
AB We report the second known family with a very rare, maternally inherited missense m.8851T>C mutation in the mitochondrial MTATP6 gene. A failure to thrive, microcephaly, psychomotor retardation and hypotonia were present in a 3-year-old girl with a high mtDNA mutation load (87-97%). Ataxia and Leigh syndrome were subsequently documented in a neurological examination and brain MRI. A muscle biopsy demonstrated decreased ATP synthase and an accumulation of succinate dehydrogenase products, indicating mitochondrial myopathy. Her 36-year-old mother (68% blood heteroplasmy) developed peripheral neuropathy and muscle weakness at the age of 22 years. Our findings extend the clinical and laboratory phenotype associated with the m.8851T>C mutation. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Honzik, Tomas; Tesarova, Marketa; Vinsova, Kamila; Hansikova, Hana; Magner, Martin; Kratochvilova, Hana; Zeman, Jiri] Charles Univ Prague, Dept Pediat & Adolescent Med, Fac Med 1, Prague 12808 2, Czech Republic.
   [Honzik, Tomas; Tesarova, Marketa; Vinsova, Kamila; Hansikova, Hana; Magner, Martin; Kratochvilova, Hana; Zeman, Jiri; Jesina, Pavel] Gen Univ Hosp Prague, Prague 12808 2, Czech Republic.
   [Jesina, Pavel] Charles Univ Prague, Inst Inherited Metab Dis, Fac Med 1, Prague 12808 2, Czech Republic.
   [Zamecnik, Josef] Charles Univ Prague, Dept Pathol & Mol Med, Fac Med 2, Prague 12808 2, Czech Republic.
   [Zamecnik, Josef] Teaching Hosp Motol Prague, Prague, Czech Republic.
C3 Charles University Prague; General University Hospital Prague; Charles University Prague; Motol University Hospital; Charles University Prague
RP Jesina, P (corresponding author), Charles Univ Prague, Inst Inherited Metab Dis, Fac Med 1, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM pavel.jesina@vfn.cz
FU [PRVOUK-P24/LF1/3];  [RVO-VFN64165/2012]
CR Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
NR 13
TC 8
Z9 9
U1 1
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JAN 15
PY 2013
VL 108
IS 1
BP 102
EP 105
DI 10.1016/j.ymgme.2012.11.002
PG 4
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 075BW
UT WOS:000313859800017
PM 23206802
DA 2024-11-01
ER

PT J
AU DiMauro, S
AF DiMauro, Salvatore
TI Mitochondrial encephalomyopathies-Fifty years on The Robert Wartenberg Lecture
SO NEUROLOGY
LA English
DT Article
ID hereditary optic neuropathy; phosphatidylcholine biosynthesis; muscular-dystrophy; dna mutation; disease; mtdna; heteroplasmy; deletions; dynamics; muscle
C1 Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.
C3 Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.
EM sd12@columbia.edu
FU NICHD [P01HD032062]; NINDS/NICHD [U54NS078059]; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF)
CR Al-Saif A, 2012, ANN NEUROL, V72, P510, DOI 10.1002/ana.23641
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Belzil VV, 2012, ANN NEUROL, V72, P479, DOI 10.1002/ana.23678
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009
   Chrzanowska-Lightowlers Z M A, 2011, NEUROMUSCUL DISORD, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   Craven L, 2011, HUM MOL GENET, V20, PR168, DOI 10.1093/hmg/ddr373
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DiMauro S, 2013, MITOCHONDRIAL DISORD, V0, P3
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Ríos PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Ropper AH, 2012, ANN NEUROL, V72, P1, DOI 10.1002/ana.23657
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   SENGERS RCA, 1985, BRIT HEART J, V54, P543
   Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002
NR 58
TC 24
Z9 26
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JUL 16
PY 2013
VL 81
IS 3
BP 281
EP 291
DI 10.1212/WNL.0b013e31829bfe89
PG 11
WC Clinical Neurology
SC Neurosciences & Neurology
GA 304JP
UT WOS:000330743200016
PM 23858410
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   Rahman, S
   Wedatilake, Y
   Polke, JM
   Cirak, S
   Foley, AR
   Sailer, A
   Hurles, ME
   Stalker, J
   Hargreaves, I
   Woodward, CE
   Sweeney, MG
   Muntoni, F
   Houlden, H
   Taanman, JW
   Hanna, MG
AF Pitceathly, Robert D. S.
   Rahman, Shamima
   Wedatilake, Yehani
   Polke, James M.
   Cirak, Sebahattin
   Foley, A. Reghan
   Sailer, Anna
   Hurles, Matthew E.
   Stalker, Jim
   Hargreaves, Iain
   Woodward, Cathy E.
   Sweeney, Mary G.
   Muntoni, Francesco
   Houlden, Henry
   Taanman, Jan-Willem
   Hanna, Michael G.
TI <i>NDUFA4</i> Mutations Underlie Dysfunction of a Cytochrome <i>c</i> Oxidase Subunit Linked to Human Neurological Disease
SO CELL REPORTS
LA English
DT Article
ID oxidative-phosphorylation enzymes; mitochondrial-dna depletion; complex-i; sequencing data; quantification; fibroblasts; deficiency; mechanisms; framework; muscle
AB The molecular basis of cytochrome c oxidase (COX, complex IV) deficiency remains genetically undetermined in many cases. Homozygosity mapping and whole-exome sequencing were performed in a consanguineous pedigree with isolated COX deficiency linked to a Leigh syndrome neurological phenotype. Unexpectedly, affected individuals harbored homozygous splice donor site mutations in NDUFA4, a gene previously assigned to encode a mitochondrial respiratory chain complex I (NADH: ubiquinone oxidoreductase) subunit. Western blot analysis of denaturing gels and immunocytochemistry revealed undetectable steady-state NDUFA4 protein levels, indicating that the mutation causes a loss-of-function effect in the homozygous state. Analysis of one- and two-dimensional blue-native polyacrylamide gels confirmed an interaction between NDUFA4 and the COX enzyme complex in control muscle, whereas the COX enzyme complex without NDUFA4 was detectable with no abnormal subassemblies in patient muscle. These observations support recent work in cell lines suggesting that NDUFA4 is an additional COX subunit and demonstrate that NDUFA4 mutations cause human disease. Our findings support reassignment of the NDUFA4 protein to complex IV and suggest that patients with unexplained COX deficiency should be screened for NDUFA4 mutations.
C1 [Pitceathly, Robert D. S.; Rahman, Shamima; Houlden, Henry; Hanna, Michael G.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.; Rahman, Shamima; Houlden, Henry; Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Rahman, Shamima; Wedatilake, Yehani] UCL Inst Child Hlth, Clin & Mol Genet Unit, Mitochondrial Res Grp, London WC1N 1EH, England.
   [Polke, James M.; Woodward, Cathy E.; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Cirak, Sebahattin; Foley, A. Reghan; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England.
   [Cirak, Sebahattin; Foley, A. Reghan; Muntoni, Francesco] Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 1EH, England.
   [Sailer, Anna; Houlden, Henry; Hanna, Michael G.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Hurles, Matthew E.; Stalker, Jim] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Taanman, Jan-Willem] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Wellcome Trust Sanger Institute; University of London; University College London
RP Hanna, MG (corresponding author), UCL Inst Neurol, MRC Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
EM m.hanna@ucl.ac.uk
FU Wellcome Trust [WT091310]; Medical Research Council (MRC) grant [G0800674]; Wellcome Research Training Fellowship; Great Ormond Street Hospital Children's Charity; MRC Centre grant [G0601943]; Myositis Support Group; EU FP7 Bio-NMD grant; UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children; NIHR UCLH/UCL Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; MRC [G108/638, G1001253, G0601943, MR/J004758/1, G0802760, G0800674, MR/K000608/1] Funding Source: UKRI
CR Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415
   PETROVABENEDICT R, 1992, J INHERIT METAB DIS, V15, P943, DOI 10.1007/BF01800243
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Rickwood D, 1987, MITOCHONDRIA: A PRATICAL APPROACH, V0, P1
   Sambrook J, 1990, COLD SPRING HARBOR LABORATORIES, V186, P182
   SCHAGGER H, 1995, ELECTROPHORESIS, V16, P763, DOI 10.1002/elps.11501601125
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   SINJORGO KMC, 1987, BIOCHIM BIOPHYS ACTA, V890, P144, DOI 10.1016/0005-2728(87)90015-6
   Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
NR 26
TC 93
Z9 102
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
EI 
J9 CELL REP
JI Cell Reports
PD JUN 15
PY 2013
VL 3
IS 6
BP 1795
EP 1805
DI 10.1016/j.celrep.2013.05.005
PG 11
WC Cell Biology
SC Cell Biology
GA 184ON
UT WOS:000321901200006
PM 23746447
DA 2024-11-01
ER

PT J
AU Da, YW
   Zhang, XX
   Li, F
   Yang, XP
   Zhang, XQ
   Jia, JP
AF Da, Yuwei
   Zhang, Xuxiang
   Li, Fang
   Yang, Xiaoping
   Zhang, Xinqing
   Jia, Jianping
TI Posterior Reversible Encephalopathy Syndrome in a Leber Hereditary Optic Neuropathy Patient With Mitochondrial DNA 11778G&gt;A Point Mutation
SO JOURNAL OF NEURO-OPHTHALMOLOGY
LA English
DT Article
ID lhon/melas overlap syndrome; white-matter disease; multiple-sclerosis; 11778-mtdna mutation; leukoencephalopathy; involvement; melas
AB Leber hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that primarily affects the optic nerve. We report a case of reduced visual acuity secondary to optic atrophy in a 13-year-old boy. Transient seizures developed subsequently. Serial magnetic resonance imaging of the brain showed posterior reversible encephalopathy syndrome. Ragged red fibers were not detected on skeletal muscle biopsy. A 11778G>A mitochondrial DNA point mutation was identified in the lymphocytes isolated from peripheral blood. His younger brother was a carrier with the same mutation. The presentation of this case is unusual documenting LHON in association with PRES.
C1 [Da, Yuwei; Li, Fang; Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing 100053, Peoples R China.
   Capital Med Univ, Xuan Wu Hosp, Dept Ophthalmol, Beijing 100053, Peoples R China.
   [Yang, Xiaoping] Capital Med Univ, Xuan Wu Hosp, Dept Radiol, Beijing 100053, Peoples R China.
C3 Capital Medical University; Capital Medical University; Capital Medical University
RP Jia, JP (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing 100053, Peoples R China.
EM jiaxuanwu@126.com
FU Beijing Municipal Health Bureau
CR BARBIROLI B, 1995, NEUROLOGY, V45, P1364, DOI 10.1212/WNL.45.7.1364
   Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Finsterer J, 2009, BLOOD PRESSURE, V18, P126, DOI 10.1080/08037050902975106
   Grazina MM, 2007, EUR J PAEDIATR NEURO, V11, P115, DOI 10.1016/j.ejpn.2006.11.015
   Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803
   Horváth R, 2000, J NEUROL, V247, P65, DOI 10.1007/s004150050015
   Jansen PHP, 1996, J NEUROL SCI, V135, P176, DOI 10.1016/0022-510X(95)00287-C
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   Lev D, 2002, EUR J PAEDIATR NEUROL, V6, P121, DOI 10.1053/ejpn.2001.0558
   McKinney AM, 2007, AM J ROENTGENOL, V189, P904, DOI 10.2214/AJR.07.2024
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Perez F, 2009, CLIN NEUROL NEUROSUR, V111, P83, DOI 10.1016/j.clineuro.2008.06.021
   Powell ES, 2007, J EMERG MED, V33, P377, DOI 10.1016/j.jemermed.2007.02.025
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Renard D, 2010, NEUROLOGY, V75, PE9, DOI 10.1212/WNL.0b013e3181e8e73e
NR 17
TC 3
Z9 3
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1070-8022
EI 1536-5166
J9 J NEURO-OPHTHALMOL
JI J. Neuro-Ophthal.
PD SEP 15
PY 2013
VL 33
IS 3
BP 276
EP 278
DI 10.1097/WNO.0b013e31828f8d75
PG 3
WC Clinical Neurology; Ophthalmology
SC Neurosciences & Neurology; Ophthalmology
GA 235GC
UT WOS:000325704000019
PM 23782927
DA 2024-11-01
ER

PT J
AU Pareyson, D
   Piscosquito, G
   Moroni, I
   Salsano, E
   Zeviani, M
AF Pareyson, Davide
   Piscosquito, Giuseppe
   Moroni, Isabella
   Salsano, Ettore
   Zeviani, Massimo
TI Peripheral neuropathy in mitochondrial disorders
SO LANCET NEUROLOGY
LA English
DT Review
ID charcot-marie-tooth; progressive external ophthalmoplegia; differentiation-associated protein-1; genotype-phenotype correlations; onset spinocerebellar ataxia; mitofusin 2 mutations; optic atrophy; neurogastrointestinal encephalomyopathy; leigh-syndrome; demyelinating polyneuropathy
AB Why is peripheral neuropathy common but mild in many mitochondrial disorders, and why is it, in some cases, the predominant or only manifestation? Although this question remains largely unanswered, recent advances in cellular and molecular biology have begun to clarify the importance of mitochondrial functioning and distribution in the peripheral nerve. Mutations in proteins involved in mitochondrial dynamics (ie, fusion and fission) frequently result in a Charcot-Marie-Tooth phenotype. Peripheral neuropathies with different phenotypic presentations occur in mitochondrial diseases associated with abnormalities in mitochondrial DNA replication and maintenance, or associated with defects in mitochondrial respiratory chain complex V. Our knowledge of mitochondrial disorders is rapidly growing as new nuclear genes are identified and new phenotypes described. Early diagnosis of mitochondrial disorders, essential to provide appropriate genetic counselling, has become crucial in a few treatable conditions. Recognising and diagnosing an underlying mitochondrial defect in patients presenting with peripheral neuropathy is therefore of paramount importance.
C1 [Pareyson, Davide; Piscosquito, Giuseppe; Salsano, Ettore] IRCCS Fdn, C Besta Neurol Inst, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, I-20133 Milan, Italy.
   [Moroni, Isabella] IRCCS Fdn, C Besta Neurol Inst, Dept Child Neurol, Child Neurol Unit, I-20133 Milan, Italy.
   [Zeviani, Massimo] IRCCS Fdn, C Besta Neurol Inst, Dept Diagnost & Appl Technol, Mol Neurogenet Unit, I-20133 Milan, Italy.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge, England.
RP Pareyson, D (corresponding author), IRCCS Fdn, C Besta Neurol Inst, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Via Celoria 11, I-20133 Milan, Italy.
EM davide.pareyson@istituto-besta.it
FU Telethon Italy [GPP10005, GGP11011]; US National Institutes of Health (NINDS/ORD); Muscular Dystrophy Association; Charcot-Marie-Tooth Association (CMTA); MRC [MC_UP_1002/1] Funding Source: UKRI
CR Adhya S, 2011, MITOCHONDRION, V11, P839, DOI 10.1016/j.mito.2011.06.003
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Banchs I, 2008, NEUROMUSCULAR DISORD, V18, P974, DOI 10.1016/j.nmd.2008.09.006
   Barboni P, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws280
   Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Boaretto F, 2010, NEUROLOGY, V74, P1919, DOI 10.1212/WNL.0b013e3181e240f9
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Brockmann K, 2008, J NEUROL, V255, P1049, DOI 10.1007/s00415-008-0847-1
   Calvo J, 2009, ARCH NEUROL-CHICAGO, V66, P1511, DOI 10.1001/archneurol.2009.284
   Carelli V, 2013, CURR OPIN NEUROL, V26, P52, DOI 10.1097/WCO.0b013e32835c5f0b
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Cassereau J, 2011, NEUROLOGY, V76, P1524, DOI 10.1212/WNL.0b013e318217e77d
   Cassereau J, 2011, ORPHANET J RARE DIS, V6, P0, DOI 10.1186/1750-1172-6-87
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Chung KW, 2010, J NEUROL NEUROSUR PS, V81, P1203, DOI 10.1136/jnnp.2009.181669
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   Craven L, 2011, HUM MOL GENET, V20, PR168, DOI 10.1093/hmg/ddr373
   Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798
   Del Bo R, 2008, NEUROLOGY, V71, P1959, DOI 10.1212/01.wnl.0000327095.32005.a4
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Filosto M, 2011, J INHERIT METAB DIS, V34, P1199, DOI 10.1007/s10545-011-9332-6
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gilhuis HJ, 2006, NEUROMUSCULAR DISORD, V16, P394, DOI 10.1016/j.nmd.2006.03.006
   González-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   HANNA MG, 2005, PERIPHERAL NEUROPATH, V0, P1937
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kennerson ML, 2013, HUM MOL GENET, V22, P1404, DOI 10.1093/hmg/dds557
   Klopstock T, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws279
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012
   Moran NF, 2008, NEUROLOGY, V71, P686, DOI 10.1212/01.wnl.0000324602.97205.ab
   Moroni I, 2009, NEUROMUSCULAR DISORD, V19, P476, DOI 10.1016/j.nmd.2009.04.014
   Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451
   Needham M, 2007, J NEUROL NEUROSUR PS, V78, P99, DOI 10.1136/jnnp.2005.078857
   Nelis E, 2002, NEUROLOGY, V59, P1865, DOI 10.1212/01.WNL.0000036272.36047.54
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3
   Pedrola L, 2008, J CELL MOL MED, V12, P679, DOI 10.1111/j.1582-4934.2007.00158.x
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Reilly MM, 2011, J PERIPHER NERV SYST, V16, P1, DOI 10.1111/j.1529-8027.2011.00324.x
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   Said G, 2005, J NEUROL, V252, P655, DOI 10.1007/s00415-005-0712-4
   Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   Sevilla T, 2008, BRAIN, V131, P3051, DOI 10.1093/brain/awn228
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Sivera R, 2010, J PERIPHER NERV SYST, V15, P334, DOI 10.1111/j.1529-8027.2010.00286.x
   Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Synofzik M, 2012, EUR J NEUROL, V19, Pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   Takahashi R, 2012, INTERNAL MED, V51, P791, DOI 10.2169/internalmedicine.51.6676
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Vital A, 2012, NEUROMUSCULAR DISORD, V22, P735, DOI 10.1016/j.nmd.2012.04.001
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Xu WY, 2012, AM J HUM GENET, V91, P1088, DOI 10.1016/j.ajhg.2012.09.018
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Zhu D, 2005, NEUROLOGY, V65, P496, DOI 10.1212/01.wnl.0000171345.62270.29
   Zimón M, 2011, NEUROLOGY, V77, P540, DOI 10.1212/WNL.0b013e318228fc70
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 105
TC 89
Z9 97
U1 0
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD OCT 15
PY 2013
VL 12
IS 10
BP 1011
EP 1024
DI 10.1016/S1474-4422(13)70158-3
PG 14
WC Clinical Neurology
SC Neurosciences & Neurology
GA 237XV
UT WOS:000325905800013
PM 24050734
DA 2024-11-01
ER

PT J
AU Martínez-Azorín, F
   Calleja, M
   Hernández-Sierra, R
   Farr, CL
   Kaguni, LS
AF Martinez-Azorin, Francisco
   Calleja, Manuel
   Hernandez-Sierra, Rosana
   Farr, Carol L.
   Kaguni, Laurie S.
TI MUSCLE-SPECIFIC OVEREXPRESSION OF THE CATALYTIC SUBUNIT OF DNA POLYMERASE γ INDUCES PUPAL LETHALITY IN Drosophila melanogaster
SO ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Article
DE apoptosis; DNA polymerase gamma; Drosophila melanogaster; mitochondria; oxidative phosphorylation
ID mitochondrial transcription factor; accessory subunit; mtdna polymerase; cell-death; factor-a; expression; apoptosis; depletion; disease; embryos
AB We show the physiological effects and molecular characterization of overexpression of the catalytic core of mitochondrial DNA (mtDNA) polymerase (pol -) in muscle of Drosophila melanogaster. Muscle-specific overexpression of pol - using the UAS/GAL4 (where UAS is upstream activation sequence) system produced more than 90% of lethality at the end of pupal stage at 25 degrees C, and the survivor adult flies showed a significant reduction in life span. The survivor flies displayed a decreased mtDNA level that is accompanied by a corresponding decrease in the levels of the nucleoid-binding protein mitochondrial transcription factor A (mtTFA). Furthermore, an increase in apoptosis is detected in larvae and adults overexpressing pol -. We suggest that the pupal lethality and reduced life span of survivor adult flies are both caused mainly by massive apoptosis of muscle cells induced by mtDNA depletion. (C) 2013 Wiley Periodicals, Inc.
C1 [Martinez-Azorin, Francisco; Hernandez-Sierra, Rosana] Univ Autonoma Madrid, Dept Bioquim, Fac Med CIBERER ISCIII, Inst Invest Biomed Alberto Sols CSIC, Madrid, Spain.
   [Martinez-Azorin, Francisco] Hosp 12 Octubre I 12, CIBERER ISCIII, Lab Enfermedades Mitocondriales, Inst Invest, E-28041 Madrid, Spain.
   [Calleja, Manuel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC, Madrid, Spain.
   [Hernandez-Sierra, Rosana] Hosp 12 Octubre I 12, Inst Invest, Lab Biogenesis Mitocondrial, E-28041 Madrid, Spain.
   [Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
C3 Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Hospital Universitario 12 de Octubre; Michigan State University; Michigan State University
RP Martínez-Azorín, F (corresponding author), Hosp 12 Octubre I 12, Ctr Actividades Ambulatorias CAA, Lab Enfermedades Mitocondriales, Inst Invest, 6a Planta,Bloque Labs,Avda Cordoba S-N, E-28041 Madrid, Spain.
EM fmartinez@h12o.es
FU European Union [QLG1-CT-2001-00966]; National Institutes of Health [GM45295]; Spanish Ministerio de Ciencia e Innovacion [PI10/00063]
CR BRAND AH, 1993, DEVELOPMENT, V118, P401
   CALLEJA M, 1993, J BIOL CHEM, V268, P18891
   Clavería C, 1998, EMBO J, V17, P7199, DOI 10.1093/emboj/17.24.7199
   Denton D, 2008, METHOD ENZYMOL, V446, P17, DOI 10.1016/S0076-6879(08)01602-9
   Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   GARESSE R, 1988, GENETICS, V118, P649
   Goto A, 2001, BIOCHEM J, V354, P243, DOI 10.1042/0264-6021:3540243
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301
   Lewis DL, 1996, J BIOL CHEM, V271, P23389, DOI 10.1074/jbc.271.38.23389
   LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787
   Mansouri A, 2003, HEPATOLOGY, V38, P715, DOI 10.1053/jhep.2003.50353
   Martínez-Azorín F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x
   McCall K, 2009, METHODS MOL BIOL, V559, P343, DOI 10.1007/978-1-60327-017-5_24
   Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019
   Orfanos Z, 2008, J MUSCLE RES CELL M, V29, P185, DOI 10.1007/s10974-009-9166-0
   Roote CE, 1996, DEVELOPMENT, V122, P1985
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202
   TAUTZ D, 1988, MOL BIOL EVOL, V5, P366
   Wang YX, 1999, J BIOL CHEM, V274, P28972, DOI 10.1074/jbc.274.41.28972
   Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640
   Zaffran S, 1997, DEVELOPMENT, V124, P2087
   Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102
NR 33
TC 1
Z9 1
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0739-4462
EI 1520-6327
J9 ARCH INSECT BIOCHEM
JI Arch. Insect Biochem. Physiol.
PD JUL 15
PY 2013
VL 83
IS 3
BP 127
EP 137
DI 10.1002/arch.21101
PG 11
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA 164DV
UT WOS:000320390000003
PM 23729397
DA 2024-11-01
ER

PT J
AU Pinós, T
   Melià, MJ
   Ortiz, N
   Martinez-Vea, A
   Raventós-Estellé, A
   Gallardo, E
   Hernández-Losa, J
   Cámara, Y
   Andreu, AL
   García-Arumí, E
AF Pinos, Tomas
   Jesus Melia, Maria
   Ortiz, Nicolau
   Martinez-Vea, Albert
   Raventos-Estelle, Antoni
   Gallardo, Eduard
   Hernandez-Losa, Javier
   Camara, Yolanda
   Andreu, Antoni L.
   Garcia-Arumi, Elena
TI Identification of the novel mutation m.5658T&gt;C in the mitochondrial tRNA(Asn) gene in a patient with myopathy, bilateral ptosis and ophthalmoparesis
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondria; mt-tRNA (Asn); Myopathy; Laser capture microdissection
ID ragged-red fibers; trna(lys) gene; myoclonus epilepsy; disease; dna; g8363a; a8296g
AB We report a heteroplasmic novel mutation m.5658T>C in the mt-tRNA(Asn) gene in a patient who initially presented myopathy, bilateral ptosis and ophthalmoparesis and several years later developed a non-nephrotic proteinuria. The muscle biopsy showed cytochrome c oxidase (COX) negative and ragged red fibers and in the kidney biopsy that was taken in order to identify the causes of non-nephrotic proteinuria, a focal segmental glomerulosclerosis was observed. Using laser capture microdissection we isolated COX negative fibers and COX positive fibers from the muscle of the patient and determined that there was a clear increase in the mutation load in the COX negative muscle fibers. However, the low degree of mutation load found in the renal biopsy of the patient does not allow us to conclude that the m.5658T>C mutation is responsible for focal glomerulosclerosis. Additionally, we hypothesize that the mutated m.5658T nucleotide might be structurally relevant, as it is one of the fifteen nucleotides conserved in all the species analyzed and is situated contiguously to the discriminator base in the 3'end of the mt-tRNA, where the tRNase Z cleaves the 3'trailer sequence during mt-tRNA maturation. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Pinos, Tomas; Jesus Melia, Maria; Camara, Yolanda; Andreu, Antoni L.; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Hosp Univ Vall dHebron Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain.
   [Hernandez-Losa, Javier] Univ Autonoma Barcelona, Hosp Univ Vall dHebron Inst Recerca VHIR, Serv Anat Patol, E-08193 Barcelona, Spain.
   [Gallardo, Eduard] Univ Autonoma Barcelona, Inst Recerca Hosp Santa Creu & St Pau, Lab Malalties Neuromusculars, E-08193 Barcelona, Spain.
   [Ortiz, Nicolau] Hosp Univ St Joan, Seccio Neurol, Reus, Spain.
   [Martinez-Vea, Albert] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Serv Nephrol, Tarragona, Spain.
   [Raventos-Estelle, Antoni] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Pathol Serv, Tarragona, Spain.
   [Pinos, Tomas; Jesus Melia, Maria; Camara, Yolanda; Andreu, Antoni L.; Garcia-Arumi, Elena] ISCIII, CIBERER, Barcelona, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain.
EM elena.garcia@vhir.org
FU Spanish Instituto de Salud Carlos III [PI07/0347, PI08/90355, PS09/01602]
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bailey T L, 1994, PROC INT CONF INTELL SYST MOL BIOL, V2, P28
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dubowitz C, 2007, MUSCLE BIOPSY PRACTI, V3rd, P0
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   King TE, 1967, METHODS ENZYMOLOGY, V10, P322, DOI 10.1016/0076-6879(67)10061-X
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Marotta M, 2007, NEUROMUSCULAR DISORD, V17, P707, DOI 10.1016/j.nmd.2007.05.007
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, PW605, DOI 10.1093/nar/gki447
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 33
TC 4
Z9 5
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR 15
PY 2013
VL 23
IS 4
BP 330
EP 336
DI 10.1016/j.nmd.2013.01.001
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 127LY
UT WOS:000317701700008
PM 23375258
DA 2024-11-01
ER

PT J
AU Hämäläinen, RH
   Manninen, T
   Koivumäki, H
   Kislin, M
   Otonkoski, T
   Suomalainen, A
AF Hamalainen, Riikka H.
   Manninen, Tuula
   Koivumaki, Hanna
   Kislin, Mikhail
   Otonkoski, Timo
   Suomalainen, Anu
TI Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A&gt;G mutation in human induced pluripotent stem cell-derived disease model
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE mitochondria; disease modeling
ID stroke-like episodes; mitochondrial-dna mutations; complex-i deficiency; lactic-acidosis; clinical-features; rapid segregation; balbiani body; melas; encephalopathy; myopathy
AB Mitochondrial DNA (mtDNA) mutations manifest with vast clinical heterogeneity. The molecular basis of this variability is mostly unknown because the lack of model systems has hampered mechanistic studies. We generated induced pluripotent stem cells from patients carrying the most common human disease mutation in mtDNA, m.3243A>G, underlying mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. During reprogramming, heteroplasmic mtDNA showed bimodal segregation toward homoplasmy, with concomitant changes in mtDNA organization, mimicking mtDNA bottleneck during epiblast specification. Induced pluripotent stem cell-derived neurons and various tissues derived from teratomas manifested cell-type specific respiratory chain (RC) deficiency patterns. Similar to MELAS patient tissues, complex I defect predominated. Upon neuronal differentiation, complex I specifically was sequestered in perinuclear PTEN-induced putative kinase 1 (PINK1) and Parkin-positive autophagosomes, suggesting active degradation through mitophagy. Other RC enzymes showed normal mitochondrial network distribution. Our data show that cellular context actively modifies RC deficiency manifestation in MELAS and that autophagy is a significant component of neuronal MELAS pathogenesis.
C1 [Hamalainen, Riikka H.; Manninen, Tuula; Koivumaki, Hanna; Otonkoski, Timo; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Helsinki 00280, Finland.
   [Kislin, Mikhail] Univ Helsinki, Ctr Neurosci, Helsinki 00790, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki 00280, Finland.
EM anu.wartiovaara@helsinki.fi
FU Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University of Helsinki; European Research Council
CR ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   De Smedt V, 2000, GENESIS, V26, P208, DOI 10.1002/(SICI)1526-968X(200003)26:3<208::AID-GENE6>3.0.CO;2-N
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nakada K, 2011, EXP ANIM TOKYO, V60, P421
   Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Suhr ST, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008124
   SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trokovic R, 2013, STEM CELLS DEV, V22, P114, DOI 10.1089/scd.2012.0157
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
NR 56
TC 154
Z9 165
U1 0
U2 9
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 17
PY 2013
VL 110
IS 38
BP E3622
EP E3630
DI 10.1073/pnas.1311660110
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 219GW
UT WOS:000324495300013
PM 24003133
DA 2024-11-01
ER

PT J
AU Vattemi, G
   Marini, M
   Ferreri, NR
   Hao, SJ
   Malatesta, M
   Meneguzzi, A
   Guglielmi, V
   Fava, C
   Minuz, P
   Tomelleri, G
AF Vattemi, Gaetano
   Marini, Matteo
   Ferreri, Nicholas R.
   Hao, Shoujin
   Malatesta, Manuela
   Meneguzzi, Alessandra
   Guglielmi, Valeria
   Fava, Cristiano
   Minuz, Pietro
   Tomelleri, Giuliano
TI Overexpression of TNF-α in mitochondrial diseases caused by mutations in mtDNA: evidence for signaling through its receptors on mitochondria
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Mitochondrial diseases; Tumor necrosis factor-alpha; TNF receptor type 1; TNF receptor type 2; Mitochondria; Free radicals
ID tumor-necrosis-factor; factor-induced apoptosis; inflammatory myopathy; skeletal-muscle; insulin-resistance; expression; differentiation; inhibition; activation; mechanisms
AB Mitochondrial diseases (MDs) are heterogeneous disorders due to impaired respiratory chain function causing defective ATP production. Although the disruption of oxidative phosphorylation is central to the MD pathophysiology, other factors may contribute to these disorders. We investigated the expression and the cellular localization of TNF-alpha and its receptors, TNFR1 and TNFR2, in muscle biopsies from 15 patients with mitochondrial respiratory chain dysfunction. Our data unambiguously demonstrate that TNF-alpha is expressed in muscle fibers with abnormal focal accumulations of mitochondria, so-called ragged red fibers, and is delivered to mitochondria where both receptors are localized. Moreover TNF receptors are differentially regulated in patients' muscle in which the expression levels of TNFR1 mRNA are decreased and those of TNFR2 mRNA are increased compared with controls. These findings suggest for the first time that TNF-alpha could exert a direct effect on mitochondria via its receptors. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Vattemi, Gaetano; Marini, Matteo; Guglielmi, Valeria; Tomelleri, Giuliano] Univ Verona, Sect Clin Neurol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37134 Verona, Italy.
   [Ferreri, Nicholas R.; Hao, Shoujin] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.
   [Malatesta, Manuela] Univ Verona, Sect Anat & Histol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37134 Verona, Italy.
   [Meneguzzi, Alessandra; Fava, Cristiano; Minuz, Pietro] Univ Verona, Sect Internal Med, Dept Biomed & Surg Sci, I-37134 Verona, Italy.
C3 University of Verona; New York Medical College; University of Verona; University of Verona
RP Vattemi, G (corresponding author), Univ Verona, Sect Clin Neurol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37134 Verona, Italy.
EM gaetano.vattemi@univr.it
CR Al-Lamki RS, 2009, AM J TRANSPLANT, V9, P2679, DOI 10.1111/j.1600-6143.2009.02831.x
   Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x
   Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287
   Busquets S, 2003, CYTOKINE, V22, P1, DOI 10.1016/S1043-4666(03)00098-X
   De Bleecker JL, 1999, NEUROMUSCULAR DISORD, V9, P239, DOI 10.1016/S0960-8966(98)00126-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002
   Harry GJ, 2008, J NEUROCHEM, V106, P281, DOI 10.1111/j.1471-4159.2008.05382.x
   Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V330, P17
   James AM, 2002, J BIOMED SCI, V9, P475, DOI 10.1159/000064721
   Keller C, 2006, CYTOKINE, V36, P141, DOI 10.1016/j.cyto.2006.10.014
   Kuru S, 2003, ACTA NEUROPATHOL, V105, P217, DOI 10.1007/s00401-002-0632-4
   Lacerda L, 2010, BASIC RES CARDIOL, V105, P751, DOI 10.1007/s00395-010-0113-4
   LANCASTER JR, 1989, FEBS LETT, V248, P169, DOI 10.1016/0014-5793(89)80454-5
   Ledgerwood EC, 1998, LAB INVEST, V78, P1583
   Li YP, 2001, FASEB J, V15, P1413, DOI 10.1096/fj.00-0632fje
   LINDBERG C, 1995, SCAND J IMMUNOL, V41, P421, DOI 10.1111/j.1365-3083.1995.tb03587.x
   Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008
   Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245
   Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939
   Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504
   TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292
   Tews DS, 1996, J NEUROPATH EXP NEUR, V55, P342, DOI 10.1097/00005072-199603000-00009
   TORREAMIONE G, 1995, CIRCULATION, V92, P1487, DOI 10.1161/01.CIR.92.6.1487
   VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 29
TC 9
Z9 9
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT 15
PY 2013
VL 63
IS 
BP 108
EP 114
DI 10.1016/j.freeradbiomed.2013.04.025
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 200TV
UT WOS:000323094700009
PM 23619127
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Kunz, WS
AF Zsurka, Gabor
   Kunz, Wolfram S.
TI Mitochondrial involvement in neurodegenerative diseases
SO IUBMB LIFE
LA English
DT Review
DE mitochondria; neurodegenerative diseases; reactive oxygen species
ID dominant optic atrophy; progressive external ophthalmoplegia; alpha-ketoglutarate dehydrogenase; electron-transport chain; substantia-nigra neurons; dna-polymerase-gamma; kinesin heavy-chain; superoxide-production; complex-i; brain mitochondria
AB The classical bioenergetical view of the involvement of mitochondria in neurogeneration is based on the fact that mitochondria are the central players of ATP synthesis in neurons and their failure leads to neuronal dysfunction and eventually to cell death. Mutations in at least 39 genes in inherited neurodegenerative disorders seem to alter directly or indirectly mitochondrial function. Most of these mutations do not directly affect oxidative phosphorylation, but act through disturbed mitochondrial dynamics and quality control. This, however, does not invalidate the bioenergetic hypothesis. Neurodegeneration is not necessarily associated with a gross failure of ATP production, but might rather be a consequence of local insufficiencies of ATP supply in critical compartments of neurons, like the presynaptic terminal. We hypothesize that slow disease progression, at least in a subgroup of neurodegenerative diseases, can be explained by the parallel action of subcellular ATP insufficiency and clonal expansion of somatic mitochondrial DNA mutations, and particularly deletions. (c) 2013 IUBMB Life, 65(3):263272, 2013
C1 Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany.
   Univ Bonn, Life & Brain Ctr, D-53105 Bonn, Germany.
C3 University of Bonn; University of Bonn
RP Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Dept Epileptol, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
FU Bundesministerium fur Bildung und Forschung [mitoNET 01GM0868]; Deutsche Forschungsgemeinschaft [SFB TR3 A11, D12]; Stiftung fur Medizinische Wissenschaft, Frankfurt am Main
CR Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ASTRUP J, 1981, STROKE, V12, P726, DOI 10.1161/01.STR.12.6.726
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bindokas VP, 1998, J NEUROSCI, V18, P4570
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200
   Campbell GR, 2012, ACTA NEUROPATHOL, V124, P209, DOI 10.1007/s00401-012-1001-9
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Cooper AJL, 1997, THE MOLECULAR AND GENETIC BASIS OF NEUROLOGICAL DISEASE, V0, P1195
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   Fransson Å, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gal S, 2005, J NEUROCHEM, V95, P79, DOI 10.1111/j.1471-4159.2005.03341.x
   Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2
   Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Gispert S, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005777
   Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067
   Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gulyás AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x
   Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x
   Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Krause KH, 2004, JPN J INFECT DIS, V57, P0
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Kudin AP, 2005, BIOMED PHARMACOTHER, V59, P163, DOI 10.1016/j.biopha.2005.03.012
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200
   Langeveld CH, 1996, NEUROREPORT, V7, P1833, DOI 10.1097/00001756-199607290-00029
   LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9
   Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Malinska D, 2010, BBA-BIOENERGETICS, V1797, P1163, DOI 10.1016/j.bbabio.2010.03.001
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   Näpänkangas JP, 2012, J MOL CELL CARDIOL, V53, P906, DOI 10.1016/j.yjmcc.2012.09.011
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655
   Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526
   Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071
   Schmucker S, 2010, HUM MOL GENET, V19, PR103, DOI 10.1093/hmg/ddq165
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spencer JPE, 1998, J NEUROCHEM, V71, P2112
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9
   THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094
   Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018
   Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748
   Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 86
TC 34
Z9 35
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD MAR 15
PY 2013
VL 65
IS 3
BP 263
EP 272
DI 10.1002/iub.1126
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 096OW
UT WOS:000315415100011
PM 23341346
DA 2024-11-01
ER

PT J
AU Lim, SC
   Friemel, M
   Marum, JE
   Tucker, EJ
   Bruno, DL
   Riley, LG
   Christodoulou, J
   Kirk, EP
   Boneh, A
   DeGennaro, CM
   Springer, M
   Mootha, VK
   Rouault, TA
   Leimkuhler, S
   Thorburn, DR
   Compton, AG
AF Lim, Sze Chern
   Friemel, Martin
   Marum, Justine E.
   Tucker, Elena J.
   Bruno, Damien L.
   Riley, Lisa G.
   Christodoulou, John
   Kirk, Edwin P.
   Boneh, Avihu
   DeGennaro, Christine M.
   Springer, Michael
   Mootha, Vamsi K.
   Rouault, Tracey A.
   Leimkuehler, Silke
   Thorburn, David R.
   Compton, Alison G.
TI Mutations in LYRM4, encoding ironsulfur cluster biogenesis factor ISD11, cause deficiency of multiple respiratory chain complexes
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID iron-sulfur cluster; scaffold protein; mitochondrial disease; cysteine desulfurase; lactic-acidosis; causes myopathy; 1st year; gene; iscu; maturation
AB Ironsulfur clusters (ISCs) are important prosthetic groups that define the functions of many proteins. Proteins with ISCs (called ironsulfur or FeS proteins) are present in mitochondria, the cytosol, the endoplasmic reticulum and the nucleus. They participate in various biological pathways including oxidative phosphorylation (OXPHOS), the citric acid cycle, iron homeostasis, heme biosynthesis and DNA repair. Here, we report a homozygous mutation in LYRM4 in two patients with combined OXPHOS deficiency. LYRM4 encodes the ISD11 protein, which forms a complex with, and stabilizes, the sulfur donor NFS1. The homozygous mutation (c.203GT, p.R68L) was identified via massively parallel sequencing of 1000 mitochondrial genes (MitoExome sequencing) in a patient with deficiency of complexes I, II and III in muscle and liver. These three complexes contain ISCs. Sanger sequencing identified the same mutation in his similarly affected cousin, who had a more severe phenotype and died while a neonate. Complex IV was also deficient in her skeletal muscle. Several other FeS proteins were also affected in both patients, including the aconitases and ferrochelatase. Mutant ISD11 only partially complemented for an ISD11 deletion in yeast. Our in vitro studies showed that the l-cysteine desulfurase activity of NFS1 was barely present when co-expressed with mutant ISD11. Our findings are consistent with a defect in the early step of ISC assembly affecting a broad variety of FeS proteins. The differences in biochemical and clinical features between the two patients may relate to limited availability of cysteine in the newborn period and suggest a potential approach to therapy.
C1 [Lim, Sze Chern; Marum, Justine E.; Tucker, Elena J.; Bruno, Damien L.; Boneh, Avihu; Thorburn, David R.; Compton, Alison G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Lim, Sze Chern; Marum, Justine E.; Tucker, Elena J.; Boneh, Avihu; Thorburn, David R.; Compton, Alison G.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.
   [Friemel, Martin; Leimkuehler, Silke] Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, D-14476 Potsdam, Germany.
   [Bruno, Damien L.; Boneh, Avihu; Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia.
   [Riley, Lisa G.; Christodoulou, John] Childrens Hosp, Genet Metab Disorders Res Unit, Westmead, NSW 2145, Australia.
   [Christodoulou, John] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.
   [Christodoulou, John] Univ Sydney, Discipline Genet Med, Sydney, NSW 2006, Australia.
   [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW 2031, Australia.
   [DeGennaro, Christine M.; Springer, Michael; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.
   [Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Mootha, Vamsi K.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02141 USA.
   [Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Mol Med, NIH, Bethesda, MD 20892 USA.
C3 Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Potsdam; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; University of Sydney; NSW Health; Sydney Childrens Hospitals Network; University of Sydney; University of Sydney; NSW Health; Sydney Childrens Hospitals Network; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
RP Compton, AG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
EM alison.compton@mcri.edu.au
FU NHLBI Lung GO Sequencing Project [HL-102923]; NHLBI WHI Sequencing Project [HL-102924]; NHLBI Broad GO Sequencing Project [HL-102925]; NHLBI Seattle GO Sequencing Project [HL-102926]; NHLBI Heart GO Sequencing Project [HL-103010]; NHLBI Melbourne Research Scholarship; NHLBI Australian National Health and Medical Research Council; NHLBI Victorian Government; NHLBI Eunice Kennedy Shriver National Institute of Child Health and Human Development; NHLBI Deutsche Forschungsgemeinschaft
CR Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104
   Bruno DL, 2011, J MED GENET, V48, P831, DOI 10.1136/jmedgenet-2011-100372
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   Condò I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200
   Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010
   Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38
   Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105
   Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672
   Ferrer- Corte` s X, 2012, J INHERIT METAB DIS, V0, P1
   FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028
   Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07
   Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI 10.1038/NMETH.1318
   Haack TB, 2013, J INHERIT METAB DIS, V36, P55, DOI 10.1007/s10545-012-9489-7
   Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6
   Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161
   Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200
   Leimkühler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200
   Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1445, DOI 10.1001/archneur.60.10.1445
   Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200
   Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mühlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Pandey A, 2011, J BIOL CHEM, V286, P38242, DOI 10.1074/jbc.M111.288522
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schmucker S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016199
   Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038
   Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582
   Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239
   Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014
   Springer M, 2010, MOL SYST BIOL, V6, P0, DOI 10.1038/msb.2010.19
   Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679
   Tenisch EV, 2012, NEUROLOGY, V79, P391, DOI 10.1212/WNL.0b013e3182611232
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100
   Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906
   Xia HY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0047847
   Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   ZLOTKIN SH, 1988, PEDIATR RES, V24, P326, DOI 10.1203/00006450-198809000-00010
   ZLOTKIN SH, 1982, PEDIATR RES, V16, P65
NR 71
TC 79
Z9 103
U1 1
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD NOV 15
PY 2013
VL 22
IS 22
BP 4460
EP 4473
DI 10.1093/hmg/ddt295
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 248EA
UT WOS:000326675300002
PM 23814038
DA 2024-11-01
ER

PT J
AU Monnot, S
   Samuels, DC
   Hesters, L
   Frydman, N
   Gigarel, N
   Burlet, P
   Kerbrat, V
   Lamazou, F
   Frydman, R
   Benachi, A
   Feingold, J
   Rotig, A
   Munnich, A
   Bonnefont, JP
   Steffann, J
AF Monnot, Sophie
   Samuels, David C.
   Hesters, Laetitia
   Frydman, Nelly
   Gigarel, Nadine
   Burlet, Philippe
   Kerbrat, Violaine
   Lamazou, Frederic
   Frydman, Rene
   Benachi, Alexandra
   Feingold, Josue
   Rotig, Agnes
   Munnich, Arnold
   Bonnefont, Jean-Paul
   Steffann, Julie
TI Mutation dependance of the mitochondrial DNA copy number in the first stages of human embryogenesis
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID ragged-red fibers; threshold expression; mouse embryos; polar body; oocytes; muscle; heteroplasmy; transcripts; merrf; melas
AB Mitochondrial DNA (mtDNA) content is thought to remain stable over the preimplantation period of human embryogenesis that is, therefore, suggested to be entirely dependent on ooplasm mtDNA capital. We have explored the impact of two disease-causing mutations [m.3243AG myopathy, encephalopathy, lactic acidosis and stroke-like syndrome (MELAS) and m.8344AG myoclonic epilepsy associated with ragged-red fibers (MERRF)] on mtDNA amounts in human oocytes and day 45 preimplantation embryos. The mtDNA amount was stable in MERRF and control materials, whereas gradually increasing from the germinal vesicle of oogenesis to the blastocyst stage of embryogenesis in MELAS cells, MELAS embryos carrying 3-fold higher mtDNA amount than control embryos (P 0.0003). A correlation between mtDNA copy numbers and mutant loads was observed in MELAS embryos (R-2 0.42, P 0.0013), suggestive of a compensation for the respiratory chain defect resulting from high mutation levels. These results suggest that mtDNA can replicate in early embryos and emphasize the need for sufficient amount of wild-type mtDNA to sustain embryonic development in humans.
C1 [Monnot, Sophie; Gigarel, Nadine; Burlet, Philippe; Feingold, Josue; Rotig, Agnes; Munnich, Arnold; Bonnefont, Jean-Paul; Steffann, Julie] Univ Paris 05, Hop Necker Enfants Malad, Inst Imagine, F-75015 Paris 15, France.
   [Monnot, Sophie; Gigarel, Nadine; Burlet, Philippe; Feingold, Josue; Rotig, Agnes; Munnich, Arnold; Bonnefont, Jean-Paul; Steffann, Julie] Univ Paris 05, Hop Necker Enfants Malad, INSERM U781, F-75015 Paris 15, France.
   [Samuels, David C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA.
   [Hesters, Laetitia; Frydman, Nelly] Hop Antoine Beclere, Serv Biol & Genet Reprod, F-92141 Clamart, France.
   [Kerbrat, Violaine; Lamazou, Frederic; Frydman, Rene; Benachi, Alexandra] Hop Antoine Beclere, Serv Gynecol Obstet & Med Reprod, Unite INSERM U782, F-92141 Clamart, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP
RP Monnot, S (corresponding author), Hop Necker Enfants Malad, Genet Lab, Tour Lavoisier 3Eme Etage,149 Rue Sevres, F-75015 Paris, France.
EM sophie.monnot@inserm.fr
FU Association Francaise contre les Myopathies
CR Barritt J A, 2002, REPROD BIOMED ONLINE, V4, P243
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chan CCW, 2005, MOL HUM REPROD, V11, P843, DOI 10.1093/molehr/gah243
   Chiaratti MR, 2010, BIOL REPROD, V82, P76, DOI 10.1095/biolreprod.109.077776
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389
   Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8
   EBERT KM, 1988, J REPROD FERTIL, V82, P145, DOI 10.1530/jrf.0.0820145
   ELMEZIANE A, 1989, EMBO J, V8, P1649, DOI 10.1002/j.1460-2075.1989.tb03555.x
   Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010
   Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005
   May-Panloup P, 2005, REPROD BIOL ENDOCRIN, V3, P0, DOI 10.1186/1477-7827-3-65
   May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667
   McConnell JML, 2004, REPROD BIOMED ONLINE, V9, P418, DOI 10.1016/S1472-6483(10)61277-1
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2
   Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425
   Silvestri G, 2000, AM J MED GENET, V94, P201, DOI 10.1002/1096-8628(20000918)94:3<201::AID-AJMG5>3.0.CO;2-2
   Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536
   Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003
   Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
NR 28
TC 61
Z9 62
U1 0
U2 27
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 1
PY 2013
VL 22
IS 9
BP 1867
EP 1872
DI 10.1093/hmg/ddt040
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 123ZD
UT WOS:000317431100015
PM 23390135
DA 2024-11-01
ER

PT J
AU Gropman, AL
AF Gropman, Andrea L.
TI Neuroimaging in Mitochondrial Disorders
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Brain injury; diffusion tensor imaging (DTI); functional MRI (fMRI); inborn error of metabolism; metabolism; magnetic resonance imaging (MRI); magnetic resonance spectroscopy (MRS); metabolism; mitochondrial disorder
ID magnetic-resonance-spectroscopy; proton mr spectroscopy; alpers-huttenlocher-syndrome; respiratory-chain defects; stroke-like episodes; leigh-syndrome; melas-syndrome; human brain; diagnostic evaluation; clinical spectrum
AB Mutations in either nuclear DNA or mitochondrial DNA can result in disruption of oxidative phosphorylation and lead to mitochondrial dysfunction. Mitochondrial disease manifestations occur predominantly in the central nervous system, peripheral nervous system, and/or involve several organ systems. The consequences range from manifestations of a single organ or tissues, such as muscle fatigue, if confined only to muscle, seizures, intellectual disabilities, dementia, and stroke (if to the central nervous system), leading to disability or even early death. The definitive diagnosis of a mitochondrial disorder can be difficult to establish. Criteria and checklists have been established and are more reflective of adult disease. However, in children, when symptoms suggest a mitochondrial disease, neuroimaging features may have more diagnostic impact and additionally these can be used to follow the course, evolution, and recovery of the disease. This review will demonstrate the common neuroimaging patterns in patients with mitochondrial disorders and point out how various newer neuroimaging modalities may be exploited to glean information as to the different aspects of mitochondrial dysfunction or resulting neurological and cognitive disruption, although reports in the literature using these methods remain sparse.
C1 [Gropman, Andrea L.] Childrens Natl Med Ctr, Dept Pediat & Neurol, Washington, DC 20010 USA.
   [Gropman, Andrea L.] George Washington Univ Hlth Sci, Washington, DC 20010 USA.
C3 Children's National Health System; George Washington University
RP Gropman, AL (corresponding author), Childrens Natl Med Ctr, Dept Pediat & Neurol, Washington, DC 20010 USA.
EM agropman@childrensnational.org
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   BARKOVICH AJ, 1988, RADIOLOGY, V166, P173, DOI 10.1148/radiology.166.1.3336675
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1006/jmrb.1996.0086
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958
   Blüml S, 1999, MAGNET RESON MED, V42, P643, DOI 10.1002/(SICI)1522-2594(199910)42:4<643::AID-MRM5>3.0.CO;2-N
   Brockmann K, 2004, NEURORADIOLOGY, V46, P267, DOI 10.1007/s00234-004-1181-7
   Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334
   Burgeois M, 1992, BRAIN DEV, V14, P404
   Cakmakci H, 2010, EUR J RADIOL, V74, PE162, DOI 10.1016/j.ejrad.2009.05.048
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Castro-Gago M, 1999, REV NEUROLOGIA, V29, P912, DOI 10.33588/rn.2910.99062
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Feng Feng, 2006, CHINESE MEDICAL SCIENCES JOURNAL, V21, P234
   Finsterer J, 2010, EPILEPTIC DISORD, V12, P330, DOI 10.1684/epd.2010.0338
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P143, DOI 10.1017/S0317167100006508
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Gropman AL, 2004, MITOCHONDRION, V4, P503, DOI 10.1016/j.mito.2004.07.009
   Gropman AL, 2005, MOL GENET METAB, V86, P2, DOI 10.1016/j.ymgme.2005.07.009
   Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   Haas RH, 1900, V94, V0, P16
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HATTEN HP, 1991, PEDIATR RADIOL, V21, P477, DOI 10.1007/BF02011716
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hoisington L, 1998, RADIOL TECHNOL, V69, P351
   Ishak GE, 2012, AM J NEURORADIOL, V33, P1726, DOI 10.3174/ajnr.A3045
   Iwata O, 2004, PEDIATR INT, V46, P141, DOI 10.1046/j.1442-200x.2004.01874.x
   Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Lin DDM, 2003, AM J NEURORADIOL, V24, P33
   Lincke CR, 1996, NEUROPEDIATRICS, V27, P216, DOI 10.1055/s-2007-973792
   Liu ZH, 2011, NEURORADIOLOGY, V53, P227, DOI 10.1007/s00234-010-0729-y
   Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976
   Mailhard P, 2013, AM J NEURORADIOL, V34, P54, DOI 10.3174/ajnr.A3146
   Masucci JP, 1997, MOL CELL BIOCHEM, V174, P215, DOI 10.1023/A:1006808524536
   MATTHEWS PM, 1991, NEUROLOGY, V41, P1043, DOI 10.1212/WNL.41.7.1043
   MEDINA L, 1990, AM J ROENTGENOL, V154, P1269, DOI 10.2214/ajr.154.6.2159689
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Panigrahy A, 2010, PEDIATR RADIOL, V40, P3, DOI 10.1007/s00247-009-1450-z
   Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019
   Renard D, 2010, NEUROLOGY, V75, PE9, DOI 10.1212/WNL.0b013e3181e8e73e
   Ross BD, 1996, NMR BIOMED, V9, P279, DOI 10.1002/(SICI)1099-1492(199610)9:7<279::AID-NBM435>3.0.CO;2-V
   Roy C S, 1890, J PHYSIOL, V11, P85
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   VANDERKNAAP MS, 1991, NEURORADIOLOGY, V33, P478, DOI 10.1007/BF00588038
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Weinstock A, 2002, J CHILD NEUROL, V17, P47, DOI 10.1177/088307380201700112
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Wolf NI, 2003, NEUROPEDIATRICS, V34, P156
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Xu V, 2008, SEMIN NEUROL, V28, P407, DOI 10.1055/s-0028-1083685
NR 79
TC 52
Z9 58
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD APR 15
PY 2013
VL 10
IS 2
BP 273
EP 285
DI 10.1007/s13311-012-0161-6
PG 13
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 127EC
UT WOS:000317677900009
PM 23208728
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Orsucci, D
   Angelini, C
   Bertini, E
   Carelli, V
   Comi, GP
   Minetti, C
   Moggio, M
   Mongini, T
   Servidei, S
   Tonin, P
   Toscano, A
   Uziel, G
   Bruno, C
   Ienco, EC
   Filosto, M
   Lamperti, C
   Martinelli, D
   Moroni, I
   Musumeci, O
   Pegoraro, E
   Ronchi, D
   Santorelli, FM
   Sauchelli, D
   Scarpelli, M
   Sciacco, M
   Spinazzi, M
   Valentino, ML
   Vercelli, L
   Zeviani, M
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Angelini, Corrado
   Bertini, Enrico
   Carelli, Valerio
   Comi, Giacomo Pietro
   Minetti, Carlo
   Moggio, Maurizio
   Mongini, Tiziana
   Servidei, Serenella
   Tonin, Paola
   Toscano, Antonio
   Uziel, Graziella
   Bruno, Claudio
   Ienco, Elena Caldarazzo
   Filosto, Massimiliano
   Lamperti, Costanza
   Martinelli, Diego
   Moroni, Isabella
   Musumeci, Olimpia
   Pegoraro, Elena
   Ronchi, Dario
   Santorelli, Filippo Maria
   Sauchelli, Donato
   Scarpelli, Mauro
   Sciacco, Monica
   Spinazzi, Marco
   Valentino, Maria Lucia
   Vercelli, Liliana
   Zeviani, Massimo
   Siciliano, Gabriele
TI Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation
SO NEUROLOGY
LA English
DT Article
ID ragged-red fibers; mitochondrial-dna disease; transfer rnalys mutation; myoclonic epilepsy; clinical-features; involvement; disorders
AB Objectives: Myoclonic epilepsy with ragged-red fibers (MERRF) is a rare mitochondrial syndrome, mostly caused by the 8344A>G mitochondrial DNA mutation. Most of the previous studies have been based on single case/family reports or series with few patients. The primary aim of this study was the characterization of a large cohort of patients with the 8344A>G mutation. The secondary aim was revision of the previously published data. Methods: Retrospective, database-based study (Nation-wide Italian Collaborative Network of Mitochondrial Diseases) and systematic revision. Results: Forty-two patients carrying the mutation were identified. The great majority did not have full-blown MERRF syndrome. Myoclonus was present in 1 of 5 patients, whereas myopathic signs and symptoms, generalized seizures, hearing loss, eyelid ptosis, and multiple lipomatosis represented the most common clinical features. Some asymptomatic mutation carriers have also been observed. Myoclonus was more strictly associated with ataxia than generalized seizures in adult 8344A>G subjects. Considering all of the 321 patients so far available, including our dataset and previously published cases, at the mean age of approximately 35 years, the clinical picture was characterized by the following signs/symptoms, in descending order: myoclonus, muscle weakness, ataxia (35%-45% of patients); generalized seizures, hearing loss (25%-34.9%); cognitive impairment, multiple lipomatosis, neuropathy, exercise intolerance (15%-24.9%); and increased creatine kinase levels, ptosis/ophthalmoparesis, optic atrophy, cardiomyopathy, muscle wasting, respiratory impairment, diabetes, muscle pain, tremor, migraine (5%-14.9%). Conclusions: Our results showed higher clinical heterogeneity than commonly thought. Moreover, MERRF could be better defined as a myoclonic ataxia rather than a myoclonic epilepsy.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Ienco, Elena Caldarazzo; Siciliano, Gabriele] Univ Pisa, Neurol Clin, I-56100 Pisa, Italy.
   [Angelini, Corrado; Pegoraro, Elena; Spinazzi, Marco] Univ Padua, Neurol Clin, Venice, Italy.
   [Angelini, Corrado; Pegoraro, Elena; Spinazzi, Marco] IRCCS S Camillo, Venice, Italy.
   [Bertini, Enrico; Martinelli, Diego] Bambino Gesu Pediat Hosp, Rome, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, IRCCS Ist Sci Neurol, I-40126 Bologna, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
   [Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
   [Minetti, Carlo; Bruno, Claudio] Univ Genoa, Neuropediat & Muscle Disorders Unit, Genoa, Italy.
   [Minetti, Carlo; Bruno, Claudio] G Gaslini Inst Children, Genoa, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular Unit, Milan, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Univ Milan, Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Turin, Dept Neurosci, I-10124 Turin, Italy.
   [Servidei, Serenella; Sauchelli, Donato] Catholic Univ, Inst Neurol, Rome, Italy.
   [Tonin, Paola; Scarpelli, Mauro] Univ Verona, Neurol Clin, I-37100 Verona, Italy.
   [Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Dept Neurosci, I-98100 Messina, Italy.
   [Uziel, Graziella; Moroni, Isabella] Fdn Carlo Besta Inst Neurology IRCCS, Child Neurol Unit, Milan, Italy.
   [Lamperti, Costanza; Zeviani, Massimo] Fdn Carlo Besta Inst Neurology IRCCS, Unit Mol Neurogenet, Milan, Italy.
   [Filosto, Massimiliano] Univ Hosp Spedali Civili, Neurol Clin, Brescia, Italy.
   [Santorelli, Filippo Maria] IRCCS Stella Maris, Pisa, Italy.
C3 University of Pisa; University of Padua; IRCCS Ospedale San Camillo; IRCCS Bambino Gesu; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Turin; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona; University of Messina; Fondazione IRCCS Istituto Neurologico Carlo Besta; Fondazione IRCCS Istituto Neurologico Carlo Besta; Hospital Spedali Civili Brescia; IRCCS Fondazione Stella Maris
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, I-56100 Pisa, Italy.
EM mancusomichelangelo@gmail.com
FU Telethon [GUP09004]; MRC [MC_UP_1002/1] Funding Source: UKRI
CR Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   DiMauro S, 2002, ADV NEUROL, V89, P217
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   GRAF WD, 1993, ANN NEUROL, V33, P640, DOI 10.1002/ana.410330613
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2012, NEUROL SCI, V33, P449, DOI 10.1007/s10072-011-0703-4
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   NOER AS, 1991, AM J HUM GENET, V49, P715
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shibasaki H, 2011, MOVEMENT DISORD, V26, P1142, DOI 10.1002/mds.23673
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
NR 19
TC 128
Z9 134
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY 15
PY 2013
VL 80
IS 22
BP 2049
EP 2054
DI 10.1212/WNL.0b013e318294b44c
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 300LX
UT WOS:000330466500017
PM 23635963
DA 2024-11-01
ER

PT J
AU Craigen, WJ
   Graham, BH
   Wong, LJ
   Scaglia, F
   Lewis, RA
   Bonnen, PE
AF Craigen, William J.
   Graham, Brett H.
   Wong, Lee-Jun
   Scaglia, Fernando
   Lewis, Richard Alan
   Bonnen, Penelope E.
TI Exome sequencing of a patient with suspected mitochondrial disease reveals a likely multigenic etiology
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Encephalomyopathy; Lowe syndrome; OCRL; SETX; Diagnostics; Genocopy
ID generation; disorders; framework
AB Background: The clinical features of mitochondrial disease are complex and highly variable, leading to challenges in establishing a specific diagnosis. Despite being one of the most commonly occurring inherited genetic diseases with an incidence of 1/5000, similar to 90% of these complex patients remain without a DNA-based diagnosis. We report our efforts to identify the pathogenetic cause for a patient with typical features of mitochondrial disease including infantile cataracts, CPEO, ptosis, progressive distal muscle weakness, and ataxia who carried a diagnosis of mitochondrial disease for over a decade. Methods: Whole exome sequencing and bioinformatic analysis of these data were conducted on the proband. Results: Exome sequencing studies showed a homozygous splice site mutation in SETX, which is known to cause Spinocerebellar Ataxia, Autosomal Recessive 1 (SCAR1). Additionally a missense mutation was identified in a highly conserved position of the OCRL gene, which causes Lowe Syndrome and Dent Disease 2. Conclusions: This patient's complex phenotype reflects a complex genetic etiology in which no single gene explained the complete clinical presentation. These genetic studies reveal that this patient does not have mitochondrial disease but rather a genocopy caused by more than one mutant locus. This study demonstrates the benefit of exome sequencing in providing molecular diagnosis to individuals with complex clinical presentations.
C1 [Craigen, William J.; Graham, Brett H.; Wong, Lee-Jun; Scaglia, Fernando; Lewis, Richard Alan; Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Craigen, William J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA.
   [Scaglia, Fernando] Texas Childrens Hosp, Clin Care Ctr, Houston, TX 77030 USA.
   [Bonnen, Penelope E.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Bonnen, PE (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
EM pbonnen@bcm.edu
FU Texas Norman Hackerman Advanced Research Program [[THECB] 02006]; Research to Prevent Blindness, New York, N.Y.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Anheim M, 2009, BRAIN, V132, P2688, DOI 10.1093/brain/awp211
   Bainbridge MN, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-7-r68
   BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Davydov EV, 2010, PLOS COMPUT BIOL, V6, P0, DOI 10.1371/journal.pcbi.1001025
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031
   Huang BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/j.ejmg.2010.07.001
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
NR 18
TC 9
Z9 10
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2350
EI 
J9 BMC MED GENET
JI BMC Med. Genet.
PD AUG 16
PY 2013
VL 14
IS 
BP 
EP 
DI 10.1186/1471-2350-14-83
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA 204CA
UT WOS:000323341300001
PM 23947751
DA 2024-11-01
ER

PT J
AU Monden, Y
   Mori, M
   Kuwajima, M
   Goto, T
   Yamagata, T
   Momoi, MY
AF Monden, Yukifumi
   Mori, Masato
   Kuwajima, Mari
   Goto, Tamako
   Yamagata, Takanori
   Momoi, Mariko Y.
TI Late-onset Leigh syndrome with myoclonic epilepsy with ragged-red fibers
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Leigh syndrome; MERRF; m.8344A > G
ID mitochondrial-dna mutation; merrf; disease; family; mtdna
AB We report the case of a boy with myoclonic epilepsy with ragged-red fibers (MERRF) who had astatic seizures since 2 years of age and later developed ataxia, absence seizures, and myoclonus. Almost homoplasmic A8344G mutation of mitochondrial DNA (m.8344A>G mutation) was detected in lymphocytes. He developed late-onset Leigh syndrome (LS) when he contracted pneumonia at 6 years. He developed bulbar palsy and deep coma. MRI demonstrated lesions in the brainstem, basal ganglia, and cerebral cortex. Three similar cases have been reported; two carried the almost-homoplasmic m.8344A>G mutation in muscle tissue. These suggested that almost homoplastic m.8344A>G mutation developed clinical phenotype of MERRF in the early stage and late-onset Leigh syndrome in the late course of the disease. (C) 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Monden, Yukifumi; Mori, Masato; Kuwajima, Mari; Goto, Tamako; Yamagata, Takanori; Momoi, Mariko Y.] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan.
C3 Jichi Medical University
RP Mori, M (corresponding author), Jichi Med Univ, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi, Japan.
EM morim@jichi.ac.jp
FU Grants-in-Aid for Scientific Research [23390275] Funding Source: KAKEN
CR Arpa J, 1997, ACTA NEUROL SCAND, V96, P65
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   PICCOLO G, 1993, ACTA NEUROL SCAND, V88, P406, DOI 10.1111/j.1600-0404.1993.tb05368.x
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   YONEDA M, 1991, NEUROLOGY, V41, P1838, DOI 10.1212/WNL.41.11.1838
NR 10
TC 12
Z9 15
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 
J9 BRAIN DEV-JPN
JI Brain Dev.
PD JUN 15
PY 2013
VL 35
IS 6
BP 582
EP 585
DI 10.1016/j.braindev.2012.08.006
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 148LG
UT WOS:000319245500011
PM 22981260
DA 2024-11-01
ER

PT J
AU Reeve, A
   Meagher, M
   Lax, N
   Simcox, E
   Hepplewhite, P
   Jaros, E
   Turnbull, D
AF Reeve, Amy
   Meagher, Martin
   Lax, Nichola
   Simcox, Eve
   Hepplewhite, Philippa
   Jaros, Evelyn
   Turnbull, Doug
TI The Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra Neurons
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID kearns-sayre-syndrome; progressive external ophthalmoplegia; polymerase-gamma mutations; complex i deficiency; parkinsons-disease; pars compacta; dopaminergic-neurons; clinical-disease; disector counts; polg1 mutations
AB Mitochondrial defects within substantia nigra (SN) neurons are implicated in the pathogenesis of Parkinson's disease. SN neurons show increased mitochondrial defects, mitochondrial DNA deletion levels, and susceptibility to such dysfunction, although the role of mitochondria in neuronal degeneration remains uncertain. In this study, we addressed this important question by exploring changes within the mitochondria of SN neurons from patients with primary mitochondrial diseases to determine whether mitochondrial dysfunction leads directly to neuronal cell loss. We counted the pigmented neurons and quantified mitochondrial respiratory activity, deficiencies in mitochondrial proteins, and the percentage of pathogenic mutations in single neurons. We found evidence of defects of both complex I and complex IV of the respiratory chain in all patients. We found that marked neuronal cell loss was only observed in a few patients with mitochondrial disease and that all these patients had mutations in polymerase gamma (POLG), which leads to the formation of multiple mitochondrial DNA deletions over time, similar to aging and Parkinson's disease. Interestingly, we detected alpha-synuclein pathology in two mitochondrial patients with POLG mutations. Our observations highlight the complex relationship between mitochondrial dysfunction and the susceptibility of SN neurons to degeneration and alpha-synuclein pathology. Our finding that the loss of SN neurons was only severe in patients with POLG mutations suggests that acquired mitochondrial defects may be less well tolerated by SN neurons than by inherited ones.
C1 [Reeve, Amy; Simcox, Eve; Hepplewhite, Philippa; Turnbull, Doug] Newcastle Univ, Ctr Brain Ageing & Vital, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Reeve, Amy; Meagher, Martin; Lax, Nichola; Simcox, Eve; Hepplewhite, Philippa; Turnbull, Doug] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Jaros, Evelyn] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res Newcastle Biomed Res Ctr Agein, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Jaros, Evelyn] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Turnbull, D (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU Newcastle University Centre for Brain Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0700718, G0400074]; The Wellcome Trust Centre for Mitochondrial Research [G906919]; National Institute for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Diseases; Alzheimer's Society; Alzheimer's Research Trust; Brains for Dementia Research Project; MRC [G0900652, G0400074, G0502157, G0700718] Funding Source: UKRI
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Celotto AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025823
   Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865
   Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MA SY, 1995, NEUROPATH APPL NEURO, V21, P341, DOI 10.1111/j.1365-2990.1995.tb01068.x
   MA SY, 1995, NEUROPATH APPL NEURO, V21, P10, DOI 10.1111/j.1365-2990.1995.tb01023.x
   Mahad DJ, 2009, J NEUROSCI METH, V184, P310, DOI 10.1016/j.jneumeth.2009.08.020
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031
   Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045
   Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195
NR 56
TC 74
Z9 79
U1 0
U2 14
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 
J9 J NEUROSCI
JI J. Neurosci.
PD JUN 26
PY 2013
VL 33
IS 26
BP 10790
EP 10801
DI 10.1523/JNEUROSCI.3525-12.2013
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 171LE
UT WOS:000320928900022
PM 23804100
DA 2024-11-01
ER

PT J
AU Zapico, SC
   Ubelaker, DH
AF Zapico, Sara C.
   Ubelaker, Douglas H.
TI mtDNA Mutations and Their Role in Aging, Diseases and Forensic Sciences
SO AGING AND DISEASE
LA English
DT Review
DE Mitochondrial DNA (mtDNA); Electron Transport Chain (ETC); Reactive Oxygen Species (ROS); Aging; Diseases; Forensic Sciences
ID mitochondrial-dna deletions; progressive external ophthalmoplegia; familial alzheimers-disease; precursor protein gene; respiratory-chain diseases; large-scale deletions; human skeletal-muscle; oxidative stress; point mutations; superoxide-dismutase
AB Mitochondria are independent organelles with their own DNA. As a primary function, mitochondria produce the energy for the cell through Oxidative Phosphorylation (OXPHOS) in the Electron Transport Chain (ETC). One of the toxic products of this process is Reactive Oxygen Species (ROS), which can induce oxidative damage in macromolecules like lipids, proteins and DNA. Mitochondrial DNA (mtDNA) is less protected and has fewer reparation mechanisms than nuclear DNA (nDNA), and as such is more exposed to oxidative, mutation-inducing damage. This review analyzes the causes and consequences of mtDNA mutations and their relationship with the aging process. Neurodegenerative diseases, related with the aging, are consequences of mtDNA mutations resulting in a decrease in mitochondrial function. Also described are "mitochondrial diseases", pathologies produced by mtDNA mutations and whose symptoms are related with mitochondrial dysfunction. Finally, mtDNA haplogroups are defined in this review; these groups are important for determination of geographical origin of an individual. Additionally, different haplogroups exhibit variably longevity and risk of certain diseases. mtDNA mutations in aging and haplogroups are of special interest to forensic science research. Therefore this review will help to clarify the key role of mtDNA mutations in these processes and support further research in this area.
C1 [Zapico, Sara C.; Ubelaker, Douglas H.] Natl Museum Nat Hist, Smithsonian Inst, Dept Anthropol, Washington, DC 20560 USA.
C3 Smithsonian Institution; Smithsonian National Museum of Natural History
RP Zapico, SC (corresponding author), Natl Museum Nat Hist, Smithsonian Inst, Dept Anthropol, MRC112, Washington, DC 20560 USA.
EM saiczapico@gmail.com
FU Smithsonian Institution
CR Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373
   Carew Jennifer S, 2002, MOL CANCER, V1, P9, DOI 10.1186/1476-4598-1-9
   CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0
   Chen A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046473
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Coffey G, 1999, NUCLEIC ACIDS RES, V27, P3348, DOI 10.1093/nar/27.16.3348
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Czarnecka AM, 2011, J AGING RES, V2011, P0, DOI 10.4061/2011/136435
   DAutréaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fogg Vanessa C, 2011, CHIN J CANCER, V30, P526, DOI 10.5732/cjc.011.10018
   Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1
   FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525
   Gilkerson RW, 2009, INT J BIOCHEM CELL B, V41, P1899, DOI 10.1016/j.biocel.2009.03.016
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gray MW, 2001, GENOME BIOL, V2, P0
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Gredilla Ricardo, 2010, J AGING RES, V2011, P257093, DOI 10.4061/2011/257093
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293
   Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lacan M, 2011, INT J LEGAL MED, V125, P293, DOI 10.1007/s00414-010-0440-x
   Lacan M, 2009, INT J LEGAL MED, V123, P161, DOI 10.1007/s00414-008-0266-y
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138
   Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mao Chih-Chieh, 2009, CHANG GUNG MED J, V32, P354
   Martin LJ, 2012, PROG MOL BIOL TRANSL, V107, P355, DOI 10.1016/B978-0-12-385883-2.00005-9
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   McInerny SC, 2009, MECH AGEING DEV, V0, P0
   Meissner C, 1997, INT J LEGAL MED, V110, P288, DOI 10.1007/s004140050089
   Meissner C, 1999, FORENSIC SCI INT, V105, P115, DOI 10.1016/S0379-0738(99)00126-7
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mielnik-Sikorska M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054360
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mörnstad H, 1999, INT J LEGAL MED, V112, P98, DOI 10.1007/s004140050209
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nelson TM, 2007, CROAT MED J, V48, P460
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Núnez C, 2011, CROAT MED J, V52, P336, DOI 10.3325/cmj.2011.52.336
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Orth M, 2003, NEUROSCI LETT, V351, P29, DOI 10.1016/S0304-3940(03)00941-8
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Papiha SS, 1998, J CLIN PATHOL, V51, P117, DOI 10.1136/jcp.51.2.117
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Quintáns B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005
   Ren WH, 2008, CLIN EXP PHARMACOL P, V35, P1477, DOI 10.1111/j.1440-1681.2008.05028.x
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0
   Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   SHUSTER RC, 1988, BIOCHEM BIOPH RES CO, V155, P1360, DOI 10.1016/S0006-291X(88)81291-9
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Singh Keshav K, 2009, V471, V0, PP291, DOI 10.1007/978-1-59745-416-2_15
   Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sue CM, 2000, BRAIN PATHOL, V10, P442
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Thèves C, 2006, J FORENSIC SCI, V51, P865, DOI 10.1111/j.1556-4029.2006.00163.x
   Thompson LV, 2006, EXP GERONTOL, V41, P1220, DOI 10.1016/j.exger.2006.10.018
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Tilley L, 1998, J CLIN PATHOL-MOL PA, V51, P293, DOI 10.1136/mp.51.6.293
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verma Mukesh, 2007, CANCER RES, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WARBURG O, 1956, SCIENCE, V124, P269
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Zapico SC, 2013, AGEING RES REV, V12, P605, DOI 10.1016/j.arr.2013.02.002
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   Zhang CF, 1997, BIOCHEM BIOPH RES CO, V230, P630, DOI 10.1006/bbrc.1996.6020
NR 146
TC 47
Z9 65
U1 0
U2 25
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
EI 
J9 AGING DIS
JI Aging Dis.
PD DEC 15
PY 2013
VL 4
IS 6
BP 364
EP 380
DI 10.14336/AD.2013.0400364
PG 17
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA AI5KB
UT WOS:000336903900006
PM 24307969
DA 2024-11-01
ER

PT J
AU Gamba, J
   Gamba, LT
   Rodrigues, GS
   Kiyomoto, BH
   Moraes, CT
   Tengan, CH
AF Gamba, Juliana
   Gamba, Luana T.
   Rodrigues, Gabriela S.
   Kiyomoto, Beatriz H.
   Moraes, Carlos T.
   Tengan, Celia H.
TI Nitric Oxide Synthesis Is Increased in Cybrid Cells with m.3243A&gt;G Mutation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mitochondria; nitric oxide; arginine; mitochondrial disease; mitochondrial DNA
ID stroke-like episodes; l-arginine; in-vivo; spectrophotometric method; lactic-acidosis; muscle-fibers; melas; encephalopathy; mitochondria; citrulline
AB Nitric oxide (NO) is a free radical and a signaling molecule in several pathways, produced by nitric oxide synthase (NOS) from the conversion of L-arginine to citrulline. Supplementation of L-arginine has been used to treat MELAS (mitochondrial encephalopathy with lactic acidosis and stroke like syndrome), a mitochondrial disease caused by the m. 3243A>G mutation. Low levels of serum arginine and endothelium dysfunction have been reported in MELAS and this treatment may increase NO in endothelial cells and promote vasodilation, decreasing cerebral ischemia and strokes. Although clinical benefits have been reported, little is known about NO synthesis in MELAS. In this study we found that osteosarcoma derived cybrid cells with high levels of m. 3243A>G had increased nitrite, an NO metabolite, and increased intracellular NO, demonstrated by an NO fluorescent probe (DAF-FM). Muscle vessels from patients with the same mutation had increased staining in NADPH diaphorase, suggestive of increased NOS. These results indicate increased production of NO in cells harboring the m. 3243A>G, however no nitrated protein was detected by Western blotting. Further studies are necessary to clarify the exact mechanisms of L-arginine effect to determine the appropriate clinical use of this drug therapy.
C1 [Gamba, Juliana; Gamba, Luana T.; Rodrigues, Gabriela S.; Kiyomoto, Beatriz H.; Tengan, Celia H.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04039032 Sao Paulo, Brazil.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol & Cell Biol, Miami, FL 33101 USA.
C3 Universidade Federal de Sao Paulo (UNIFESP); University of Miami
RP Tengan, CH (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, R Pedro de Toledo 781, BR-04039032 Sao Paulo, Brazil.
EM juliana.gamba@unifesp.br; luana_biologa@hotmail.com; 1000gabi@gmail.com; bhkiyomoto@unifesp.br; cmoraes@med.miami.edu; chtengan@unifesp.br
FU Fundacao de Amparo a Pesquisa de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
CR Abraham MB, 2012, J PAEDIATR CHILD H, V48, PE96, DOI 10.1111/j.1440-1754.2011.02074.x
   Arakawa K, 2010, CIRC J, V74, P2702, DOI 10.1253/circj.CJ-10-0044
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Barrientos Antoni, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1903s63
   Boveris A, 2000, ANN NY ACAD SCI, V899, P121
   Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001
   Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007
   Desquiret-Dumas V, 2012, BBA-MOL BASIS DIS, V1822, P1019, DOI 10.1016/j.bbadis.2012.01.010
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Elly L, 2009, METHOD ENZYMOL, V456, P169, DOI 10.1016/S0076-6879(08)04409-1
   Frandsen U, 1996, BIOCHEM BIOPH RES CO, V227, P88, DOI 10.1006/bbrc.1996.1472
   Gerard JM, 1997, J TOXICOL-CLIN TOXIC, V35, P621, DOI 10.3109/15563659709001243
   Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6
   Haqqani AS, 2002, J BIOL CHEM, V277, P3614, DOI 10.1074/jbc.M105730200
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6
   Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oliveira KK, 2013, ANAL BIOCHEM, V435, P57, DOI 10.1016/j.ab.2012.12.002
   Planitzer G, 2000, HISTOCHEM J, V32, P303, DOI 10.1023/A:1004041129915
   Ridnour LA, 2000, ANAL BIOCHEM, V281, P223, DOI 10.1006/abio.2000.4583
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209
   Tengan CH, 2007, BIOCHEM BIOPH RES CO, V359, P771, DOI 10.1016/j.bbrc.2007.05.184
   Vattemi G, 2011, MOL CELL PROTEOMICS, V10, P0, DOI 10.1074/mcp.M110.002964
   Yoneda M, 2012, BBA-GEN SUBJECTS, V1820, P615, DOI 10.1016/j.bbagen.2011.04.018
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 42
TC 12
Z9 14
U1 0
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
EI 
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 15
PY 2013
VL 14
IS 1
BP 394
EP 410
DI 10.3390/ijms14010394
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 077SS
UT WOS:000314048800024
PM 23263669
DA 2024-11-01
ER

PT J
AU Picca, A
   Fracasso, F
   Pesce, V
   Cantatore, P
   Joseph, AM
   Leeuwenburgh, C
   Gadaleta, MN
   Lezza, AMS
AF Picca, Anna
   Fracasso, Flavio
   Pesce, Vito
   Cantatore, Palmiro
   Joseph, Anna-Maria
   Leeuwenburgh, Christiaan
   Gadaleta, Maria Nicola
   Lezza, Angela Maria Serena
TI Age- and calorie restriction-related changes in rat brain mitochondrial DNA and TFAM binding
SO AGE
LA English
DT Article
DE Aging rat frontal cortex mitochondria; Calorie restriction diet; TFAM amount; mtDNA content; mtDNA 4,8-kb deletion content; mtDNA-TFAM binding
ID transcription factor-a; aging skeletal-muscle; base excision-repair; oxidative stress; lon protease; copy number; dietary restriction; gene-expression; phenotypic alterations; degenerative diseases
AB Aging markedly affects mitochondrial biogenesis and functions particularly in tissues highly dependent on the organelle's bioenergetics capability such as the brain's frontal cortex. Calorie restriction (CR) diet is, so far, the only intervention able to delay or prevent the onset of several age-related alterations in different organisms. We determined the contents of mitochondrial transcription factor A (TFAM), mitochondrial DNA (mtDNA), and the 4.8-kb mtDNA deletion in the frontal cortex from young (6-month-old) and aged (26-month-old), ad libitum-fed (AL) and calorie-restricted (CR), rats. We found a 70 % increase in TFAM amount, a 25 % loss in mtDNA content, and a 35 % increase in the 4.8-kb deletion content in the aged AL animals with respect to the young rats. TFAM-specific binding to six mtDNA regions was analyzed by mtDNA immunoprecipitation and semiquantitative polymerase chain reaction (PCR), showing a marked age-related decrease. Quantitative real-time PCR at two subregions involved in mtDNA replication demonstrated, in aged AL rats, a remarkable decrease (60-70 %) of TFAM-bound mtDNA. The decreased TFAM binding is a novel finding that may explain the mtDNA loss in spite of the compensatory TFAM increased amount. In aged CR rats, TFAM amount increased and mtDNA content decreased with respect to young rats' values, but the extent of the changes was smaller than in aged AL rats. Attenuation of the age-related effects due to the diet in the CR animals was further evidenced by the unchanged content of the 4.8-kb deletion with respect to that of young animals and by the partial prevention of the age-related decrease in TFAM binding to mtDNA.
C1 [Picca, Anna; Fracasso, Flavio; Pesce, Vito; Cantatore, Palmiro; Gadaleta, Maria Nicola; Lezza, Angela Maria Serena] Univ Bari, Dept Biosci Biotechnol & Pharmacol Sci, I-70125 Bari, Italy.
   [Cantatore, Palmiro; Gadaleta, Maria Nicola] CNR Natl Res Council Italy, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.
   [Joseph, Anna-Maria; Leeuwenburgh, Christiaan] Univ Florida, Inst Aging, Dept Aging & Geriatr Res, Div Biol Aging, Gainesville, FL USA.
C3 Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); State University System of Florida; University of Florida
RP Lezza, AMS (corresponding author), Univ Bari, Dept Biosci Biotechnol & Pharmacol Sci, Via Orabona 4, I-70125 Bari, Italy.
EM a.lezza@biologia.uniba.it
FU University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center [1 P30 AG028740];  [RBNE08HWLZ_012];  [NIA R01 AG17994]
CR Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Bagh MB, 2011, BIOGERONTOLOGY, V12, P119, DOI 10.1007/s10522-010-9301-8
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barger JL, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002264
   Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009
   Carter CS, 2007, APPL PHYSIOL NUTR ME, V32, P954, DOI 10.1139/H07-085
   Cassano P, 2006, REJUV RES, V9, P211, DOI 10.1089/rej.2006.9.211
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cotrina ML, 2002, J NEUROSCI RES, V67, P1
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Fontana L, 2009, CURR OPIN GASTROEN, V25, P144, DOI 10.1097/MOG.0b013e32831ef1ba
   Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011
   Grill JD, 2002, BRAIN RES, V937, P8, DOI 10.1016/S0006-8993(02)02457-5
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Guevara R, 2011, CELL PHYSIOL BIOCHEM, V27, P201, DOI 10.1159/000327945
   Guevara R, 2009, FREE RADICAL BIO MED, V46, P169, DOI 10.1016/j.freeradbiomed.2008.09.035
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hiona A, 2004, ANN NY ACAD SCI, V1019, P96, DOI 10.1196/annals.1297.018
   Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaur M, 2008, BIOGERONTOLOGY, V9, P441, DOI 10.1007/s10522-008-9168-0
   Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200
   Mansour H, 2008, AGING CELL, V7, P526, DOI 10.1111/j.1474-9726.2008.00402.x
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MIQUEL J, 1986, FREE RADICALS AGING, V0, P51
   Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002
   Navarro A, 2008, AM J PHYSIOL-REG I, V294, PR501, DOI 10.1152/ajpregu.00492.2007
   Navarro A, 2010, FRONT AGING NEUROSCI, V2, P0, DOI 10.3389/fnagi.2010.00034
   Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020
   Opalach K, 2010, REJUV RES, V13, P65, DOI 10.1089/rej.2009.0892
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   PEINADO MA, 1993, ANAT REC, V237, P104, DOI 10.1002/ar.1092370110
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Pollack M, 2001, J GERONTOL A-BIOL, V56, PB475, DOI 10.1093/gerona/56.11.B475
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   Quintas A, 2012, EXP GERONTOL, V47, P198, DOI 10.1016/j.exger.2011.11.010
   Rangaraju S, 2009, AGING CELL, V8, P178, DOI 10.1111/j.1474-9726.2009.00460.x
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   Seo AY, 2006, ANTIOXID REDOX SIGN, V8, P529, DOI 10.1089/ars.2006.8.529
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shi L, 2007, EXP NEUROL, V206, P70, DOI 10.1016/j.expneurol.2007.03.026
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SOONG NW, 1992, NAT GENET, V2, P318
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   Turlejski K, 2002, PROG BRAIN RES, V136, P39
   Ugarte N, 2010, ANTIOXID REDOX SIGN, V13, P539, DOI 10.1089/ars.2009.2998
   Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
NR 87
TC 47
Z9 51
U1 1
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 
J9 AGE
JI Age
PD OCT 15
PY 2013
VL 35
IS 5
BP 1607
EP 1620
DI 10.1007/s11357-012-9465-z
PG 14
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 219XO
UT WOS:000324545200007
PM 22945739
DA 2024-11-01
ER

PT J
AU Shahni, R
   Wedatilake, Y
   Cleary, MA
   Lindley, KJ
   Sibson, KR
   Rahman, S
AF Shahni, Rojeen
   Wedatilake, Yehani
   Cleary, Maureen A.
   Lindley, Keith J.
   Sibson, Keith R.
   Rahman, Shamima
TI A Distinct Mitochondrial Myopathy, Lactic Acidosis and Sideroblastic Anemia (MLASA) Phenotype Associates with <i>YARS2</i> Mutations
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE sideroblastic anemia; MLASA; YARS2; mitochondrial disease; mitochondrial myopathy; lactic acidosis
ID missense mutation; gene; dna
AB Nuclear-encoded disorders of mitochondrial translation are clinically and genetically heterogeneous. Genetic causes include defects of mitochondrial aminoacyl-tRNA synthetases, and factors required for initiation, elongation and termination of protein synthesis as well as ribosome recycling. We report on a new case of myopathy, lactic acidosis and sideroblastic anemia (MLASA) syndrome caused by defective mitochondrial tyrosyl aminoacylation. The patient presented at 1 year with anemia initially attributed to iron deficiency. Bone marrow aspirate at 5 years revealed ringed sideroblasts but transfusion dependency did not occur until 11 years. Other clinical features included lactic acidosis, poor weight gain, hypertrophic cardiomyopathy and severe myopathy leading to respiratory failure necessitating ventilatory support. Long-range PCR excluded mitochondrial DNA rearrangements. Clinical diagnosis of MLASA prompted direct sequence analysis of the YARS2 gene encoding the mitochondrial tyrosyl-tRNA synthetase, which revealed homozygosity for a known pathogenic mutation, c.156C>G;p.F52L. Comparison with four previously reported cases demonstrated remarkable clinical homogeneity. First line investigation of MLASA should include direct sequence analysis of YARS2 and PUS1 (encoding a tRNA modification factor) rather than muscle biopsy. Early genetic diagnosis is essential for counseling and to facilitate appropriate supportive therapy. Reasons for segregation of specific clinical phenotypes with particular mitochondrial aminoacyl tRNA-synthetase defects remain unknown. (c) 2013 Wiley Periodicals, Inc.
C1 [Shahni, Rojeen; Wedatilake, Yehani; Rahman, Shamima] UCL, Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, London WC1N 1EH, England.
   [Cleary, Maureen A.; Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London, England.
   [Lindley, Keith J.] Great Ormond St Hosp Sick Children, Gastroenterol Unit, London, England.
   [Sibson, Keith R.] Great Ormond St Hosp Sick Children, Haematol Unit, London, England.
C3 University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Rahman, S (corresponding author), UCL, Inst Child Hlth, Mitochondrial Res Grp, Clin & Mol Genet Unit, 30 Guilford St, London WC1N 1EH, England.
EM shamima.rahman@ucl.ac.uk
FU Great Ormond Street Hospital Children's Charity; Wellcome Trust Research Training Fellowship
CR Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, V0, PP525, DOI 10.1182/asheducation-2011.1.525
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Rahman S, 2000, J INHERIT METAB DIS, V23, P753, DOI 10.1023/A:1005611803306
   Rahman S, 2013, NEUROMUSCULAR DISORD, V23, P506, DOI 10.1016/j.nmd.2013.03.004
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
NR 17
TC 39
Z9 42
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD SEP 15
PY 2013
VL 161
IS 9
BP 2334
EP 2338
DI 10.1002/ajmg.a.36065
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA 263HQ
UT WOS:000327798800030
PM 23918765
DA 2024-11-01
ER

PT J
AU Plummer, C
   Spring, PJ
   Marotta, R
   Chin, J
   Taylor, G
   Sharpe, D
   Athanasou, NA
   Thyagarajan, D
   Berkovic, SF
AF Plummer, C.
   Spring, P. J.
   Marotta, R.
   Chin, J.
   Taylor, G.
   Sharpe, D.
   Athanasou, N. A.
   Thyagarajan, D.
   Berkovic, S. F.
TI Multiple Symmetrical Lipomatosis - A mitochondrial disorder of brown fat
SO MITOCHONDRION
LA English
DT Article
DE Multiple Symmetrical Lipomatosis; Madelung's Disease; Brown fat; Uncoupling protein-1 mRNA; Adipocyte fatty-acid protein-2
ID red fibers merrf; madelungs-disease; uncoupling protein; adipose-tissue; dna mutations; myoclonus epilepsy; cerebellar-ataxia; a8344g mutation; messenger-rna; ap2 protein
AB Multiple Symmetrical Lipomatosis (MSL) is an unusual disorder characterized by the development of axial lipomas in adulthood. The pathoetiology of lipoma tissue in MSL remains unresolved. Seven patients with MSL were followed for a mean period of 12 years (8-20 years). All patients had cervical lipomas ranging from subtle lesions to disfiguring masses; six patients had peripheral neuropathy and five had proximal myopathy. Myoclonus, cerebellar ataxia and additional lipomas were variably present. All patients showed clinical progression. Muscle histopathology was consistent with mitochondrial disease. Five patients were positive for mtDNA point mutation m.8344A > G, three of whom underwent lipoma resection - all samples were positive for uncoupling protein-1 mRNA (unique to brown fat). Lipoma from one case stained positive for adipocyte fatty-acid protein-2 (unique to brown fat and immature adipocytes). This long-term study hallmarks the phenotypic heterogeneity of MSL's associated clinical features. The clinical, genetic and molecular findings substantiate the hypothesis that lipomas in MSL are due to a mitochondrial disorder of brown fat. (c) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Plummer, C.; Marotta, R.; Chin, J.] St Vincents Hosp, Ctr Clin Neurosci & Neurol Res, Fitzroy, Vic 3065, Australia.
   [Spring, P. J.; Sharpe, D.] Concord Repatriat Gen Hosp, Dept Neurol, Concord, NSW 2139, Australia.
   [Taylor, G.] Nelson Hosp, Dept Anat Pathol, Nelson 7012, New Zealand.
   [Athanasou, N. A.] Univ Oxford, Dept Musculoskeletal Pathol, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford OX3 7HE, England.
   [Thyagarajan, D.] Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia.
   [Berkovic, S. F.] Univ Melbourne, Dept Med, Heidelberg, Vic 3084, Australia.
C3 NSW Health; St Vincents Hospital Sydney; St Vincent's Health; St Vincent's Hospital Melbourne; Concord Repatriation General Hospital; University of Oxford; Monash Health; Monash Medical Centre; Monash University; University of Melbourne
RP Plummer, C (corresponding author), St Vincents Hosp, Ctr Clin Neurosci & Neurol Res, Level 5 Daly Wing,35 Victoria Parade, Fitzroy, Vic 3065, Australia.
EM chris.plummer@svhm.org.au
CR Ampollini L, 2011, NEW ENGL J MED, V364, P465, DOI 10.1056/NEJMicm1003531
   Antonická H, 1999, BIOCHEM J, V342, P537, DOI 10.1042/0264-6021:3420537
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BANERJEE SP, 1978, NATURE, V276, P407, DOI 10.1038/276407a0
   BENNETT JH, 1995, J CLIN PATHOL, V48, P950, DOI 10.1136/jcp.48.10.950
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brodie BC, 1846, LECTURES ILLUSTRATIVE OF VARIOUS SUBJECTS IN PATHOLOGY AND SURGERY. M, V0, P275
   Campos Y, 1996, NEUROLOGY, V47, P1012, DOI 10.1212/WNL.47.4.1012
   Casali C, 1999, NEUROLOGY, V52, P1103, DOI 10.1212/WNL.52.5.1103
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   EKBOM K, 1975, ACTA NEUROL SCAND, V51, P393
   ENZI G, 1984, MEDICINE, V63, P56, DOI 10.1097/00005792-198401000-00004
   Enzi G, 2002, INT J OBESITY, V26, P253, DOI 10.1038/sj.ijo.0801867
   ENZI G, 1985, MEDICINE, V64, P388, DOI 10.1097/00005792-198511000-00003
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Gabriel YA, 2001, SURGERY, V129, P117, DOI 10.1067/msy.2001.105032
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   González-García R, 2004, AESTHET PLAST SURG, V28, P108, DOI 10.1007/s00266-004-3123-5
   HALLER RG, 1984, MED CLIN N AM, V68, P91, DOI 10.1016/S0025-7125(16)31243-3
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Heckmann JG, 2000, EUR J NEUROL, V7, P243, DOI 10.1046/j.1468-1331.2000.00054.x
   Joyner CJ, 1999, PATHOL RES PRACT, V195, P461, DOI 10.1016/S0344-0338(99)80049-1
   KAZUMI T, 1994, ENDOCR J, V41, P315, DOI 10.1507/endocrj.41.315
   KLOPSTOCK T, 1994, NEUROLOGY, V44, P862, DOI 10.1212/WNL.44.5.862
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   KODISH ME, 1974, METABOLISM, V23, P937, DOI 10.1016/0026-0495(74)90043-2
   Launois PE, 1898, B SOC M D H P PARIS, V1, P298
   Madelung OW, 1888, ARCH KLIN CHIR, V37, P106
   Manieri M, 2010, NUTR METAB CARDIOVAS, V20, P567, DOI 10.1016/j.numecd.2009.04.020
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   MATTHEWS PM, 1995, NEUROLOGY, V45, P197, DOI 10.1212/WNL.45.1.197
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Nechad M, 1986, BROWN ADIPOSE TISSUE, V0, P1
   Nisoli E, 2002, J PATHOL, V198, P378, DOI 10.1002/path.1212
   PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393
   RICQUIER D, 1991, FASEB J, V5, P2237, DOI 10.1096/fasebj.5.9.1860614
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   Vilà MR, 2000, BIOCHEM BIOPH RES CO, V278, P800, DOI 10.1006/bbrc.2000.3828
   Yang T T, 2001, SARCOMA, V5, P139, DOI 10.1080/13577140120048593
NR 41
TC 56
Z9 61
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2013
VL 13
IS 4
BP 269
EP 276
DI 10.1016/j.mito.2013.03.003
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 162VR
UT WOS:000320294600002
PM 23524250
DA 2024-11-01
ER

PT J
AU Ylönen, S
   Ylikotila, P
   Siitonen, A
   Finnilä, S
   Autere, J
   Majamaa, K
AF Ylonen, S.
   Ylikotila, P.
   Siitonen, A.
   Finnila, S.
   Autere, J.
   Majamaa, K.
TI Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Molecular epidemiology; Basal ganglia diseases; Neurodegenerative diseases; POLG; Mitochondrion
ID w748s mutation; polg1; polymorphisms; variants; ataxia
AB Parkinson's disease is associated with mitochondrial dysfunction. The POLG1 gene encodes DNA-polymerase gamma, which is responsible for the replication of mitochondrial DNA. Mutations in POLG1 cause neurodegenerative diseases such as progressive external ophthalmoplegia and Alpers syndrome. In this study, we investigated if mutations in POLG1 had any correlation with Parkinson's disease. Subjects consisted of Finnish patients with early-onset Parkinson's disease (EOPD, N = 441) or late-onset Parkinson's disease (LOPD, N = 263). The POLG1 gene was screened for nine previously known mutations. Two patients were compound heterozygotes with respect to putatively pathogenic alleles. Twenty-eight patients harbored a heterozygous missense mutation, but the allele frequencies did not differ from those of the controls. Interestingly, the frequency of affected siblings was 4.6-fold higher (95 % confidence interval; 1.09, 19.5) among the patients with EOPD and with heterozygous POLG1 mutations than among patients without mutations. Clinically the patients with or without POLG1 mutations did not differ from each other. Our findings provide two lines of evidence suggesting a role for POLG1 mutations in Parkinson's disease: (1) identification of patients with compound heterozygous mutations in POLG1, and (2) higher frequency of affected siblings among the EOPD patients with heterozygous POLG1 mutations than among EOPD patients without mutations.
C1 [Ylonen, S.; Siitonen, A.; Finnila, S.; Majamaa, K.] Univ Oulu, Inst Clin Med, Dept Neurol, Oulu 90014, Finland.
   [Ylonen, S.; Siitonen, A.; Majamaa, K.] Med Res Ctr Oulu, Oulu, Finland.
   [Ylikotila, P.] Univ Turku, Dept Neurol, FIN-20520 Turku, Finland.
   [Ylikotila, P.] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland.
   [Autere, J.] Univ Eastern Finland, Dept Neurosci & Neurol, Kuopio, Finland.
   [Autere, J.] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland.
C3 University of Oulu; University of Turku; University of Turku; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital
RP Majamaa, K (corresponding author), Univ Oulu, Inst Clin Med, Dept Neurol, POB 5000, Oulu 90014, Finland.
EM kari.majamaa@oulu.fi
FU Council for Health Research of the Academy of Finland [127764]; Sigrid Juselius Foundation; Finnish Brain Foundation; Finnish Parkinson Foundation
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ali SF, 2011, INT J ENV RES PUB HE, V8, P4702, DOI 10.3390/ijerph8124702
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Fall PA, 1996, J CLIN EPIDEMIOL, V49, P637, DOI 10.1016/0895-4356(96)00003-0
   Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Gui YX, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050086
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Komulainen T, 2010, BMC NEUROL, V10, P0, DOI 10.1186/1471-2377-10-29
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Meinilä M, 2001, HUM HERED, V52, P160, DOI 10.1159/000053372
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
NR 24
TC 13
Z9 15
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD DEC 15
PY 2013
VL 260
IS 12
BP 3144
EP 3149
DI 10.1007/s00415-013-7132-7
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 264AN
UT WOS:000327849400026
PM 24122062
DA 2024-11-01
ER

PT J
AU Martikainen, MH
   Kytövuori, L
   Majamaa, K
AF Martikainen, Mika H.
   Kytovuori, Laura
   Majamaa, Kari
TI Juvenile parkinsonism, hypogonadism and Leigh-like MRI changes in a patient with m.4296G&gt;A mutation in mitochondrial DNA
SO MITOCHONDRION
LA English
DT Article
DE Hypogonadism; Leigh syndrome; Mitochondrial disease; Parkinsonism; tRNA isoleucine
ID transfer-rna genes; progressive external ophthalmoplegia; disorders; disease; myopathy; encephalopathy; abnormality; children
AB Leigh syndrome is a mitochondrial disease with considerable clinical and genetic variation. We present a 16-year-old boy with Leigh-like syndrome and broad developmental retardation, parkinsonism and hypogonadism. Sequencing of the entire mitochondrial DNA from blood revealed the m.4296G>A mutation in the MT-TI gene. The mutation was heteroplasmic with a 95% proportion of the mutant genome, while the proportion was 58% in the blood of the patient's clinically healthy mother. Our results suggest that m.4296G>A is pathogenic in humans, and that the phenotype related to this change includes Leigh-like syndrome in adolescence with parkinsonism and hypogonadism, in addition to the previously reported early infantile Leigh syndrome. (C) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Martikainen, Mika H.] Univ Turku, Turku, Finland.
   [Martikainen, Mika H.] Turku Univ Hosp, Div Clin Neurosci, FIN-20520 Turku, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Univ Oulu, Dept Clin Med Neurol, FIN-90014 Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, Oulu, Finland.
   [Kytovuori, Laura; Majamaa, Kari] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland.
C3 University of Turku; University of Turku; University of Oulu; University of Oulu; University of Oulu
RP Martikainen, MH (corresponding author), Univ Oulu, Dept Clin Med Neurol, FIN-90014 Oulu, Finland.
EM kari.majamaa@oulu.fi
CR Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   BROWN MD, 1992, AM J HUM GENET, V51, P446
   Caeic M, 2001, J CHILD NEUROL, V16, P616, DOI 10.1177/088307380101600818
   Cox R, 2012, MITOCHONDRION, V12, P258, DOI 10.1016/j.mito.2011.09.006
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2011, MOVEMENT DISORD, V26, P784, DOI 10.1002/mds.23651
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Körkkö J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Lee IC, 2012, HUM MUTAT, V0, P0
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Martikainen MH, 2012, ACTA DIABETOL, V0, P0
   Martikainen MH, 2012, NEUROEPIDEMIOLOGY, V38, P114, DOI 10.1159/000336112
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566
   QUADE A, 1992, CLIN INVESTIGATOR, V70, P396
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Rubino F, 2012, NUCLEIC ACIDS RES, V40, PD1150, DOI 10.1093/nar/gkr1086
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Vilmi T, 2005, J MOL EVOL, V60, P587, DOI 10.1007/s00239-003-0202-1
   YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 39
TC 16
Z9 16
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2013
VL 13
IS 2
BP 83
EP 86
DI 10.1016/j.mito.2013.01.012
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 125NW
UT WOS:000317547500003
PM 23395828
DA 2024-11-01
ER

PT J
AU Payne, BAI
   Wilson, IJ
   Yu-Wai-Man, P
   Coxhead, J
   Deehan, D
   Horvath, R
   Taylor, RW
   Samuels, DC
   Santibanez-Koref, M
   Chinnery, PF
AF Payne, Brendan A. I.
   Wilson, Ian J.
   Yu-Wai-Man, Patrick
   Coxhead, Jonathan
   Deehan, David
   Horvath, Rita
   Taylor, Robert W.
   Samuels, David C.
   Santibanez-Koref, Mauro
   Chinnery, Patrick F.
TI Universal heteroplasmy of human mitochondrial DNA
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID dominant optic atrophy; external ophthalmoplegia; mutations; mtdna; disease; opa1; common; sequences; ataxia; chain
AB Mammalian cells contain thousands of copies of mitochondrial DNA (mtDNA). At birth, these are thought to be identical in most humans. Here, we use long read length ultra-deep resequencing-by-synthesis to interrogate regions of the mtDNA genome from related and unrelated individuals at unprecedented resolution. We show that very low-level heteroplasmic variance is present in all tested healthy individuals, and is likely to be due to both inherited and somatic single base substitutions. Using this approach, we demonstrate an increase in mtDNA mutations in the skeletal muscle of patients with a proofreading-deficient mtDNA polymerase due to POLG mutations. In contrast, we show that OPA1 mutations, which indirectly affect mtDNA maintenance, do not increase point mutation load. The demonstration of universal mtDNA heteroplasmy has fundamental implications for our understanding of mtDNA inheritance and evolution. Ostensibly de novo somatic mtDNA mutations, seen in mtDNA maintenance disorders and neurodegenerative disease and aging, will partly be due to the clonal expansion of low-level inherited variants.
C1 [Payne, Brendan A. I.; Wilson, Ian J.; Yu-Wai-Man, Patrick; Coxhead, Jonathan; Horvath, Rita; Santibanez-Koref, Mauro; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Deehan, David] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Taylor, Robert W.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Samuels, David C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Vanderbilt University
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM patrick.chinnery@ncl.ac.uk
FU Wellcome Trust [906919]; Medical Research Council (UK); UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; MRC (UK); National Institutes of Health [GM073744]; MRC [MR/K000608/1, G1002570, G0800470, G0701386] Funding Source: UKRI
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Daly GM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028879
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Goto H, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-6-r59
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Just RS, 2009, J FORENSIC SCI, V54, P887, DOI 10.1111/j.1556-4029.2009.01069.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Quince C, 2009, NAT METHODS, V6, P639, DOI 10.1038/nmeth.1361
   Santos MA, 2011, METHOD MOL BIOL, V822, P189
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Simone D, 2011, BMC GENOMICS, V12, P0, DOI 10.1186/1471-2164-12-517
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107
   Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023
   Ye J, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-134
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 37
TC 290
Z9 325
U1 2
U2 75
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2013
VL 22
IS 2
BP 384
EP 390
DI 10.1093/hmg/dds435
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 058RP
UT WOS:000312651800015
PM 23077218
DA 2024-11-01
ER

PT J
AU Montiel-Sosa, JF
   Herrero, MD
   Munoz, MD
   Aguirre-Campa, LE
   Pérez-Ramírez, G
   García-Ramírez, R
   Ruiz-Pesini, E
   Montoya, J
AF Francisco Montiel-Sosa, Jose
   Dolores Herrero, Maria
   de Lourdes Munoz, Maria
   Enrique Aguirre-Campa, Luis
   Perez-Ramirez, Gerardo
   Garcia-Ramirez, Ruben
   Ruiz-Pesini, Eduardo
   Montoya, Julio
TI Phylogenetic analysis of mitochondrial DNA in a patient with Kearns-Sayre syndrome containing a novel 7629-bp deletion
SO MITOCHONDRIAL DNA
LA English
DT Article
DE Disease; native American; haplogroup
ID progressive external ophthalmoplegia; large-scale deletions; direct repeats; respiratory-chain; common deletion; mtdna; sequences; cells; generation; integrity
AB Mitochondrial DNA mutations have been associated with different illnesses in humans, such as Kearns-Sayre syndrome (KSS), which is related to deletions of different sizes and positions among patients. Here, we report a Mexican patient with typical features of KSS containing a novel deletion of 7629 bp in size with 85% heteroplasmy, which has not been previously reported. Sequence analysis revealed 3-bp perfect short direct repeats flanking the deletion region, in addition to 7-bp imperfect direct repeats within 9-10 bp. Furthermore, sequencing, alignment and phylogenetic analysis of the hypervariable region revealed that the patient may belong to a founder Native American haplogroup C4c.
C1 [Francisco Montiel-Sosa, Jose; Dolores Herrero, Maria; Ruiz-Pesini, Eduardo; Montoya, Julio] Univ Zaragoza, CIBER Enfermedades Raras CIBERER, Dept Biochem & Mol & Cellular Biol, Zaragoza, Spain.
   [Francisco Montiel-Sosa, Jose] UNAM, Fac Estudios Super Cuautitlan, Dept Biol Sci, Cuautitlan 54740, Mexico.
   [de Lourdes Munoz, Maria; Perez-Ramirez, Gerardo] Ctr Invest & Estudios Avanzados IPN, San Pedro Zacatenco 07360, Gustavo A Mader, Mexico.
   [Enrique Aguirre-Campa, Luis; Garcia-Ramirez, Ruben] IMSS, Ctr Med Nacl Siglo XXI, Dept Neurol & Paediat, Mexico City, DF, Mexico.
C3 University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Mexicano del Seguro Social
RP Munoz, MD (corresponding author), Ctr Invest & Estudios Avanzados IPN, Av Inst Politecn Nacl 2508, San Pedro Zacatenco 07360, Gustavo A Mader, Mexico.
EM lmunoz@cinvestav.mx
FU Direccion General de Asuntos del Personal Academico from UNAM; Instituto de Ciencia y Tecnologia del Distrito Federal [PICSA10-189]
CR ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9
   Ascaso FJ, 2010, CLIN EXP OPHTHALMOL, V38, P812, DOI 10.1111/j.1442-9071.2010.02335.x
   Ashizawa T, 2001, ARCH NEUROL-CHICAGO, V58, P1053, DOI 10.1001/archneur.58.7.1053
   BARRIENTOS A, 1995, MED CLIN-BARCELONA, V105, P180
   BERENBAUM F, 1990, NEUROLOGY, V40, P193, DOI 10.1212/WNL.40.1.193
   BLOK RB, 1995, HUM GENET, V95, P75
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Carod-Artal FJ, 2006, NEUROLOGIA, V21, P357
   Carod-Artal FJ, 2006, MED CLIN-BARCELONA, V126, P457, DOI 10.1016/S0025-7753(06)71972-8
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chabrol B, 1997, NEUROLOGY, V49, P308, DOI 10.1212/WNL.49.1.308-b
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chiaratti MR, 2011, MITOCHONDRION, V11, P820, DOI 10.1016/j.mito.2010.11.004
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Cwerman-Thibault H, 2011, J INHERIT METAB DIS, V34, P327, DOI 10.1007/s10545-010-9131-5
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   DeCoo IFM, 1997, J NEUROL SCI, V149, P37, DOI 10.1016/S0022-510X(97)05366-5
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Delgado-Sánchez R, 2007, REV NEUROLOGIA, V44, P18, DOI 10.33588/rn.4401.2006032
   Derenko M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032179
   Derenko M, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015214
   DiMauro S, 2003, MITOCHONDRIAL DNA DE, V0, P0
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Gutiérrez A, 2009, REV NEUROLOGIA, V49, P248, DOI 10.33588/rn.4905.2009282
   Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012
   Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   Marin-Garcia J, 2000, J CHILD NEUROL, V15, P555, DOI 10.1177/088307380001500812
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   NARANJO IC, 1988, STROKE, V19, P533, DOI 10.1161/01.STR.19.4.533
   Provenzale JM, 1996, NEUROLOGY, V46, P826, DOI 10.1212/WNL.46.3.826
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   REMES AM, 1993, GENOMICS, V16, P256, DOI 10.1006/geno.1993.1170
   Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000
   Roels F, 2009, BMC CLIN PATHOL, V9, P0, DOI 10.1186/1472-6890-9-4
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Santos Janine H, 2002, METHODS MOL BIOL, V197, P159, DOI 10.1385/1-59259-284-8:159
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Solano A, 2003, J MED GENET, V40, P0, DOI 10.1136/jmg.40.7.e86
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tamm E, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000829
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, PS55, DOI 10.1007/s10545-009-9020-y
   Vázquez-Acevedo M, 2002, NEUROL SCI, V23, P247, DOI 10.1007/s100720200050
   Wilichowski E, 1997, PEDIATR RES, V41, P193, DOI 10.1203/00006450-199702000-00007
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 72
TC 6
Z9 7
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD AUG 15
PY 2013
VL 24
IS 4
BP 420
EP 431
DI 10.3109/19401736.2012.760550
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 181UT
UT WOS:000321695300036
PM 23391298
DA 2024-11-01
ER

PT J
AU Campbell, GR
   Reeve, AK
   Ziabreva, I
   Reynolds, R
   Turnbull, DM
   Mahad, DJ
AF Campbell, Graham R.
   Reeve, Amy K.
   Ziabreva, Iryna
   Reynolds, Richard
   Turnbull, Doug M.
   Mahad, Don J.
TI No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
DE Mitochondria; muscle; multiple sclerosis
ID oxidase activity; dysfunction; mutations; single; women; gene
AB Background: Mitochondrial dysfunction is an established feature of multiple sclerosis (MS). We recently described high levels of mitochondrial DNA (mtDNA) deletions within respiratory enzyme-deficient (lacking mitochondrial respiratory chain complex IV with intact complex II) neurons and choroid plexus epithelial cells in progressive MS. Objectives: The objective of this paper is to determine whether respiratory enzyme deficiency and mtDNA deletions in MS were in excess of age-related changes within muscle, which, like neurons, are post-mitotic cells that frequently harbour mtDNA deletions with ageing and in disease. Methods: In progressive MS cases (n=17), known to harbour an excess of mtDNA deletions in the central nervous system (CNS), and controls (n=15), we studied muscle (paraspinal) and explored mitochondria in single fibres. Histochemistry, immunohistochemistry, laser microdissection, real-time polymerase chain reaction (PCR), long-range PCR and sequencing were used to resolve the single muscle fibres. Results: The percentage of respiratory enzyme-deficient muscle fibres, mtDNA deletion level and percentage of muscle fibres harbouring high levels of mtDNA deletions were not significantly different in MS compared with controls. Conclusion: Our findings do not provide support to the existence of a diffuse mitochondrial abnormality involving multiple systems in MS. Understanding the cause(s) of the CNS mitochondrial dysfunction in progressive MS remains a research priority.
C1 [Campbell, Graham R.; Mahad, Don J.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland.
   [Reeve, Amy K.; Ziabreva, Iryna; Turnbull, Doug M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Reynolds, Richard] Imperial Coll Fac Med, Wolfson Neurosci Labs, London, England.
C3 University of Edinburgh; Newcastle University - UK; Imperial College London
RP Mahad, DJ (corresponding author), Univ Edinburgh, Ctr Neuroregenerat, Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland.
EM dmahad@staffmail.ed.ac.uk
FU Wellcome Trust; Newcastle Healthcare Charity; Newcastle upon Tyne Hospitals NHS charity; Lifelong Health and Wellbeing Initiative [G0700718]; Wellcome Trust Centre for Mitochondrial Research [906919]; Newcastle NIHR Biomedical Research Centre; MRC [G0700718, MR/K000608/1] Funding Source: UKRI
CR Abadi A, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006518
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Broadwater L, 2011, BBA-MOL BASIS DIS, V1812, P630, DOI 10.1016/j.bbadis.2011.01.012
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Campbell GR, 2012, ACTA NEUROPATHOL, V124, P209, DOI 10.1007/s00401-012-1001-9
   Campbell GR, 2012, CNS NEUROL DISORD-DR, V11, P589
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kumleh HH, 2006, J NEUROL SCI, V243, P65, DOI 10.1016/j.jns.2005.11.030
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Mähler A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043675
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nociti V, 2009, J NEUROL SCI, V287, P288, DOI 10.1016/j.jns.2009.07.009
   Palace J, 2009, J NEUROL SCI, V286, P24, DOI 10.1016/j.jns.2009.09.009
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Patte M, 2003, J FR OPHTALMOL, V26, P381
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Witte ME, 2013, ACTA NEUROPATHOL, V125, P231, DOI 10.1007/s00401-012-1052-y
   Witte ME, 2010, MITOCHONDRION, V10, P411, DOI 10.1016/j.mito.2010.05.014
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 31
TC 11
Z9 13
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC 15
PY 2013
VL 19
IS 14
BP 1858
EP 1866
DI 10.1177/1352458513490547
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 256LG
UT WOS:000327311100010
PM 23787892
DA 2024-11-01
ER

PT J
AU Stumpf, JD
   Saneto, RP
   Copeland, WC
AF Stumpf, Jeffrey D.
   Saneto, Russell P.
   Copeland, William C.
TI Clinical and Molecular Features of <i>POLG</i>-Related Mitochondrial Disease
SO COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY
LA English
DT Article
ID dna-polymerase-gamma; progressive external ophthalmoplegia; sensory ataxic neuropathy; saccharomyces-cerevisiae; w748s mutation; autosomal-dominant; oxidative stress; point mutations; alpers-syndrome; mtdna
AB The inability to replicate mitochondrial genomes (mtDNA) by the mitochondrial DNA polymerase (pol gamma) leads to a subset of mitochondrial diseases. Many mutations in POLG, the gene that encodes pol gamma, have been associated with mitochondrial diseases such as myocerebrohepatopathy spectrum (MCHS) disorders, Alpers-Huttenlocher syndrome, myoclonic epilepsy myopathy sensory ataxia (MEMSA), ataxia neuropathy spectrum (ANS), and progressive external ophthalmoplegia (PEO). This chapter explores five important topics in POLG- related disease: (1) clinical symptoms that identify and distinguish POLGrelated diseases, (2) molecular characterization of defects in polymerase activity by POLG disease variants, (3) the importance of holoenzyme formation in disease presentation, (4) the role of pol gamma exonuclease activity and mutagenesis in disease and aging, and (5) novel approaches to therapy and avoidance of toxicity based on primary research in pol gamma replication.
C1 [Stumpf, Jeffrey D.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Saneto, Russell P.] Univ Washington, Div Pediat Neurol, Seattle Childrens Hosp, Seattle, WA 98105 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Seattle Children's Hospital; University of Washington; University of Washington Seattle
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Intramural Research Program of the National Institutes of Health; National Institute of Environmental Health Sciences [ES 065078]; Mitochondrial Research Guild at Seattle Children's Hospital
CR Aitken H, 2009, NEUROLOGY, V72, PE86, DOI 10.1212/WNL.0b013e3181a411b8
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chinnery Patrick F, 2008, NEUROMUSCUL DISORD, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Cohen BH, 2010, GENE REV GENE TESTS, V0, P0
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   McElhinny SAN, 2006, CELL CYCLE, V5, P958, DOI 10.4161/cc.5.9.2736
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TULINIUS MH, 1991, BRAIN DEV-JPN, V13, P167, DOI 10.1016/S0387-7604(12)80024-6
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 91
TC 85
Z9 104
U1 0
U2 23
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1943-0264
EI 
J9 CSH PERSPECT BIOL
JI Cold Spring Harbor Perspect. Biol.
PD APR 15
PY 2013
VL 5
IS 4
BP 
EP 
DI 10.1101/cshperspect.a011395
PG 17
WC Cell Biology
SC Cell Biology
GA 120MT
UT WOS:000317175200009
PM 23545419
DA 2024-11-01
ER

PT J
AU Stumpf, JD
   Copeland, WC
AF Stumpf, Jeffrey D.
   Copeland, William C.
TI The Exonuclease Activity of the Yeast Mitochondrial DNA Polymerase γ Suppresses Mitochondrial DNA Deletions Between Short Direct Repeats in <i>Saccharomyces cerevisiae</i>
SO GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; oxidative stress; mutations; mtdna; disease; polg; quantification; replication; depletion; fidelity
AB The importance of mitochondrial DNA (mtDNA) deletions in the progeroid phenotype of exonuclease-deficient DNA polymerase gamma mice has been intensely debated. We show that disruption of Mip1 exonuclease activity increases mtDNA deletions 160-fold, whereas disease-associated polymerase variants were mostly unaffected, suggesting that exonuclease activity is vital to avoid deletions during mtDNA replication.
C1 [Stumpf, Jeffrey D.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Room E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU NIEHS; National Institutes of Health [ES-065078]
CR AZPIROZ R, 1993, MOL BIOL CELL, V4, P21, DOI 10.1091/mbc.4.1.21
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   JOYCE CM, 1989, J BIOL CHEM, V264, P10858
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LEHMAN IR, 1964, J BIOL CHEM, V239, P2628
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 37
TC 13
Z9 13
U1 0
U2 5
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD JUN 15
PY 2013
VL 194
IS 2
BP 519
EP 522
DI 10.1534/genetics.113.150920
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 156IG
UT WOS:000319814700020
PM 23589460
DA 2024-11-01
ER

PT J
AU Katada, S
   Mito, T
   Ogasawara, E
   Hayashi, JI
   Nakada, K
AF Katada, Shun
   Mito, Takayuki
   Ogasawara, Emi
   Hayashi, Jun-Ichi
   Nakada, Kazuto
TI Mitochondrial DNA with a Large-Scale Deletion Causes Two Distinct Mitochondrial Disease Phenotypes in Mice
SO G3-GENES GENOMES GENETICS
LA English
DT Article
DE mitochondria; mitochondrial DNA; pathogenic mutation; mitochondrial diseases; model mice
ID pearson syndrome; mutant mtdna; mito-mice; disorders; muscle; mouse
AB Studies in patients have suggested that the clinical phenotypes of some mitochondrial diseases might transit from one disease to another (e.g., Pearson syndrome [PS] to Kearns-Sayre syndrome) in single individuals carrying mitochondrial (mt) DNA with a common deletion (Delta mtDNA), but there is no direct experimental evidence for this. To determine whether Delta mtDNA has the pathologic potential to induce multiple mitochondrial disease phenotypes, we used trans-mitochondrial mice with a heteroplasmic state of wild-type mtDNA and Delta mtDNA (mito-mice Delta). Late-stage embryos carrying >= 50%.mtDNA showed abnormal hematopoiesis and iron metabolism in livers that were partly similar to PS (PS-like phenotypes), although they did not express sideroblastic anemia that is a typical symptom of PS. More than half of the neonates with PS-like phenotypes died by 1 month after birth, whereas the rest showed a decrease of Delta mtDNA load in the affected tissues, peripheral blood and liver, and they recovered from PS-like phenotypes. The proportion of mtDNA in various tissues of the surviving mito-mice. increased with time, and Kearns-Sayre syndrome 2 like phenotypes were expressed when the proportion of Delta mtDNA in various tissues reached > 70-80%. Our model mouse study clearly showed that a single Delta mtDNA was responsible for at least two distinct disease phenotypes at different ages and suggested that the level and dynamics of Delta mtDNA load in affected tissues would be important for the onset and transition of mitochondrial disease phenotypes in mice.
C1 [Katada, Shun; Mito, Takayuki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058575, Japan.
   [Ogasawara, Emi; Hayashi, Jun-Ichi; Nakada, Kazuto] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058575, Japan.
   [Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan.
C3 University of Tsukuba; University of Tsukuba; University of Tsukuba
RP Nakada, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.
EM knakada@biol.tsukuba.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23240058, 25250011]; MEXT [22650091]; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [22650091, 25250011, 23240058] Funding Source: KAKEN
CR Camaschella C, 2008, BRIT J HAEMATOL, V143, P27, DOI 10.1111/j.1365-2141.2008.07290.x
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   DiMauro S, 2011, SEMIN FETAL NEONAT M, V16, P181, DOI 10.1016/j.siny.2011.04.010
   Gurgey A, 1996, PEDIATR NEPHROL, V10, P637
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103
   Ogasawara E, 2010, HUM MOL GENET, V19, P3179, DOI 10.1093/hmg/ddq228
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Singer D, 2007, COMP BIOCHEM PHYS A, V148, P780, DOI 10.1016/j.cbpa.2007.05.004
   Tanaka D, 2008, MOL BRAIN, V1, P0, DOI 10.1186/1756-6606-1-21
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 23
TC 15
Z9 15
U1 1
U2 12
PU GENETICS SOC AM
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 2160-1836
EI 
J9 G3-GENES GENOM GENET
JI G3-Genes Genomes Genet.
PD SEP 1
PY 2013
VL 3
IS 9
BP 1545
EP 1552
DI 10.1534/g3.113.007245
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 215XI
UT WOS:000324244000010
PM 23853091
DA 2024-11-01
ER

PT J
AU Meyers, DE
   Basha, HI
   Koenig, MK
AF Meyers, Deborah E.
   Basha, Haseeb Ilias
   Koenig, Mary Kay
TI Mitochondrial Cardiomyopathy Pathophysiology, Diagnosis, and Management
SO TEXAS HEART INSTITUTE JOURNAL
LA English
DT Review
DE Cardiomyopathies/genetics/pathology/therapy; DNA; mitochondrial/analysis/genetics; energy; metabolism/physiology; electron transport/physiology; genetic predisposition; to disease; heart diseases/genetics; mitochondria/physiology; mitochondrial; diseases/complications/diagnosis/genetics/physiopathology/drug; therapy; risk; factors; ventricular dysfunction; left/genetics
ID ventricular non-compaction; stroke-like episodes; respiratory-chain; cardiac involvement; dna mutations; disorders; metabolism; disease; children; criteria
AB Mitochondrial disease is a heterogeneous group of multisystemic diseases that develop consequent to mutations in nuclear or mitochondrial DNA. The prevalence of inherited mitochondrial disease has been estimated to be greater than 1 in 5,000 births; however, the diagnosis and treatment of this disease are not taught in most adult-cardiology curricula. Because mitochondrial diseases often occur as a syndrome with resultant multiorgan dysfunction, they might not immediately appear to be specific to the cardiovascular system. Mitochondrial cardiomyopathy can be described as a myocardial condition characterized by abnormal heart-muscle structure, function, or both, secondary to genetic defects involving the mitochondrial respiratory chain, in the absence of concomitant coronary artery disease, hypertension, valvular disease, or congenital heart disease. The typical cardiac manifestations of mitochondrial disease hypertrophic and dilated cardiomyopathy, arrhythmias, left ventricular myocardial noncom paction, and heart failure can worsen acutely during a metabolic crisis. The optimal management of mitochondrial disease necessitates the involvement of a multidisciplinary team, careful evaluations of patients, and the anticipation of iatrogenic and noniatrogenic complications. In this review, we describe the complex pathophysiology of mitochondrial disease and its clinical features. We focus on current practice in the diagnosis and treatment of patients with mitochondrial cardiomyopathy, including optimal therapeutic management and long-term monitoring. We hope that this information will serve as a guide for practicing cardiologists who treat patients thus affected.
C1 [Meyers, Deborah E.] Texas Heart Inst, Adv Heart Failure Program, Houston, TX 77030 USA.
   [Basha, Haseeb Ilias] Michigan State Univ, Hurley Med Ctr, Dept Internal Med, Flint, MI 48503 USA.
   [Koenig, Mary Kay] Univ Texas Houston, Sch Med, Mitochondrial Dis Ctr, Dept Pediat,Div Child & Adolescent Neurol, Houston, TX 77030 USA.
C3 Texas Heart Institute; Michigan State University; University of Texas System; University of Texas Health Science Center Houston
RP Meyers, DE (corresponding author), Texas Heart Inst, C 355K,6770 Bertner Ave, Houston, TX 77030 USA.
EM DMeyers@texasheart.org
CR ALLARD MF, 1994, AM J PHYSIOL, V267, PH742, DOI 10.1152/ajpheart.1994.267.2.H742
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   CHRISTE ME, 1994, J MOL CELL CARDIOL, V26, P1371, DOI 10.1006/jmcc.1994.1155
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DiMauro S, 1999, J CHILD NEUROL, V14, PS23, DOI 10.1177/0883073899014001051
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0
   Flynn NE, 2002, BIOMED PHARMACOTHER, V56, P427, DOI 10.1016/S0753-3322(02)00273-1
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gillis LA, 2003, GASTROENTEROL CLIN N, V32, P789, DOI 10.1016/S0889-8553(03)00052-9
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Golden AS, 2012, PEDIATR TRANSPLANT, V16, P265, DOI 10.1111/j.1399-3046.2011.01635.x
   Häberle J, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-32
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Hsu CH, 2005, ANN NY ACAD SCI, V1042, P36, DOI 10.1196/annals.1338.004
   Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jenni R, 2007, HEART, V93, P11, DOI 10.1136/hrt.2005.082271
   Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kohli SK, 2008, EUR HEART J, V29, P89, DOI 10.1093/eurheartj/ehm481
   Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012
   Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI 10.2217/fca.11.79
   Martin DS, 2013, CRIT CARE MED, V41, P423, DOI 10.1097/CCM.0b013e31826a44f6
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Nachman MW, 1996, GENETICS, V142, P953
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Rötig A, 2003, J NEPHROL, V16, P286
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sambandam Nandakumar, 2002, HEART FAIL REV, V7, P161
   Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Stöllberger C, 2002, AM J CARDIOL, V90, P899, DOI 10.1016/S0002-9149(02)02723-6
   TAEGTMEYER H, 1988, HYPERTENSION, V11, P416, DOI 10.1161/01.HYP.11.5.416
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Taylor GP, 2004, PEDIATR DEVEL PATHOL, V7, P620, DOI 10.1007/s10024-004-5050-5
   Thavendiranathan P, 2013, HEART, V99, P681, DOI 10.1136/heartjnl-2012-302816
   Venditti P, 2013, MITOCHONDRION, V13, P71, DOI 10.1016/j.mito.2013.01.008
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wallace DC, 2010, GENE DEV, V24, P1571, DOI 10.1101/gad.1960210
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
NR 59
TC 160
Z9 176
U1 1
U2 11
PU TEXAS HEART INST
PI HOUSTON
PA PO BOX 20345, HOUSTON, TX 77225-0345 USA
SN 0730-2347
EI 1526-6702
J9 TEX HEART I J
JI Tex. Heart Inst. J.
PD SEP 15
PY 2013
VL 40
IS 4
BP 385
EP 394
DI 
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 273FQ
UT WOS:000328521000007
PM 24082366
DA 2024-11-01
ER

PT J
AU Baric, I
   Fumic, K
   Ramadza, DP
   Sperl, W
   Zimmermann, FA
   Muacevic-Katanec, D
   Mitrovic, Z
   Pazanin, L
   Sojat, LC
   Kekez, T
   Reiner, Z
   Mayr, JA
AF Baric, Ivo
   Fumic, Ksenija
   Ramadza, Danijela Petkovic
   Sperl, Wolfgang
   Zimmermann, Franz A.
   Muacevic-Katanec, Diana
   Mitrovic, Zoran
   Pazanin, Leo
   Sojat, Ljerka Cvitanovic
   Kekez, Tihomir
   Reiner, Zeljko
   Mayr, Johannes A.
TI Mitochondrial myopathy associated with a novel 5522G&gt;A mutation in the mitochondrial tRNA<SUP>Trp</SUP> gene
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mitochondrial myopathy; mtDNA mutation; tRNA(Trp)
ID transfer-rna; point mutation; dna; genome; encephalopathy; pathogenicity; deficiency; disorders; insertion
AB We report a novel pathogenic mutation of the mitochondrial transfer RNA (tRNA) gene for tryptophan in a patient with isolated myopathy and persistently elevated creatine kinase. Muscle studies revealed ragged red fibres and decreased activity of respiratory chain complex I and cytochrome c oxidase (COX). Sequencing of the 22 mitochondrial tRNA genes revealed a mutation m.5522G>A, which alters a conserved base pairing in the D-stem of the tRNA for tryptophan. The mutation was heteroplasmic with a mutational load between 88 and 99% in COX-negative fibres. This case contributes to the genetic heterogeneity of mitochondrial diseases caused by mutations in mitochondrial tRNA genes.
C1 [Baric, Ivo; Ramadza, Danijela Petkovic] Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb 10000, Croatia.
   [Baric, Ivo; Muacevic-Katanec, Diana; Reiner, Zeljko] Univ Zagreb, Sch Med, Zagreb 41001, Croatia.
   [Fumic, Ksenija] Univ Hosp Ctr Zagreb, Dept Paediat, Clin Inst Lab Diag, Zagreb 10000, Croatia.
   [Sperl, Wolfgang; Zimmermann, Franz A.; Mayr, Johannes A.] Paracelsus Med Univ, Dept Paediat, Salzburg, Austria.
   [Muacevic-Katanec, Diana; Reiner, Zeljko] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb 10000, Croatia.
   [Mitrovic, Zoran] Univ Hosp Ctr Zagreb, Natl Ctr Neuromuscular Dis, Zagreb 10000, Croatia.
   [Mitrovic, Zoran] Univ Hosp Ctr Zagreb, Dept Neurol, Zagreb 10000, Croatia.
   [Pazanin, Leo] Univ Hosp Ctr Zagreb, Clin Inst Pathol & Cytol, Zagreb 10000, Croatia.
   [Sojat, Ljerka Cvitanovic] Univ Hosp Ctr Sestre Milosrdnice, Dept Paediat, Zagreb, Croatia.
   [Kekez, Tihomir] Univ Hosp Ctr Zagreb, Dept Surg, Zagreb 10000, Croatia.
C3 University of Zagreb; University of Zagreb; University of Zagreb; Paracelsus Private Medical University; University of Zagreb; University of Zagreb; University of Zagreb; University of Zagreb; University of Zagreb
RP Baric, I (corresponding author), Univ Hosp Ctr Zagreb, Dept Paediat, Kispaticeva 12, Zagreb 10000, Croatia.
EM ibaric@kbc-zagreb.hr
FU Ministry of Science, Education and Sport, Republic of Croatia [108-1081870-1885]; E-rare 2 (European Research Projects on Rare Diseases) 'Mitochondriopathy-Network for diagnostics and therapy (GENOMIT)'; FWF [I 920-B13]
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Baird MF, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/960363
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chinnery PF, 1999, J MED GENET, V36, P425
   Crimi M, 2008, INT J NANOMED, V3, P51
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001
   MITOMAP, 2012, MITOMAP HUM MIT GEN, V0, P0
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Servidei Serenella, 2003, NEUROMUSCUL DISORD, V13, P848
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 34
TC 11
Z9 12
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD AUG 15
PY 2013
VL 21
IS 8
BP 871
EP 875
DI 10.1038/ejhg.2012.272
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 185FI
UT WOS:000321951100014
PM 23232693
DA 2024-11-01
ER

PT J
AU Hsiao, CW
   Peng, TI
   Peng, AC
   Reiter, RJ
   Tanaka, M
   Lai, YK
   Jou, MJ
AF Hsiao, Chia-Wei
   Peng, Tsung-I.
   Peng, Alexander C.
   Reiter, Russel J.
   Tanaka, Masashi
   Lai, Yiu-Kay
   Jou, Mei-Jie
TI Long-term Aβ exposure augments mCa<SUP>2+</SUP>-independent mROS-mediated depletion of cardiolipin for the shift of a lethal transient mitochondrial permeability transition to its permanent mode in NARP cybrids: a protective targeting of melatonin
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE amyloid beta-peptide; cardiolipin; mCa(2+); melatonin; mitochondrial reactive oxygen species; neurological muscle weakness; ataxia; and retinitis pigmentosa cybrids; transient-MPT
ID oxygen species generation; alzheimers-disease; amyloid-beta; oxidative stress; calcium homeostasis; cognitive decline; induced apoptosis; t8993g mutation; common deletion; ros release
AB Mitochondrial dysfunction is a hallmark of amyloid beta-peptide (A beta)-induced neurodegeneration of Alzheimer's disease (AD). This study investigated whether mtDNA T8993G mutation-induced complex V inhibition, clinically associated with neurological muscle weakness, ataxia, and retinitis pigmentosa (NARP), is a potential risk factor for AD and the pathological link for long-term exposure of A beta-induced mitochondrial toxicity and apoptosis in NARP cybrids. Using noninvasive fluorescence probe-coupled laser scanning imaging microscopy and NARP cybrids harboring 98% mutant genes along with its parental 143B osteosarcoma cells, we demonstrated that A beta-augmented mitochondrial Ca2+ (mCa(2+))-independent mitochondrial reactive oxygen species (mROS) formation for a cardiolipin (CL, a major mitochondrial protective phospholipid)-dependent lethal modulation of the mitochondrial permeability transition (MPT). A beta augmented not only the amount but also the propagation rate of mROS-induced mROS formation to significantly depolarize mitochondrial membrane potential (Delta Psi(m)) and reduce mCa(2+) stress. A beta-augmented mROS oxidized and depleted CL, thereby enhances mitochondrial fission and movement retardation, which promoted the NARP-augmented lethal transient-MPT (t-MPT) to switch to its irreversible mode of permanent-MPT (p-MPT). Interestingly, melatonin, a multiple mitochondrial protector, markedly reduced A beta-augmented mROS formation and therefore significantly reduced mROS-mediated depolarization of Delta Psi(m), fission of mitochondria and retardation of mitochondrial movement to stabilize CL and hence the MPT. In the presence of melatonin, A beta-promoted p-MPT was reversed to a protective t-MPT, which preserved Delta Psi(m) and lowered elevated mCa(2+) to sublethal levels for an enhanced mCa(2+)-dependent O-2 consumption. Thus, melatonin may potentially rescue AD patients associated with NARP symptoms.
C1 [Hsiao, Chia-Wei; Lai, Yiu-Kay] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan.
   [Hsiao, Chia-Wei; Lai, Yiu-Kay] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.
   [Peng, Tsung-I.] Chang Gung Mem Hosp, Dept Neurol, Kee Lung Med Ctr, Kee Lung, Taiwan.
   [Peng, Tsung-I.] Chang Gung Univ, Dept Med, Tao Yuan 333, Taiwan.
   [Peng, Alexander C.] Williston Northampton Sch, Easthampton, MA USA.
   [Reiter, Russel J.] Univ Texas San Antonio, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Tokyo, Japan.
   [Jou, Mei-Jie] Chang Gung Univ, Dept Physiol & Pharmacol, Coll Med, Tao Yuan 333, Taiwan.
C3 National Tsing Hua University; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University; University of Texas System; University of Texas Health Science Center at San Antonio; Tokyo Metropolitan Institute of Gerontology; Chang Gung University
RP Jou, MJ (corresponding author), Chang Gung Univ, Dept Physiol & Pharmacol, Sch Med, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.
EM mjjou@mail.cgu.edu.tw
FU Chang Gung Medical Research Foundation, Taiwan [CMRPD 180491-3, CMRPD 170411-3, CMRPG 270341-2]
CR Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Alikhani N, 2009, J BIOENERG BIOMEMBR, V41, P447, DOI 10.1007/s10863-009-9244-4
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8
   Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001
   Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002
   Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005
   Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5
   Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Clementi ME, 2005, FEBS LETT, V579, P2913, DOI 10.1016/j.febslet.2005.04.041
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Dragicevic N, 2011, J PINEAL RES, V51, P75, DOI 10.1111/j.1600-079X.2011.00864.x
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005
   Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6
   Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008
   Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x
   Glabe CG, 2006, NEUROLOGY, V66, PS74, DOI 10.1212/01.wnl.0000192103.24796.42
   Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386
   Griffiths EJ, 2012, ADV EXP MED BIOL, V942, P249, DOI 10.1007/978-94-007-2869-1_11
   Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   He Y, 2011, ASN NEURO, V3, P13, DOI 10.1042/AN20100025
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hung CHL, 2010, AGEING RES REV, V9, P447, DOI 10.1016/j.arr.2010.05.003
   Jou MJ, 2008, ADV DRUG DELIVER REV, V60, P1512, DOI 10.1016/j.addr.2008.06.004
   Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x
   Jou MJ, 2011, J PINEAL RES, V50, P427, DOI 10.1111/j.1600-079X.2011.00861.x
   Jou MJ, 2010, J PINEAL RES, V48, P20, DOI 10.1111/j.1600-079X.2009.00721.x
   Jou MJ, 2004, J PINEAL RES, V37, P55, DOI 10.1111/j.1600-079X.2004.00140.x
   Jou MJ, 2002, J BIOMED SCI, V9, P507
   Jou MJ, 2004, ANN NY ACAD SCI, V1011, P45, DOI 10.1196/annals.1293.005
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   Kim HS, 2002, NEUROREPORT, V13, P1989, DOI 10.1097/00001756-200210280-00032
   LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960
   Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mancuso M, 2007, ANTIOXID REDOX SIGN, V9, P1631, DOI 10.1089/ars.2007.1761
   Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3
   Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045
   Moreira PI, 2007, ANTIOXID REDOX SIGN, V9, P1621, DOI 10.1089/ars.2007.1703
   Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304
   Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Onyango IG, 2005, NEUROBIOL DIS, V19, P312, DOI 10.1016/j.nbd.2005.01.026
   Onyango I, 2006, J ALZHEIMERS DIS, V9, P183
   Pagani Lucia, 2011, INT J ALZHEIMERS DIS, V2011, P925050, DOI 10.4061/2011/925050
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Park J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023211
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x
   Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754
   Reddy PH, 2006, NEUROBIOL AGING, V27, P1060, DOI 10.1016/j.neurobiolaging.2005.04.014
   Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106
   Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943
   Rosales-Corral SA, 2012, J PINEAL RES, V52, P167, DOI 10.1111/j.1600-079X.2011.00937.x
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Sanz-Blasco S, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002718
   SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467
   Schönfeld P, 2007, ANTIOXID REDOX SIGN, V9, P191, DOI 10.1089/ars.2007.9.191
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Sheehan JP, 1997, J NEUROSCI, V17, P4612
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje
   Tillement L, 2006, STEROIDS, V71, P725, DOI 10.1016/j.steroids.2006.05.003
   Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009
   Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x
   Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x
   Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6
   Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009
   ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367
   Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
   Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029
NR 95
TC 22
Z9 22
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD JAN 15
PY 2013
VL 54
IS 1
BP 107
EP 125
DI 10.1111/jpi.12004
PG 19
WC Endocrinology & Metabolism; Neurosciences; Physiology
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 088PV
UT WOS:000314848500011
PM 24446866
DA 2024-11-01
ER

PT J
AU Palin, EJH
   Paetau, A
   Suomalainen, A
AF Palin, Eino J. H.
   Paetau, Anders
   Suomalainen, Anu
TI Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders
SO BRAIN
LA English
DT Article
DE parkinsonism; mitochondrial disorders; mitochondrial dysfunction; mitochondrial DNA; ataxia
ID progressive external ophthalmoplegia; onset spinocerebellar ataxia; autosomal recessive ataxia; substantia-nigra neurons; sensory neuropathy; juvenile parkinsonism; multiple deletions; dopamine neurons; w748s mutation; disease
AB Genetic evidence from recessively inherited Parkinson's disease has indicated a clear causative role for mitochondrial dysfunction in Parkinson's disease. This role has long been discussed based on findings that toxic inhibition of mitochondrial respiratory complex I caused parkinsonism and that tissues of patients with Parkinson's disease show complex I deficiency. Disorders of mitochondrial DNA maintenance are a common cause of inherited neurodegenerative disorders, and lead to mitochondrial DNA deletions or depletion and respiratory chain defect, including complex I deficiency. However, parkinsonism associates typically with defects of catalytic domain of mitochondrial DNA polymerase gamma. Surprisingly, however, not all mutations affecting DNA polymerase gamma manifest as parkinsonism, but, for example, spacer region mutations lead to spinocerebellar ataxia and/or severe epilepsy. Furthermore, defective Twinkle helicase, a close functional companion of DNA polymerase gamma in mitochondrial DNA replication, results in infantile-onset spinocerebellar ataxia, epilepsy or adult-onset mitochondrial myopathy, but not typically parkinsonism. Here we sought for clues for this specificity in the neurological manifestations of mitochondrial DNA maintenance disorders by studying mesencephalic neuropathology of patients with DNA polymerase gamma or Twinkle defects, with or without parkinsonism. We show here that all patients with mitochondrial DNA maintenance disorders had neuronopathy in substantia nigra, most severe in DNA polymerase gamma-associated parkinsonism. The oculomotor nucleus was also affected, but less severely. In substantia nigra, all patients had a considerable decrease of respiratory chain complex I, but other respiratory chain enzymes were not affected. Complex I deficiency did not correlate with parkinsonism, age, affected gene or inheritance. We conclude that the cell number in substantia nigra correlated well with parkinsonism in DNA polymerase gamma and Twinkle defects. However, complex I defect is a general consequence of mitochondrial DNA maintenance defects, and does not explain manifestation of parkinsonism or degree of mesencephalic cell death in patients with mitochondrial DNA maintenance disorders.
C1 [Palin, Eino J. H.; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, FIN-00290 Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Cent Hosp, Dept Pathol, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital
RP Palin, EJH (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, R C518B,POB 63, FIN-00290 Helsinki, Finland.
EM eino.palin@helsinki.fi
FU Finnish Parkinson Foundation; Finnish Foundation for Medicine; Sigrid Juselius Foundation; Academy of Finland; University of Helsinki; European Research Council
CR Albanese A, 2005, NEUROLOGY, V64, P1958, DOI 10.1212/01.WNL.0000163999.72864.FD
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Dekker M, 2003, MOVEMENT DISORD, V18, P751, DOI 10.1002/mds.10422
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Gasser T, 2011, MOVEMENT DISORD, V26, P1042, DOI 10.1002/mds.23637
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Guo JF, 2008, MOVEMENT DISORD, V23, P2074, DOI 10.1002/mds.22156
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477
   Ibáñez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005
   Khan NL, 2003, BRAIN, V126, P1279, DOI 10.1093/brain/awg142
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LANGSTON JW, 1983, NEW ENGL J MED, V309, P310
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Lill CM, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002548
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Lücking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497
   Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Simón-Sánchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van de Warrenburg BPC, 2001, NEUROLOGY, V56, P555, DOI 10.1212/WNL.56.4.555
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
NR 61
TC 38
Z9 39
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 
J9 BRAIN
JI Brain
PD AUG 15
PY 2013
VL 136
IS 
BP 2379
EP 2392
DI 10.1093/brain/awt160
PG 14
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 190KG
UT WOS:000322338000012
PM 23811324
DA 2024-11-01
ER

PT J
AU Konovalova, S
   Tyynismaa, H
AF Konovalova, Svetlana
   Tyynismaa, Henna
TI Mitochondrial aminoacyl-tRNA synthetases in human disease
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Review
DE Mitochondria; Mitochondrial disease; Aminoacyl-tRNA synthetases
ID spinal-cord involvement; brain-stem; lactic-acidosis; causes myopathy; mutations; leukoencephalopathy; gene; recognition; yars2; dars2
AB Mitochondrial aminoacyl-tRNA synthetases (mtARSs) are essential in the process of transferring genetic information from mitochondrial DNA to the complexes of the oxidative phosphorylation system. These synthetases perform an integral step in the initiation of mitochondrial protein synthesis by charging tRNAs with their cognate amino acids. All mtARSs are encoded by nuclear genes, nine of which have recently been described as disease genes for mitochondrial disorders. Unexpectedly, the clinical presentations of these diseases are highly specific to the affected synthetase. Encephalopathy is the most common manifestation but again with gene-specific outcomes. Other clinical presentations include myopathy with anemia, cardiomyopathy, tubulopathy and hearing loss with female ovarian dysgenesis. Here we review the described mutation types and the associated patient phenotypes. The identified mutation spectrum suggests that only mutation types that allow some residual tRNA-charging activity can result in the described mtARS diseases but the molecular mechanisms behind the selective tissue involvement are not currently understood. (C) 2013 Elsevier Inc. All rights reserved.
C1 Biomed Helsinki, Res Programs Unit, Mol Neurol, Helsinki 00014, Finland.
   Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki 00014, Finland.
C3 University of Helsinki; University of Helsinki
RP Tyynismaa, H (corresponding author), Biomed Helsinki, R-C512A,Haartmaninkatu 8, Helsinki 00014, Finland.
EM henna.tyynismaa@helsinki.fi
FU Academy of Finland, Sigrid Juselius Foundation; University of Helsinki; Arvo and Lea Ylppo Foundation; Orion Farmos Research Foundation and Centre for International Mobility for research
CR Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527
   Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9
   Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811
   Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956
   Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727
   KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4
   Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005
   Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210
   McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008
   Miyake N, 2011, CLIN GENET, V80, P293, DOI 10.1111/j.1399-0004.2011.01644.x
   Motley WW, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002399
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Synofzik M, 2011, J MED GENET, V48, P713, DOI 10.1136/jmg.2011.090282
   Thiffault I, 2006, BRAIN, V129, P2332, DOI 10.1093/brain/awl110
   van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795
   Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210
   Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11
   Xu XL, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1686
NR 38
TC 124
Z9 138
U1 2
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD APR 15
PY 2013
VL 108
IS 4
BP 206
EP 211
DI 10.1016/j.ymgme.2013.01.010
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 112HJ
UT WOS:000316583000002
PM 23433712
DA 2024-11-01
ER

PT J
AU McKinney, EA
   Oliveira, MT
AF McKinney, Emily A.
   Oliveira, Marcos T.
TI Replicating animal mitochondrial DNA
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Review
DE DNA replication; mitochondria; mtSSB; pol gamma; Twinkle
ID progressive external ophthalmoplegia; light-strand origins; n-terminal domain; functional interactions; biochemical defects; accessory subunit; polymerase gamma; helicase twinkle; binding protein; mtdna helicase
AB The field of mitochondrial DNA (mtDNA) replication has been experiencing incredible progress in recent years, and yet little is certain about the mechanism(s) used by animal cells to replicate this plasmid-like genome. The long-standing strand-displacement model of mammalian mtDNA replication (for which single-stranded DNA intermediates are a hallmark) has been intensively challenged by a new set of data, which suggests that replication proceeds via coupled leading-and lagging-strand synthesis (resembling bacterial genome replication) and/or via long stretches of RNA intermediates laid on the mtDNA lagging-strand (the so called RITOLS). The set of proteins required for mtDNA replication is small and includes the catalytic and accessory subunits of DNA polymerase gamma, the mtDNA helicase Twinkle, the mitochondrial single-stranded DNA-binding protein, and the mitochondrial RNA polymerase (which most likely functions as the mtDNA primase). Mutations in the genes coding for the first three proteins are associated with human diseases and premature aging, justifying the research interest in the genetic, biochemical and structural properties of the mtDNA replication machinery. Here we summarize these properties and discuss the current models of mtDNA replication in animal cells.
C1 [McKinney, Emily A.; Oliveira, Marcos T.] Univ Tampere, Inst Biomed Technol, Tampere 33014, Finland.
C3 Tampere University
RP Oliveira, MT (corresponding author), Univ Tampere, Inst Biomed Technol, Biokatu 6, Tampere 33014, Finland.
EM marcos.oliveira@uta.fi
CR BOGENHAGEN D, 1979, COLD SPRING HARB SYM, V43, P253, DOI 10.1101/SQB.1979.043.01.031
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Joers P, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053249
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   NASS MMK, 1980, J MOL BIOL, V140, P257, DOI 10.1016/0022-2836(80)90105-9
   NASS MMK, 1980, J MOL BIOL, V140, P231, DOI 10.1016/0022-2836(80)90104-7
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Oliveira MT, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015379
   Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Scheffler IE, 2008, MITOCHONDRIA, V0, P1
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 58
TC 52
Z9 70
U1 0
U2 23
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670 RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PD JUN 15
PY 2013
VL 36
IS 3
BP 308
EP 315
DI 10.1590/S1415-47572013000300002
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 209AO
UT WOS:000323725500002
PM 24130435
DA 2024-11-01
ER

PT J
AU Tam, ZY
   Gruber, J
   Halliwell, B
   Gunawan, R
AF Tam, Zhi Yang
   Gruber, Jan
   Halliwell, Barry
   Gunawan, Rudiyanto
TI Mathematical Modeling of the Role of Mitochondrial Fusion and Fission in Mitochondrial DNA Maintenance
SO PLOS ONE
LA English
DT Article
ID in-vivo; deletion mutations; clonal expansion; human-cells; turnover; dynamics; mtdna; complementation; nucleoids; muscle
AB Accumulation of mitochondrial DNA (mtDNA) mutations has been implicated in a wide range of human pathologies, including neurodegenerative diseases, sarcopenia, and the aging process itself. In cells, mtDNA molecules are constantly turned over (i.e. replicated and degraded) and are also exchanged among mitochondria during the fusion and fission of these organelles. While the expansion of a mutant mtDNA population is believed to occur by random segregation of these molecules during turnover, the role of mitochondrial fusion-fission in this context is currently not well understood. In this study, an in silico modeling approach is taken to investigate the effects of mitochondrial fusion and fission dynamics on mutant mtDNA accumulation. Here we report model simulations suggesting that when mitochondrial fusion-fission rate is low, the slow mtDNA mixing can lead to an uneven distribution of mutant mtDNA among mitochondria in between two mitochondrial autophagic events leading to more stochasticity in the outcomes from a single random autophagic event. Consequently, slower mitochondrial fusion-fission results in higher variability in the mtDNA mutation burden among cells in a tissue over time, and mtDNA mutations have a higher propensity to clonally expand due to the increased stochasticity. When these mutations affect cellular energetics, nuclear retrograde signalling can upregulate mtDNA replication, which is expected to slow clonal expansion of these mutant mtDNA. However, our simulations suggest that the protective ability of retrograde signalling depends on the efficiency of fusion-fission process. Our results thus shed light on the interplay between mitochondrial fusion-fission and mtDNA turnover and may explain the mechanism underlying the experimentally observed increase in the accumulation of mtDNA mutations when either mitochondrial fusion or fission is inhibited.
C1 [Tam, Zhi Yang; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, Zurich, Switzerland.
   [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Dept Biochem, Ctr Life Sci, Singapore 117548, Singapore.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore
RP Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, Zurich, Switzerland.
EM rudi.gunawan@chem.ethz.ch
FU ETH Zurich; National University of Singapore (FRC) [R-279-000-299-112]; Ministry of Education Singapore [MOE2010-T2-2-048]
CR Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101
   Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292
   Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   DAurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Figge MT, 2012, PLOS COMPUT BIOL, V8, P0, DOI 10.1371/journal.pcbi.1002576
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hori A, 2011, GENES CELLS, V16, P527, DOI 10.1111/j.1365-2443.2011.01504.x
   Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274
   HUEMER RP, 1971, EXP GERONTOL, V6, P259, DOI 10.1016/0531-5565(71)90038-6
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kraytsberg Y, 2003, MECH AGEING DEV, V124, P49, DOI 10.1016/S0047-6374(02)00169-0
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Matsumoto M, 1998, ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION, V8, P3, DOI 10.1145/272991.272995
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Parone PA, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003257
   Poole AC, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010054
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, P0, DOI 10.1371/journal.pcbi.1000572
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Saunter CD, 2009, FEBS LETT, V583, P1267, DOI 10.1016/j.febslet.2009.02.041
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Twig G, 2006, AM J PHYSIOL-CELL PH, V291, PC176, DOI 10.1152/ajpcell.00348.2005
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 50
TC 39
Z9 43
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD OCT 11
PY 2013
VL 8
IS 10
BP 
EP 
DI 10.1371/journal.pone.0076230
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 236SL
UT WOS:000325819400049
PM 24146842
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Orsucci, D
   Ienco, EC
   Ricci, G
   Ali, G
   Servadio, A
   Fontanini, G
   Filosto, M
   Vielmi, V
   Rocchi, A
   Petrozzi, L
   LoGerfo, A
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Ienco, Elena Caldarazzo
   Ricci, Giulia
   Ali, Greta
   Servadio, Adele
   Fontanini, Gabriella
   Filosto, Massimiliano
   Vielmi, Valentina
   Rocchi, Anna
   Petrozzi, Lucia
   LoGerfo, Annalisa
   Siciliano, Gabriele
TI An "inflammatory" mitochondrial myopathy. A case report
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE CPEO; Inflammation; IVIg; mtDNA; Respiratory failure
ID progressive external ophthalmoplegia; multiple-sclerosis; dna; neurodegeneration; mutation; disease; gene
AB We describe a case of an adult male patient with progressive external ophthalmoplegia and upper limb weakness, who presented with an episode of sudden respiratory failure. Muscle biopsy showed ragged-red and COX-negative fibers associated with discrete inflammatory infiltrates and necrotizing features. Apart from artificial ventilator support, he was treated with intravenous immunoglobulins and carnitine, with excellent clinical outcome. Mitochondrial DNA analysis revealed the 3251A > G mutation, previously reported in association with rapidly progressive mitochondrial myopathy and respiratory failure. Our case expands the spectrum of this mutation and suggests a therapeutib attempt with immunoglobulins in mitochondrial patients with acute respiratory failure, at least when this mutation and/or muscle inflammation is present. Moreover, this case supports the idea of a "pathologic inflammatory response induced by mitochondrial disease; such an abnormal response may be a contributory factor in disease progression or acute exacerbation typical of some mitochondrial diseases, but further studies are needed. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Ienco, Elena Caldarazzo; Ricci, Giulia; Rocchi, Anna; Petrozzi, Lucia; LoGerfo, Annalisa; Siciliano, Gabriele] Univ Pisa, Neurol Clin, I-56126 Pisa, Italy.
   [Ali, Greta; Servadio, Adele; Fontanini, Gabriella] Univ Pisa, Dept Surg, Div Anat Pathol, I-56126 Pisa, Italy.
   [Filosto, Massimiliano; Vielmi, Valentina] Univ Brescia, Neurol Inst, I-25121 Brescia, Italy.
C3 University of Pisa; University of Pisa; University of Brescia
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Via Roma 67, I-56126 Pisa, Italy.
EM mancusomichelangelo@gmail.com
FU Telethon Grant [GUP09004]
CR Cohen O, 1998, J NEUROL NEUROSUR PS, V64, P410, DOI 10.1136/jnnp.64.3.410
   Di Filippo M, 2010, J ALZHEIMERS DIS, V20, PS369, DOI 10.3233/JAD-2010-100543
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y
   Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36
   Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750
   Kiyomoto BH, 2006, J NEUROL NEUROSUR PS, V77, P541, DOI 10.1136/jnnp.2005.079954
   Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005
   Latronico N, 2012, CURR OPIN RHEUMATOL, V24, P616, DOI 10.1097/BOR.0b013e3283588d2f
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Satoh M, 2012, CLIN REV ALLERG IMMU, V42, P16, DOI 10.1007/s12016-011-8286-7
   Slee M, 2011, J CLIN NEUROSCI, V18, P1318, DOI 10.1016/j.jocn.2011.02.019
   SWEENEY MG, 1993, Q J MED, V86, P709
   Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 19
TC 11
Z9 12
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD NOV 15
PY 2013
VL 23
IS 11
BP 907
EP 910
DI 10.1016/j.nmd.2013.07.011
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 243LN
UT WOS:000326318000008
PM 24011700
DA 2024-11-01
ER

PT J
AU Ronchi, D
   Di Fonzo, A
   Lin, WQ
   Bordoni, A
   Liu, CW
   Fassone, E
   Pagliarani, S
   Rizzuti, M
   Zheng, L
   Filosto, M
   Ferrò, MT
   Ranieri, M
   Magri, F
   Peverelli, L
   Li, HZ
   Yuan, YC
   Corti, S
   Sciacco, M
   Moggio, M
   Bresolin, N
   Shen, BH
   Comi, GP
AF Ronchi, Dario
   Di Fonzo, Alessio
   Lin, Weiqiang
   Bordoni, Andreina
   Liu, Changwei
   Fassone, Elisa
   Pagliarani, Serena
   Rizzuti, Mafalda
   Zheng, Li
   Filosto, Massimiliano
   Ferro, Maria Teresa
   Ranieri, Michela
   Magri, Francesca
   Peverelli, Lorenzo
   Li, Hongzhi
   Yuan, Yate-Ching
   Corti, Stefania
   Sciacco, Monica
   Moggio, Maurizio
   Bresolin, Nereo
   Shen, Binghui
   Comi, Giacomo Pietro
TI Mutations in <i>DNA2</i> Link Progressive Myopathy to Mitochondrial DNA Instability
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID enzymatic-property; replication; disease; repair; deletions; protein; twinkle; flap
AB Syndromes associated with multiple mtDNA deletions are due to different molecular defects that can result in a wide spectrum of predominantly adult-onset clinical presentations, ranging from progressive external ophthalmoplegia (PRO) to multisystemic disorders of variable severity. The autosomal-dominant form of PEO is genetically heterogeneous. Recently, causative mutations have been reported in several nuclear genes that encode proteins of the mtDNA replisome machinery (POLG, POLG2, and C10orf2) or that are involved in pathways for the synthesis of deoxyribonuclotides (ANTI and RRM2B). Despite these findings, putative mutations remain unknown in half of the subjects with PEO. We report the identification, by exome sequencing, of mutations in DNA2 in adult-onset individuals with a form of mitochondrial myopathy featuring instability of muscle mtDNA. DNA2 encodes a helicase/nuclease family member that is most likely involved in mtDNA replication, as well as in the long-patch base-excision repair (LP-BER) pathway. In vitro biochemical analysis of purified mutant proteins revealed a severe impairment of nuclease, helicase, and ATPase activities. These results implicate human DNA2 and the LP-BER pathway in the pathogenesis of adult-onset disorders of mtDNA maintenance.
C1 [Ronchi, Dario; Di Fonzo, Alessio; Bordoni, Andreina; Pagliarani, Serena; Rizzuti, Mafalda; Ranieri, Michela; Magri, Francesca; Corti, Stefania; Bresolin, Nereo; Comi, Giacomo Pietro] Univ Milan, Ist Ricovero & Cura,Neurol Unit, Carattere Sci Fdn Ca Granda Osped Maggiore Policl, Dino Ferrari Ctr,Neurosci Sect,Dept Pathophysiol, I-20122 Milan, Italy.
   [Lin, Weiqiang; Liu, Changwei; Zheng, Li; Shen, Binghui] Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA 91010 USA.
   [Fassone, Elisa] UCL, Inst Child Hlth, Mitochondrial Res Grp, London WC1N 3BG, England.
   [Filosto, Massimiliano] Spedali Civil Brescia, Univ Hosp, Sect Neuromuscular Dis & Neuropathies, I-25123 Brescia, Italy.
   [Ferro, Maria Teresa] Osped Maggiore Crema, Neurol Unit, I-26013 Crema, Italy.
   [Corti, Stefania; Bresolin, Nereo; Comi, Giacomo Pietro] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20122 Milan, Italy.
   [Peverelli, Lorenzo; Sciacco, Monica; Moggio, Maurizio] Univ Milan, Carattere Sci Fdn Ca Granda Osped Maggiore Policl, Ist Ricovero & Cura, Neuromuscular Unit,Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Li, Hongzhi; Yuan, Yate-Ching] City Hope Comprehens Canc Ctr, Beckman Res Inst, Bioinformat Core, Duarte, CA 91010 USA.
   [Bresolin, Nereo] Ist Ricovero & Cura Carattere Sci Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; City of Hope; Beckman Research Institute of City of Hope; University of London; University College London; Hospital Spedali Civili Brescia; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; City of Hope; Beckman Research Institute of City of Hope; IRCCS Eugenio Medea
RP Shen, BH (corresponding author), Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA 91010 USA.
EM bshen@coh.org; giacomo.comi@unimi.it
FU Telethon [GTB07001ER, GUP09004]; Eurobiobank project [QLTR-2001-02769]; National Institutes of Health [R01CA085344]; Associazione Amici del Centro Dino Ferrari, University of Milan
CR Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200
   Budd ME, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004267
   BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Gilissen C, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-228
   Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102
   Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004
   Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 19
TC 101
Z9 108
U1 0
U2 18
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD FEB 7
PY 2013
VL 92
IS 2
BP 293
EP 300
DI 10.1016/j.ajhg.2012.12.014
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 093GL
UT WOS:000315179600015
PM 23352259
DA 2024-11-01
ER

PT J
AU Gai, XW
   Ghezzi, D
   Johnson, MA
   Biagosch, CA
   Shamseldin, HE
   Haack, TB
   Reyes, A
   Tsukikawa, M
   Sheldon, CA
   Srinivasan, S
   Gorza, M
   Kremer, LS
   Wieland, T
   Strom, TM
   Polyak, E
   Place, E
   Consugar, M
   Ostrovsky, J
   Vidoni, S
   Robinson, AJ
   Wong, LJ
   Sondheimer, N
   Salih, MA
   Al-Jishi, E
   Raab, CP
   Bean, C
   Furlan, F
   Parini, R
   Lamperti, C
   Mayr, JA
   Konstantopoulou, V
   Huemer, M
   Pierce, EA
   Meitinger, T
   Freisinger, P
   Sperl, W
   Prokisch, H
   Alkuraya, FS
   Falk, MJ
   Zeviani, M
AF Gai, Xiaowu
   Ghezzi, Daniele
   Johnson, Mark A.
   Biagosch, Caroline A.
   Shamseldin, Hanan E.
   Haack, Tobias B.
   Reyes, Aurelio
   Tsukikawa, Mai
   Sheldon, Claire A.
   Srinivasan, Satish
   Gorza, Matteo
   Kremer, Laura S.
   Wieland, Thomas
   Strom, Tim M.
   Polyak, Erzsebet
   Place, Emily
   Consugar, Mark
   Ostrovsky, Julian
   Vidoni, Sara
   Robinson, Alan J.
   Wong, Lee-Jun
   Sondheimer, Neal
   Salih, Mustafa A.
   Al-Jishi, Emtethal
   Raab, Christopher P.
   Bean, Charles
   Furlan, Francesca
   Parini, Rossella
   Lamperti, Costanza
   Mayr, Johannes A.
   Konstantopoulou, Vassiliki
   Huemer, Martina
   Pierce, Eric A.
   Meitinger, Thomas
   Freisinger, Peter
   Sperl, Wolfgang
   Prokisch, Holger
   Alkuraya, Fowzan S.
   Falk, Marni J.
   Zeviani, Massimo
TI Mutations in <i>FBXL4</i>, Encoding a Mitochondrial Protein, Cause Early-Onset Mitochondrial Encephalomyopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID ubiquitin ligases; disease; scf; reveals
AB Whole-exome sequencing and autozygosity mapping studies, independently performed in subjects with defective combined mitochondrial OXPHOS-enzyme deficiencies, identified a total of nine disease-segregating FBXL4 mutations in seven unrelated mitochondrial disease families, composed of six singletons and three siblings. All subjects manifested early-onset lactic acidemia, hypotonia, and developmental delay caused by severe encephalomyopathy consistently associated with progressive cerebral atrophy and variable involvement of the white matter, deep gray nuclei, and brainstem structures. A wide range of other multisystem features were variably seen, including dysmorphism, skeletal abnormalities, poor growth, gastrointestinal dysmotility, renal tubular acidosis, seizures, and episodic metabolic failure. Mitochondrial respiratory chain deficiency was present in muscle or fibroblasts of all tested individuals, together with markedly reduced oxygen consumption rate and hyperfragmentation of the mitochondrial network in cultured cells. In muscle and fibroblasts from several subjects, substantially decreased mtDNA content was observed. FBXL4 is a member of the F-box family of proteins, some of which are involved in phosphorylation-dependent ubiquitination and/or G protein receptor coupling. We also demonstrate that FBXL4 is targeted to mitochondria and localizes in the intermembrane space, where it participates in an approximately 400 kDa protein complex. These data strongly support a role for FBXL4 in controlling bioenergetic homeostasis and mtDNA maintenance. FBXL4 mutations are a recurrent cause of mitochondrial encephalomyopathy onset in early infancy.
C1 [Gai, Xiaowu] Loyola Univ, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA.
   [Ghezzi, Daniele; Lamperti, Costanza; Zeviani, Massimo] Inst Neurol Besta, Dept Mol Neurogenet, I-23888 Milan, Italy.
   [Johnson, Mark A.; Reyes, Aurelio; Vidoni, Sara; Robinson, Alan J.; Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Biagosch, Caroline A.; Haack, Tobias B.; Gorza, Matteo; Kremer, Laura S.; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Biagosch, Caroline A.; Haack, Tobias B.; Gorza, Matteo; Kremer, Laura S.; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Shamseldin, Hanan E.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
   [Tsukikawa, Mai; Sheldon, Claire A.; Polyak, Erzsebet; Place, Emily; Sondheimer, Neal; Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet & Metab Dis, Philadelphia, PA 19104 USA.
   [Tsukikawa, Mai; Sheldon, Claire A.; Polyak, Erzsebet; Place, Emily; Sondheimer, Neal; Falk, Marni J.] Univ Penn, Perleman Sch Med, Philadelphia, PA 19104 USA.
   [Srinivasan, Satish; Ostrovsky, Julian] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.
   [Place, Emily; Pierce, Eric A.] Harvard Univ, Sch Med, MEEI, Ocular Genom Inst, Boston, MA 02114 USA.
   [Consugar, Mark; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Salih, Mustafa A.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia.
   [Salih, Mustafa A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia.
   [Al-Jishi, Emtethal] Arabian Gulf Univ, Manama, Bahrain.
   [Raab, Christopher P.; Bean, Charles] Thomas Jefferson Univ, Nemours AI DuPont Hosp Children, Dept Pediat, Wilmington, DE 19803 USA.
   [Furlan, Francesca; Parini, Rossella] Fdn MBBM, San Gerardo Univ Hosp, Dept Pediat, Unit Metab Disorders, I-20900 Monza, Italy.
   [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Dept Paediat, A-5020 Salzburg, Austria.
   [Konstantopoulou, Vassiliki] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.
   [Huemer, Martina] LKH Bregenz, Dept Pediat, A-6900 Bregenz, Austria.
   [Pierce, Eric A.] Harvard Univ, Sch Med, Dept Ophthalmol, Berman Gund Lab Study Retinal Degenerat,MEEI, Boston, MA 02114 USA.
   [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany.
   [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia.
C3 Loyola University Chicago; Fondazione IRCCS Istituto Neurologico Carlo Besta; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; King Faisal Specialist Hospital & Research Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Baylor College of Medicine; King Saud University; King Khalid University Hospital; King Saud University; Arabian Gulf University; Nemours Alfred I. duPont Hospital for Children; Jefferson University; Paracelsus Private Medical University; Medical University of Vienna; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Alfaisal University
RP Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
EM falkuraya@kfshrc.edu.sa; mdz21@mrc-mbu.cam.ac.uk
FU Fondazione Telethon [GGP11011, GPP10005]; CARIPLO Foundation, Italy [2011/0526]; Italian Ministry of Health [GR2010-2316392]; Pierfranco and Luisa Mariani Foundation of Italy; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); German Federal Ministry of Education and Research (BMBF) [0315494A]; German Network for Mitochondrial Disorders [01GM0867, 01GM1113C]; E-rare grant GenoMit [JTC2011, 01GM1207, FWF I 920-B13]; EU FP7 Mitochondrial European Educational Training project (Meet); European Research Council [FP7-322424]; Medical Research Council (UK); Deanship of Scientific Research at King Saud University, Riyadh [301]; Penn Genome Frontiers Institute; National Institutes of Health [R03-DK082446, R01-EY012910, P30EY014104-MEEI, 1G20RR030939]; Foerderer Award for Excellence from the Children's Hospital of Philadelphia Research Institute; Telethon Italy [GTB12001]; MRC [MC_UP_1002/1, MC_U105674181] Funding Source: UKRI
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383
   Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624
   Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dingley S, 2012, METHODS MOL BIOL, V837, P231, DOI 10.1007/978-1-61779-504-6_16
   Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0
   Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361
   Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001
   Ghezzi D, 2009, HUM MOL GENET, V18, P1058, DOI 10.1093/hmg/ddn441
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HECKMATT JZ, 1984, ARCH DIS CHILD, V59, P528, DOI 10.1136/adc.59.6.528
   Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571
   Horvath IT, 2012, TOP CURR CHEM, V308, P1, DOI 10.1007/978-3-642-25234-1
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580
   Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533
   Van Rechem C, 2011, J BIOL CHEM, V286, P30462, DOI 10.1074/jbc.M111.273508
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027
   Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964
NR 34
TC 117
Z9 124
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD SEP 5
PY 2013
VL 93
IS 3
BP 482
EP 495
DI 10.1016/j.ajhg.2013.07.016
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA 297QB
UT WOS:000330268900007
PM 23993194
DA 2024-11-01
ER

PT J
AU Obara-Moszynska, M
   Maceluch, J
   Bobkowski, W
   Baszko, A
   Jaremba, O
   Krawczynski, MR
   Niedziela, M
AF Obara-Moszynska, Monika
   Maceluch, Jaroslaw
   Bobkowski, Waldemar
   Baszko, Artur
   Jaremba, Oskar
   Krawczynski, Maciej R.
   Niedziela, Marek
TI A novel mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome: a late-onset of the fatal cardiac conduction deficit and cardiomyopathy accompanying long-term rGH treatment
SO BMC PEDIATRICS
LA English
DT Article
DE Growth hormone treatment; Mitochondrial disease; Atrio-ventricular block; Cardiomyopathy; Short stature
ID ophthalmoplegia; dysfunction
AB Background: Kearns-Sayre Syndrome (KSS) is a multisystem disorder caused by a dysfunction of the oxidative phosphorylation system within mitochondria. Mitochondrial DNA (mtDNA) rearrangements are a key molecular feature of this disease, which manifest a broad phenotypic spectrum. Case presentation: Here, we present a boy with KSS whose symptoms included cardiac conduction deficit, cardiomyopathy and growth hormone (GH) deficiency. The patient showed typical symptoms for KSS from early childhood (chronic progressive external ophthalmoplegia, retinopathy, short stature). Long-range PCR analysis disclosed a 7663-base pair heteroplasmic deletion in the mtDNA encompassing nucleotides 6340-14003. At 12 years of age, GH deficiency was recognized and recombinant growth hormone (rGH) therapy was started. At 15 years of age, a complete atrioventicular block was diagnosed and the patient received a pacemaker. During the following 6 months, progressive deterioration of the left ventricle was observed and an echocardiogram showed features of dilated cardiomyopathy. The rGH treatment was then discontinued at a final height of 163 cm. Unfortunately, due to multi-organ insufficiency and inflammation, the patient died at the age of 18 years. Conclusions: The response to rGH therapy in the patient was very satisfactory. The large mtDNA deletion had no apparent impact on the response to rGH. Cardiac disturbances occurred as part of the syndrome and were not related to rGH therapy; however, the progression of the disease led to death.
C1 [Obara-Moszynska, Monika; Maceluch, Jaroslaw; Niedziela, Marek] Poznan Univ Med Sci, Dept Pediat Endocrinol & Rheumatol, PL-60572 Poznan, Poland.
   [Bobkowski, Waldemar; Jaremba, Oskar] Poznan Univ Med Sci, Dept Pediat Cardiol & Nephrol, PL-60572 Poznan, Poland.
   [Baszko, Artur] Poznan Univ Med Sci, Dept Cardiol 2, PL-60572 Poznan, Poland.
   [Krawczynski, Maciej R.] Poznan Univ Med Sci, Dept Med Genet, PL-60572 Poznan, Poland.
C3 Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences
RP Obara-Moszynska, M (corresponding author), Poznan Univ Med Sci, Dept Pediat Endocrinol & Rheumatol, 27-33 Szpitalna St, PL-60572 Poznan, Poland.
EM m.moszynska@ump.edu.pl
FU MNiSzW [2 P05A 070 30]
CR BERENBAUM F, 1990, NEUROLOGY, V40, P193, DOI 10.1212/WNL.40.1.193
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Bhati RS, 2005, J HEART LUNG TRANSPL, V24, P2286, DOI 10.1016/j.healun.2005.05.012
   Bindoff L, 2003, EUR HEART J, V24, P221, DOI 10.1016/S0195-668X(02)00694-2
   BURNS EC, 1982, ACTA PAEDIATR SCAND, V71, P693, DOI 10.1111/j.1651-2227.1982.tb09504.x
   Chawla S, 2008, PEDIATR CARDIOL, V29, P659, DOI 10.1007/s00246-007-9040-z
   Colao A, 2009, BEST PRACT RES CL EN, V23, PS31, DOI 10.1016/S1521-690X(09)70006-5
   DIMAURO S, 1991, REV NEUROL, V147, P443
   Genth-Zotz S, 1999, CIRCULATION, V99, P18, DOI 10.1161/01.CIR.99.1.18
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   MACELUCH JA, 2007, PEDIATR ENDOCR REV P, V4, P117
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Naheed Z, 2012, PEDIAT CARDIOL, V0, P0
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Perrot A, 2001, J CARDIAC SURG, V16, P127, DOI 10.1111/j.1540-8191.2001.tb00497.x
   POULTON J, 1989, LANCET, V1, P236
   QUADE A, 1992, CLIN INVESTIGATOR, V70, P396
   REISS K, 1994, EXP CELL RES, V213, P463, DOI 10.1006/excr.1994.1224
   RODRIGUES EA, 1989, BRIT HEART J, V62, P185
   Smith SC, 2008, HEART RHYTHM, V5, P934, DOI 10.1016/j.hrthm.2008.04.015
   Verhelst J, 2009, EUR J ENDOCRINOL, V161, PS41, DOI 10.1530/EJE-09-0291
   Wallace DC, 1994, HUMAN GENE MAPPING 1, V0, P813
NR 23
TC 18
Z9 21
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2431
EI 
J9 BMC PEDIATR
JI BMC Pediatr.
PD FEB 20
PY 2013
VL 13
IS 
BP 
EP 
DI 10.1186/1471-2431-13-27
PG 9
WC Pediatrics
SC Pediatrics
GA 104KN
UT WOS:000315991900001
PM 23421922
DA 2024-11-01
ER

PT J
AU Paredes, JA
   Zhou, XS
   Höglund, S
   Karlsson, A
AF Paredes, Joao A.
   Zhou, Xiaoshan
   Hoglund, Stefan
   Karlsson, Anna
TI Gene Expression Deregulation in Postnatal Skeletal Muscle of TK2 Deficient Mice Reveals a Lower Pool of Proliferating Myogenic Progenitor Cells
SO PLOS ONE
LA English
DT Article
ID mitochondrial thymidine kinase; cardiomyocyte dna-synthesis; retinoblastoma protein; deoxynucleotide pools; depletion myopathy; mouse-tissue; stem-cells; differentiation; inhibition; mtdna
AB Loss of thymidine kinase 2 (TK2) causes a heterogeneous myopathic form of mitochondrial DNA (mtDNA) depletion syndrome (MDS) in humans that predominantly affects skeletal muscle tissue. In mice, TK2 deficiency also affects several tissues in addition to skeletal muscle, including brain, heart, adipose tissue, kidneys and causes death about 3 weeks after birth. We analysed skeletal muscle and heart muscle tissues of Tk2 knockout mice at postnatal development phase and observed that TK2 deficient pups grew slower and their skeletal muscles appeared significantly underdeveloped, whereas heart was close to normal in size. Both tissues showed mtDNA depletion and mitochondria with altered ultrastructure, as revealed by transmission electron microscopy. Gene expression microarray analysis showed a strong down-regulation of genes involved in cell cycle and cell proliferation in both tissues, suggesting a lower pool of undifferentiated proliferating cells. Analysis of isolated primary myoblasts from Tk2 knockout mice showed slow proliferation, less ability to differentiate and signs of premature senescence, even in absence of mtDNA depletion. Our data demonstrate that TK2 deficiency disturbs myogenic progenitor cells function in postnatal skeletal muscle and we propose this as one of the causes of underdeveloped phenotype and myopathic characteristic of the TK2 deficient mice, in addition to the progressive mtDNA depletion, mitochondrial damage and respiratory chain deficiency in post-mitotic differentiated tissue.
C1 [Paredes, Joao A.; Zhou, Xiaoshan; Karlsson, Anna] Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden.
   [Hoglund, Stefan] Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital; Uppsala University
RP Paredes, JA (corresponding author), Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden.
EM joao.paredes@ki.se
FU Swedish Cancer Society; Swedish Research Council; Karolinska Institute; board of research at the Karolinska Institute; research committee at the Karolinska hospital
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   BERK AJ, 1973, J BIOL CHEM, V248, P2722
   BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
   Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Dimri GP, 1996, MOL CELL BIOL, V16, P2987
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Dou QP, 1996, PROG NUCLEIC ACID RE, V53, P197, DOI 10.1016/S0079-6603(08)60145-2
   DOU QP, 1994, J BIOL CHEM, V269, P1306
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C
   Gurer C, 2005, J VIROL, V79, P5557, DOI 10.1128/JVI.79.9.5557-5567.2005
   Höglund S, 2002, ANTIMICROB AGENTS CH, V46, P3597, DOI 10.1128/AAC.46.11.3597-3605.2002
   Huang DY, 2001, BIOCHEM J, V356, P829, DOI 10.1042/0264-6021:3560829
   Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200
   Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209
   Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163
   Machida N, 1997, J MOL CELL CARDIOL, V29, P1895, DOI 10.1006/jmcc.1997.0427
   MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McGeachie JK, 1999, J ANAT, V194, P287, DOI 10.1046/j.1469-7580.1999.19420287.x
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352
   Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877
   PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Rumyantsev P P, 1977, INT REV CYTOL, V51, P186
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097
   Shamir R, 2005, BMC BIOINFORMATICS, V6, P0, DOI 10.1186/1471-2105-6-232
   Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425
   Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835
   Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, PH220, DOI 10.1152/ajpheart.1997.272.1.H220
   Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15
   Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, PR1271, DOI 10.1152/ajpregu.00472.2006
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230
   Villarroya J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029691
   Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145
   Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359
   White RB, 2010, BMC DEV BIOL, V10, P0, DOI 10.1186/1471-213X-10-21
   ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 62
TC 7
Z9 7
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JAN 14
PY 2013
VL 8
IS 1
BP 
EP 
DI 10.1371/journal.pone.0053698
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 087KE
UT WOS:000314759400069
PM 23341978
DA 2024-11-01
ER

PT J
AU Buda, P
   Piekutowska-Abramczuk, D
   Karkucinska-Wieckowska, A
   Jurkiewicz, E
   Chelstowska, S
   Pajdowska, M
   Migdal, M
   Ksiazyk, J
   Kotulska, K
   Pronicka, E
AF Buda, Piotr
   Piekutowska-Abramczuk, Dorota
   Karkucinska-Wieckowska, Agnieszka
   Jurkiewicz, Elzbieta
   Chelstowska, Sylwia
   Pajdowska, Magdalena
   Migdal, Marek
   Ksiazyk, Janusz
   Kotulska, Katarzyna
   Pronicka, Ewa
TI "Drop attacks" as first clinical symptoms in a child carrying MTTK m.8344A&gt;G mutation
SO FOLIA NEUROPATHOLOGICA
LA English
DT Article
DE Leigh syndrome; MERRF mutation; pyruvate dehydrogenase dysfunction; ketogenic diet
ID leigh-syndrome; a8344g mutation; merrf; deficiency; features
AB We describe a child with dyslexia and difficulty in school who, at the age of 13 years, began to suffer from several head injuries resulting from falls of uncertain cause. Two years later, the patient developed symptoms of a severe mitochondria, disorder (involving bulbar-pyramidal paralysis, ophthalmoplegia, and hyperlactatemia) that coincided with VPA administration. Brain MR imaging revealed rapidly developing Leigh syndrome (LS), and muscle biopsy showed ragged blue fibres (RBF). A diminished expression of the E1 alpha subunit of pyruvate dehydrogenase was found in muscle homogenate (signal 28.7% of normal). The accurate diagnosis of mitochondrially inherited LS (MILS) and the identification of an almost homoplasmic m.8344G>A mutation in the MTTK gene was delayed due to an initial incorrect diagnosis of epilepsy, misdiagnosis of neuroinfection, and failure to note LS on the first brain MRI. Periods of exacerbation or improvement were observed in association with the administration of certain drugs or procedures (VPA administration or intensive rehabilitation associated with worsening; ketogenic diet associated with remission). However, the random association of these factors with natural disease fluctuations cannot be excluded. Conclusions: 1) To improve the early detection of mitochondrial disorder, we recommend screening for mtDNA (and nDNA) mutations in all patients with LS present on brain MRI. 2) Brain MRI protocols should include diffusion-weighted and T2-weighted imaging, and LS-like changes should be analysed by a neuro radiologist experienced in the field. 3) Additional controlled studies are urgently needed to assess the causal relationship between management strategies and the natural history of the disease. Until the association between VPA and disease exacerbation can be ruled out, VPA should be avoided in patients with these symptoms unless the mitochondria( disorder has been excluded.
C1 [Buda, Piotr; Ksiazyk, Janusz] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, PL-04730 Warsaw, Poland.
   [Piekutowska-Abramczuk, Dorota; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Karkucinska-Wieckowska, Agnieszka] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland.
   [Jurkiewicz, Elzbieta; Chelstowska, Sylwia] Childrens Mem Hlth Inst, Dept Radiol, MR Unit, PL-04730 Warsaw, Poland.
   [Pajdowska, Magdalena] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, PL-04730 Warsaw, Poland.
   [Migdal, Marek] Childrens Mem Hlth Inst, Dept Anaesthesia & Intens Care, PL-04730 Warsaw, Poland.
   [Kotulska, Katarzyna] Childrens Mem Hlth Inst, Dept Child Neurol & Epileptol, PL-04730 Warsaw, Poland.
C3 Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute
RP Kotulska, K (corresponding author), Childrens Mem Hlth Inst, Dept Child Neurol & Epileptol, Al Dzieci Polskich, PL-04730 Warsaw, Poland.
EM k.kotulska@czd.pl
FU Children's Memorial Health Institute for young researchers [M2/2012]
CR Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Koene S, 2011, J INHERIT METAB DIS, V34, P315, DOI 10.1007/s10545-010-9162-y
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Piekutowska-Abramczuk D, 2008, NEUROL NEUROCHIR POL, V42, P238
   Piekutowska-Abramczuk D, 2009, EUR J PAEDIATR NEURO, V13, P146, DOI 10.1016/j.ejpn.2008.03.009
   Pronicka E, 2001, J INHERIT METAB DIS, V24, P707, DOI 10.1023/A:1012937204315
   Pronicka E, 2011, MED SCI MONITOR, V17, PCR203, DOI 10.12659/MSM.881716
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Swiderska N, 2010, J CHILD NEUROL, V25, P782, DOI 10.1177/0883073809347594
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Wexler ID, 1997, NEUROLOGY, V49, P1655, DOI 10.1212/WNL.49.6.1655
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
NR 19
TC 8
Z9 8
U1 0
U2 6
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA KLEEBERGA ST 2, POZNAN, 61-615, POLAND
SN 1641-4640
EI 1509-572X
J9 FOLIA NEUROPATHOL
JI Folia Neuropathol.
PD JUN 15
PY 2013
VL 51
IS 4
BP 347
EP 354
DI 10.5114/fn.2013.39726
PG 8
WC Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 288FW
UT WOS:000329598400010
PM 24374964
DA 2024-11-01
ER

PT J
AU Kornblum, C
   Nicholls, TJ
   Haack, TB
   Schöler, S
   Peeva, V
   Danhauser, K
   Hallmann, K
   Zsurka, G
   Rorbach, J
   Iuso, A
   Wieland, T
   Sciacco, M
   Ronchi, D
   Comi, GP
   Moggio, M
   Quinzii, CM
   DiMauro, S
   Calvo, SE
   Mootha, VK
   Klopstock, T
   Strom, TM
   Meitinger, T
   Minczuk, M
   Kunz, WS
   Prokisch, H
AF Kornblum, Cornelia
   Nicholls, Thomas J.
   Haack, Tobias B.
   Schoeler, Susanne
   Peeva, Viktoriya
   Danhauser, Katharina
   Hallmann, Kerstin
   Zsurka, Gabor
   Rorbach, Joanna
   Iuso, Arcangela
   Wieland, Thomas
   Sciacco, Monica
   Ronchi, Dario
   Comi, Giacomo P.
   Moggio, Maurizio
   Quinzii, Catarina M.
   DiMauro, Salvatore
   Calvo, Sarah E.
   Mootha, Vamsi K.
   Klopstock, Thomas
   Strom, Tim M.
   Meitinger, Thomas
   Minczuk, Michal
   Kunz, Wolfram S.
   Prokisch, Holger
TI Loss-of-function mutations in <i>MGME1</i> impair mtDNA replication and cause multisystemic mitochondrial disease
SO NATURE GENETICS
LA English
DT Article
ID human dna2; deficiency; depletion; protein; gene; polg; twinkle; kinase; repair
AB Known disease mechanisms in mitochondria! DNA (mtDNA) maintenance disorders alter either the mitochondrial replication machinery (POLG, POLG2 and C10orf2)(1-3) or the biosynthesis pathways of deoxyribonucleoside 5'-triphosphates for mtDNA synthesis(4-11). However, in many of these disorders, the underlying genetic defect has yet to be discovered. Here, we identify homozygous nonsense and missense mutations in the orphan gene C20orf72 in three families with a mitochondrial syndrome characterized by external ophthalmoplegia, emaciation and respiratory failure. Muscle biopsies showed mtDNA depletion and multiple mtDNA deletions. C20orf72, hereafter MGME1 (mitochondrial genome maintenance exonuclease 1), encodes a mitochondria! RecB-type exonuclease belonging to the PD-(D/E)XK nuclease superfamily. We show that MGME1 cleaves single-stranded DNA and processes DNA flap substrates. Fibroblasts from affected individuals do not repopulate after chemically induced mtDNA depletion. They also accumulate intermediates of stalled replication and show increased levels of 7S DNA, as do MGME1-depleted cells. Thus, we show that MGME1-mediated mtDNA processing is essential for mitochondrial genome maintenance.
C1 [Kornblum, Cornelia] Univ Bonn, Dept Neurol, Med Ctr, Bonn, Germany.
   [Nicholls, Thomas J.; Rorbach, Joanna; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge, England.
   [Haack, Tobias B.; Danhauser, Katharina; Iuso, Arcangela; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany.
   [Haack, Tobias B.; Danhauser, Katharina; Iuso, Arcangela; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Munich, Germany.
   [Schoeler, Susanne; Peeva, Viktoriya; Hallmann, Kerstin; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany.
   [Schoeler, Susanne; Peeva, Viktoriya; Hallmann, Kerstin; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Life & Brain Ctr, Bonn, Germany.
   [Sciacco, Monica; Moggio, Maurizio] Univ Milan, Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Neuromuscular Unit, Osped Maggiore Policlin,Ctr Dino Ferrari, Milan, Italy.
   [Ronchi, Dario; Comi, Giacomo P.] Univ Milan, Fdn IRCCS Ca Granda, Neurol Unit, Osped Maggiore Policlin,Ctr Dino Ferrari, Milan, Italy.
   [Quinzii, Catarina M.; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol & Med, Boston, MA 02114 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA.
   [Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
C3 University of Bonn; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Bonn; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Munich
RP Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge, England.
EM michal.minczuk@mrc-mbu.cam.ac.uk; wolfram.kunz@ukb.uni-bonn.de
FU Medical Research Council UK; German Bundesministerium fur Bildung und Forschung (BMBF) [SysMBo 0315494A]; E-Rare project GENOMIT [01GM1207]; German Network for mitochondrial disorders (mitoNET) [mitoNET 01GM0862, 01GM1113A, mitoNET 01GM0867, 01GM1113C, mitoNET 01GM0868]; Deutsche Forschungsgemeinschaft [SFB TR3 All, D12]; US National Institutes of Health [GM077465, GM097136]; Associazione Amici del Centro Dino Ferrari; University of Milan; Telethon project [GTB07001ER]; Eurobiobank project [QLTR-2001-02769]; Criobanca Automatizzata di Materiale Biologico [R.F.02.187]; MRC [MC_U105697135] Funding Source: UKRI
CR Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 28
TC 171
Z9 184
U1 3
U2 30
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD FEB 15
PY 2013
VL 45
IS 2
BP 214
EP 219
DI 10.1038/ng.2501
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 081PB
UT WOS:000314333000019
PM 23313956
DA 2024-11-01
ER

PT J
AU Guitart, T
   Picchioni, D
   Pineyro, D
   de Pouplana, LR
AF Guitart, Tanit
   Picchioni, Daria
   Pineyro, David
   Ribas de Pouplana, Lluis
TI Human mitochondrial disease-like symptoms caused by a reduced tRNA aminoacylation activity in flies
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID transfer rnaleu(uur) gene; dna mutation; synthetase mutations; lactic-acidosis; transmitochondrial mice; point mutation; brain-stem; drosophila; myopathy; mtdna
AB The translation of genes encoded in the mitochondrial genome requires specific machinery that functions in the organelle. Among the many mutations linked to human disease that affect mitochondrial translation, several are localized to nuclear genes coding for mitochondrial aminoacyl-transfer RNA synthetases. The molecular significance of these mutations is poorly understood, but it is expected to be similar to that of the mutations affecting mitochondrial transfer RNAs. To better understand the molecular features of diseases caused by these mutations, and to improve their diagnosis and therapeutics, we have constructed a Drosophila melanogaster model disrupting the mitochondrial seryl-tRNA synthetase by RNA interference. At the molecular level, the knockdown generates a reduction in transfer RNA serylation, which correlates with the severity of the phenotype observed. The silencing compromises viability, longevity, motility and tissue development. At the cellular level, the knockdown alters mitochondrial morphology, biogenesis and function, and induces lactic acidosis and reactive oxygen species accumulation. We report that administration of antioxidant compounds has a palliative effect of some of these phenotypes. In conclusion, the fly model generated in this work reproduces typical characteristics of pathologies caused by mutations in the mitochondrial aminoacylation system, and can be useful to assess therapeutic approaches.
C1 [Guitart, Tanit; Picchioni, Daria; Pineyro, David; Ribas de Pouplana, Lluis] Inst Res Biomed IRB Barcelona, Gene Translat Lab, Barcelona 08028, Catalonia, Spain.
   [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Catalonia, Spain.
C3 Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA
RP de Pouplana, LR (corresponding author), Inst Res Biomed IRB Barcelona, Gene Translat Lab, C Baldiri Reixac 10, Barcelona 08028, Catalonia, Spain.
EM lluis.ribas@irbbarcelona.org
FU Spanish Ministry of Economy and Innovation [BIO2012-32200, BIO2013-09776]; Government of Catalonia [FI-DGR 2011]; ICREA Funding Source: Custom
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36
   Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527
   Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Butow R A, 1996, METHODS ENZYMOL, V264, P265, DOI 10.1016/S0076-6879(96)64026-9
   Cardaioli E, 2006, NEUROMUSCULAR DISORD, V16, P26, DOI 10.1016/j.nmd.2005.11.001
   Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h
   Gnaiger E, 2011, MITOPATHWAYS RESP ST, V0, P0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Guitart T, 2010, J BIOL CHEM, V285, P38157, DOI 10.1074/jbc.M110.167486
   Gutmann I, 1974, METHODS OF ENZYMATIC ANALYSIS. L-, V0, P0
   He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3
   Li J, 2008, GENET MOL RES, V7, P1054, DOI 10.4238/vol7-4gmr480
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   MITA S, 1995, MUSCLE NERVE, V0, PS113
   Motley WW, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002399
   Ogasawara E, 2010, HUM MOL GENET, V19, P3179, DOI 10.1093/hmg/ddq228
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Owusu-Ansah E, 2008, NAT PROTOC, V0, P0, DOI DOI 10.1038/nprot.2008.23
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   PHILLIPS RG, 1990, DEVELOPMENT, V110, P105
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11
   Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schrier SA, 2012, DISCOV MED, V13, P143
   Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Storkebaum E, 2009, P NATL ACAD SCI USA, V106, P11782, DOI 10.1073/pnas.0905339106
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Toivonen JM, 2001, GENETICS, V159, P241
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Tuppen HAL, 2012, EUR J HUM GENET, V20, P897, DOI 10.1038/ejhg.2012.44
   Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003
   Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109
   WILHELM ML, 1992, NUCLEIC ACIDS RES, V20, P4106, DOI 10.1093/nar/20.15.4106
   Wong LJC, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.040626
   Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009
NR 69
TC 10
Z9 11
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 15
PY 2013
VL 41
IS 13
BP 6595
EP 6608
DI 10.1093/nar/gkt402
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 192BK
UT WOS:000322458800027
PM 23677612
DA 2024-11-01
ER

PT J
AU Wen, B
   Li, DL
   Shan, JL
   Liu, SP
   Li, W
   Zhao, YY
   Lin, PF
   Zheng, JF
   Li, DN
   Gong, YQ
   Yan, CZ
AF Wen, Bing
   Li, Duoling
   Shan, Jingli
   Liu, Shuping
   Li, Wei
   Zhao, Yuying
   Lin, Pengfei
   Zheng, Jinfan
   Li, Danian
   Gong, Yaoqin
   Yan, Chuanzhu
TI Increased muscle coenzyme Q10 in riboflavin responsive MADD with <i>ETFDH</i> gene mutations due to secondary mitochondrial proliferation
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE ETFDH gene; CoQ10; Riboflavin; Mitochondrion
ID electron-transfer; ppar-alpha; metabolism; ubiquinone; deficiency; enzymes; tissue
AB Multiple acyl-coenzyme A dehydrogenation deficiency (MADD) has a wide range of phenotypic variation ranging from a neonatal lethal form to a mild late-onset form. Our previous data showed that in a group of Chinese patients, a mild type of MADD characterized by myopathy with clinically no other systemic involvement was caused by mutations in electron transfer flavoprotein dehydrogenase (ETFDH) gene, which encodes electron transfer flavoprotein: ubiquinone oxidoreductase (ETF:QO). Coenzyme Q10 (CoQ10), a downstream electron receptor of ETF:QO was first reported deficient in muscle of MADD patients with ETFDH gene mutations. Nevertheless, this result was not confirmed in a recently published study. Therefore to elucidate muscle CoQ10 level in a large group of MADD patients may provide further insight into the pathomechanism and therapeutic strategies. In this study, we found that 34 riboflavin responsive patients with ETFDH gene mutations had an elevated CoQ10 pool in muscle by high performance liquid chromatography (HPLC). However, when CoQ10 levels were normalized to citrate synthase, a marker of mitochondrial mass, there was no significant difference between patients and normal controls. Meanwhile, the increased mitochondrial DNA copy number in muscle also supported that the elevated CoQ10 pool was mainly due to mitochondrial mass proliferation. The expression of CoQ10 biosynthesis genes showed no significant changes whereas genes involved in lipid metabolism, such as PPAR alpha, were marked up regulated. Our results suggested that CoQ10 seems not to be a primary factor in riboflavin responsive MADD and the apparent increase in CoQ10 may be secondary to mitochondrial proliferation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Wen, Bing; Li, Duoling; Shan, Jingli; Liu, Shuping; Li, Wei; Zhao, Yuying; Lin, Pengfei; Zheng, Jinfan; Li, Danian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Brain Sci Res Inst, Jinan 250012, Peoples R China.
   [Wen, Bing; Li, Duoling; Shan, Jingli; Liu, Shuping; Li, Wei; Zhao, Yuying; Lin, Pengfei; Zheng, Jinfan; Li, Danian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Peoples R China.
   [Gong, Yaoqin; Yan, Chuanzhu] Shandong Univ, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Peoples R China.
   [Gong, Yaoqin; Yan, Chuanzhu] Shandong Univ, Inst Med Genet, Sch Med, Jinan 250012, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan 250012, Peoples R China.
EM czyan@yahoo.cn
FU National Natural Science Foundation of China [30970993, 81171182]; Ministry of Health of China
CR Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017
   Aberg F, 1996, CHEM-BIOL INTERACT, V99, P205, DOI 10.1016/0009-2797(95)03670-9
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   Dipple KM, 2001, MOL GENET METAB, V74, P45, DOI 10.1006/mgme.2001.3227
   ERNSTER L, 1992, BIOFACTORS, V3, P241
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Liang WC, 2009, NEUROMUSCULAR DISORD, V19, P212, DOI 10.1016/j.nmd.2009.01.008
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7
   Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799
   Tang PH, 2004, CLIN CHIM ACTA, V341, P173, DOI 10.1016/j.cccn.2003.12.002
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Vockley J, 2008, J INHERIT METAB DIS, V31, P619, DOI 10.1007/s10545-008-1005-8
   Wang ZQ, 2011, J MOL MED, V89, P569, DOI 10.1007/s00109-011-0725-7
   Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007
   Wen B, 2010, J NEUROL NEUROSUR PS, V81, P231, DOI 10.1136/jnnp.2009.176404
   Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002
   Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103
NR 21
TC 24
Z9 27
U1 1
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUN 15
PY 2013
VL 109
IS 2
BP 154
EP 160
DI 10.1016/j.ymgme.2013.04.007
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 163RO
UT WOS:000320354800006
PM 23628458
DA 2024-11-01
ER

PT J
AU Emmanuele, V
   Sotiriou, E
   Rios, PG
   Ganesh, J
   Ichord, R
   Foley, AR
   Akman, HO
   DiMauro, S
AF Emmanuele, Valentina
   Sotiriou, Evangelia
   Rios, Purificacion Gutierrez
   Ganesh, Jaya
   Ichord, Rebecca
   Foley, A. Reghan
   Akman, H. Orhan
   DiMauro, Salvatore
TI A Novel Mutation in the Mitochondrial DNA Cytochrome <i>b</i> Gene (<i>MTCYB</i>) in a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes Syndrome
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE cytochrome b, MTCYB; mtDNA; MELAS, mitochondria
ID complex-iii deficiency; progressive exercise intolerance; stop-codon mutation; respiratory-chain; missense mutation; point mutation; oxidase deficiency; l-arginine; myopathy; disorder
AB Mutations in the mitochondrial DNA cytochrome b gene (MTCYB) have been commonly associated with isolated mitochondrial myopathy and exercise intolerance, rarely with multisystem disorders, and only once with a parkinsonism/mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) overlap syndrome. Here, we describe a novel mutation (m.14864 T > C) in MTCYB in a 15-year-old girl with a clinical history of migraines, epilepsy, sensorimotor neuropathy, and strokelike episodes, a clinical picture reminiscent of MELAS. The mutation, which changes a highly conserved cysteine to arginine at amino acid position 40 of cytochrome b, was heteroplasmic in muscle, blood, fibroblasts, and urinary sediment from the patient but absent in accessible tissues from her asymptomatic mother. This case demonstrates that MTCYB must be included in the already long list of mitochondrial DNA genes that have been associated with the MELAS phenotype.
C1 [Emmanuele, Valentina; Sotiriou, Evangelia; Rios, Purificacion Gutierrez; Akman, H. Orhan; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Emmanuele, Valentina] Univ Genoa, Pediat Clin, IRCCS G Gaslini Inst, Genoa, Italy.
   [Ganesh, Jaya] Childrens Hosp Philadelphia, Sect Metab Dis, Philadelphia, PA 19104 USA.
   [Ichord, Rebecca] Univ Penn, Childrens Hosp Philadelphia, Dept Neurol & Pediat, Philadelphia, PA 19104 USA.
   [Ichord, Rebecca] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Foley, A. Reghan] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.
   [Foley, A. Reghan] Great Ormond St Hosp Sick Children, London, England.
C3 Columbia University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP DiMauro, S (corresponding author), Columbia Univ Coll Phys & Surg, Room 4-424B,630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
FU National Institutes of Health [HD32062]; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia, Spain
CR Andreu AL, 1999, MOL GENET METAB, V67, P49, DOI 10.1006/mgme.1999.2843
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Besch D, 2000, OPHTHALMOLOGE, V97, P27, DOI 10.1007/PL00007105
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Chen J, 2009, J MAGN RESON IMAGING, V29, P282, DOI 10.1002/jmri.21641
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   KENNAWAY N G, 1984, PEDIATRIC RESEARCH, V18, P991, DOI 10.1203/00006450-198418100-00017
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Mourmans J, 1997, J NEUROL SCI, V149, P111, DOI 10.1016/S0022-510X(97)05379-3
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Schnaufer A, 2000, CURR GENET, V37, P234, DOI 10.1007/s002940050525
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Wang J, 2006, NEUROIMAG CLIN N AM, V16, P149, DOI 10.1016/j.nic.2005.10.002
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
NR 36
TC 28
Z9 29
U1 0
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD FEB 15
PY 2013
VL 28
IS 2
BP 236
EP 242
DI 10.1177/0883073812445787
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 075QO
UT WOS:000313901800010
PM 22638077
DA 2024-11-01
ER

PT J
AU Cohen, BH
AF Cohen, Bruce H.
TI Neuromuscular and Systemic Presentations in Adults: diagnoses beyond MERRF and MELAS
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondria; mtDNA; Myopathy; Clinical evaluation; Muscle enzymology; Mitochondrial genetics
ID respiratory-chain disorders; hereditary optic neuropathy; kearns-sayre syndrome; mitochondrial-dna damage; chronic-fatigue-syndrome; ehlers-danlos-syndrome; cytochrome-c-oxidase; stroke-like episodes; diabetes-mellitus; lactic-acidosis
AB Mitochondrial diseases are a diverse group of inherited and acquired disorders that result in inadequate energy production. They can be caused by inheritable genetic mutations, acquired somatic mutations, and exposure to toxins (including some prescription medications). Normal mitochondrial physiology is responsible, in part, for the aging process itself, as free radical production within the mitochondria results in a lifetime burden of oxidative damage to DNA, especially the mitochondrial DNA that, in turn, replicate the mutational burden in future copies of itself, and lipid membranes. Primary mitochondrial diseases are those caused by mutations in genes that encode for mitochondrial structural and enzymatic proteins, and those proteins required for mitochondrial assembly and maintenance. A number of common adult maladies are associated with defective mitochondrial energy production and function, including diabetes, obesity, hyperthyroidism, hypothyroidism, and hyperlipidemia. Mitochondrial dysfunction has been demonstrated in many neurodegenerative disorders, including Alzheimer's disease, Parkinson disease, amyotrophic lateral sclerosis, and some cancers. Polymorphisms in mitochondrial DNA have been linked to disease susceptibility, including death from sepsis and survival after head injury. There is considerable overlap in symptoms caused by primary mitochondrial diseases and those illnesses that affect mitochondrial function, but are not caused by primary mutations, as well as disorders that mimic mitochondrial diseases, but are caused by other identified mutations. Evaluation of these disorders is complex, expensive, and not without false-negative and false-positive results that can mislead the physician. Most of the common heritable mitochondrial disorders have been well-described in the literature, but can be overlooked by many clinicians if they are uneducated about these disorders. In general, the evaluation of the classic mitochondrial disorders has become straightforward if the clinician recognized the phenotype and orders appropriate confirmatory testing. However, the majority of patients referred for a mitochondrial evaluation do not have a clear presentation that allows for rapid identification and testing. This article provides introductory comments on mitochondrial structure, physiology, and genetics, but will focus on the presentation and evaluation of adults with mitochondrial symptoms, but who may not have a primary mitochondrial disease.
C1 Childrens Hosp Med Ctr Akron, NeuroDev Sci Ctr, Akron, OH 44308 USA.
RP Cohen, BH (corresponding author), Childrens Hosp Med Ctr Akron, NeuroDev Sci Ctr, 215 West Bowery St,Suite 4400, Akron, OH 44308 USA.
EM bcohen@chmca.org
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 1987, N ENGL J MED, V317, P493
   Ballana E, 2006, BIOCHEM BIOPH RES CO, V341, P950, DOI 10.1016/j.bbrc.2006.01.049
   Barbeau A, 1996, S PROGR MUSK DYSTR B, V0, P102
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bindoff L, 2006, MITOCHONDRIAL MEDICINE, V0, P143
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bird TD, 1998, GENEREVIEWS, V0, P0
   Celletti C, 2012, RES DEV DISABIL, V33, P1914, DOI 10.1016/j.ridd.2012.06.018
   Chalmers RM, 1999, BBA-BIOENERGETICS, V1410, P147, DOI 10.1016/S0005-2728(98)00163-7
   CHEN CM, 1995, EUR NEUROL, V35, P281, DOI 10.1159/000117150
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooper J M, 1994, MITOCHONDRIAL DISORDERS IN NEUROLOGY, V0, P1
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   DiMauro S, 1997, MOL GENETIC BASIS NE, V0, P201
   DiMauro S, 2006, MITOCHONDRIAL MEDICINE, V0, P7
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Fischel-Ghodsian N, 1998, P SOC EXP BIOL MED, V218, P1
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Gerrits KHL, 2013, MUSCLE NERVE, V47, P96, DOI 10.1002/mus.23482
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Goto Y, 1990, NATURE, V348, P653
   Griggs RC, 1999, NEW ENGL J MED, V341, P1077, DOI 10.1056/NEJM199909303411411
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hammans SR, 1994, MITOCHONDRIAL DISORD, V0, P1
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirano M, 2006, MITOCHONDRIAL MEDICINE, V0, P27
   Huang CC, 1999, ACTA NEUROL SCAND, V99, P125, DOI 10.1111/j.1600-0404.1999.tb00670.x
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Jacobs HT, 1997, ANN MED, V29, P483, DOI 10.3109/07853899709007472
   Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001
   KENNY D, 1990, AM HEART J, V120, P440, DOI 10.1016/0002-8703(90)90097-H
   Kerrison JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P298
   KURATSUNE H, 1994, CLIN INFECT DIS S1, V18, P62
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   LIETMAN PS, 1971, MOL PHARMACOL, V7, P122
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mashima Y, 1996, CLIN GENET, V50, P535
   Matsuzaki M, 2002, NEUROPEDIATRICS, V33, P271, DOI 10.1055/s-2002-36742
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Michot C, 2012, J INHERIT METAB DIS, V35, P1119, DOI 10.1007/s10545-012-9461-6
   Morris AAM, 1999, LIVER, V19, P357, DOI 10.1111/j.1478-3231.1999.tb00063.x
   Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Odawara M, 1996, ANN NY ACAD SCI, V786, P72, DOI 10.1111/j.1749-6632.1996.tb39053.x
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PEYRONNARD JM, 1980, ANN NEUROL, V7, P262, DOI 10.1002/ana.410070310
   PLIOPLYS AV, 1995, NEUROPSYCHOBIOLOGY, V32, P132, DOI 10.1159/000119226
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   QUADE A, 1992, CLIN INVESTIGATOR, V70, P396
   Quinlivan R, 2012, DEV MED CHILD NEUROL, V54, P886, DOI 10.1111/j.1469-8749.2012.04320.x
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Schon EA, 1994, MITOCHONDRIAL DNA AND THE GENETICS OF MITOCHONDRIAL DISEASE, V0, P31
   Schrier SA, 2011, CURR OPIN OPHTHALMOL, V22, P325, DOI 10.1097/ICU.0b013e328349419d
   Serviddio G, 2011, EXPERT REV GASTROENT, V5, P233, DOI 10.1586/EGH.11.11
   Shoffner JM, 1995, METABOLIC MOL BASES, V7th, P1535
   Sitarz KS, 2012, CURR NEUROL NEUROSCI, V12, P308, DOI 10.1007/s11910-012-0260-0
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Smits B, 2011, MITOCHONDRION, V11, P735, DOI 10.1016/j.mito.2011.05.005
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095
   Vial G, 2010, ACTA BIOCHIM POL, V57, P389
   Voermans NC, 2009, ANN NEUROL, V65, P687, DOI 10.1002/ana.21643
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wallace D C, 1997, THE MOLECULAR AND GENETIC BASIS OF NEUROLOGICAL DISEASE, V0, P237
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wenning GK, 2009, J NEUROL, V256, P1791, DOI 10.1007/s00415-009-5173-8
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   YANG CY, 1995, CLIN ENDOCRINOL, V43, P235, DOI 10.1111/j.1365-2265.1995.tb01922.x
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001
NR 91
TC 21
Z9 24
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD APR 15
PY 2013
VL 10
IS 2
BP 227
EP 242
DI 10.1007/s13311-013-0188-3
PG 16
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 127EC
UT WOS:000317677900005
PM 23549648
DA 2024-11-01
ER

PT J
AU Cherry, ABC
   Gagne, KE
   Mcloughlin, EM
   Baccei, A
   Gorman, B
   Hartung, O
   Miller, JD
   Zhang, J
   Zon, RL
   Ince, TA
   Neufeld, EJ
   Lerou, PH
   Fleming, MD
   Daley, GQ
   Agarwal, S
AF Cherry, Anne B. C.
   Gagne, Katelyn E.
   Mcloughlin, Erin M.
   Baccei, Anna
   Gorman, Bryan
   Hartung, Odelya
   Miller, Justine D.
   Zhang, Jin
   Zon, Rebecca L.
   Ince, Tan A.
   Neufeld, Ellis J.
   Lerou, Paul H.
   Fleming, Mark D.
   Daley, George Q.
   Agarwal, Suneet
TI Induced Pluripotent Stem Cells with a Mitochondrial DNA Deletion
SO STEM CELLS
LA English
DT Article
DE Induced pluripotent stem cells; Pearson's marrow pancreas syndrome; Mitochondrial DNA; Heteroplasmy; Human genetics; Hematopoiesis
ID mutation; mtdna; fibroblasts; generation; genetics; patient; muscle
AB In congenital mitochondrial DNA (mtDNA) disorders, a mixture of normal and mutated mtDNA (termed heteroplasmy) exists at varying levels in different tissues, which determines the severity and phenotypic expression of disease. Pearson marrow pancreas syndrome (PS) is a congenital bone marrow failure disorder caused by heteroplasmic deletions in mtDNA. The cause of the hematopoietic failure in PS is unknown, and adequate cellular and animal models are lacking. Induced pluripotent stem (iPS) cells are particularly amenable for studying mtDNA disorders, as cytoplasmic genetic material is retained during direct reprogramming. Here, we derive and characterize iPS cells from a patient with PS. Taking advantage of the tendency for heteroplasmy to change with cell passage, we isolated isogenic PS-iPS cells without detectable levels of deleted mtDNA. We found that PS-iPS cells carrying a high burden of deleted mtDNA displayed differences in growth, mitochondrial function, and hematopoietic phenotype when differentiated in vitro, compared to isogenic iPS cells without deleted mtDNA. Our results demonstrate that reprogramming somatic cells from patients with mtDNA disorders can yield pluripotent stem cells with varying burdens of heteroplasmy that might be useful in the study and treatment of mitochondrial diseases. STEM CELLS2013;31:1287-1297
C1 [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Neufeld, Ellis J.; Daley, George Q.; Agarwal, Suneet] Boston Childrens Hosp, Stem Cell Transplantat Program, Div Hematol Oncol, Boston, MA USA.
   [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Daley, George Q.; Agarwal, Suneet] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.
   [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Daley, George Q.; Agarwal, Suneet] Harvard Stem Cell Inst, Cambridge, MA USA.
   [Cherry, Anne B. C.; Gagne, Katelyn E.; Mcloughlin, Erin M.; Hartung, Odelya; Miller, Justine D.; Zhang, Jin; Zon, Rebecca L.; Daley, George Q.; Agarwal, Suneet] Manton Ctr Orphan Dis Res, Boston, MA USA.
   [Cherry, Anne B. C.; Mcloughlin, Erin M.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   [Cherry, Anne B. C.; Mcloughlin, Erin M.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Boston Childrens Hosp, Dept Newborn Med, Boston, MA USA.
   [Baccei, Anna; Gorman, Bryan; Lerou, Paul H.] Harvard Univ, Sch Med, Boston, MA USA.
   [Ince, Tan A.] Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Dept Pathol, Miami, FL 33136 USA.
   [Ince, Tan A.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA.
   [Fleming, Mark D.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA.
C3 Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Miami; University of Miami; Harvard University; Boston Children's Hospital
RP Agarwal, S (corresponding author), 3 Blackfan Circle,CLS 3002, Boston, MA 02115 USA.
EM george.daley@childrens.harvard.edu; suneet.agarwal@childrens.harvard.edu
FU National Heart, Lung, and Blood Institute [U01 HL100001]; Progenitor Cell Biology Consortium; Manton Center for Orphan Disease Research;  [K08 HL089150]
CR Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7
   Cerdan C, 2007, CURR PROTOC STEM CEL, V0, P0, DOI DOI 10.3324/haematol.12594
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Cock HR, 1998, ANN NEUROL, V44, P187, DOI 10.1002/ana.410440208
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105
   Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177
   Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92
   Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   ROTIG A, 1989, LANCET, V1, P902
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Shoubridge E A, 2000, HUM REPROD, V15 Suppl 2, P229
   SIMONSZ HJ, 1992, DOC OPHTHALMOL, V82, P73, DOI 10.1007/BF00156996
   Swerdlow RH, 2002, ARCH PATHOL LAB MED, V126, P271
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   vandeCorput MPC, 1997, J HISTOCHEM CYTOCHEM, V45, P55
   Varum S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020914
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weber K, 1997, AM J HUM GENET, V60, P373
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
NR 33
TC 78
Z9 84
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD JUL 15
PY 2013
VL 31
IS 7
BP 1287
EP 1297
DI 10.1002/stem.1354
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 176XB
UT WOS:000321339000008
PM 23400930
DA 2024-11-01
ER

PT J
AU Lee, IC
   Lee, NC
   Lu, JJ
   Su, PH
AF Lee, Inn-Chi
   Lee, Ni-Chung
   Lu, Jang-Jih
   Su, Pen-Hua
TI Mitochondrial Depletion Causes Neonatal-Onset Leigh Syndrome, Myopathy, and Renal Tubulopathy
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial depletion; Leigh syndrome; newborn; myopathy; renal tubulopathy
ID cytochrome-c-oxidase; surf1 gene-mutations; dna depletion; sucla2 mutations; cox deficiency; encephalomyopathy; hypertrichosis; disease; rrm2b
AB The authors describe a newborn with postnatal myopathy who subsequently developed feeding difficulties, ophthalmoplegia, ptosis, encephalopathy, and seizures. She became ventilator dependent after sudden apnea. The myopathy was without ragged red fibers in the muscle biopsy. An electron transport chain study showed a markedly generalized low level of enzyme activity, particularly in complexes I, I + III, and IV. An initial electroencephalogram finding was normal; subsequent electroencephalograms showed suppression bursts. The mitochondrial copy number in skeletal muscle was 2% of normal.
C1 [Lee, Inn-Chi; Su, Pen-Hua] Chung Shan Med Univ Hosp, Dept Pediat, Taichung 402, Taiwan.
   [Lee, Inn-Chi; Su, Pen-Hua] Chung Shan Med Univ, Inst Med, Sch Med, Taichung, Taiwan.
   [Lee, Ni-Chung] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan.
   [Lu, Jang-Jih] Linkou Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan.
C3 Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital
RP Lee, IC (corresponding author), Chung Shan Med Univ Hosp, Dept Pediat, 0 Chien Kuo N Rd,Sec 1, Taichung 402, Taiwan.
EM y610@mercury.csmu.edu.tw
FU National Taiwan University Hospital, Taipei, Taiwan [99-N1440]
CR Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Dahl H-HM, 1992, HUMAN MUTATION, V1, P97, DOI 10.1002/humu.1380010203
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Ostergaard E, 2005, AM J MED GENET A, V138A, P384, DOI 10.1002/ajmg.a.30972
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Williams SL, 2001, MOL GENET METAB, V73, P340, DOI 10.1006/mgme.2001.3206
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yüksel A, 2006, PEDIATR NEUROL, V34, P486, DOI 10.1016/j.pediatrneurol.2005.10.020
   Zeviani M, 2001, CURR OPIN NEUROL, V14, P553, DOI 10.1097/00019052-200110000-00002
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 24
TC 6
Z9 8
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR 15
PY 2013
VL 28
IS 3
BP 404
EP 408
DI 10.1177/0883073812469722
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 127ER
UT WOS:000317680100018
PM 23307888
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, C
   Smith, FE
   Firbank, MJ
   Guthrie, G
   Guthrie, S
   Gorman, GS
   Taylor, RW
   Turnbull, DM
   Griffiths, PG
   Blamire, AM
   Chinnery, PF
   Yu-Wai-Man, P
AF Yu-Wai-Man, Cynthia
   Smith, Fiona E.
   Firbank, Michael J.
   Guthrie, Grant
   Guthrie, Stuart
   Gorman, Grainne S.
   Taylor, Robert W.
   Turnbull, Douglass M.
   Griffiths, Philip G.
   Blamire, Andrew M.
   Chinnery, Patrick F.
   Yu-Wai-Man, Patrick
TI Extraocular Muscle Atrophy and Central Nervous System Involvement in Chronic Progressive External Ophthalmoplegia
SO PLOS ONE
LA English
DT Article
ID mitochondrial disease; mr; mutations; myopathy; spectrum; brain
AB Background: Chronic progressive external ophthalmoplegia (CPEO) is a classical mitochondrial ocular disorder characterised by bilateral progressive ptosis and ophthalmoplegia. These ocular features can develop either in isolation or in association with other prominent neurological deficits (CPEO+). Molecularly, CPEO can be classified into two distinct genetic subgroups depending on whether patients harbour single, large-scale mitochondrial DNA (mtDNA) deletions or multiple mtDNA deletions secondary to a nuclear mutation disrupting mtDNA replication or repair. The aim of this magnetic resonance imaging (MRI) study was to investigate whether the ophthalmoplegia in CPEO is primarily myopathic in origin or whether there is evidence of contributory supranuclear pathway dysfunction. Methods: Ten age-matched normal controls and twenty patients with CPEO were recruited nine patients with single, large-scale mtDNA deletions and eleven patients with multiple mtDNA deletions secondary to mutations in POLG, PEO1, OPA1, and RRM2B. All subjects underwent a standardised brain and orbital MRI protocol, together with proton magnetic resonance spectroscopy in two voxels located within the parietal white matter and the brainstem. Results: There was evidence of significant extraocular muscle atrophy in patients with single or multiple mtDNA deletions compared with controls. There was no significant difference in metabolite concentrations between the patient and control groups in both the parietal white matter and brainstem voxels. Volumetric brain measurements revealed marked cortical and cerebellar atrophy among patients with CPEO+ phenotypes. Conclusion: The results of this study support a primary myopathic aetiology for the progressive limitation of eye movements that develops in CPEO.
C1 [Yu-Wai-Man, Cynthia; Guthrie, Grant; Guthrie, Stuart; Griffiths, Philip G.; Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Firbank, Michael J.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Gorman, Grainne S.; Turnbull, Douglass M.; Chinnery, Patrick F.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Douglass M.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Chinnery, Patrick F.; Yu-Wai-Man, Patrick] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK
RP Yu-Wai-Man, P (corresponding author), Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
EM Patrick.Yu-Wai-Man@ncl.ac.uk
FU Newcastle Joint Research Executive Scientific Committee (JRESC); Medical Research Council (MRC, UK); Wellcome Trust; MRC [MR/K000608/1, G0700718, G1002570, G0701386] Funding Source: UKRI
CR Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   DAROFF RB, 1966, NEUROLOGY, V16, P161, DOI 10.1212/WNL.16.2_Part_1.161
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kapeller P, 1996, J NEUROL SCI, V135, P126, DOI 10.1016/0022-510X(95)00290-I
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Taherian K, 2007, EYE, V21, P639, DOI 10.1038/sj.eye.6702296
   VIVIAN AJ, 1993, EYE, V7, P565, DOI 10.1038/eye.1993.123
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2012, BRIT J OPHTHALMOL, V96, P1536, DOI 10.1136/bjophthalmol-2012-302566
NR 20
TC 20
Z9 20
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD SEP 27
PY 2013
VL 8
IS 9
BP 
EP 
DI 10.1371/journal.pone.0075048
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 228WY
UT WOS:000325223900035
PM 24086434
DA 2024-11-01
ER

PT J
AU Siriwardena, K
   MacKay, N
   Levandovskiy, V
   Blaser, S
   Raiman, J
   Kantor, PF
   Ackerley, C
   Robinson, BH
   Schulze, A
   Cameron, JM
AF Siriwardena, Komudi
   MacKay, Nevena
   Levandovskiy, Valeriy
   Blaser, Susan
   Raiman, Julian
   Kantor, Paul F.
   Ackerley, Cameron
   Robinson, Brian H.
   Schulze, Andreas
   Cameron, Jessie M.
TI Mitochondrial citrate synthase crystals: Novel finding in Sengers syndrome caused by acylglycerol kinase (<i>AGK</i>) mutations
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Sengers syndrome; Mitochondria; Free radicals; Exome sequencing; Acylglycerol kinase
ID complex-i deficiency; oxygen-free radicals; congenital cataract; lipid-peroxidation; lactic-acidosis; protein; cardiolipin; generation; alignment; cardiomyopathy
AB We report on two families with Sengers syndrome and mutations in the acylglycerol kinase gene (AGK). In the first family, two brothers presented with vascular strokes, lactic acidosis, cardiomyopathy and cataracts, abnormal muscle cell histopathology and mitochondrial function. One proband had very abnormal mitochondria with citrate synthase crystals visible in electron micrographs, associated with markedly high citrate synthase activity. Exome sequencing was used to identify mutations in the AGK gene in the index patient. Targeted sequencing confirmed the same homozygous mutation (c.3G>A, p.M1I) in the brother. The second family had four affected members, of which we examined two. They also presented with similar clinical symptoms, but no strokes. Postmortem heart and skeletal muscle tissues showed low complex I, Ill and IV activities in the heart, but normal in the muscle. Skin fibroblasts showed elevated lactate/pyruvate ratios and low complex I + III activity. Targeted sequencing led to identification of a homozygous c.979A>T, p.K327* mutation. AGK is located in the mitochondria and phosphorylates monoacylglycerol and diacylglycerol to lysophosphatidic acid and phosphatidic acid. Disruption of these signaling molecules affects the mitochondria's response to superoxide radicals, resulting in oxidative damage to mitochondrial DNA, lipids and proteins, and stimulation of cellular detoxification pathways. High levels of manganese superoxide dismutase protein were detected in all four affected individuals, consistent with increased free radical damage. Phosphatidic acid is also involved in the synthesis of phospholipids and its loss will result in changes to the lipid composition of the inner mitochondrial membrane. These effects manifest as cataract formation in the eye, respiratory chain dysfunction and cardiac hypertrophy in heart tissue. These two pedigrees confirm that mutation of AGK is responsible for the severe neonatal presentation of Sengers syndrome. The identification of citrate synthase precipitates by electron microscopy and the presence of vascular strokes in two siblings may expand the cellular and clinical phenotype of this disease. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Siriwardena, Komudi; Raiman, Julian; Schulze, Andreas] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Siriwardena, Komudi; Raiman, Julian; Robinson, Brian H.; Schulze, Andreas] Univ Toronto, Toronto, ON M5G 1X8, Canada.
   [MacKay, Nevena; Ackerley, Cameron] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada.
   [Levandovskiy, Valeriy; Robinson, Brian H.; Schulze, Andreas; Cameron, Jessie M.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada.
   [Blaser, Susan] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada.
   [Kantor, Paul F.] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada.
   [Robinson, Brian H.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto
RP Cameron, JM (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM jessie.cameron@sickkids.ca
FU MitoMarch for Kirkland
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36
   Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071
   Badawi R A, 2012, SCOTT MED J, V57, P60, DOI 10.1258/smj.2011.011280
   Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123
   Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152
   CRUYSBERG JRM, 1986, AM J OPHTHALMOL, V102, P740, DOI 10.1016/0002-9394(86)90402-2
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X
   Homer N, 2010, GENOME BIOL, V11, P0, DOI 10.1186/gb-2010-11-10-r99
   Homer N, 2009, PLOS ONE, V4, PA95, DOI 10.1371/journal.pone.0007767
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, PL328, DOI 10.1152/ajplung.90431.2008
   KATSUMATA K, 1994, BIOCHEM BIOPH RES CO, V202, P102, DOI 10.1006/bbrc.1994.1899
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Luo XP, 1997, J CLIN INVEST, V99, P2877, DOI 10.1172/JCI119481
   Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Perry MS, 2008, PEDIATR NEUROL, V39, P113, DOI 10.1016/j.pediatrneurol.2008.05.003
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Pitkanen S, 1996, BIOCHEM MOL MED, V59, P134, DOI 10.1006/bmme.1996.0078
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Pitkanen S, 1996, PEDIATR RES, V39, P513, DOI 10.1203/00006450-199603000-00021
   Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ragan CI, 1987, MITOCHONDRIA PRACTIC, V0, P79
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   RAHA S, 2003, HEART AND METABOLISM, V19, P4
   ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005
   Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003
   Waggoner DW, 2004, J BIOL CHEM, V279, P38228, DOI 10.1074/jbc.M405932200
   WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97
NR 43
TC 27
Z9 29
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JAN 15
PY 2013
VL 108
IS 1
BP 40
EP 50
DI 10.1016/j.ymgme.2012.11.282
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 075BW
UT WOS:000313859800007
PM 23266196
DA 2024-11-01
ER

PT J
AU Eschbach, J
   Sinniger, J
   Bouitbir, J
   Fergani, A
   Schlagowski, AI
   Zoll, J
   Geny, B
   René, F
   Larmet, Y
   Marion, V
   Baloh, RH
   Harms, MB
   Shy, ME
   Messadeq, N
   Weydt, P
   Loeffler, JP
   Ludolph, AC
   Dupuis, L
AF Eschbach, Judith
   Sinniger, Jerome
   Bouitbir, Jamal
   Fergani, Anissa
   Schlagowski, Anna-Isabel
   Zoll, Joffrey
   Geny, Bernard
   Rene, Frederique
   Larmet, Yves
   Marion, Vincent
   Baloh, Robert H.
   Harms, Matthew B.
   Shy, Michael E.
   Messadeq, Nadia
   Weydt, Patrick
   Loeffler, Jean-Philippe
   Ludolph, Albert C.
   Dupuis, Luc
TI Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE Dynein; Spinal muscular atrophy; Motor neuron disease; Charcot-Marie-Tooth disease; Mitochondria; Diabetes
ID marie-tooth-disease; neuronal migration defects; type-2 diabetes-mellitus; cytoplasmic dynein; sensory neuropathy; dna instability; mouse model; axon loss; transport; gene
AB Mutations in the DYNC1H1 gene encoding for dynein heavy chain cause two closely related human motor neuropathies, dominant spinal muscular atrophy with lower extremity predominance (SMA-LED) and axonal Charcot-Marie-Tooth (CMT) disease, and lead to sensory neuropathy and striatal atrophy in mutant mice. Dynein is the molecular motor carrying mitochondria retrogradely on microtubules, yet the consequences of dynein mutations on mitochondrial physiology have not been explored. Here, we show that mouse fibroblasts bearing heterozygous or homozygous point mutation in Dync1h1, similar to human mutations, show profoundly abnormal mitochondrial morphology associated with the loss of mitofusin 1. Furthermore, heterozygous Dync1h1 mutant mice display progressive mitochondrial dysfunction in muscle and mitochondria progressively increase in size and invade sarcomeres. As a likely consequence of systemic mitochondrial dysfunction, Dync1h1 mutant mice develop hyperinsulinemia and hyperglycemia and progress to glucose intolerance with age. Similar defects in mitochondrial morphology and mitofusin levels are observed in fibroblasts from patients with SMA-LED. Last, we show that Dync1h1 mutant fibroblasts show impaired perinuclear clustering of mitochondria in response to mitochondrial uncoupling. Our results show that dynein function is required for the maintenance of mitochondrial morphology and function with aging and suggest that mitochondrial dysfunction contributes to dynein-dependent neurological diseases, such as SMA-LED. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Eschbach, Judith; Sinniger, Jerome; Fergani, Anissa; Rene, Frederique; Larmet, Yves; Loeffler, Jean-Philippe; Dupuis, Luc] INSERM, U1118, F-67085 Strasbourg, France.
   [Eschbach, Judith; Sinniger, Jerome; Fergani, Anissa; Rene, Frederique; Larmet, Yves; Loeffler, Jean-Philippe; Dupuis, Luc] Univ Strasbourg, Fac Med, UMRS1118, F-67085 Strasbourg, France.
   [Eschbach, Judith; Weydt, Patrick; Ludolph, Albert C.; Dupuis, Luc] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany.
   [Bouitbir, Jamal; Schlagowski, Anna-Isabel; Zoll, Joffrey; Geny, Bernard] Univ Strasbourg, Fac Med, EA 3072, F-67085 Strasbourg, France.
   [Bouitbir, Jamal; Schlagowski, Anna-Isabel; Zoll, Joffrey; Geny, Bernard] New Civil Hosp, CHRU Strasbourg, Physiol & Funct Explorat Dept, F-67091 Strasbourg, France.
   [Marion, Vincent] Univ Strasbourg, Lab Physiopathol Syndromes Rares Hereditaires, INSERM, AVENIR,EA3949, F-67085 Strasbourg, France.
   [Baloh, Robert H.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
   [Harms, Matthew B.] Washington Univ, St Louis, MO 63110 USA.
   [Shy, Michael E.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.
   [Messadeq, Nadia] Univ Strasbourg, CNRS, INSERM, IGBMC,UMR7104,U964, F-67500 Illkirch Graffenstaden, France.
C3 Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ulm University; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lorraine; Cedars Sinai Medical Center; Washington University (WUSTL); University of Iowa; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)
RP Dupuis, L (corresponding author), INSERM, Fac Med, U1118, Bat 3,8E Etage,11 Rue Humann, F-67085 Strasbourg, France.
EM ldupuis@unistra.fr
FU Agence Nationale de la Recherche [ANR JCJC Dynemit]; Association pour la recherche sur la SLA et les autres maladies du motoneurone (ARSla); Thierry Latran Foundation; Association pour la recherche et le developpement de moyens de lutte contre les maladies neurodegeneratives (AREMANE); European Community's Health Seventh Framework Programme [259867]; Association francaise de lutte contre les myopathies (AFM); Helmholtz Institute [RNA dysmetabolism in ALS and FTD]; Muscular Dystrophy Association; Charcot Marie Tooth Association; National Institute of Health (NIH) [U54NS065712, NS055980, NS069669]; Mercator Professorship (DFG); contrat d'interface INSERM/AP-HP; Chaire d'excellence INSERM/Universite de Strasbourg; Burroughs Wellcome Fund
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013
   Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   BEAL MF, 1993, J NEUROSCI, V13, P4181
   Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008
   Braunstein KE, 2010, HUM MOL GENET, V19, P4385, DOI 10.1093/hmg/ddq361
   BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105
   Çelik M, 2001, DIABETIC MED, V18, P685, DOI 10.1046/j.1464-5491.2001.00530-2.x
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007
   Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002
   Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314
   Dupuis L, 2009, EXP NEUROL, V215, P146, DOI 10.1016/j.expneurol.2008.09.019
   El-Kadi AM, 2010, J BIOL CHEM, V285, P18627, DOI 10.1074/jbc.M110.129320
   Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004
   Eschbach J, 2011, BBA-MOL BASIS DIS, V1812, P59, DOI 10.1016/j.bbadis.2010.09.009
   Gentil BJ, 2012, FASEB J, V26, P1194, DOI 10.1096/fj.11-196345
   Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129
   Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05
   Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039
   Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105
   Koç F, 2006, INT J NEUROSCI, V116, P103, DOI 10.1080/00207450500341431
   Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039
   Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091
   Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120
   Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ori-McKenney KM, 2011, NEURAL DEV, V6, P0, DOI 10.1186/1749-8104-6-26
   Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127
   Ota T, 2003, DIABETIC MED, V20, P420, DOI 10.1046/j.1464-5491.2003.009173.x
   Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009
   Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257
   Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb
   Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299
   Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002
   Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
NR 51
TC 39
Z9 47
U1 1
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD OCT 15
PY 2013
VL 58
IS 
BP 220
EP 230
DI 10.1016/j.nbd.2013.05.015
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 207GC
UT WOS:000323585900026
PM 23742762
DA 2024-11-01
ER

PT J
AU Kazachkova, N
   Ramos, A
   Santos, C
   Lima, M
AF Kazachkova, Nadiya
   Ramos, Amanda
   Santos, Cristina
   Lima, Manuela
TI Mitochondrial DNA Damage Patterns and Aging: Revising the Evidences for Humans and Mice
SO AGING AND DISEASE
LA English
DT Review
DE aging; mtDNA; damage patterns; deletion; copy number; point mutation
ID mtdna point mutations; human skeletal-muscle; 4977 bp deletion; substantia-nigra; copy number; mouse-tissue; human brain; human heart; age; accumulation
AB A significant body of work, accumulated over the years, strongly suggests that damage in mitochondrial DNA (mtDNA) contributes to aging in humans. Contradictory results, however, are reported in the literature, with some studies failing to provide support to this hypothesis. With the purpose of further understanding the aging process, several models, among which mouse models, have been frequently used. Although important affinities are recognized between humans and mice, differences on what concerns physiological properties, disease pathogenesis as well as life-history exist between the two; the extent to which such differences limit the translation, from mice to humans, of insights on the association between mtDNA damage and aging remains to be established. In this paper we revise the studies that analyze the association between patterns of mtDNA damage and aging, investigating putative alterations in mtDNA copy number as well as accumulation of deletions and of point mutations. Reports from the literature do not allow the establishment of a clear association between mtDNA copy number and age, either in humans or in mice. Further analysis, using a wide spectrum of tissues and a high number of individuals would be necessary to elucidate this pattern. Likewise humans, mice demonstrated a clear pattern of age-dependent and tissue-specific accumulation of mtDNA deletions. Deletions increase with age, and the highest amount of deletions has been observed in brain tissues both in humans and mice. On the other hand, mtDNA point mutations accumulation has been clearly associated with age in humans, but not in mice. Although further studies, using the same methodologies and targeting a larger number of samples would be mandatory to draw definitive conclusions, the revision of the available data raises concerns on the ability of mouse models to mimic the mtDNA damage patterns of humans, a fact with implications not only for the study of the aging process, but also for investigations of other processes in which mtDNA dysfunction is a hallmark, such as neurodegeneration.
C1 [Kazachkova, Nadiya; Ramos, Amanda; Lima, Manuela] Univ Azores, Dept Biol, CIRN, P-9501801 Ponta Delgada, Azores, Portugal.
   [Kazachkova, Nadiya; Ramos, Amanda; Lima, Manuela] Univ Porto, IBMC, P-4100 Oporto, Portugal.
   [Santos, Cristina] Univ Autonoma Barcelona, Unitat Antropol Biol, E-08193 Barcelona, Spain.
C3 Universidade dos Acores; Universidade do Porto; Autonomous University of Barcelona
RP Kazachkova, N (corresponding author), Univ Azores, Dept Biol, CIRN, Rua Mae Deus,Apartado 1422, P-9501801 Ponta Delgada, Azores, Portugal.
EM nadya@uac.pt
CR Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Gomez-Cabrera MC, 2012, CLIN CHEM LAB MED, V50, P1287, DOI 10.1515/cclm-2011-0795
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Dai JG, 2005, J EXP BIOL, V208, P4445, DOI 10.1242/jeb.01920
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Demetrius L, 2006, ANN NY ACAD SCI, V1067, P66, DOI 10.1196/annals.1354.010
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FERRIS SD, 1983, GENETICS, V105, P681
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Gerhard GS, 2002, MECH AGEING DEV, V123, P155, DOI 10.1016/S0047-6374(01)00328-1
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kazachkova N, 2013, NEURODEGENER DIS, V11, P206, DOI 10.1159/000339207
   Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kovalenko SA, 1998, ANN NY ACAD SCI, V854, P171, DOI 10.1111/j.1749-6632.1998.tb09900.x
   Kovalenko SA, 1998, BIOCHEM MOL BIOL INT, V46, P1233
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Medawar PB, 1952, UNSOLVED PROBLEM BIO, V0, P0
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Ross OA, 2002, EXP GERONTOL, V37, P329, DOI 10.1016/S0531-5565(01)00200-5
   Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141
   Scheffler IE, 2008, MITOCHONDRIA, V0, P1
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Song XF, 2005, GENE, V350, P193, DOI 10.1016/j.gene.2005.02.008
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   Takai D, 1995, BIOCHEM BIOPH RES CO, V217, P668, DOI 10.1006/bbrc.1995.2826
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Thèves C, 2006, J FORENSIC SCI, V51, P865, DOI 10.1111/j.1556-4029.2006.00163.x
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1992, BIOCHEM INT, V26, P457
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Zeng ZH, 1999, J CELL BIOCHEM, V73, P545, DOI 10.1002/(SICI)1097-4644(19990615)73:4<545::AID-JCB12>3.0.CO;2-Q
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhang Y, 2007, BIOSENS BIOELECTRON, V23, P438, DOI 10.1016/j.bios.2007.06.010
   Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480
NR 94
TC 46
Z9 59
U1 0
U2 17
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
EI 
J9 AGING DIS
JI Aging Dis.
PD DEC 15
PY 2013
VL 4
IS 6
BP 337
EP 350
DI 10.14336/AD.2013.0400337
PG 14
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA AI5KB
UT WOS:000336903900004
PM 24307967
DA 2024-11-01
ER

PT J
AU Kinghorn, KJ
   Kaliakatsos, M
   Blakely, EL
   Taylor, RW
   Rich, P
   Clarke, A
   Omer, S
AF Kinghorn, K. J.
   Kaliakatsos, M.
   Blakely, E. L.
   Taylor, R. W.
   Rich, P.
   Clarke, A.
   Omer, S.
TI Hypertrophic olivary degeneration on magnetic resonance imaging in mitochondrial syndromes associated with <i>POLG</i> and <i>SURF1</i> mutations
SO JOURNAL OF NEUROLOGY
LA English
DT Review
DE POLG; SURF1; Hypertrophic olivary degeneration; MR imaging; Guillain-Mollaret triangle; Dento-rubro-olivary pathway
ID leigh-syndrome; ataxic neuropathy; palatal tremor; gene-mutations; cox deficiency
AB Hypertrophic olivary degeneration (HOD) is associated with lesions within the dento-rubro-olivary pathway or Guillain-Mollaret triangle and may be associated clinically with palatal tremor. Here we report HOD on brain magnetic resonance (MR) imaging in three patients with progressive mitochondrial syndromes in the absence of palatal tremor. Two of the patients were found to have identical compound heterozygous mutations in the POLG gene, encoding the catalytic subunit of the mitochondrial DNA polymerase-gamma, but presented with different clinical phenotypes. The first patient displayed the clinical syndrome of sensory ataxia, neuropathy, dysarthria, and ophthalmoparesis (SANDO), while the second patient was affected by a neurological disorder consisting of an ophthalmoplegia, myopathy, and neuropathy. The third case was a child with Leigh syndrome due to SURF1 gene mutations, who presented with a generalized tremor. We discuss the brain MR imaging findings in these three cases along with a literature review on the MR features of previously reported cases of patients with POLG gene mutations and Leigh disease due to SURF1 gene mutations. Our findings suggest that the presence of HOD, in the appropriate clinical setting, should alert the clinician to the possibility of a mitochondrial disorder and the need to screen for mutations in POLG and SURF1 genes.
C1 [Kinghorn, K. J.; Omer, S.] St George Hosp, Dept Neurol, London, England.
   [Kaliakatsos, M.; Clarke, A.] St George Hosp, Dept Paediat Neurol, London, England.
   [Blakely, E. L.; Taylor, R. W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Rich, P.] St George Hosp, Dept Neuroradiol, London, England.
C3 City St Georges, University of London; City St Georges, University of London; Newcastle University - UK; City St Georges, University of London
RP Omer, S (corresponding author), St George Hosp, Dept Neurol, London, England.
EM salah.omer@stgeorges.nhs.uk
FU Wellcome Trust Centre for Mitochondrial Research [906919]; UK NHS; MRC [MR/K000608/1] Funding Source: UKRI
CR BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Barkovich AJ, 2005, PEDIAT NEUROIMAGING, V0, P76
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   GAUTIER JC, 1961, BRAIN, V84, P341, DOI 10.1093/brain/84.3.341
   Goyal M, 2000, AM J NEURORADIOL, V21, P1073
   Guillain G, 1931, REV NEUROL PARIS, V2545, P566
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Johansen KK, 2008, MOVEMENT DISORD, V23, P1624, DOI 10.1002/mds.22178
   Komulainen T, 2010, BMC NEUROL, V10, P0, DOI 10.1186/1471-2377-10-29
   Lax N, 2012, MITOCHONDRIAL DYSFUNCTION IN NEURODEGENERATIVE DISORDERS, V0, P21
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Melick NR, 2007, PEDIATR NEUROL, V37, P280, DOI 10.1016/j.pediatrneurol.2007.06.015
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishie M, 2002, BRAIN, V125, P1348, DOI 10.1093/brain/awf126
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Trelles J-O, 1935, THESIS PARIS, V0, P0
   Trelles JO, 1943, REV NEUROPSIQUAT, V6, P433
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Xie S, 2009, CLIN IMAG, V33, P1, DOI 10.1016/j.clinimag.2008.08.001
NR 31
TC 34
Z9 35
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD JAN 15
PY 2013
VL 260
IS 1
BP 3
EP 9
DI 10.1007/s00415-012-6564-9
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA 063NV
UT WOS:000313007600002
PM 22729384
DA 2024-11-01
ER

PT J
AU Eluamai, A
   Brooks, K
AF Eluamai, Anusha
   Brooks, Kelly
TI Effect of aerobic exercise on mitochondrial DNA and aging
SO JOURNAL OF EXERCISE SCIENCE & FITNESS
LA English
DT Review
DE Aerobic exercise; Aging; DNA
ID mtdna; mutations; muscle; deletions; damage
AB The aging process occurs at different rates among different tissues. The complication of the definition of aging is due to the occurrence of various diseases that modify body functions and tissue structure. Advances in medicine and public health have considerably increased life expectancy over the past 200 years. An enormous effort has recently been expended to understand how the aging process is regulated at the molecular and cellular levels with hopes to find a way to extend maximal life span. There are several determinants of life span, but one common thread that has emerged in a variety of species from yeast to rodents is regulation of life span by mitochondria. Mitochondria decay that occurs with age cannot be counteracted unless physical activity is enhanced. As the frontiers of understanding the senescence and life span increases, the countermeasures for reducing aging senescence has brought to light the effectiveness of enhanced physical activities in aging individuals. Regular aerobic exercise may increase healthy life expectance and prolong life through beneficial effects at the mitochondrial level. Copyright (C) 2013, The Society of Chinese Scholars on Exercise Physiology and Fitness. Published by Elsevier (Singapore) Pte Ltd. All rights reserved.
C1 [Eluamai, Anusha; Brooks, Kelly] Texas A&M Univ Corpus Christi, Corpus Christi, TX 78412 USA.
C3 Texas A&M University System; Texas A&M University Corpus Christi
RP Brooks, K (corresponding author), Texas A&M Univ Corpus Christi, 6300 Ocean Dr, Corpus Christi, TX 78412 USA.
EM kelly.brooks@tamucc.edu
CR Aminuddin A, 2011, NEW IRAQI J MED, V7, P52
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bloomer RJ, 2005, J STRENGTH COND RES, V19, P276
   Jafari A, 2005, BRIT J SPORT MED, V39, P517, DOI 10.1136/bjsm.2004.014068
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   LeBlanc PJ, 2004, J PHYSIOL-LONDON, V557, P559, DOI 10.1113/jphysiol.2003.058263
   Lindstedt SL, 2001, J EXP BIOL, V204, P3195
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Marcuello A, 2012, J APPL PHYSIOL, V99, P1372
   Mirzaei B, 2010, S AFR J RES SPORT PH, V32, P99
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Timmons JA, 2012, J APPL PHYSIOL, V108, P1487
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
NR 20
TC 10
Z9 14
U1 1
U2 18
PU ELSEVIER SINGAPORE PTE LTD
PI SINGAPORE
PA 3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE
SN 1728-869X
EI 
J9 J EXERC SCI FIT
JI J. Exerc. Sci. Fit.
PD JUN 15
PY 2013
VL 11
IS 1
BP 1
EP 5
DI 10.1016/j.jesf.2013.03.003
PG 5
WC Sport Sciences
SC Sport Sciences
GA 181RJ
UT WOS:000321685900001
DA 2024-11-01
ER

PT J
AU Fortini, P
   Ferretti, C
   Dogliotti, E
AF Fortini, Paola
   Ferretti, Chiara
   Dogliotti, Eugenia
TI The response to DNA damage during differentiation: Pathways and consequences
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Review
DE DNA repair; DNA damage response; Apoptosis; Autophagy; Cell differentiation; Stem cells
ID embryonic stem-cells; double-strand breaks; nucleotide excision-repair; skeletal-muscle differentiation; homologous recombination; mitochondrial biogenesis; somatic-cells; self-renewal; life-span; cycle
AB Damage to genomic DNA triggers a prompt set of signaling events known as the DNA damage response (DDR) which coordinates DNA repair, cell cycle arrest and ultimately cell death or senescence. Although activation of adequate DNA damage signaling and repair systems depends on the type of lesion and the cell-cycle phase in which it occurs, emerging evidence indicates that DNA repair and DDR function differently in different cellular contexts. Depending on the time maintenance and function of a specific cell type the risk of accumulating DNA damage may vary. For instance, damage to stem cells if not repaired can lead to mutation amplification or propagation through the processes of self-renewal and differentiation, respectively, whereas damage to post-mitotic cells can affect mostly tissue homeostasis. Stem cells are therefore expected to address DNA damage differently from their somatic counterparts. In this review the information available on the common and distinct mechanisms of control of genome integrity utilized by different cell types along the self-renewal/differentiation program will be reviewed, with special emphasis on their roles in the prevention of aging and disease. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Fortini, Paola; Ferretti, Chiara; Dogliotti, Eugenia] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy.
C3 Istituto Superiore di Sanita (ISS)
RP Dogliotti, E (corresponding author), Ist Super Sanita, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.
EM eugenia.dogliotti@iss.it
FU Associazione Italiana per la Ricerca sul Cancro; ISS-NIH
CR Adams Bret R, 2010, AGING (ALBANY NY), V2, P582
   Adams BR, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010001
   Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x
   Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991
   Bai L, 2008, MOL CELL BIOCHEM, V307, P129, DOI 10.1007/s11010-007-9592-5
   Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776
   Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007
   Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276
   Biton S, 2007, DNA REPAIR, V6, P128, DOI 10.1016/j.dnarep.2006.10.019
   Biton S, 2006, J BIOL CHEM, V281, P17482, DOI 10.1074/jbc.M601895200
   Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179
   Bogomazova AN, 2011, AGING-US, V3, P1
   Botrugno OA, 2012, CLIN CANCER RES, V18, P2436, DOI 10.1158/1078-0432.CCR-11-0767
   Boucas Jorge, 2012, FRONTIERS IN GENETICS, V3, P159, DOI 10.3389/fgene.2012.00159
   Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392
   Briegert M, 2007, CANCER RES, V67, P26, DOI 10.1158/0008-5472.CAN-06-3712
   Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199
   Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Cleaver JE, 2012, NAT GENET, V44, P477, DOI 10.1038/ng.2255
   de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53
   Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179
   Frappart PO, 2008, DNA REPAIR, V7, P1051, DOI 10.1016/j.dnarep.2008.03.007
   Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0
   GREEN MHL, 1994, MUTAT RES, V315, P25, DOI 10.1016/0921-8777(94)90024-8
   Groth P, 2012, NUCLEIC ACIDS RES, V40, P6585, DOI 10.1093/nar/gks315
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105
   Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101
   Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424
   Hyka-Nouspikel N, 2011, BLOOD, V117, P6277, DOI 10.1182/blood-2010-12-326637
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064
   Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0
   Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480
   Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398
   Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004
   Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375
   Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211
   Mariño G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001
   Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   Meulle A, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003345
   Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016
   Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Momcilovic O, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013410
   Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123
   Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Naka K, 2011, INT J HEMATOL, V93, P434, DOI 10.1007/s12185-011-0793-z
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006
   Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P965, DOI 10.1007/s00018-009-8734-1
   Nouspikel T, 2006, P NATL ACAD SCI USA, V103, P16188, DOI 10.1073/pnas.0607769103
   Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103
   Pattison JS, 2011, CIRC RES, V109, P151, DOI 10.1161/CIRCRESAHA.110.237339
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542
   Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023
   Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035
   Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721
   Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x
   Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129
   Sherman MH, 2010, MOL CELL, V39, P873, DOI 10.1016/j.molcel.2010.08.019
   Shubassi G, 2012, CANCER RES, V72, P1332, DOI 10.1158/0008-5472.CAN-11-3172
   Simonatto M, 2011, CELL CYCLE, V10, P2355, DOI 10.4161/cc.10.14.15948
   Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228
   Smith MI, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005097
   Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059
   Tanida I, 2006, AUTOPHAGY, V2, P264, DOI 10.4161/auto.2871
   Taylor R, 2011, CURR PHARM DESIGN, V17, P2056, DOI 10.2174/138161211796904768
   Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007
   Tichy ED, 2011, DNA REPAIR, V10, P445, DOI 10.1016/j.dnarep.2011.01.008
   Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058
   Tomashevski A, 2010, CELL DEATH DIFFER, V17, P1189, DOI 10.1038/cdd.2009.221
   Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639
   van der Wees C, 2007, MUTAT RES-FUND MOL M, V614, P16, DOI 10.1016/j.mrfmmm.2006.06.005
   Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276
   Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084
   Vázquez P, 2012, AUTOPHAGY, V8, P187, DOI 10.4161/auto.8.2.18535
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003
   Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173
   Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639
   Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006
   Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106
   Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443
   Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005
   Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914
NR 106
TC 41
Z9 45
U1 0
U2 26
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-1964
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD MAR-APR 15
PY 2013
VL 743
IS 
BP 160
EP 168
DI 10.1016/j.mrfmmm.2013.03.004
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 165JW
UT WOS:000320481200017
PM 23562804
DA 2024-11-01
ER

PT J
AU Chanprasert, S
   Wang, J
   Weng, SW
   Enns, GM
   Boué, DR
   Wong, BL
   Mendell, JR
   Perry, DA
   Sahenk, Z
   Craigen, WJ
   Alcala, FJC
   Pascual, JM
   Melancon, S
   Zhang, VW
   Scaglia, F
   Wong, LJC
AF Chanprasert, Sirisak
   Wang, Jing
   Weng, Shao-Wen
   Enns, Gregory M.
   Boue, Daniel R.
   Wong, Brenda L.
   Mendell, Jerry R.
   Perry, Deborah A.
   Sahenk, Zarife
   Craigen, William J.
   Climent Alcala, Francisco J.
   Pascual, Juan M.
   Melancon, Serge
   Zhang, Victor Wei
   Scaglia, Fernando
   Wong, Lee-Jun C.
TI Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (<i>TK2</i>) gene
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Thymidine kinase 2 gene; Myopathic mtDNA depletion syndrome
ID mtdna depletion; triphosphate pools; replication; deficiency; spectrum; diseases; defect
AB Mitochondrial DNA (mtDNA) depletion syndromes (MDSs) are a clinically and molecularly heterogeneous group of mitochondrial cytopathies characterized by severe mtDNA copy number reduction in affected tissues. Clinically, MDSs are mainly categorized as myopathic, encephalomyopathic, hepatocerebral, or multi-systemic forms. To date, the myopathic form of MDS is mainly caused by mutations in the TK2 gene, which encodes thymidine kinase 2, the first and rate limiting step enzyme in the phosphorylation of pyrimidine nucleosides. We analyzed 9 unrelated families with 11 affected subjects exhibiting the myopathic form of MDS, by sequencing the TK2 gene. Twelve mutations including 4 novel mutations were detected in 9 families. Skeletal muscle specimens were available from 7 out of 11 subjects. Respiratory chain enzymatic activities in skeletal muscle were measured in 6 subjects, and enzymatic activities were reduced in 3 subjects. Quantitative analysis of mtDNA content in skeletal muscle was performed in 5 subjects, and marked mtDNA content reduction was observed in each. In addition, we outline the molecular and clinical characteristics of this syndrome in a total of 52 patients including those previously reported, and a total of 36 TK2 mutations are summarized. Clinically, hypotonia and proximal muscle weakness are the major phenotypes present in all subjects. In summary, our study expands the molecular and clinical spectrum associated with TK2 deficiency. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Chanprasert, Sirisak; Wang, Jing; Weng, Shao-Wen; Craigen, William J.; Zhang, Victor Wei; Scaglia, Fernando; Wong, Lee-Jun C.] Baylor Coll Med, Houston, TX 77030 USA.
   [Weng, Shao-Wen] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Dept Internal Med,Chang Gung Mem Hosp, Kaohsiung, Taiwan.
   [Boue, Daniel R.; Sahenk, Zarife] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.
   [Boue, Daniel R.; Sahenk, Zarife] Nationwide Childrens Hosp, Clin Neuromuscular Lab, Columbus, OH USA.
   [Wong, Brenda L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Neurol, Cincinnati, OH 45229 USA.
   [Mendell, Jerry R.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.
   [Perry, Deborah A.] Childrens Hosp & Med Ctr, Dept Pathol, Omaha, NE USA.
   [Enns, Gregory M.] Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA USA.
   [Pascual, Juan M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Climent Alcala, Francisco J.] Hosp La Paz, Madrid, Spain.
   [Melancon, Serge] McGill Univ, Div Med Genet, Montreal, PQ, Canada.
   [Craigen, William J.; Scaglia, Fernando] Texas Childrens Hosp, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hospital Universitario La Paz; McGill University; Baylor College of Medicine
RP Wong, LJC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BESTWICK RK, 1982, J BIOL CHEM, V257, P9300
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Mikkelsen NE, 2003, BIOCHEMISTRY-US, V42, P5706, DOI 10.1021/bi0340043
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Venegas V, 2011, CURRENT PROTOCOL HUM, V0, P0
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 33
TC 31
Z9 40
U1 0
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT 15
PY 2013
VL 110
IS 1-2
BP 153
EP 161
DI 10.1016/j.ymgme.2013.07.009
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 209ZP
UT WOS:000323799400021
PM 23932787
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Ahting, U
AF Finsterer, Josef
   Ahting, Uwe
TI Mitochondrial Depletion Syndromes in Children and Adults
SO CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
LA English
DT Review
ID progressive external ophthalmoplegia; phosphorylase gene-mutations; recessive twinkle mutations; polymerase gamma deficiency; thymidine kinase-2 gene; dna depletion; mtdna depletion; alpers-syndrome; polg1 mutations; deoxyguanosine kinase
AB To highlight differences between early-onset and adult mitochondrial depletion syndromes (MDS) concerning etiology and genetic background, pathogenesis, phenotype, clinical presentation and their outcome. MDSs most frequently occur in neonates, infants, or juveniles and more rarely in adolescents or adults. Mutated genes phenotypically presenting with adult-onset MDS include POLG1, TK2, TYMP, RRM2B, or PEO1/twinkle. Adult MDS manifest similarly to early-onset MDS, as myopathy, encephalomyopathy, hepato-cerebral syndrome, or with chronic progressive external ophthalmoplegia (CPEO), fatigue, or only minimal muscular manifestations. Diagnostic work-up or treatment is not at variance from early-onset cases. Histological examination of muscle may be normal but biochemical investigations may reveal multiple respiratory chain defects. The outcome appears to be more favorable in adult than in early-onset forms. Mitochondrial depletion syndromes is not only a Condition of neonates, infants, or juveniles but rarely also occurs in adults, presenting with minimal manifestations or manifestations like in the early-onset forms. Outcome of adult-onset MDS appears more favorable than early-onset MDS.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Ahting, Uwe] Tech Univ Munich, Humangenet Lab, D-80290 Munich, Germany.
C3 Rudolfstiftung Hospital; Technical University of Munich
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Cardaioli E, 2010, NEUROL SCI, V31, P491, DOI 10.1007/s10072-010-0225-5
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Douglas GV, 2011, J HUM GENET, V56, P834, DOI 10.1038/jhg.2011.112
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2012, ARCH NEUROL-CHICAGO, V0, P1
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Haudry C, 2012, MOL GENET METAB, V107, P700, DOI 10.1016/j.ymgme.2012.10.008
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Honzik T, 2006, CAS LEK CESK, V145, P665
   Jones SP, 2005, JAIDS-J ACQ IMM DEF, V40, P565, DOI 10.1097/01.qai.0000187443.30838.3e
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kasapkara CS, 2012, J PEDIAT GA IN PRESS, V0, P0
   Kiliç M, 2011, TURKISH J PEDIATR, V53, P79
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Laforce R, 2009, CLIN NEUROL NEUROSUR, V111, P691, DOI 10.1016/j.clineuro.2009.05.005
   Lamperti C, 2012, MOL GENET METAB, V107, P403, DOI 10.1016/j.ymgme.2012.08.020
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Massa R, 2009, NEUROMUSCULAR DISORD, V19, P837, DOI 10.1016/j.nmd.2009.08.013
   McComsey GA, 2008, ANTIVIR THER, V13, P715
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Merkle A N, 2012, AJNR AM J NEURORADIOL, V33, PE34, DOI 10.3174/ajnr.A2455
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nasi M, 2011, ANTIVIR THER, V16, P365, DOI 10.3851/IMP1764
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nobre S, 2012, BMJ CASE RE IN PRESS, V0, P0
   OKAMURA K, 1976, J NEUROL SCI, V27, P79, DOI 10.1016/0022-510X(76)90236-7
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2009, GENEREVIEWS, V0, P0
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2010, EUR J PEDIATR, V169, P201, DOI 10.1007/s00431-009-1007-z
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Pinti M, 2010, AIDS, V24, P841, DOI 10.1097/QAD.0b013e32833779a3
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y
   RICCI E, 1992, BRAIN PATHOL, V2, P141, DOI 10.1111/j.1750-3639.1992.tb00682.x
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Rohrbach M, 2009, FETAL DIAGN THER, V25, P177, DOI 10.1159/000209385
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sakamoto O, 2011, PEDIATR INT, V53, P921, DOI 10.1111/j.1442-200X.2011.03412.x
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scaglia F, 1993, GENEREVIEWS, V0, P0
   Scalais E, 2012, EUR J PAEDIATR NEURO, V16, P542, DOI 10.1016/j.ejpn.2012.01.013
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Slama A, 2005, MOL GENET METAB, V84, P326, DOI 10.1016/j.ymgme.2004.12.004
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P0
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Valayannopoulos V, 2010, MITOCHONDRION, V10, P335, DOI 10.1016/j.mito.2010.02.006
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 99
TC 21
Z9 22
U1 0
U2 9
PU CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC
PI CALGARY
PA 709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA
SN 0317-1671
EI 
J9 CAN J NEUROL SCI
JI Can. J. Neurol. Sci.
PD SEP 15
PY 2013
VL 40
IS 5
BP 635
EP 644
DI 10.1017/S0317167100014852
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA 241WW
UT WOS:000326200400005
PM 23968935
DA 2024-11-01
ER

PT J
AU Warda, M
   Kim, HK
   Kim, N
   Ko, KS
   Rhee, BD
   Han, J
AF Warda, Mohamad
   Kim, Hyoung Kyu
   Kim, Nari
   Ko, Kyung Soo
   Rhee, Byoung Doo
   Han, Jin
TI A matter of life, death and diseases: mitochondria from a proteomic perspective
SO EXPERT REVIEW OF PROTEOMICS
LA English
DT Review
DE apoptosis; mitochondria; oxidative stress; proteome
ID myocardial ischemia-reperfusion; radical oxidative stress; cytochrome-c release; fatty-acid oxidation; k-atp channels; alzheimers-disease; parkinsons-disease; endoplasmic-reticulum; dna mutations; skeletal-muscle
AB Mitochondria are highly ordered, integrated organelles that energize cellular activities and contribute to programmed death by initiating disciplined apoptotic cascades. This review seeks to clarify our understanding of mitochondrial structural-functional integrity beyond the resolved nuclear genome by unraveling the dynamic mitochondrial proteome and elucidating proteome/genome interplay. The roles of mechanochemical coupling between mitoskeleton and cytoskeleton and crosstalk with other organelles in orchestrating cellular outcomes are explained. The authors also review the modulation of mitochondrial-related oxidative stress on apoptosis and cancer development and the context is applied to interpret pathogenetic events in neurodegenerative disorders and cardiovascular diseases. The accumulated proteomics evidence is used to describe the integral role that mitochondria play and how they influence other intracellular organelles. Possible mitochondrial-targeted therapeutic interventions are also discussed.
C1 [Warda, Mohamad] Cairo Univ, Fac Vet Med, Biochem Mol Biol & Chem Nutr Dept, Giza, Egypt.
   [Kim, Hyoung Kyu; Kim, Nari; Ko, Kyung Soo; Rhee, Byoung Doo; Han, Jin] Inje Univ, Natl Res Lab Mitochondrial Signaling, Dept Physiol, Coll Med,Cardiovasc & Metab Dis Ctr, Pusan, South Korea.
C3 Egyptian Knowledge Bank (EKB); Cairo University; Inje University
RP Warda, M (corresponding author), Cairo Univ, Fac Vet Med, Biochem Mol Biol & Chem Nutr Dept, Giza, Egypt.
EM maawarda@eun.eg; phyhanj@inje.ac.kr
FU Inje University; Priority Research Centers Program through the National Research Foundation of Korea(NRF); Ministry of Education, Science and Technology [2010-0020224, 2012R1A2A1A03007595]
CR Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7
   Alzualde A, 2010, J NEUROPATH EXP NEUR, V69, P789, DOI 10.1097/NEN.0b013e3181e85737
   Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013
   Babiychuk EB, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023706
   Beal MF, 2000, ANN NY ACAD SCI, V924, P164
   Bennett MJ, 2000, CRIT REV CL LAB SCI, V37, P1, DOI 10.1080/10408360091174169
   Bereiter-Hahn J, 2010, INT REV CEL MOL BIO, V284, P1, DOI 10.1016/S1937-6448(10)84001-8
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   BRDICZKA D, 1994, MOL CELL BIOCHEM, V133, P69, DOI 10.1007/BF01267948
   Bresalier RS, 1997, CANCER, V80, P776
   Buchwalow IB, 2001, MOL CELL BIOCHEM, V217, P73, DOI 10.1023/A:1007286602865
   Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3
   Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6
   Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033
   Carito V, 2012, BBA-GEN SUBJECTS, V1820, P96, DOI 10.1016/j.bbagen.2011.10.015
   Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308
   Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181
   Chen XL, 2012, PROTEIN CELL, V3, P648, DOI 10.1007/s13238-012-2043-4
   Chen XL, 2010, EXPERT REV PROTEOMIC, V7, P333, DOI 10.1586/EPR.10.22
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Chiang SF, 2012, INT J MOL MED, V29, P365, DOI 10.3892/ijmm.2011.849
   Chu VC, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028551
   Cloonan SM, 2012, CURR OPIN IMMUNOL, V24, P32, DOI 10.1016/j.coi.2011.11.001
   Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, PE749, DOI 10.1152/ajpendo.00363.2011
   DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213
   Dang VC, 2006, AM J PHYSIOL-HEART C, V290, PH1808, DOI 10.1152/ajpheart.00772.2005
   Davidson PJ, 2002, GLYCOBIOLOGY, V12, P329, DOI 10.1093/glycob/12.5.329
   Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023
   Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233
   Di Lisa F, 2003, BASIC RES CARDIOL, V98, P235, DOI 10.1007/s00395-003-0415-x
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Duneau M, 2005, EXP CELL RES, V302, P194, DOI 10.1016/j.yexcr.2004.08.041
   Durazo SA, 2012, MITOCHONDRION, V12, P190, DOI 10.1016/j.mito.2011.11.001
   Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4
   Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Fraser F, 1998, BIOCHEM J, V329, P225, DOI 10.1042/bj3290225
   Fujimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P635, DOI 10.1016/j.bbrc.2011.12.022
   Fukumori T, 2004, CANCER RES, V64, P3376, DOI 10.1158/0008-5472.CAN-04-0336
   Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039
   García-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039
   Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104
   Giebelstein J, 2012, DIABETOLOGIA, V55, P1114, DOI 10.1007/s00125-012-2456-x
   Goldstein B, 2000, DEV DYNAM, V218, P23, DOI 10.1002/(SICI)1097-0177(200005)218:1<23::AID-DVDY3>3.0.CO;2-Z
   Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044
   Gonzalez P, 2007, BIOCHEMISTRY-US, V46, P7374, DOI 10.1021/bi700213p
   Good PF, 1996, AM J PATHOL, V149, P21
   Gottlieb RA, 2003, BASIC RES CARDIOL, V98, P242, DOI 10.1007/s00395-003-0404-0
   Gottlieb RA, 2001, BIOL SIGNAL RECEPT, V10, P147
   Gottlieb Roberta A, 2007, METHODS MOL BIOL, V357, P127
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Gray MW, 2001, GENOME BIOL, V2, P0
   Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1
   Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903
   Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878
   Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, PH921, DOI 10.1152/ajpheart.00421.2003
   Gross GJ, 2002, BRIT J PHARMACOL, V137, P939, DOI 10.1038/sj.bjp.0704965
   Hahn T, 2012, CURR PHARM BIOTECHNO, V0, P0
   Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128
   Hales KG, 2004, MITOCHONDRION, V4, P285, DOI 10.1016/j.mito.2004.05.007
   Han J, 2002, AM J PHYSIOL-HEART C, V283, PH1545, DOI 10.1152/ajpheart.01052.2001
   Hanley PJ, 2002, J PHYSIOL-LONDON, V542, P735, DOI 10.1113/jphysiol.2002.023960
   Heath-Engel HM, 2012, BBA-MOL CELL RES, V1823, P335, DOI 10.1016/j.bbamcr.2011.11.020
   Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x
   Jakupciak JP, 2005, J MOL DIAGN, V7, P258, DOI 10.1016/S1525-1578(10)60553-3
   James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200
   Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147
   Jiang XS, 2005, MOL CELL PROTEOMICS, V4, P12, DOI 10.1074/mcp.M400079-MCP200
   Jobson RW, 2010, MITOCHONDRION, V10, P540, DOI 10.1016/j.mito.2010.05.013
   Kagan J, 2005, CRIT REV CL LAB SCI, V42, P453, DOI 10.1080/10408360500295477
   Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260
   Kartha GK, 2008, ACTA DIABETOL, V45, P75, DOI 10.1007/s00592-008-0025-z
   Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6
   Khairallah RJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0034402
   Kim HK, 2007, AM J PHYSIOL-CELL PH, V293, PC761, DOI 10.1152/ajpcell.00043.2007
   Kim N, 2006, PROTEOMICS, V6, P1237, DOI 10.1002/pmic.200500291
   Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8
   Krügel K, 2011, EXP EYE RES, V92, P87, DOI 10.1016/j.exer.2010.11.007
   Kuerschner L, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031342
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   KUROIWA T, 1994, MICROSC RES TECHNIQ, V27, P220, DOI 10.1002/jemt.1070270304
   Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592
   Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200
   Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7
   Li X, 2004, J MOL CELL CARDIOL, V36, P161, DOI 10.1016/j.yjmcc.2003.10.019
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Lo MC, 2010, ANN NY ACAD SCI, V1201, P1, DOI 10.1111/j.1749-6632.2010.05630.x
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   MacAlpine DM, 2000, EMBO J, V19, P767, DOI 10.1093/emboj/19.4.767
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Melkikh AV, 2012, PROG BIOPHYS MOL BIO, V109, P33, DOI 10.1016/j.pbiomolbio.2012.04.008
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Miura T, 2004, AM J PHYSIOL-HEART C, V286, PH214, DOI 10.1152/ajpheart.00441.2003
   Miura T, 2010, AM J PHYSIOL-HEART C, V298, PH1115, DOI 10.1152/ajpheart.00879.2009
   Miyama A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027883
   Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495
   Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   Naitoh K, 2006, CARDIOVASC RES, V70, P374, DOI 10.1016/j.cardiores.2006.01.023
   NAKAMURA K, 1993, ONCOGENE, V8, P3133
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nomoto S, 2002, CLIN CANCER RES, V8, P481
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732
   Olmos PR, 2011, J OTOLARYNGOL-HEAD N, V40, P93, DOI 10.2310/7070.2010.100078
   Padilla F, 2003, AM J PHYSIOL-HEART C, V285, PH1909, DOI 10.1152/ajpheart.00438.2003
   Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200
   Parrella P, 2001, CANCER RES, V61, P7623
   Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005
   Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102
   Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104
   Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Przyklenk K, 2005, J PHARMACOL EXP THER, V314, P1386, DOI 10.1124/jpet.105.087742
   Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011
   Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x
   Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514
   Quarato G, 2011, MITOCHONDRION, V11, P764, DOI 10.1016/j.mito.2011.06.014
   Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166
   Rebelato E, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0024507
   Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393
   Reddy PH, 2006, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/JBB/2006/31372
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   Rodríguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003
   Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de
   Ruiz-Romero C, 2006, OSTEOARTHR CARTILAGE, V14, P507, DOI 10.1016/j.joca.2005.12.004
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257
   Saks VA, 1996, MOL CELL BIOCHEM, V161, P195, DOI 10.1007/BF00240050
   Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103
   Sano R, 2012, GENE DEV, V26, P1041, DOI 10.1101/gad.184325.111
   Santos JM, 2011, INVEST OPHTH VIS SCI, V52, P8791, DOI 10.1167/iovs.11-8203
   Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017
   Schilling T, 2011, J CELL PHYSIOL, V226, P3295, DOI 10.1002/jcp.22675
   SCHOEPPNER HL, 1995, CANCER, V75, P2818, DOI 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#
   Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, PH1740, DOI 10.1152/ajpheart.00442.2002
   Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x
   Siegelin MD, 2010, MOL CANCER THER, V9, P1638, DOI 10.1158/1535-7163.MCT-10-0097
   Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009
   Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Smith MA, 1997, J NEUROSCI, V17, P2653
   SMITH MA, 1994, ANN NY ACAD SCI, V738, P447
   SMITH MA, 1994, AM J PATHOL, V145, P42
   Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003
   Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Souchelnytskyi S, 2005, PROTEOMICS, V5, P4123, DOI 10.1002/pmic.200500135
   Sourris KC, 2012, FREE RADICAL BIO MED, V52, P716, DOI 10.1016/j.freeradbiomed.2011.11.017
   STAAL FJT, 1994, P NATL ACAD SCI USA, V91, P3619, DOI 10.1073/pnas.91.9.3619
   STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496
   Struewing IT, 2006, J BIOL CHEM, V281, P7282, DOI 10.1074/jbc.M511182200
   Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12
   Tell G, 2001, MUTAT RES-DNA REPAIR, V485, P143, DOI 10.1016/S0921-8777(00)00068-9
   Touyz RM, 2005, CAN J PHYSIOL PHARM, V83, P91, DOI 10.1139/Y05-006
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Van Cuong D, 2007, AM J PHYSIOL-HEART C, V293, PH1457, DOI 10.1152/ajpheart.01282.2006
   VANDERKLEI IJ, 1994, MICROSC RES TECHNIQ, V27, P284, DOI 10.1002/jemt.1070270404
   Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274
   Velazquez JLP, 2000, NEUROSCIENCE, V97, P363
   Verma M, 2003, NAT REV CANCER, V3, P789, DOI 10.1038/nrc1192
   Wagner I, 1997, EMBO J, V16, P7317, DOI 10.1093/emboj/16.24.7317
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Warburg O, 1930, THE METABOLISM OF TUMORS, V0, P0
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101
   Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481
   Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151
   Wong R, 2010, AM J PHYSIOL-HEART C, V298, PH75, DOI 10.1152/ajpheart.00515.2009
   Woo DK, 2009, BBA-GENE REGUL MECH, V1789, P135, DOI 10.1016/j.bbagrm.2008.09.008
   Wu CC, 2012, ANTIOXID REDOX SIGNA, V0, P0
   Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022
   Yang SH, 2009, J BIOL CHEM, V284, P9540, DOI 10.1074/jbc.M808246200
   Ye L, 2011, BRAIN RES, V1411, P57, DOI 10.1016/j.brainres.2011.07.011
   Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200
   Yuan HP, 2010, FEBS J, V277, P5061, DOI 10.1111/j.1742-4658.2010.07911.x
   Zamorano S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0037782
   Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763
   Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c
   Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011
   Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084
NR 193
TC 17
Z9 17
U1 0
U2 30
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-9450
EI 1744-8387
J9 EXPERT REV PROTEOMIC
JI Expert Rev. Proteomics
PD FEB 15
PY 2013
VL 10
IS 1
BP 97
EP 111
DI 10.1586/EPR.12.69
PG 15
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 093AB
UT WOS:000315163000017
PM 23414362
DA 2024-11-01
ER

PT J
AU Li, HZ
   Sharma, LK
   Li, YF
   Hu, PQ
   Idowu, A
   Liu, DH
   Lu, JX
   Bai, YD
AF Li, Hongzhi
   Sharma, Lokendra Kumar
   Li, Youfen
   Hu, Peiqing
   Idowu, Abimbola
   Liu, Danhui
   Lu, Jianxin
   Bai, Yidong
TI Comparative bioenergetic study of neuronal and muscle mitochondria during aging
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Mitochondria; Aging; Skeletal muscle; Synaptosome; Cybrid; Free radicals
ID oxidative-phosphorylation; dna mutations; human fibroblasts; skeletal-muscle; mtdna mutations; cells; decline; brain; respiration; superoxide
AB Mitochondrial respiratory chain defects have been associated with various diseases and with normal aging, particularly in tissues with high energy demands, including brain and skeletal muscle. Tissue-specific manifestation of mitochondria DNA (mtDNA) mutations and mitochondrial dysfunction are hallmarks of mitochondrial diseases although the underlying mechanisms are largely unclear. Previously, we and others have established approaches for transferring mtDNA from muscle and synaptosomes of mice at various ages to cell cultures. In this study, we carried out a comprehensive bioenergetic analysis of cells bearing mitochondria derived from young, middle-aged, and old mouse skeletal muscles and synaptosomes. Significant age-associated alterations in oxidative phosphorylation and regulation during aging were observed in cybrids carrying mitochondria from both skeletal muscle and synaptosomes. Our results also revealed that loss of oxidative phosphorylation capacity may occur at various ages in muscle and brain. These findings indicate the existence of a tissue-specific regulatory mechanism for oxidative phosphorylation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Li, Hongzhi; Liu, Danhui; Lu, Jianxin] Wenzhou Med Coll, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China.
   [Li, Hongzhi; Sharma, Lokendra Kumar; Li, Youfen; Hu, Peiqing; Idowu, Abimbola; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Li, Youfen] Xi An Jiao Tong Univ, Sch Life Sci, Xian 710049, Shanxi, Peoples R China.
C3 Wenzhou Medical University; University of Texas System; University of Texas Health Science Center at San Antonio; Xi'an Jiaotong University
RP Bai, YD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
EM baiy@uthscsa.edu
FU National Institutes of Health [R01 AG025223]; Morrison Trust
CR Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Anderton BH, 2002, MECH AGEING DEV, V123, P811, DOI 10.1016/S0047-6374(01)00426-2
   Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026
   Bai YD, 2005, ANN NY ACAD SCI, V1042, P25, DOI 10.1196/annals.1338.003
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Bishop NA, 1900, V464, V0, P529
   BOSS GR, 1981, WESTERN J MED, V135, P434
   Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Li Y, 1900, V38, V0, P1913
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921
   Montoya J, 2009, ADV EXP MED BIOL, V652, P47, DOI 10.1007/978-90-481-2813-6_5
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Navarro A, 2009, J BIOENERG BIOMEMBR, V41, P517, DOI 10.1007/s10863-009-9250-6
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Parihar MS, 2004, J CLIN NEUROSCI, V11, P456, DOI 10.1016/j.jocn.2003.12.007
   POLOSA PL, 1991, J BIOL CHEM, V266, P10011
   Rossi Paola, 2008, CURR AGING SCI, V1, P182
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696
   Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457
NR 43
TC 17
Z9 22
U1 0
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT 15
PY 2013
VL 63
IS 
BP 30
EP 40
DI 10.1016/j.freeradbiomed.2013.04.030
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 200TV
UT WOS:000323094700002
PM 23643721
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Chamkha, I
   Mezghani, N
   Ben Ayed, I
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Chamkha, Imen
   Mezghani, Najla
   Ben Ayed, Imen
   Fakhfakh, Faiza
TI Screening of mitochondrial mutations in Tunisian patients with mitochondrial disorders: An overview study
SO MITOCHONDRIAL DNA
LA English
DT Review
DE Mitochondrial mutation; deafness; Leigh syndrome; KSS; Pearson syndrome; diabetes
ID 12s ribosomal-rna; kearns-sayre-syndrome; stroke-like episodes; marrow-pancreas-syndrome; syndromic hearing-loss; diabetes-mellitus; leigh-syndrome; point mutation; wolfram-syndrome; dna deletion
AB To investigate the spectrum of common mitochondrial mutations in Tunisia during the years of 2002-2012, 226 patients with mitochondrial disorders were clinically diagnosed with hearing loss, Leigh syndrome (LS), diabetes, cardiomyopathy, Kearns-Sayre syndrome (KSS), Pearson syndrome (PS), myopathy, mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) and Wolfram syndrome. Restriction fragment length polymorphism (PCR-RFLP), radioactive PCR, single specific primer-PCR (SSP-PCR) analysis and PCR-sequencing methods were used to identify the mutations. Two cases with m. 1555A > G mutation and two families with the novel 12S rRNA m. 735A > G transition were detected in patients with hearing loss. Three cases with m. 8993T > G mutation, two patients with the novel m. 5523T > G and m. 5559A > G mutations in the tRNA(Trp) gene, and two individuals with the undescribed m. 9478T > C mutation in the cytochrome c oxidase subunit III (COXIII) gene were found with LS. In addition, one case with hypertrophic cardiomyopathy and deafness presented the ND1 m. 3395A > G mutation and the tRNA(Ile) m.4316A > G variation. Besides, multiple mitochondrial deletions were detected in patients with KSS, PS, and Wolfram syndrome. The m. 14709T > C mutation in the tRNA(Glu) was reported in four maternally inherited diabetes and deafness patients and a novel tRNA(Val) m. 1640A > G mutation was detected in a MELAS patient.
C1 [Mkaouar-Rebai, Emna; Chamkha, Imen; Mezghani, Najla; Ben Ayed, Imen; Fakhfakh, Faiza] Univ Sfax, Fac Med Sfax, Human Mol Genet Lab, Sfax, Tunisia.
C3 Universite de Sfax
RP Mkaouar-Rebai, E (corresponding author), Fac Med Sfax, Human Mol Genet Lab, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com; faiza.fakhfakh@gmail.com
FU Ministry of Higher Education and Scientific Research in Tunisia
CR Aharoni S, 2010, J NEUROL SCI, V296, P101, DOI 10.1016/j.jns.2010.06.029
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Au WS, 2008, J MOL ENDOCRINOL, V41, P229, DOI 10.1677/JME-08-0080
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Barrientos A, 1996, AM J HUM GENET, V58, P963
   Ben Ayed I, 2011, BIOCHEM BIOPH RES CO, V411, P381, DOI 10.1016/j.bbrc.2011.06.154
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BLAW ME, 1990, J CHILD NEUROL, V5, P186, DOI 10.1177/088307389000500305
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7
   Chamkha I, 2011, BIOCHEM BIOPH RES CO, V404, P504, DOI 10.1016/j.bbrc.2010.12.012
   Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cremers CW, 1977, ACTA PAEDIATR SC S, V264, P0
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Dai P, 2006, BIOCHEM BIOPH RES CO, V340, P194, DOI 10.1016/j.bbrc.2005.11.156
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   De Kremer RD, 2001, AM J MED GENET, V99, P83, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1136>3.0.CO;2-X
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632
   Deschauer M, 2000, MOL GENET METAB, V70, P235, DOI 10.1006/mgme.2000.3002
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   ENTER C, 1991, HUM GENET, V88, P233
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Ferlin T, 1997, J PEDIATR-US, V131, P447, DOI 10.1016/S0022-3476(97)80074-1
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hirai M, 1998, J CLIN ENDOCR METAB, V83, P992, DOI 10.1210/jc.83.3.992
   Hobbie SN, 2006, BIOCHIMIE, V88, P1033, DOI 10.1016/j.biochi.2006.04.008
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10
   Kameoka K, 1998, DIABETES CARE, V21, P2034, DOI 10.2337/diacare.21.11.2034
   Kawarai T, 1997, NEUROLOGY, V49, P598, DOI 10.1212/WNL.49.2.598
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007
   Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1
   MarinGarcia J, 1996, PEDIATR CARDIOL, V17, P387, DOI 10.1007/s002469900084
   Martin L, 2000, BRIT J DERMATOL, V143, P876, DOI 10.1046/j.1365-2133.2000.03797.x
   Matsumoto Joyce, 2005, REV NEUROL DIS, V2, P30
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V407, P747, DOI 10.1016/j.bbrc.2011.03.094
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   MIYABAYASHI S, 1991, J INHERIT METAB DIS, V14, P805, DOI 10.1007/BF01799954
   Mkaouar-Rebai E, 2006, BIOCHEM BIOPH RES CO, V340, P1251, DOI 10.1016/j.bbrc.2005.12.123
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Mkaouar-Rebai E, 2010, BIOSCIENCE REP, V30, P405, DOI 10.1042/BSR20090120
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   Mkaouar-Rebai E, 2010, J CHILD NEUROL, V25, P770, DOI 10.1177/0883073809344351
   Mkaouar-Rebai E, 2009, PEDIATR NEUROL, V40, P437, DOI 10.1016/j.pediatrneurol.2009.01.004
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W
   PAGE MM, 1976, Q J MED, V45, P505
   Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pistilli D, 2003, HUM PATHOL, V34, P1058, DOI 10.1053/S0046-8177(03)00344-7
   POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Ramírez-Miranda A, 2008, ARCH SOC ESP OFTALMOL, V83, P155
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Rötig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Tang XW, 2007, GENE, V393, P11, DOI 10.1016/j.gene.2007.01.001
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Toth T, 1998, CLIN GENET, V53, P210
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8
   Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478
   Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yau Eric KC, 2009, HONG KONG MEDICAL JOURNAL, V15, P374
   Zifa E, 2008, MITOCHONDRION, V8, P229, DOI 10.1016/j.mito.2008.04.001
NR 135
TC 9
Z9 10
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD JUN 15
PY 2013
VL 24
IS 3
BP 163
EP 178
DI 10.3109/19401736.2012.748045
PG 16
WC Genetics & Heredity
SC Genetics & Heredity
GA 148FB
UT WOS:000319227400001
PM 23301511
DA 2024-11-01
ER

PT J
AU Koczor, CA
   Torres, RA
   Fields, EJ
   Boyd, A
   He, S
   Patel, N
   Lee, EK
   Samarel, AM
   Lewis, W
AF Koczor, Christopher A.
   Torres, Rebecca A.
   Fields, Earl J.
   Boyd, Amy
   He, Stanley
   Patel, Nilamkumar
   Lee, Eva K.
   Samarel, Allen M.
   Lewis, William
TI Thymidine kinase and mtDNA depletion in human cardiomyopathy: epigenetic and translational evidence for energy starvation
SO PHYSIOLOGICAL GENOMICS
LA English
DT Article
DE dilated cardiomyopathy; mitochondria; mitochondrial DNA; thymidine kinase
ID mitochondrial-dna depletion; large gene lists; failing heart; deoxyribonucleoside kinases; substrate-specificity; oxidative stress; tk2 deficiency; phosphorylation; myopathy; failure
AB This study addresses how depletion of human cardiac left ventricle (LV) mitochondrial DNA (mtDNA) and epigenetic nuclear DNA methylation promote cardiac dysfunction in human dilated cardiomyopathy (DCM) through regulation of pyrimidine nucleotide kinases. Samples of DCM LV and right ventricle (n = 18) were obtained fresh at heart transplant surgery. Parallel samples from nonfailing (NF) controls (n = 12) were from donor hearts found unsuitable for clinical use. We analyzed abundance of mtDNA and nuclear DNA (nDNA) using qPCR. LV mtDNA was depleted in DCM (50%, P < 0.05 each) compared with NF. No detectable change in RV mtDNA abundance occurred. DNA methylation and gene expression were determined using microarray analysis (GEO accession number: GSE43435). Fifty-seven gene promoters exhibited DNA hypermethylation or hypomethylation in DCM LVs. Among those, cytosolic thymidine kinase 1 (TK1) was hypermethylated. Expression arrays revealed decreased abundance of the TK1 mRNA transcript with no change in transcripts for other relevant thymidine metabolism enzymes. Quantitative immunoblots confirmed decreased TK1 polypeptide steady state abundance. TK1 activity remained unchanged in DCM samples while mitochondrial thymidine kinase (TK2) activity was significantly reduced. Compensatory TK activity was found in cardiac myocytes in the DCM LV. Diminished TK2 activity is mechanistically important to reduced mtDNA abundance and identified in DCM LV samples here. Epigenetic and genetic changes result in changes in mtDNA and in nucleotide substrates for mtDNA replication and underpin energy starvation in DCM.
C1 [Koczor, Christopher A.; Torres, Rebecca A.; Fields, Earl J.; Boyd, Amy; He, Stanley; Lewis, William] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Patel, Nilamkumar; Samarel, Allen M.] Loyola Univ, Chicago Stritch Sch Med, Cardiovasc Inst, Maywood, IL 60153 USA.
   [Lee, Eva K.] Georgia Inst Technol, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA.
C3 Emory University; Loyola University Chicago; University System of Georgia; Georgia Institute of Technology
RP Lewis, W (corresponding author), Emory Univ, Sch Med, Dept Pathol, 7117 Woodruff Mem Bldg,101 Woodruff Circle, Atlanta, GA 30322 USA.
EM wlewis@emory.edu
FU National Institute on Drug Abuse Grant [DA-030996]
CR Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9
   BAANDRUP U, 1981, BRIT HEART J, V45, P475
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Elpeleg O, 2003, PEDIATR RES, V54, P153, DOI 10.1203/01.PDR.0000072796.25097.A5
   Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Jüllig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Koczor CA, 1900, DOI 10.1152/PHYSIOLGENOMICS.00013.2013, V0, P0
   KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686
   Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1
   Kohler JJ, 2008, CHEM RES TOXICOL, V21, P990, DOI 10.1021/tx8000219
   Kohler JJ, 2009, LAB INVEST, V89, P782, DOI 10.1038/labinvest.2009.39
   Kohler JJ, 2009, LAB INVEST, V89, P122, DOI 10.1038/labinvest.2008.121
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Marín-García J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1
   Mestroni L, 2008, HURSTS HEART, V0, P803
   MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pérez-Pérez MJ, 2005, CURR TOP MED CHEM, V5, P1205, DOI 10.2174/156802605774463097
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rosca MG, 2009, J BIOENERG BIOMEMBR, V41, P107, DOI 10.1007/s10863-009-9215-9
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada-Reisch A, 2004, NUCLEOS NUCLEOT NUCL, V23, P1205, DOI 10.1081/NCN-200027480
   Samarel A, 2008, HURSTS HEART, V0, P123
   Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001
   Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006
   Villarroya J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029691
   Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P400, DOI 10.1080/15257771003741042
   Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2552, DOI 10.1128/AAC.00109-11
NR 46
TC 16
Z9 19
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1094-8341
EI 1531-2267
J9 PHYSIOL GENOMICS
JI Physiol. Genomics
PD JUL 15
PY 2013
VL 45
IS 14
BP 590
EP 596
DI 10.1152/physiolgenomics.00014.2013
PG 7
WC Cell Biology; Genetics & Heredity; Physiology
SC Cell Biology; Genetics & Heredity; Physiology
GA 183KY
UT WOS:000321814800003
PM 23695887
DA 2024-11-01
ER

PT J
AU Gispert, S
   Parganlija, D
   Klinkenberg, M
   Dröse, S
   Wittig, I
   Mittelbronn, M
   Grzmil, P
   Koob, S
   Hamann, A
   Walter, M
   Büchel, F
   Adler, T
   de Angelis, MH
   Busch, DH
   Zell, A
   Reichert, AS
   Brandt, U
   Osiewacz, HD
   Jendrach, M
   Auburger, G
AF Gispert, Suzana
   Parganlija, Dajana
   Klinkenberg, Michael
   Droese, Stefan
   Wittig, Ilka
   Mittelbronn, Michel
   Grzmil, Pawel
   Koob, Sebastian
   Hamann, Andrea
   Walter, Michael
   Buechel, Finja
   Adler, Thure
   de Angelis, Martin Hrabe
   Busch, Dirk H.
   Zell, Andreas
   Reichert, Andreas S.
   Brandt, Ulrich
   Osiewacz, Heinz D.
   Jendrach, Marina
   Auburger, Georg
TI Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID unfolded protein response; cause ovarian dysgenesis; perrault syndrome; transcription factor; skeletal-muscle; stress-response; quality-control; animal-models; mice lacking; mouse model
AB The caseinolytic peptidase P (CLPP) is conserved from bacteria to humans. In the mitochondrial matrix, it multi-merizes and forms a macromolecular proteasome-like cylinder together with the chaperone CLPX. In spite of a known relevance for the mitochondrial unfolded protein response, its substrates and tissue-specific roles are unclear in mammals. Recessive CLPP mutations were recently observed in the human Perrault variant of ovarian failure and sensorineural hearing loss. Here, a first characterization of CLPP null mice demonstrated complete female and male infertility and auditory deficits. Disrupted spermatogenesis already at the spermatid stage and ovarian follicular differentiation failure were evident. Reduced pre-/post-natal survival and marked ubiquitous growth retardation contrasted with only light impairment of movement and respiratory activities. Interestingly, the mice showed resistance to ulcerative dermatitis. Systematic expression studies detected up-regulation of other mitochondrial chaperones, accumulation of CLPX and mtDNA as well as inflammatory factors throughout tissues. T-lymphocytes in the spleen were activated. Thus, murine Clpp deletion represents a faithful Perrault model. The disease mechanism probably involves deficient clearance of mitochondrial components and inflammatory tissue destruction.
C1 [Gispert, Suzana; Parganlija, Dajana; Klinkenberg, Michael; Jendrach, Marina; Auburger, Georg] Goethe Univ Frankfurt, Sch Med, D-60590 Frankfurt, Germany.
   [Droese, Stefan; Wittig, Ilka; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, Ctr Biol Chem,Cluster Excellence Macromol Complex, D-60590 Frankfurt, Germany.
   [Mittelbronn, Michel] Goethe Univ Frankfurt, Sch Med, Edinger Inst, Neurol Inst, D-60590 Frankfurt, Germany.
   [Grzmil, Pawel] Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany.
   [Grzmil, Pawel] Jagiellonian Univ, Dept Genet & Evolut, PL-30387 Krakow, Poland.
   [Koob, Sebastian; Reichert, Andreas S.] Goethe Univ Frankfurt, Ctr Mol Med, Buchmann Inst Mol Life Sci & Mitochondrial Biol, D-60438 Frankfurt, Germany.
   [Hamann, Andrea; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Fac Biosci, Cluster Excellence Macromol Complexes, D-60590 Frankfurt, Germany.
   [Walter, Michael] Univ Tubingen, Inst Med Genet, D-72076 Tubingen, Germany.
   [Buechel, Finja; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, D-72076 Tubingen, Germany.
   [Adler, Thure; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Munich, Germany.
   [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany.
C3 Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Gottingen; Jagiellonian University; Goethe University Frankfurt; Goethe University Frankfurt; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich
RP Auburger, G (corresponding author), Goethe Univ Frankfurt, Sch Med, Bldg 89,Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM auburger@em.uni-frankfurt.de
FU German Federal Ministry for Education and Research (BMBF) [0315584A]; German Federal Ministry for Education and Research (BMBF) through the National Genome Research Network NGFN-Plus [01GS08134/01GS08138]; German Federal Ministry for Education and Research (BMBF) through the German Network for Mitochondrial Disorders mito NET [01GM1113B]; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 815, A02, Z1]; Cluster of Excellence Frankfurt Macromolecular Complexes [EXC115]
CR Aldridge JE, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000874
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Andresen BS, 2000, MAMM GENOME, V11, P275, DOI 10.1007/s003350010052
   Angeles A, 2012, FRONT BIOSCI-LANDMRK, V17, P1904, DOI 10.2741/4027
   Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06
   Broadley SA, 2008, TRENDS CELL BIOL, V18, P1, DOI 10.1016/j.tcb.2007.11.003
   Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200
   Cacace AT, 2011, AUDIOL NEURO-OTOL, V16, P398, DOI 10.1159/000323276
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Corydon TJ, 2000, MAMM GENOME, V11, P899, DOI 10.1007/s003350010173
   Czyz A, 2001, ARCH VIROL, V146, P1487, DOI 10.1007/s007050170073
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Dröse S, 2006, J BIOL CHEM, V281, P23733, DOI 10.1074/jbc.M602570200
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1
   Fischer F, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2397
   Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004
   Fiumara A, 2004, AM J MED GENET A, V128A, P246, DOI 10.1002/ajmg.a.20616
   Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104
   Frees D, 2012, J PROTEOME RES, V11, P95, DOI 10.1021/pr200956s
   Gentleman RC, 2004, GENOME BIOL, V5, P0, DOI 10.1186/gb-2004-5-10-r80
   George SK, 2011, AGING CELL, V10, P584, DOI 10.1111/j.1474-9726.2011.00686.x
   Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x
   Gispert S, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005777
   Gnaiger E, 2007, MITOCHONDRIAL PATHWA, V0, P1
   Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317
   Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14
   Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0
   Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108
   Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014
   Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590
   Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng015
   Ishii T, 2011, BMB REP, V44, P298, DOI 10.5483/BMBRep.2011.44.5.298
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200
   Kasashima K, 2012, EXP CELL RES, V318, P2335, DOI 10.1016/j.yexcr.2012.07.012
   Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8
   Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967
   Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587
   Laker RC, 2012, AM J PHYSIOL-ENDOC M, V302, PE1221, DOI 10.1152/ajpendo.00583.2011
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2001, TRENDS MOL MED, V7, P578, DOI 10.1016/S1471-4914(01)02167-0
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Levéen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031
   Liang HY, 2009, J BIOL CHEM, V284, P30836, DOI 10.1074/jbc.M109.032839
   LINSSEN WHJP, 1994, AM J MED GENET, V51, P81, DOI 10.1002/ajmg.1320510117
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu B, 2008, BIOL REPROD, V78, P601, DOI 10.1095/biolreprod.107.065987
   Manfredi AA, 2010, NEW ENGL J MED, V362, P2132, DOI 10.1056/NEJMcibr1003521
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Meek K, 2009, J IMMUNOL, V183, P2529, DOI 10.4049/jimmunol.0801406
   Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200
   Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002
   Neher SB, 2006, MOL CELL, V22, P193, DOI 10.1016/j.molcel.2006.03.007
   NISHI Y, 1988, AM J MED GENET, V31, P623, DOI 10.1002/ajmg.1320310317
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   OHandley D, 2002, J MOL BIOL, V322, P311, DOI 10.1016/S0022-2836(02)00755-6
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PALLISTER PD, 1979, AM J MED GENET, V4, P239, DOI 10.1002/ajmg.1320040306
   Paul E, 2009, MAMM GENOME, V20, P92, DOI 10.1007/s00335-008-9168-z
   Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521
   Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, P0, DOI 10.3402/pba.v1i0.7202
   Pewe L, 1998, J VIROL, V72, P5912, DOI 10.1128/JVI.72.7.5912-5918.1998
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007
   Pierson TM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002325
   Raineri I, 2001, FREE RADICAL BIO MED, V31, P1018, DOI 10.1016/S0891-5849(01)00686-4
   Ranquet C, 2005, J MOL BIOL, V353, P186, DOI 10.1016/j.jmb.2005.08.015
   Rantanen A, 2000, HUM REPROD, V15 Suppl 2, P86
   Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200
   Santagata S, 1999, J BIOL CHEM, V274, P16311, DOI 10.1074/jbc.274.23.16311
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795
   Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005
   SHAH AJ, 1982, J NEUROL SCI, V55, P25, DOI 10.1016/0022-510X(82)90167-8
   Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Smyth GK, 2004, STAT APPL GENET MOL BIOL, V3, P1, DOI 10.2202/1544-6115.1027
   Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Sundberg JP, 2011, VET PATHOL, V48, P513, DOI 10.1177/0300985810379431
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002
   Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003
   Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wells T, 2012, HUM MOL GENET, V21, P4836, DOI 10.1093/hmg/dds315
   Will Y, 2000, HEPATOLOGY, V32, P740, DOI 10.1053/jhep.2000.17913
   Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Yoda E, 2010, J LIPID RES, V51, P3003, DOI 10.1194/jlr.M008060
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zheng B, 2002, PHYSIOL PLANTARUM, V114, P92, DOI 10.1034/j.1399-3054.2002.1140113.x
   Zhou RR, 2010, CURR GENET, V56, P101, DOI 10.1007/s00294-010-0291-5
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 116
TC 147
Z9 170
U1 2
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 15
PY 2013
VL 22
IS 24
BP 4871
EP 4887
DI 10.1093/hmg/ddt338
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 259QY
UT WOS:000327542600001
PM 23851121
DA 2024-11-01
ER

PT J
AU Paneni, F
   Costantino, S
   Volpe, M
   Lüscher, TF
   Cosentino, F
AF Paneni, Francesco
   Costantino, Sarah
   Volpe, Massimo
   Luescher, Thomas Felix
   Cosentino, Francesco
TI Epigenetic signatures and vascular risk in type 2 diabetes: A clinical perspective
SO ATHEROSCLEROSIS
LA English
DT Review
DE Epigenetic changes; Vascular risk; Oxidative stress; Diabetes
ID protein-kinase-c; smooth-muscle-cells; factor-kappa-b; cardiovascular-disease; multifactorial intervention; high glucose; resveratrol supplementation; endothelial function; primary prevention; metabolic memory
AB Risk of diabetic complications continues to escalate overtime despite a multifactorial intervention with glucose-lowering drugs, anti-hypertensive agents and statins. In this perspective, a mechanisms-based therapeutic approach to vascular disease in diabetes represents a major challenge. Epigenetic signatures are emerging as important determinants of vascular disease in this setting. Methylation and acetylation of DNA and histones is a reversible process leading to dysregulation of oxidant and inflammatory genes such as mitochondrial adaptor p66(Shc) and transcription factor NF-kB p65. Epigenetic modifications associated with diabetes may contribute to the early identification of high risk individuals. Ongoing epigenomic analyses will be instrumental in identifying the epigenetic variations that are specifically associated with cardiovascular disease in patients with diabetes. Here, we describe a complex scenario of epigenetic changes and their putative link with diabetic vascular disease. Pharmacological reprogramming of diabetes-induced epigenetic signatures may be a promising option to dampen oxidative stress and inflammation, and thus prevent cardiovascular complications in this setting. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Paneni, Francesco; Costantino, Sarah; Luescher, Thomas Felix; Cosentino, Francesco] Univ Zurich Irchel, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   [Paneni, Francesco; Costantino, Sarah; Luescher, Thomas Felix; Cosentino, Francesco] Univ Hosp, Zurich, Switzerland.
   [Paneni, Francesco; Volpe, Massimo] IRCCS Neuromed, Pozzilli, Italy.
   [Volpe, Massimo] Univ Rome Sapienza, Dept Clin & Mol Med, Rome, Italy.
   [Luescher, Thomas Felix] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8006 Zurich, Switzerland.
C3 University of Zurich; University of Zurich; University Zurich Hospital; IRCCS Neuromed; Sapienza University Rome; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)
RP Cosentino, F (corresponding author), Univ Zurich Irchel, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM f_cosentino@hotmail.com
CR Abbott A, 2010, NATURE, V463, P596, DOI 10.1038/463596b
   Allan GM, 2013, CIRCULATION, V127, P1948, DOI 10.1161/CIRCULATIONAHA.112.000412
   Arca M, 2012, CURR VASC PHARMACOL, V10, P684, DOI 10.2174/157016112803520864
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359
   Beckman JA, 2013, EUR HEART J, V0, P0
   Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579
   Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666
   Brown AS, 2008, SCHIZOPHRENIA BULL, V34, P1054, DOI 10.1093/schbul/sbn096
   Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104
   Ceriello A, 2010, EUR J CARDIOV PREV R, V17, PS15, DOI 10.1097/01.hjr.0000368193.24732.66
   Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824
   Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5
   Collins R, 2003, LANCET, V361, P2005
   Cooper ME, 2010, CIRC RES, V107, P1403, DOI 10.1161/CIRCRESAHA.110.223552
   Cosentino F, 2008, ARTERIOSCL THROM VAS, V28, P622, DOI 10.1161/ATVBAHA.107.156059
   El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188
   El-Osta A, 2012, CURR OPIN LIPIDOL, V23, P24, DOI 10.1097/MOL.0b013e32834f319d
   Fioretto P, 2010, NAT REV ENDOCRINOL, V6, P19, DOI 10.1038/nrendo.2009.213
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245
   Gæde P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1
   Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117
   Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839
   Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346
   Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265
   Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177
   Jung CH, 2013, ARCH PHARM RES, V36, P201, DOI 10.1007/s12272-013-0020-y
   Keating ST, 2012, J CARDIOVASC TRANSL, V5, P399, DOI 10.1007/s12265-012-9380-9
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Kim CS, 2011, CARDIOVASC RES, V92, P466, DOI 10.1093/cvr/cvr250
   Kim GH, 2013, ANTIOXID REDOX SIGN, V18, P1920, DOI 10.1089/ars.2012.4926
   Kim JK, 2012, CIRCULATION, V125, P1081, DOI 10.1161/CIRCULATIONAHA.111.090134
   Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233
   Krishna SM, 2013, ATHEROSCLEROSIS, V228, P295, DOI 10.1016/j.atherosclerosis.2013.02.019
   Lehnen H, 2013, MOL HUM REPROD, V19, P415, DOI 10.1093/molehr/gat020
   Lekakis J, 2005, EUR J CARDIOV PREV R, V12, P596, DOI 10.1097/00149831-200512000-00013
   Maradana MR, 2013, MOL NUTR FOOD RES, V57, P1550, DOI 10.1002/mnfr.201200791
   Marco LJ, 2012, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2012/565160
   Mehta NN, 2009, CARDIOVASC DRUG THER, V23, P17, DOI 10.1007/s10557-008-6144-5
   Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200
   Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645
   Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824
   Napoli C, 2012, CIRCULATION, V125, P2363, DOI 10.1161/CIRCULATIONAHA.111.085787
   Napoli C, 2011, CARDIOVASC RES, V92, P367, DOI 10.1093/cvr/cvr201
   Pagnin E, 2005, J CLIN ENDOCR METAB, V90, P1130, DOI 10.1210/jc.2004-1283
   Paneni F, 2013, EUR HEART J, V0, P0
   Paneni F, 2013, DIABETES, V62, P1800, DOI 10.2337/db12-1648
   Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593
   Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8
   Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987
   PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502
   PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795
   Reddy MA, 2008, CIRC RES, V103, P615, DOI 10.1161/CIRCRESAHA.108.175190
   Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017
   Ruemmele FM, 2012, ANN NUTR METAB, V60, P38, DOI 10.1159/000337363
   Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151
   Srivastava G, 2009, J CARDIOVASC PHARM T, V14, P22, DOI 10.1177/1074248408329608
   Tabit CE, 2013, CIRCULATION, V127, P86, DOI 10.1161/CIRCULATIONAHA.112.127514
   Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002
   Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105
   Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, PF14, DOI 10.1152/ajprenal.00200.2010
   Volpe M, 2011, CURR HYPERTENS REP, V13, P318, DOI 10.1007/s11906-011-0205-z
   Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5
   Wang JJ, 2012, ANTIOXID REDOX SIGN, V17, P282, DOI 10.1089/ars.2011.4381
   Wong RHX, 2011, NUTR METAB CARDIOVAS, V21, P851, DOI 10.1016/j.numecd.2010.03.003
   Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200
   Zheng Z, 2012, DIABETES, V61, P217, DOI 10.2337/db11-0416
   Zhou S, 2011, CIRC RES, V109, P639, DOI 10.1161/CIRCRESAHA.111.243592
NR 76
TC 58
Z9 60
U1 0
U2 25
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT 15
PY 2013
VL 230
IS 2
BP 191
EP 197
DI 10.1016/j.atherosclerosis.2013.07.003
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 222RC
UT WOS:000324747800004
PM 24075743
DA 2024-11-01
ER

PT J
AU Yarham, JW
   Blakely, EL
   Alston, CL
   Roberts, ME
   Ealing, J
   Pal, P
   Turnbull, DM
   McFarland, R
   Taylor, RW
AF Yarham, John W.
   Blakely, Emma L.
   Alston, Charlotte L.
   Roberts, Mark E.
   Ealing, John
   Pal, Piyali
   Turnbull, Douglass M.
   McFarland, Robert
   Taylor, Robert W.
TI The m.3291T&gt;C mt-tRNA<SUP>Leu(UUR)</SUP> mutation is definitely pathogenic and causes multisystem mitochondrial disease
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial DNA disease; Lipoma; mt-tRNA(Leu(UUR)); Evolutionary conservation; Single-fibre studies; Pathogenicity
ID dna; merrf; mtdna; epilepsy; lipoma
AB Mitochondrial tRNA point mutations are important causes of human disease, and have been associated with a diverse range of clinical phenotypes. Definitively proving the pathogenicity of any given mt-tRNA mutation requires combined molecular, genetic and functional studies. Subsequent evaluation of the mutation using a pathogenicity scoring system is often very helpful in concluding whether or not the mutation is causing disease. Despite several independent reports linking the m.3291T>C mutation to disease in humans, albeit in association with several different phenotypes, its pathogenicity remains controversial. A lack of conclusive functional evidence and an over-emphasis on the poor evolutionary conservation of the affected nucleotide have contributed to this controversy. Here we describe an adult patient who presented with deafness and lipomas and evidence of mitochondrial abnormalities in his muscle biopsy, who harbours the m.3291T>C mutation, providing conclusive evidence of pathogenicity through analysis of mutation segregation with cytochrome c oxidase (COX) deficiency in single muscle fibres, underlining the importance of performing functional studies when assessing pathogenicity. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Yarham, John W.; Blakely, Emma L.; Alston, Charlotte L.; Turnbull, Douglass M.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Roberts, Mark E.; Ealing, John; Pal, Piyali] Salford Royal NHS Fdn Trust, Greater Manchester Neurosci Ctr, Dept Neurol, Salford M6 8HD, Lancs, England.
C3 Newcastle University - UK; Salford Royal NHS Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [906919]; UK NHS; Medical Research Council (UK) Centenary Early Career Award; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) [G0800674]; HEFCE/DoH Clinical Senior Lecturer Award; MRC [G0800674, G108/539, MR/K000608/1] Funding Source: UKRI
CR Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Ding Y, 2012, MITOCHONDR DNA, V23, P323, DOI 10.3109/19401736.2012.674119
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Jones AP, 2012, J PLAST RECONSTR AES, V65, PE11, DOI 10.1016/j.bjps.2011.08.004
   Kobayashi J, 2010, INTERNAL MED, V49, P479, DOI 10.2169/internalmedicine.49.2996
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Salsano E, 2011, J NEUROL SCI, V300, P165, DOI 10.1016/j.jns.2010.09.022
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Suzuki Y, 2002, DIABETES CARE, V25, P407, DOI 10.2337/diacare.25.2.407
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 22
TC 7
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD FEB 15
PY 2013
VL 325
IS 1-2
BP 165
EP 169
DI 10.1016/j.jns.2012.12.003
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 095GP
UT WOS:000315323000032
PM 23273904
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Becker, F
   Heinen, M
   Gdynia, HJ
   Lerche, H
   Kunz, WS
   Weber, YG
AF Zsurka, Gabor
   Becker, Felicitas
   Heinen, Markus
   Gdynia, Hans-Juergen
   Lerche, Holger
   Kunz, Wolfram S.
   Weber, Yvonne G.
TI Mutation in the mitochondrial tRNA<SUP>Ile</SUP> gene causes progressive myoclonus epilepsy
SO SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
LA English
DT Article
DE Myoclonic; Metabolism; Photosensitivity; Progressive; MERRF; Myoclonic epilepsy with ragged red fibres
ID features; brain
AB Purpose: The group of the rare progressive myoclonic epilepsies (PME) include a wide spectrum of mitochondrial and metabolic diseases. In juvenile and adult ages, MERRF (myoclonic epilepsy with ragged red fibres) is the most common form. The underlying genetic defect in most patients with the syndrome of MERRF is a mutation in the tRNALys gene, but mutations were also detected in the tRNAPhe gene. Method: Here, we describe a 40 year old patient with prominent myoclonic seizures since 39 years of age without a mutation in the known genes who underwent intensive clinical, genetic and functional workup. Results: The patient had a slight mental retardation and a severe progressive hearing loss based on a defect of the inner ear on both sides. Ictal electroencephalography (EEG) showed bilateral occipital and generalized spikes and polyspikes induced and aggravated by photostimulation. A cranial magnetic resonance imaging (cMRI) detected a global cortical atrophy of the brain and mild periventricular white matter lesions. The electromyography (EMG) was normal but the muscle biopsy showed abundant ragged red fibres. Sequencing of the mitochondrial DNA from the skeletal muscle biopsy revealed a novel heteroplasmic mutation (m.4279A>G) in the tRNAIle gene which was functionally relevant as tested in single skeletal muscle fibre investigations. Conclusion: Mutations in tRNAIle were described in patients with chronic progressive external ophthalmoplegia (CPEO), prominent deafness or cardiomyopathy but, up to now, not in patients with myoclonic epilepsy. The degree of heteroplasmy of this novel mitochondrial DNA mutation was 70% in skeletal muscle but only 15% in blood, pointing to the diagnostic importance of a skeletal muscle biopsy also in patients with myoclonic epilepsy. (C) 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
C1 [Zsurka, Gabor; Heinen, Markus; Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Zsurka, Gabor; Heinen, Markus; Kunz, Wolfram S.] Univ Bonn, Life & Brain Ctr, Bonn, Germany.
   [Becker, Felicitas; Lerche, Holger; Weber, Yvonne G.] Univ Tubingen, Dept Neurol & Epileptol, Hertie Inst Clin Brain Res, Tubingen, Germany.
   [Gdynia, Hans-Juergen] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.
C3 University of Bonn; University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ulm University
RP Kunz, WS (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.
EM gabor.zsurka@ukb.uni-bonn.de; felicitas.becker@uni-tuebingen.de; markus.heinen@ukb.uni-bonn.de; hansjuergen.gdynia@neurologie-kipfenberg.de; holger.lerche@uni-tuebingen.de; wolfram.kunz@ukb.uni-bonn.de; Yvonne.weber@uni-tuebingen.de
CR de Siqueira LF, 2012, J NEUROL, V257, P1612
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   KAIDO M, 1995, J NEUROL SCI, V131, P170, DOI 10.1016/0022-510X(95)00111-E
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Taniike M, 1986, BIOCH BIOPHYSICAL RE, V186, P47
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zsurka G, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2004.022566
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
NR 12
TC 13
Z9 13
U1 0
U2 8
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1059-1311
EI 1532-2688
J9 SEIZURE-EUR J EPILEP
JI Seizure
PD JUL 15
PY 2013
VL 22
IS 6
BP 483
EP 486
DI 10.1016/j.seizure.2013.03.003
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 173PU
UT WOS:000321092200015
PM 23601850
DA 2024-11-01
ER

PT J
AU Herbst, A
   Johnson, CJ
   Hynes, K
   McKenzie, D
   Aiken, JM
AF Herbst, Allen
   Johnson, Chad J.
   Hynes, Kayla
   McKenzie, Debbie
   Aiken, Judd M.
TI Mitochondrial Biogenesis Drives a Vicious Cycle of Metabolic Insufficiency and Mitochondrial DNA Deletion Mutation Accumulation in Aged Rat Skeletal Muscle Fibers
SO PLOS ONE
LA English
DT Article
ID proliferator-activated receptor; creatine-kinase; gene-expression; human-cells; wild-type; sarcopenia; alpha; respiration; disease; number
AB Aged muscles possess dysfunctional fibers that contain intracellular expansions of somatically derived mitochondrial DNA deletion mutations. At high abundance, these mutations disrupt the expression of mitochondrially-encoded protein subunits of the electron transport chain resulting in aerobic respiration deficient muscle fiber segments. These fiber segments atrophy and break contributing to the loss of muscle mass and function that occurs with age. By combining micro-dissection of individual muscle fibers with microarray analysis, we observed the response induced within these abnormal muscle fibers and detected an increase in many genes affecting metabolism and metabolic regulation. The transcriptional profile and subsequent protein validation suggested that a non-compensatory program of mitochondrial biogenesis was initiated. We hypothesized that this non-adaptive program of mitochondrial biogenesis was driving mtDNA deletion mutation accumulation. We tested this hypothesis by treating aged rats with beta-Guanidinopropionic acid, a compound that stimulates mitochondrial biogenesis. beta-Guanidinopropionic acid treatment increased muscle mitochondrial genome copy number and resulted in a 3.7 fold increase in the abundance of electron transport chain negative muscle fiber segments. We conclude that in electron transport system abnormal muscle fiber segments, a vicious cycle of metabolic insufficiency and non-compensatory mitochondrial biogenesis drive mtDNA deletion mutation accumulation.
C1 [Herbst, Allen; Aiken, Judd M.] Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Johnson, Chad J.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.
   [Hynes, Kayla; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.
C3 University of Alberta; University of Wisconsin System; University of Wisconsin Madison; University of Alberta
RP Aiken, JM (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada.
EM Judd.Aiken@ualberta.ca
FU Senior Scholar Grant from the Ellison Medical Foundation; National Institutes of Health NIA [5R01AG030423-04]
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200
   Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   EINSIEDEL LJ, 1992, J NEUROL SCI, V112, P170, DOI 10.1016/0022-510X(92)90147-D
   Evans W, 1997, J NUTR, V127, P0
   Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x
   Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Huang Da Wei, 2009, CURR PROTOC BIOINFORMATICS, VChapter 13, P0, DOI 10.1002/0471250953.bi1311s27
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921
   Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006
   Mueller-Hoecker J, 1993, VIRCHOWS ARCHIV A PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, V422, P7
   OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rosenberg IH, 1997, J NUTR, V127, P990
   ROWLEY GL, 1971, J AM CHEM SOC, V93, P5542, DOI 10.1021/ja00750a038
   Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   STADHOUDERS AM, 1994, P NATL ACAD SCI USA, V91, P5089, DOI 10.1073/pnas.91.11.5089
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230
   Tien ES, 2003, CANCER RES, V63, P5767
   TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 43
TC 17
Z9 19
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2013
VL 8
IS 3
BP 
EP 
DI 10.1371/journal.pone.0059006
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 115YY
UT WOS:000316849200126
PM 23516592
DA 2024-11-01
ER

PT J
AU El-Hattab, A
   Scaglia, F
AF El-Hattab, Ayman W.
   Scaglia, Fernando
TI Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondrial myopathy; Mitochondrial encephalomyopathy; Hepatocerebral syndrome; Mitochondrial neurogastrointestinal (MNGIE) disease; Alpers-Huttenlocher syndrome
ID neurogastrointestinal encephalomyopathy mngie; progressive external ophthalmoplegia; onset spinocerebellar ataxia; stem-cell transplantation; corrects biochemical derangements; respiratory-chain deficiency; deoxyguanosine kinase gene; multiple mtdna deletions; polg mutations; hepatocerebral form
AB Mitochondrial DNA (mtDNA) depletion syndromes (MDS) are a genetically and clinically heterogeneous group of autosomal recessive disorders that are characterized by a severe reduction in mtDNA content leading to impaired energy production in affected tissues and organs. MDS are due to defects in mtDNA maintenance caused by mutations in nuclear genes that function in either mitochondrial nucleotide synthesis (TK2, SUCLA2, SUCLG1, RRM2B, DGUOK, and TYMP) or mtDNA replication (POLG and C10orf2). MDS are phenotypically heterogeneous and usually classified as myopathic, encephalomyopathic, hepatocerebral or neurogastrointestinal. Myopathic MDS, caused by mutations in TK2, usually present before the age of 2 years with hypotonia and muscle weakness. Encephalomyopathic MDS, caused by mutations in SUCLA2, SUCLG1, or RRM2B, typically present during infancy with hypotonia and pronounced neurological features. Hepatocerebral MDS, caused by mutations in DGUOK, MPV17, POLG, or C10orf2, commonly have an early-onset liver dysfunction and neurological involvement. Finally, TYMP mutations have been associated with mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease that typically presents before the age of 20 years with progressive gastrointestinal dysmotility and peripheral neuropathy. Overall, MDS are severe disorders with poor prognosis in the majority of affected individuals. No efficacious therapy is available for any of these disorders. Affected individuals should have a comprehensive evaluation to assess the degree of involvement of different systems. Treatment is directed mainly toward providing symptomatic management. Nutritional modulation and cofactor supplementation may be beneficial. Liver transplantation remains controversial. Finally, stem cell transplantation in MNGIE disease shows promising results.
C1 [El-Hattab, Ayman W.] King Saud bin Abdulaziz Univ Hlth Sci, King Fahad Med City, Childrens Hosp, Div Med Genet,Dept Pediat, Riyadh, Saudi Arabia.
   [El-Hattab, Ayman W.] King Saud bin Abdulaziz Univ Hlth Sci, Fac Med, Riyadh, Saudi Arabia.
   [Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 King Saud Bin Abdulaziz University for Health Sciences; King Fahad Medical City; King Saud Bin Abdulaziz University for Health Sciences; Baylor College of Medicine
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,MS BCM225, Houston, TX 77030 USA.
EM fscaglia@bcm.edu
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Feranchak AP, 2007, LIVER DISEASE IN CHILDREN, V0, P190, DOI 10.1017/CBO9780511547409.012
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Hanchard NA, 2011, MOL GENET METAB, V103, P262, DOI 10.1016/j.ymgme.2011.03.006
   Hartley JN, 2012, CASE REP PEDIAT, V2012, P0, DOI 10.1155/2012/303096
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1995, NEUROPEDIATRICS, V26, P263, DOI 10.1055/s-2007-979769
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   KOSKINEN T, 1995, AM J NEURORADIOL, V16, P1427
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Merkle A N, 2012, AJNR AM J NEURORADIOL, V33, PE34, DOI 10.3174/ajnr.A2455
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Ostergaard E, 2010, EUR J PEDIATR, V169, P201, DOI 10.1007/s00431-009-1007-z
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Perez-Atayde AR, 1998, AM J SURG PATHOL, V22, P1141, DOI 10.1097/00000478-199809000-00014
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Rahman S, 2007, NEUROLOGY, V68, P1872, DOI 10.1212/01.wnl.0000265356.98295.be
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Saito K, 2012, BBA-GEN SUBJECTS, V1820, P632, DOI 10.1016/j.bbagen.2011.08.006
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Slama A, 2005, MOL GENET METAB, V86, P462, DOI 10.1016/j.ymgme.2005.09.006
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
   Taanman JW, 2002, ANN NEUROL, V52, P237, DOI 10.1002/ana.10247
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Teitelbaum JE, 2002, J PEDIATR GASTR NUTR, V35, P377, DOI 10.1097/00005176-200209000-00029
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 134
TC 225
Z9 269
U1 0
U2 67
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD APR 15
PY 2013
VL 10
IS 2
BP 186
EP 198
DI 10.1007/s13311-013-0177-6
PG 13
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 127EC
UT WOS:000317677900002
PM 23385875
DA 2024-11-01
ER

PT J
AU Fujiwara, T
   Harigae, H
AF Fujiwara, Tohru
   Harigae, Hideo
TI Pathophysiology and genetic mutations in congenital sideroblastic anemia
SO PEDIATRICS INTERNATIONAL
LA English
DT Review
DE ALAS2; congenital sideroblastic anemia; heme; iron; mitochondria
ID lactic-acidosis; causes myopathy; alas2 gene; heme; ataxia; identification; transporter; biogenesis; deficiency; mechanisms
AB Sideroblastic anemias are heterogeneous congenital and acquired disorders characterized by anemia and the presence of ringed sideroblasts in the bone marrow. Congenital sideroblastic anemia (CSA) is a rare disease caused by mutations of genes involved in heme biosynthesis, iron-sulfur [Fe-S] cluster biosynthesis, and mitochondrial protein synthesis. The most common form is X-linked sideroblastic anemia, due to mutations in the erythroid-specific -aminolevulinate synthase (ALAS2), which is the first enzyme of the heme biosynthesis pathway in erythroid cells. Other known etiologies include mutations in the erythroid specific mitochondrial transporter (SLC25A38), adenosine triphosphate (ATP) binding cassette B7 (ABCB7), glutaredoxin 5 (GLRX5), thiamine transporter SLC19A2, the RNA-modifying enzyme pseudouridine synthase (PUS1), and mitochondrial tyrosyl-tRNA synthase (YARS2), as well as mitochondrial DNA deletions. Due to its rarity, however, there have been few systematic pathophysiological and genetic investigations focusing on sideroblastic anemia. Therefore, a nationwide survey of sideroblastic anemia was conducted in Japan to investigate the epidemiology and pathogenesis of this disease. This review will cover the findings of this recent survey and summarize the current understanding of the pathophysiology and genetic mutations involved in CSA.
C1 [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 9808575, Japan.
   [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808575, Japan.
C3 Tohoku University; Tohoku University
RP Harigae, H (corresponding author), Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.
EM harigae@med.tohoku.ac.jp
FU Ministry of Health, Labour and Welfare of Japan
CR Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792
   Bekri S, 2000, BLOOD, V96, P3256
   Bekri S, 2003, BLOOD, V102, P698, DOI 10.1182/blood-2002-06-1623
   Bergmann AK, 2009, J PEDIATR-US, V155, P888, DOI 10.1016/j.jpeds.2009.06.017
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001
   COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004
   Ducamp S, 2011, HUM MUTAT, V32, P590, DOI 10.1002/humu.21455
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, V0, PP525, DOI 10.1182/asheducation-2011.1.525
   Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001
   Furuyama K, 2003, BLOOD, V101, P4623, DOI 10.1182/blood-2002-09-2804
   Furuyama K, 2002, CELL MOL BIOL, V48, P5
   Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   Harigae H, 1998, BLOOD, V91, P798, DOI 10.1182/blood.V91.3.798.798_798_805
   Harigae H, 2010, INT J HEMATOL, V92, P425, DOI 10.1007/s12185-010-0688-4
   Kaneko K, 2013, HAEMATOLOGICA, V0, P0, DOI DOI 10.3324/haematol.2013.085449
   Kannengiesser C, 2011, HAEMATOL-HEMATOL J, V96, P808, DOI 10.3324/haematol.2010.039164
   Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981
   Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372
   Ohba R, 2013, ANN HEMATOL, V92, P1, DOI 10.1007/s00277-012-1564-5
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768
   Ponka P, 2010, WILLIAMS HEMATOLOGY, V0, P865
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   WILLIAMS DM, 1983, SEMIN HEMATOL, V20, P118
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
   YUNIS AA, 1980, CLIN HAEMATOL, V9, P607
NR 36
TC 38
Z9 46
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1328-8067
EI 1442-200X
J9 PEDIATR INT
JI Pediatr. Int.
PD DEC 15
PY 2013
VL 55
IS 6
BP 675
EP 679
DI 10.1111/ped.12217
PG 5
WC Pediatrics
SC Pediatrics
GA 271BL
UT WOS:000328365300009
PM 24003969
DA 2024-11-01
ER

PT J
AU Strauss, KA
   DuBiner, L
   Simon, M
   Zaragoza, M
   Sengupta, PP
   Li, P
   Narula, N
   Dreike, S
   Platt, J
   Procaccio, V
   Ortiz-González, XR
   Puffenberger, EG
   Kelley, RI
   Morton, DH
   Narula, J
   Wallace, DC
AF Strauss, Kevin A.
   DuBiner, Lauren
   Simon, Mariella
   Zaragoza, Michael
   Sengupta, Partho P.
   Li, Peng
   Narula, Navneet
   Dreike, Sandra
   Platt, Julia
   Procaccio, Vincent
   Ortiz-Gonzalez, Xilma R.
   Puffenberger, Erik G.
   Kelley, Richard I.
   Morton, D. Holmes
   Narula, Jagat
   Wallace, Douglas C.
TI Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE ANT1; oxidative stress; mitochondrial disease; variable penetrance; oxidative phosphorylation
ID mitochondrial adp/atp carriers; hypertrophic cardiomyopathy; dilated cardiomyopathy; adaptive selection; respiratory-chain; skeletal-muscle; dna; mutations; mouse; expression
AB Mutations of both nuclear and mitochondrial DNA (mtDNA) encoded mitochondrial proteins can cause cardiomyopathy associated with mitochondria! dysfunction. Hence, the cardiac phenotype of nuclear DNA mitochondrial mutations might be modulated by mtDNA variation. We studied a 13-generation Mennonite pedigree with autosomal recessive myopathy and cardiomyopathy due to an SLC25A4 frameshift null mutation (c.523delC, p.Q175Rf5X38), which codes for the heart-muscle isoform of the adenine nucleotide translocator-1. Ten homozygous null (adenine nucleotide translocator-1(-)/(-)) patients monitored over a median of 6 years had a phenotype of progressive myocardial thickening, hyperalaninemia, lactic acidosis, exercise intolerance, and persistent adrenergic activation. Electrocardiography and echocardiography with velocity vector imaging revealed abnormal contractile mechanics, myocardial repolarization abnormalities, and impaired left ventricular relaxation. End-stage heart disease was characterized by massive, symmetric, concentric cardiac hypertrophy; widespread cardiomyocyte degeneration; overabundant and structurally abnormal mitochondria; extensive subendocardial interstitial fibrosis; and marked hypertrophy of arteriolar smooth muscle. Substantial variability in the progression and severity of heart disease segregated with maternal lineage, and sequencing of mtDNA from five maternal lineages revealed two major European haplogroups, U and H. Patients with the haplogroup U mtDNAs had more rapid and severe cardiomyopathy than those with haplogroup H.
C1 [Strauss, Kevin A.; Puffenberger, Erik G.; Morton, D. Holmes] Clin Special Children, Strasburg, PA 17579 USA.
   [Strauss, Kevin A.; DuBiner, Lauren; Puffenberger, Erik G.; Morton, D. Holmes] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17603 USA.
   [Strauss, Kevin A.; Morton, D. Holmes] Lancaster Gen Hosp, Lancaster, PA 17602 USA.
   [Simon, Mariella; Zaragoza, Michael; Dreike, Sandra; Platt, Julia; Procaccio, Vincent; Wallace, Douglas C.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.
   [Simon, Mariella; Zaragoza, Michael; Dreike, Sandra; Platt, Julia; Procaccio, Vincent; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.
   [Simon, Mariella; Zaragoza, Michael; Dreike, Sandra; Platt, Julia; Procaccio, Vincent; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
   [Sengupta, Partho P.; Narula, Jagat] Mt Sinai Med Ctr, New York, NY 10029 USA.
   [Li, Peng] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA.
   [Narula, Navneet] Weill Cornell Med Coll, Dept Pathol, New York, NY 10019 USA.
   [Dreike, Sandra] Kapiolani Med Ctr Women & Children, Honolulu, HI 96826 USA.
   [Platt, Julia] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94305 USA.
   [Procaccio, Vincent] CHU Angers, Natl Ctr Neurodegenerat & Mitochondrial Dis, Dept Biochem & Genet, F-49933 Angers, France.
   [Ortiz-Gonzalez, Xilma R.; Wallace, Douglas C.] Univ Penn, Ctr Mitochondrial & Epigenom Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.
   [Ortiz-Gonzalez, Xilma R.; Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Kelley, Richard I.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA.
C3 Franklin & Marshall College; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Icahn School of Medicine at Mount Sinai; University of California System; University of California Irvine; Cornell University; Weill Cornell Medicine; Stanford University; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Kennedy Krieger Institute; Johns Hopkins University
RP Wallace, DC (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.
EM wallaced1@email.chop.edu
FU Postdoctoral Fellowship [5T32NS007413-14]; National Institutes of Health R01 [NS41850, NS21328, DK73691]
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548
   BOULENGER J-P, 1982, ENCEPHALE, V8, P119
   Cacciapuoti F, 2011, J AM SOC HYPERTENS, V5, P449, DOI 10.1016/j.jash.2011.08.006
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   GUENTHARD J, 1995, ARCH DIS CHILD, V72, P223, DOI 10.1136/adc.72.3.223
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5
   Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501
   Lousa CD, 2005, BIOCHEMISTRY-US, V44, P4342, DOI 10.1021/bi0475370
   Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490
   Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308
   Mitchell HA, 2010, BIOCHEM PHARMACOL, V79, P801, DOI 10.1016/j.bcp.2009.10.004
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   Murdock DG, 1999, J BIOL CHEM, V274, P14429, DOI 10.1074/jbc.274.20.14429
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   NISHIZAWA M, 1987, J NEUROL SCI, V78, P189, DOI 10.1016/0022-510X(87)90060-8
   Oei TPS, 2010, BEHAV COGN PSYCHOTH, V38, P479, DOI 10.1017/S1352465810000093
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Pervanidou P, 2010, PROG BRAIN RES, V182, P149, DOI 10.1016/S0079-6123(10)82005-9
   Poole JC, 2010, BIOL CHEM, V391, P1115, DOI 10.1515/BC.2010.125
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841
   Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101
   Rollins B, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004913
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Sharieff GQ, 2006, EMERG MED CLIN N AM, V24, P195, DOI 10.1016/j.emc.2005.08.014
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Strauss KA, 2009, ANNU REV GENOM HUM G, V10, P513, DOI 10.1146/annurev-genom-082908-150040
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2013, EMERY RIMOINS PRINCI, V1, P0
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Yin H, 2005, INVEST OPHTH VIS SCI, V46, P4555, DOI 10.1167/iovs.05-0695
   Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169
NR 48
TC 80
Z9 83
U1 0
U2 9
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 26
PY 2013
VL 110
IS 9
BP 3453
EP 3458
DI 10.1073/pnas.1300690110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 102JW
UT WOS:000315841900054
PM 23401503
DA 2024-11-01
ER

PT J
AU Lax, NZ
   Gnanapavan, S
   Dowson, SJ
   Alston, CL
   He, LP
   Polvikoski, TM
   Jaros, E
   O'Donovan, DG
   Yarham, JW
   Turnbull, DM
   Dean, AF
   Taylor, RW
AF Lax, Nichola Z.
   Gnanapavan, Sharmilee
   Dowson, Sarah J.
   Alston, Charlotte L.
   He, Langping
   Polvikoski, Tuomo M.
   Jaros, Evelyn
   O'Donovan, Dominic G.
   Yarham, John W.
   Turnbull, Douglass M.
   Dean, Andrew F.
   Taylor, Robert W.
TI Early-Onset Cataracts, Spastic Paraparesis, and Ataxia Caused by a Novel Mitochondrial tRNA<SUP>Glu</SUP> (<i>MT-TE</i>) Gene Mutation Causing Severe Complex I Deficiency: A Clinical, Molecular, and Neuropathologic Study
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Mitochondrial disease; Neurodegeneration; Neurologic impairments; Neuronal complex I deficiency; tRNA mutations
ID transfer-rna mutations; stroke-like episodes; cerebellar-ataxia; external ophthalmoplegia; lactic-acidosis; point mutation; dna disease; melas; a3243g; muscle
AB Mitochondrial respiratory chain disease is associated with a spectrum of clinical presentations and considerable genetic heterogeneity. Here we report molecular genetic and neuropathologic findings from an adult with an unusual manifestation of mitochondrial DNA disease. Clinical features included early-onset cataracts, ataxia, and progressive paraparesis, with sequencing revealing the presence of a novel de novo m. 14685G>A mitochondrial tRNAGlu (MT-TE) gene mutation. Muscle biopsy showed that 13% and 34% of muscle fibers lacked cytochrome c oxidase activity and complex I subunit expression, respectively. Biochemical studies confirmed a marked decrease in complex I activity. Neuropathologic investigation revealed a large cystic lesion affecting the left putamen, caudate nucleus, and internal capsule, with evidence of marked microvacuolation, neuron loss, perivascular lacunae, and blood vessel mineralization. The internal capsule showed focal axonal loss, whereas brainstem and spinal cord showed descending anterograde degeneration in medullary pyramids and corticospinal tracts. In agreement with muscle biopsy findings, reduced complex I immunoreactivity was detected in the remaining neuronal populations, particularly in the basal ganglia and cerebellum, correlating with the neurologic dysfunction exhibited by the patient. This study emphasizes the importance of molecular genetic and postmortem neuropathologic analyses for furthering our understanding of underlying mechanisms of mitochondrial disorders.
C1 [Lax, Nichola Z.; Dowson, Sarah J.; Alston, Charlotte L.; He, Langping; Yarham, John W.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Lax, Nichola Z.; Turnbull, Douglass M.] Newcastle Univ, Sch Med, Ctr Brain Ageing & Vital, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gnanapavan, Sharmilee] Inst Neurol, Dept Neuroimmunol, London WC1N 3BG, England.
   [Polvikoski, Tuomo M.; Jaros, Evelyn] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Jaros, Evelyn] Newcastle Upon Tyne Hosp NHS Fdn Trust, UK NIHR Biomed Res Ctr Ageing & Age Related Dis, Newcastle Upon Tyne, Tyne & Wear, England.
   [O'Donovan, Dominic G.; Dean, Andrew F.] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England.
   [O'Donovan, Dominic G.] Queens Hosp, Dept Cellular Pathol, Romford, Essex, England.
C3 Newcastle University - UK; Newcastle University - UK; University of London; University College London; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [906919]; BBSRC; EPSRC; ESRC; MRC as part of the cross-council Lifelong Health and Wellbeing Initiative [G0700718]; UK NIHR Biomedical Research Centre for Ageing and Age-related Disease; UK NHS Specialist Commissioners; MRC [G0700718, G1100540, G0400074, G0502157, MR/K000608/1, G0900652] Funding Source: UKRI
CR Bene J, 2003, EUR J HUM GENET, V11, P375, DOI 10.1038/sj.ejhg.5200975
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Casali C, 1999, NEUROLOGY, V52, P1103, DOI 10.1212/WNL.52.5.1103
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Feekes JA, 2006, BRAIN, V129, P2189, DOI 10.1093/brain/awl158
   Ferrer I, 2008, GREENFIELDS NEUROPAT, V0, PP121, DOI 10.1201/b13319-4
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 38
TC 13
Z9 15
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-3069
EI 
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD FEB 15
PY 2013
VL 72
IS 2
BP 164
EP 175
DI 10.1097/NEN.0b013e31828129c5
PG 12
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 079HE
UT WOS:000314160400008
PM 23334599
DA 2024-11-01
ER

PT J
AU Hagl, S
   Kocher, A
   Schiborr, C
   Eckert, SH
   Ciobanu, I
   Birringer, M
   El-Askary, H
   Helal, A
   Khayyal, MT
   Frank, J
   Muller, WE
   Eckert, GP
AF Hagl, Stephanie
   Kocher, Alexa
   Schiborr, Christina
   Eckert, Schamim H.
   Ciobanu, Ion
   Birringer, Marc
   El-Askary, Hesham
   Helal, Amr
   Khayyal, Mohamed T.
   Frank, Jan
   Muller, Walter E.
   Eckert, Gunter P.
TI Rice bran extract protects from mitochondrial dysfunction in guinea pig brains
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Bioenergetics; Mitochondria; Brain; Nutrition; Respiration; Cardiolipin; Mitochondrial dynamics; Nitrosative stress; Oxidative stress; Rice bran extract
ID gamma-oryzanol; vitamin-e; oxidative-phosphorylation; alzheimers-disease; antioxidant activity; skeletal-muscle; dna deletions; tocotrienols; respiration; dynamics
AB Mitochondrial dysfunction plays a major role in the development of age-related neurodegenerative diseases and recent evidence suggests that food ingredients can improve mitochondrial function. In the current study we investigated the effects of feeding a stabilized rice bran extract (RBE) on mitochondrial function in the brain of guinea pigs. Key components of the rice bran are oryzanols, tocopherols and tocotrienols, which are supposed to have beneficial effects on mitochondrial function. Concentrations of a-tocotrienol and gamma-carboxyethyl hydroxychroman (CEHC) but not gamma-tocotrienol were significantly elevated in brains of RBE fed animals and thus may have provided protective properties. Overall respiration and mitochondrial coupling were significantly enhanced in isolated mitochondria, which suggests improved mitochondrial function in brains of RBE fed animals. Cells isolated from brains of RBE fed animals showed significantly higher mitochondrial membrane potential and ATP levels after sodium nitroprusside (SNP) challenge indicating resistance against mitochondrial dysfunction. Experimental evidence indicated increased mitochondrial mass in guinea pig brains, e.g. enhanced citrate synthase activity, increased cardiolipin as well as respiratory chain complex I and II and TIMM levels. In addition levels of Drp1 and fis1 were also increased in brains of guinea pigs fed RBE, indicating enhanced fission events. Thus, RBE represents a potential nutraceutical for the prevention of mitochondrial dysfunction and oxidative stress in brain aging and neurodegenerative diseases. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Hagl, Stephanie; Eckert, Schamim H.; Ciobanu, Ion; Muller, Walter E.; Eckert, Gunter P.] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany.
   [Kocher, Alexa; Schiborr, Christina; Frank, Jan] Univ Hohenheim, Stuttgart, Germany.
   [Birringer, Marc] Univ Appl Sci, Fulda, Germany.
   [El-Askary, Hesham; Khayyal, Mohamed T.] Cairo Univ, Cairo, Egypt.
   [Helal, Amr] IT&M, Giza, Egypt.
   [Frank, Jan] Univ Bonn, Bonn, Germany.
C3 Goethe University Frankfurt; University Hohenheim; Egyptian Knowledge Bank (EKB); Cairo University; University of Bonn
RP Eckert, GP (corresponding author), Goethe Univ Frankfurt, Dept Pharmacol Bioctr Niederursel, N260 Max Von Laue Str 9, D-60438 Frankfurt, Germany.
EM Gunter.Eckert@nutritional-neuroscience.com
FU EU-Egyptian Research Development & Innovation Fund [MED/2009/214-423]; German Research Foundation (DFG) [2478/4-1]
CR Aoun M, 2012, J BIOENERG BIOMEMBR, V44, P439, DOI 10.1007/s10863-012-9448-x
   Ayoub NM, 2011, CELL PROLIFERAT, V44, P516, DOI 10.1111/j.1365-2184.2011.00785.x
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berger A, 2005, EUR J NUTR, V44, P163, DOI 10.1007/s00394-004-0508-9
   Birringer M, 2002, J NUTR, V132, P3113, DOI 10.1093/jn/131.10.3113
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, PC33, DOI 10.1152/ajpcell.00243.2006
   Cicero AFG, 2001, PHYTOTHER RES, V15, P277, DOI 10.1002/ptr.907
   Das S, 2009, APPL PHYSIOL NUTR ME, V34, P124, DOI 10.1139/H08-147
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003
   Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010
   Eckert GP, 2013, NEUROCHEM INT, V62, P595, DOI 10.1016/j.neuint.2013.02.014
   Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006
   Eckert GP, 2012, MOL NEUROBIOL, V46, P136, DOI 10.1007/s12035-012-8271-z
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Frank J, 2012, AGEING RES REV, V11, P163, DOI 10.1016/j.arr.2011.06.006
   Franke C, 2007, NEUROBIOL DIS, V25, P438, DOI 10.1016/j.nbd.2006.10.004
   Fridén M, 2010, J CEREBR BLOOD F MET, V30, P150, DOI 10.1038/jcbfm.2009.200
   FUJIWARA S, 1983, CHEM PHARM BULL, V31, P645
   Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413
   Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3
   Grebenstein N, 2012, J CHROMATOGR A, V1243, P39, DOI 10.1016/j.chroma.2012.04.042
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   Hensley Kenneth, 2004, FREE RADIC BIOL MED, V36, P1
   Hoch FL, 1998, J BIOENERG BIOMEMBR, V30, P511, DOI 10.1023/A:1020576315771
   HOOD DA, 1989, EUR J BIOCHEM, V179, P275, DOI 10.1111/j.1432-1033.1989.tb14551.x
   Hütter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Igbavboa U, 2005, J NEUROL SCI, V229, P225, DOI 10.1016/j.jns.2004.11.037
   Jolitha AB, 2006, EXP GERONTOL, V41, P753, DOI 10.1016/j.exger.2006.04.007
   Juliano C, 2005, INT J PHARM, V299, P146, DOI 10.1016/j.ijpharm.2005.05.018
   Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6
   Kahlon TS, 2009, RICE BRAN PRODUCTION, V0, P[2009, c2009]
   Kaup RM, 2013, PHYTOTHER RES, V27, P264, DOI 10.1002/ptr.4705
   Kim JS, 2010, NEW BIOTECHNOL, V27, P368, DOI 10.1016/j.nbt.2010.02.018
   Kim SP, 2012, MOL NUTR FOOD RES, V56, P935, DOI 10.1002/mnfr.201200057
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658
   Laokuldilok T, 2011, J AGR FOOD CHEM, V59, P193, DOI 10.1021/jf103649q
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004
   Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021
   Müller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Mustacich DJ, 2010, FREE RADICAL BIO MED, V48, P73, DOI 10.1016/j.freeradbiomed.2009.10.024
   Navarro A, 2005, AM J PHYSIOL-REG I, V289, PR1392, DOI 10.1152/ajpregu.00834.2004
   Navarro A, 2011, AM J PHYSIOL-REG I, V300, PR827, DOI 10.1152/ajpregu.00525.2010
   Nijtmans LGJ, 2004, TOP CURR GENET, V8, P149
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI 10.1042/BSE0470037
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Park SY, 2010, ARCH PHARM RES, V33, P1589, DOI 10.1007/s12272-010-1010-y
   Parrado J, 2003, EUR J NUTR, V42, P307, DOI 10.1007/s00394-003-0424-4
   Rabol R, 2010, J CLIN ENDOCR METAB, V95, P857, DOI 10.1210/jc.2009-1844
   Ramesh BN, 2010, J ALZHEIMERS DIS, V19, P1123, DOI 10.3233/JAD-2010-1312
   Santos RX, 2010, J ALZHEIMERS DIS, V20, PS401, DOI 10.3233/JAD-2010-100666
   Schaffer S, 2012, MOL NEUROBIOL, V46, P161, DOI 10.1007/s12035-012-8282-9
   Schaffer S, 2010, PHARMACOL RES, V62, P322, DOI 10.1016/j.phrs.2010.06.004
   Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Solfrizzi V, 2011, CURR ALZHEIMER RES, V8, P520, DOI 10.2174/156720511796391809
   Stadlmann S, 2006, CELL BIOCHEM BIOPHYS, V44, P179, DOI 10.1385/CBB:44:2:179
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 74
TC 48
Z9 49
U1 0
U2 33
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD OCT 15
PY 2013
VL 76
IS 
BP 17
EP 27
DI 10.1016/j.phrs.2013.06.008
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 233WR
UT WOS:000325600700003
PM 23827162
DA 2024-11-01
ER

PT J
AU Spendiff, S
   Reza, M
   Murphy, JL
   Gorman, G
   Blakely, EL
   Taylor, RW
   Horvath, R
   Campbell, G
   Newman, J
   Lochmüller, H
   Turnbull, DM
AF Spendiff, Sally
   Reza, Mojgan
   Murphy, Julie L.
   Gorman, Grainne
   Blakely, Emma L.
   Taylor, Robert W.
   Horvath, Rita
   Campbell, Georgia
   Newman, Jane
   Lochmueller, Hanns
   Turnbull, Doug M.
TI Mitochondrial DNA deletions in muscle satellite cells: implications for therapies
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID human skeletal-muscle; kearns-sayre syndrome; real-time pcr; individual cells; point mutation; self-renewal; mtdna; encephalomyopathy; myopathy; patient
AB Progressive myopathy is a major clinical feature of patients with mitochondrial DNA (mtDNA) disease. There is limited treatment available for these patients although exercise and other approaches to activate muscle stem cells (satellite cells) have been proposed. The majority of mtDNA defects are heteroplasmic (a mixture of mutated and wild-type mtDNA present within the muscle) with high levels of mutated mtDNA and low levels of wild-type mtDNA associated with more severe disease. The culture of satellite cell-derived myoblasts often reveals no evidence of the original mtDNA mutation although it is not known if this is lost by selection or simply not present in these cells. We have explored if the mtDNA mutation is present in the satellite cells in one of the commonest genotypes associated with mitochondrial myopathies (patients with single, large-scale mtDNA deletions). Analysis of satellite cells from eight patients showed that the level of mtDNA mutation in the satellite cells is the same as in the mature muscle but is most often subsequently lost during culture. We show that there are two periods of selection against the mutated form, one early on possibly during satellite cell activation and the other during the rapid replication phase of myoblast culture. Our data suggest that the mutations are also lost during rapid replication in vivo, implying that strategies to activate satellite cells remain a viable treatment for mitochondrial myopathies in specific patient groups.
C1 [Spendiff, Sally; Murphy, Julie L.; Gorman, Grainne; Blakely, Emma L.; Taylor, Robert W.; Horvath, Rita; Campbell, Georgia; Newman, Jane; Turnbull, Doug M.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Spendiff, Sally] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada.
   [Reza, Mojgan; Horvath, Rita; Lochmueller, Hanns] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK; McGill University; Newcastle University - UK
RP Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU Medical Research Centre for Neuromuscular Diseases, Newcastle University Centre for Brain Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Medical Research Council as part of the cross-council Lifelong Health and Wellbeing Initiative [G0700718]; Wellcome Trust Centre for Mitochondrial Research [906919]; Newcastle NIHR Biomedical Research Centre; RCUK; MRC [G1000848, MR/K000608/1, G0700718] Funding Source: UKRI
CR [Anonymous], 2010, HEALTH TECHNOL ASSES, V0, P0, DOI DOI 10.1369/JHC.2010.956201
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   LANIER LL, 1986, J IMMUNOL, V136, P4480
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Rozen S, 2000, METHODS MOL BIOL, V132, P365
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 36
TC 27
Z9 28
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2013
VL 22
IS 23
BP 4739
EP 4747
DI 10.1093/hmg/ddt327
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 251ZD
UT WOS:000326973000008
PM 23847047
DA 2024-11-01
ER

PT J
AU Artuso, L
   Zoccolella, S
   Favia, P
   Amati, A
   Capozzo, R
   Logroscino, G
   Serlenga, L
   Simone, I
   Gasparre, G
   Petruzzella, V
AF Artuso, Lucia
   Zoccolella, Stefano
   Favia, Paola
   Amati, Angela
   Capozzo, Rosa
   Logroscino, Giancarlo
   Serlenga, Luigi
   Simone, Isabella
   Gasparre, Giuseppe
   Petruzzella, Vittoria
TI Mitochondrial genome aberrations in skeletal muscle of patients with motor neuron disease
SO AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION
LA English
DT Article
DE SOD1; mitochondria; DNA
ID amyotrophic-lateral-sclerosis; oxidative damage; spinal-cords; dna; gene; mutation; protein; involvement; stress; model
AB Our objective was to assess the role of defects of mitochondrial function as contributing factors in the pathogenesis and/or progression of amyotrophic lateral sclerosis (ALS); mitochondrial genome structural alterations were investigated. DNA lesions, point alterations and gross rearrangements were screened by specific applications of real-time PCR including an optimized rapid gene-specific method for the accurate quantification of mitochondrial DNA (mtDNA) lesions as well as sequencing on skeletal muscle biopsies of three patients presenting with motor neuron disease. We found a higher frequency of mtDNA lesions, including multiple deletions, particularly in the only SOD1 mutated patient as well as in a patient negative for mutations in SOD1 but presenting a severe form of the disease. The occurrence and the extent of mtDNA lesions of the cases here presented were consistent in all the examined clinical phenotypes of ALS (SOD1 related ALS, bulbar onset, spinal onset) and correlated with the severity of clinical course of the illness and with the presence of SOD1 mutation as well. In conclusion, the strong association with mtDNA damages supports the hypothesis that mitochondrial dysfunction in skeletal muscle may contribute to the pathogenesis and progression of ALS.
C1 [Artuso, Lucia; Zoccolella, Stefano; Favia, Paola; Amati, Angela; Capozzo, Rosa; Logroscino, Giancarlo; Serlenga, Luigi; Simone, Isabella; Petruzzella, Vittoria] Univ Bari Aldo Moro, Dipartimento Sci Med Base Neurosci & Organi Sanso, I-70124 Bari, Italy.
   [Gasparre, Giuseppe] Univ Bologna, UO Genet Med, Dipartimento Sci Ginecol Ostetr & Pediat, Bologna, Italy.
C3 Universita degli Studi di Bari Aldo Moro; University of Bologna
RP Petruzzella, V (corresponding author), Univ Bari Aldo Moro, Dipartimento Sci Med Base Neurosci & Organi Sanso, Piazza Giulio Cesare 11, I-70124 Bari, Italy.
EM vittoria.petruzzella@uniba.it
FU University of Bari; FIRB 'Futuro in Ricerca' project TRANSMIT
CR Andrus PK, 1998, J NEUROCHEM, V71, P2041
   Bacman SR, 2006, MOL NEUROBIOL, V33, P113, DOI 10.1385/MN:33:2:113
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x
   Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244
   Cleary JO, 2011, NEUROIMAGE, V56, P974, DOI 10.1016/j.neuroimage.2011.01.082
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Conforti FL, 2009, AMYOTROPH LATERAL SC, V10, P58, DOI 10.1080/17482960802163853
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Fischer LR, 2012, EXP NEUROL, V233, P163, DOI 10.1016/j.expneurol.2011.09.020
   Fitzmaurice PS, 1996, MUSCLE NERVE, V19, P797
   Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.0.CO;2-H
   Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489
   Hirano M, 2008, ARCH NEUROL-CHICAGO, V65, P403, DOI 10.1001/archneurol.2007.65
   Keeney PM, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-21
   Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Magrané J, 2009, ANTIOXID REDOX SIGN, V11, P1615, DOI 10.1089/ars.2009.2604
   Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5
   Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518
   Pesaresi MG, 2011, HUM MOL GENET, V20, P4196, DOI 10.1093/hmg/ddr347
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1082
   Sasaki S, 1996, NEUROSCI LETT, V204, P53, DOI 10.1016/0304-3940(96)12314-4
   Shi P, 2009, BIOCHIM BIOPHYS ACTA, V1802, P45
   SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001
   Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008
   Traub R, 2011, CURR NEUROL NEUROSCI, V11, P67, DOI 10.1007/s11910-010-0160-0
   Van Damme P, 2009, CURR OPIN NEUROL, V22, P486, DOI 10.1097/WCO.0b013e32832ffbe3
   Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   Zoccolella S, 2012, EUR J NEUROL, V19, Pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 38
TC 12
Z9 13
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2167-8421
EI 2167-9223
J9 AMYOTROPH LAT SCL FR
JI Amyotroph. Lateral Scher. Frontotemp. Degenerat.
PD MAY 15
PY 2013
VL 14
IS 4
BP 261
EP 266
DI 10.3109/21678421.2012.735239
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 143QT
UT WOS:000318883000004
PM 23134511
DA 2024-11-01
ER

PT J
AU Urbani, A
   De Canio, M
   Palmieri, F
   Sechi, S
   Bini, L
   Castagnola, M
   Fasano, M
   Modesti, A
   Roncada, P
   Timperio, AM
   Bonizzi, L
   Brunori, M
   Cutruzzolà, F
   De Pinto, V
   Di Ilio, C
   Federici, G
   Folli, F
   Foti, S
   Gelfi, C
   Lauro, D
   Lucacchini, A
   Magni, F
   Messana, I
   Pandolfi, PP
   Papa, S
   Pucci, P
   Sacchetta, P
AF Urbani, Andrea
   De Canio, Michele
   Palmieri, Ferdinando
   Sechi, Salvatore
   Bini, Luca
   Castagnola, Massimo
   Fasano, Mauro
   Modesti, Alessandra
   Roncada, Paola
   Timperio, Anna Maria
   Bonizzi, Luigi
   Brunori, Maurizio
   Cutruzzola, Francesca
   De Pinto, Vito
   Di Ilio, Carmine
   Federici, Giorgio
   Folli, Franco
   Foti, Salvatore
   Gelfi, Cecilia
   Lauro, Davide
   Lucacchini, Antonio
   Magni, Fulvio
   Messana, Irene
   Pandolfi, Pier Paolo
   Papa, Sergio
   Pucci, Piero
   Sacchetta, Paolo
TI The mitochondrial Italian Human Proteome Project initiative (mt-HPP)
SO MOLECULAR BIOSYSTEMS
LA English
DT Review
ID alzheimers-disease; neurodegenerative diseases; respiratory-chain; fatigue-syndrome; dysfunction; cancer; dna; metabolism; stress; muscle
AB Mitochondria carry maternally inherited genetic material, called the mitochondrial genome (mtDNA), which can be defined as the 25th human chromosome. The chromosome-centric Human Proteome Project (c-HPP) has initially focused its activities addressing the characterization and quantification of the nuclear encoded proteins. Following the last International HUPO Congress in Boston (September 2012) it was clear that however small the mitochondrial chromosome is, it plays an important role in many biological and physiopathological functions. Mutations in the mtDNA have been shown to be associated with dozens of unexplained disorders and the information contained in the mtDNA should be of major relevance to the understanding of many human diseases. Within this paper we describe the Italian initiative of the Human Proteome Project dedicated to mitochondria as part of both programs: chromosome-centric (c-HPP) and Biology/Disease (B/D-HPP). The mt-HPP has finally shifted the attention of the HUPO community outside the nuclear chromosomes with the general purpose to highlight the mitochondrial processes influencing the human health. Following this vision and considering the large interest and evidence collected on the non-Mendelian heredity of Homo sapiens associated with mt-chromosome and with the microbial commensal ecosystem constituting our organism we may speculate that this program will represent an initial step toward other HPP initiatives focusing on human phenotypic heredity.
C1 Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy.
   [De Canio, Michele] IRCCS Santa Lucia Fdn, Rome, Italy.
   [De Canio, Michele; Roncada, Paola; Bonizzi, Luigi] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy.
   [Palmieri, Ferdinando] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
   [Sechi, Salvatore] Natl Inst Diabet & Digest & Kidney Dis, NIH, Bethesda, MD USA.
   [Bini, Luca] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy.
   [Castagnola, Massimo] Cattolica Univ, Biochem & Clin Biochem Inst, Rome, Italy.
   [Fasano, Mauro] Univ Insubria, Dept Theoret & Appl Sci, Busto Arsizio, Italy.
   [Modesti, Alessandra] Univ Florence, Dept Biochem, Florence, Italy.
   [Roncada, Paola] Ist Sperimentale Italiano L Spallanzani, Milan, Italy.
   [Timperio, Anna Maria] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy.
   [Brunori, Maurizio; Cutruzzola, Francesca] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.
   [De Pinto, Vito] Univ Catania, Dept Biol Geol & Environm Sci, Catania, Italy.
   [Di Ilio, Carmine] CeSI Ctr Excellence Aging, Chieti, Italy.
   [Di Ilio, Carmine] Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy.
   [Federici, Giorgio] IRCCS Children Hosp Bambino Gesu, Rome, Italy.
   [Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Foti, Salvatore] Univ Catania, Dept Chem Sci, Catania, Italy.
   [Gelfi, Cecilia] SysBio Ctr Syst Biol, Milan, Italy.
   [Gelfi, Cecilia] SysBio Ctr Syst Biol, Rome, Italy.
   [Gelfi, Cecilia] IBFM CNR, Milan, Italy.
   [Lauro, Davide] Univ Roma Tor Vergata, Dept Syst Med, I-00133 Rome, Italy.
   [Lucacchini, Antonio] Univ Pisa, Dept Pharm, Pisa, Italy.
   [Magni, Fulvio] Bicocca Univ, Dept Expt Med, Milan, Italy.
   [Messana, Irene] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.
   [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.
   [Papa, Sergio] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.
   [Pucci, Piero] Univ Naples Federico II, Dipartimento Sci Chim, Naples, Italy.
   [Urbani, Andrea; Sacchetta, Paolo] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy.
C3 University of Rome Tor Vergata; IRCCS Santa Lucia; University of Milan; Universita degli Studi di Bari Aldo Moro; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Siena; Catholic University of the Sacred Heart; University of Insubria; University of Florence; IRCCS Lazzaro Spallanzani; Tuscia University; Sapienza University Rome; University of Catania; G d'Annunzio University of Chieti-Pescara; IRCCS Bambino Gesu; University of Texas System; University of Texas Health Science Center at San Antonio; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Rome Tor Vergata; University of Pisa; University of Milano-Bicocca; University of Cagliari; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; G d'Annunzio University of Chieti-Pescara
RP Urbani, A (corresponding author), Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy.
EM andrea.urbani@uniroma2.it
CR Aebersold R, 2013, J PROTEOME RES, V12, P23, DOI 10.1021/pr301151m
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Booth NE, 2012, INT J CLIN EXP MED, V5, P208
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   CIREGIA F, 2011, NEW INSIGHTS FIBROMY, V0, P149
   Cordero MD, 2011, NEW INSIGHTS FIBROMY, V0, P77
   Cossarizza A, 2003, ANTIVIR THER, V8, P315
   De Rasmo D, 2010, MITOCHONDRION, V10, P464, DOI 10.1016/j.mito.2010.04.005
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018
   Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008
   Herrmann PC, 2012, METHODS MOL BIOL, V823, P265, DOI 10.1007/978-1-60327-216-2_17
   Jiang JH, 2012, IUBMB LIFE, V64, P397, DOI 10.1002/iub.1021
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI 10.1021/pr301183aIJ
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Myhill S, 2009, INT J CLIN EXP MED, V2, P1
   Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005
   Park J H, 2000, CURR RHEUMATOL REP, V2, P131, DOI 10.1007/s11926-000-0053-3
   Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2006, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/JBB/2006/31372
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108
   Sprott H, 2004, ANN RHEUM DIS, V63, P245, DOI 10.1136/ard.2002.004762
   Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003
   Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   Wang HF, 2012, CHINESE J PHYSIOL, V55, P37, DOI 10.4077/CJP.2012.AMM107
   Warburg O, 1924, BIOCHEM Z, V152, P319, DOI 10.1085/JGP.8.6.519
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 36
TC 11
Z9 11
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 1742-206X
EI 
J9 MOL BIOSYST
JI Mol. Biosyst.
PD JUN 15
PY 2013
VL 9
IS 8
BP 1984
EP 1992
DI 10.1039/c3mb70065h
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 174ZV
UT WOS:000321199100001
PM 23712443
DA 2024-11-01
ER

PT J
AU Dolhun, R
   Presant, EM
   Hedera, P
AF Dolhun, Rachel
   Presant, Erin M.
   Hedera, Peter
TI Novel polymerase gamma (<i>POLG1</i>) gene mutation in the linker domain associated with parkinsonism
SO BMC NEUROLOGY
LA English
DT Article
DE Mitochondrial DNA polymerase gamma (POLG1); Parkinsonism; Progressive external ophthalmoplegia; Ataxia; Sensory neuropathy
ID progressive external ophthalmoplegia; familial parkinsonism; neuropathy; ataxia
AB Background: Mutations in the POLG1 gene have variable phenotypic presentations and a high degree of clinical suspicion is necessary for their recognition. Parkinsonism and ataxia are the most common movement disorders associated with POLG1 mutations but no phenotype-genotype correlation has been established. Case presentation: We identified a male patient with progressive external ophthalmoplegia who also developed a progressive bradykinesia, rigidity and camptocormia in the third decade. Parkinsonism was partially responsive to dopaminegic replacement. His father and brother had reportedly similar clinical problems. Genetic analysis identified a novel mutation p.K512M in the POLG1 gene. Conclusion: This report further expands the spectrum of POLG1-associated neurologic problems with the report of a novel mutation in the linker region of the gene, which are rarely associated with parkinsonism.
C1 [Dolhun, Rachel; Presant, Erin M.; Hedera, Peter] Vanderbilt Univ, Dept Neurol, Nashville, TN 37203 USA.
C3 Vanderbilt University
RP Hedera, P (corresponding author), Vanderbilt Univ, Dept Neurol, 465 21st Ave South,6140 MRB 3, Nashville, TN 37203 USA.
EM peter.hedera@vanderbilt.edu
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 17
TC 13
Z9 14
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2377
EI 
J9 BMC NEUROL
JI BMC Neurol.
PD JUL 18
PY 2013
VL 13
IS 
BP 
EP 
DI 10.1186/1471-2377-13-92
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 191ZW
UT WOS:000322454700001
PM 23865558
DA 2024-11-01
ER

PT J
AU Stojanovic, V
   Mayr, JA
   Sperl, W
   Barisic, N
   Doronjski, A
   Milak, G
AF Stojanovic, Vesna
   Mayr, Johannes A.
   Sperl, Wolfgang
   Barisic, Nenad
   Doronjski, Aleksandra
   Milak, Gordana
TI Infantile peripheral neuropathy, deafness, and proximal tubulopathy associated with a novel mutation of the RRM2B gene: case study
SO CROATIAN MEDICAL JOURNAL
LA English
DT Article
ID mitochondrial-dna depletion
AB Mitochondrial DNA depletion syndromes are a group of autosomal recessive hereditary disorders characterized by reduction of the amount of mitochondrial DNA in the affected tissue (muscle, liver, brain, or kidneys). We report a case of an infant with myopathy, deafness, peripheral neuropathy, nephrocalcinosis, proximal renal tubulopathy, moderate lactic acidosis, and a novel mutation of the RRM2B gene.
C1 [Stojanovic, Vesna; Barisic, Nenad; Doronjski, Aleksandra] Univ Novi Sad, Fac Med, Novi Sad 21000, Serbia.
   [Stojanovic, Vesna; Barisic, Nenad; Doronjski, Aleksandra; Milak, Gordana] Inst Child & Youth Hlth Care Vojvodina, Novi Sad, Serbia.
   [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
C3 University of Novi Sad; Paracelsus Private Medical University
RP Barisic, N (corresponding author), Univ Novi Sad, Fac Med, Inst Child & Youth Hlth Care Vojvodina, Hajduk Veljkova 10, Novi Sad 21000, Serbia.
EM barisicnenadns@gmail.com
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
NR 7
TC 13
Z9 15
U1 0
U2 8
PU MEDICINSKA NAKLADA
PI ZAGREB
PA VLASKA 69, HR-10000 ZAGREB, CROATIA
SN 0353-9504
EI 1332-8166
J9 CROAT MED J
JI Croat. Med. J.
PD DEC 15
PY 2013
VL 54
IS 6
BP 579
EP 584
DI 10.3325/cmj.2013.54.579
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 291KE
UT WOS:000329826800011
PM 24382854
DA 2024-11-01
ER

PT J
AU Spyropoulos, A
   Manford, M
   Horvath, R
   Alston, CL
   Yu-Wai-Man, P
   He, LP
   Taylor, RW
   Chinnery, PF
AF Spyropoulos, Achilles
   Manford, Mark
   Horvath, Rita
   Alston, Charlotte L.
   Yu-Wai-Man, Patrick
   He, Langping
   Taylor, Robert W.
   Chinnery, Patrick F.
TI Near-Identical Segregation of mtDNA Heteroplasmy in Blood, Muscle, Urinary Epithelium, and Hair Follicles in Twins With Optic Atrophy, Ptosis, and Intractable Epilepsy
SO JAMA NEUROLOGY
LA English
DT Article
ID complex-i deficiency; leigh-syndrome; nd6 gene; mutations; patient
AB IMPORTANCE Mitochondrial DNA (mtDNA) disorders have emerged as major causes of inherited neurologic disease. Despite being well recognized for more than 2 decades, the clinical presentation continues to broaden. The phenotypic heterogeneity is partly owing to different percentage levels of mutant mtDNA heteroplasmy in different tissues, but the factors influencing this are poorly understood. OBSERVATIONS This case report describes monozygotic male twins with ptosis, optic atrophy, and recent-onset intractable myoclonic epilepsy. The assessment of respiratory chain enzyme activities in the muscle from 1 twin revealed a severe and isolated defect involving mitochondrial complex I. Mitochondrial DNA sequencing revealed a pathogenic m.14487T>C MTND6 mutation, which was present at very high levels of heteroplasmy in muscle (84%) and lower levels in blood (15%), urinary epithelium (75%), and buccal mucosa (58%). Of particular interest, his identical twin was found to harbor very similar levels of the m. 14487T>C mutation in his blood, urine, buccal mucosa, and hair follicle DNA samples, while the presence of low levels in the mother's tissues confirmed maternal transmission. CONCLUSIONS AND RELEVANCE It was shown that m14487T>C can also cause the unusual combination of optic atrophy, ptosis, and encephalomyopathy leading to intractable seizures. Near-identical heteroplasmy levels in different tissues in both siblings support a nuclear genetic mechanism controlling the tissue segregation of mtDNA mutations.
C1 [Spyropoulos, Achilles; Horvath, Rita; Yu-Wai-Man, Patrick; Chinnery, Patrick F.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Manford, Mark] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.
   [Alston, Charlotte L.; He, Langping; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK; University of Cambridge; Newcastle University - UK
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
FU Wellcome Trust; MRC [G0701386, G1002570, MR/K000608/1] Funding Source: UKRI
CR Andrew T, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022332
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Jokinen R, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001161
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Leshinsky-Silver E, 2011, J CHILD NEUROL, V26, P476, DOI 10.1177/0883073810384615
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
NR 16
TC 15
Z9 15
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 15
PY 2013
VL 70
IS 12
BP 1552
EP 1555
DI 10.1001/jamaneurol.2013.4111
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA 295LS
UT WOS:000330118200013
PM 24126373
DA 2024-11-01
ER

PT J
AU Gaweda-Walerych, K
   Zekanowski, C
AF Gaweda-Walerych, Katarzyna
   Zekanowski, Cezary
TI The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson's Disease
SO CURRENT GENOMICS
LA English
DT Article
DE Association studies; Mitochondrial dysfunction; mtDNA haplogroups; Nuclear genes; Parkinson's disease; Polymorphism
ID transcription-factor-a; complex-i deficiency; single-nucleotide polymorphisms; onset alzheimers-disease; genome-wide association; telomere length; respiratory-chain; polymerase-gamma; substantia-nigra; skeletal-muscle
AB Mitochondrial dysfunction and oxidative stress are the major factors implicated in Parkinson's disease (PD) pathogenesis. The maintenance of healthy mitochondria is a very complex process coordinated bi-genomically. Here, we review association studies on mitochondrial haplogroups and subhaplogroups, discussing the underlying molecular mechanisms. We also focus on variation in the nuclear genes (NDUFV2, PGC-1alpha, HSPA9, LRPPRC, MTIF3, POLG1, and TFAM encoding NADH dehydrogenase (ubiquinone) flavoprotein 2, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, mortalin, leucine-rich pentatricopeptide repeat containing protein, translation initiation factor 3, mitochondrial DNA polymerase gamma, and mitochondrial transcription factor A, respectively) primarily linked to regulation of mitochondrial functioning that recently have been associated with PD risk. Possible interactions between mitochondrial and nuclear genetic variants and related proteins are discussed.
C1 [Gaweda-Walerych, Katarzyna; Zekanowski, Cezary] Polish Acad Sci, Mossakowski Med Res Ctr, Neurogenet Lab, PL-02106 Warsaw, Poland.
C3 Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences
RP Gaweda-Walerych, K (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Neurogenet Lab, Pawinskiego 5, PL-02106 Warsaw, Poland.
EM kasiawal@libero.it
CR Abahuni N, 2007, NEUROSCI LETT, V414, P126, DOI 10.1016/j.neulet.2006.12.053
   Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007
   Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609
   Anvret A, 2010, PARKINSONS DIS-US, V2010, P0, DOI 10.4061/2010/491751
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Behrouz B, 2010, NEUROSCI LETT, V486, P228, DOI 10.1016/j.neulet.2010.09.059
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI 10.2217/EPI.11.109
   Bender A, 2006, NAT GENET, V0, P0
   Berg Daniela, 2012, PARKINSONISM RELAT DISORD, V18 Suppl 1, PS195, DOI 10.1016/S1353-8020(11)70061-X
   Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Borland MK, 2009, BBA-MOL BASIS DIS, V1792, P68, DOI 10.1016/j.bbadis.2008.09.014
   Bove Jordi, 2005, NEURORX, V2, P484, DOI 10.1602/neurorx.2.3.484
   Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370
   Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2
   Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865
   Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647
   Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178
   Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618
   Clark J, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-69
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   Aguiar PDC, 2008, MOVEMENT DISORD, V23, P1228, DOI 10.1002/mds.22032
   De Mena L, 2009, J NEURAL TRANSM, V116, P1289, DOI 10.1007/s00702-009-0273-2
   Deeb SS, 2009, PPAR RES, V2009, P0, DOI 10.1155/2009/649286
   Ding HL, 2011, MOVEMENT DISORD, V26, P2283, DOI 10.1002/mds.23934
   Domínguez-Garrido E, 2009, BIOGERONTOLOGY, V10, P435, DOI 10.1007/s10522-008-9186-y
   Drozak Jakub, 2005, POSTEPY HIG MED DOSW (ONLINE), V59, P405
   Eerola J, 2010, J GERONTOL A-BIOL, V65, P1181, DOI 10.1093/gerona/glq125
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5
   Elson Joanna L, 2007, BIOCHEM J, V404, P0
   Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977
   Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Fernández-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, P0, DOI 10.1186/1471-2474-12-283
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Fujioka S, 2012, NEURODEGENER DIS, V10, P257, DOI 10.1159/000334285
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9
   Gaweda-Walerych K, 2013, ACTA NEUROBIOL EXP, V73, P199, DOI 10.55782/ane-2013-1931
   Gaweda-Walerych K, 2012, PARKINSONISM RELAT D, V18, P520, DOI 10.1016/j.parkreldis.2012.01.021
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003
   Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101
   Gu M, 1998, J NEUROL SCI, V158, P24, DOI 10.1016/S0022-510X(98)00095-1
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Günther C, 2004, NEUROSCI LETT, V369, P219, DOI 10.1016/j.neulet.2004.07.070
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hattori N, 1998, GENOMICS, V49, P52, DOI 10.1006/geno.1997.5192
   Hawkes CH, 2008, MOVEMENT DISORD, V23, P1799, DOI 10.1002/mds.22242
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Holt IJ, 2012, COLD SPRING HARB PERSPECT BIOL, V0, P0
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2011, NEUROBIOL AGING, V32, P0, DOI 10.1016/j.neurobiolaging.2011.05.022
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200
   Hwang S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022116
   Iwaasa M, 2002, J NEUROCHEM, V82, P30, DOI 10.1046/j.1471-4159.2002.00996.x
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   Jin JH, 2005, MOL BRAIN RES, V134, P119, DOI 10.1016/j.molbrainres.2004.10.003
   Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200
   Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Kenney MC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054339
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571
   Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834
   Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Lill CM, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002548
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin TK, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/824275
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Liu XM, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-104
   Lücking CB, 2003, ARCH NEUROL-CHICAGO, V60, P1253, DOI 10.1001/archneur.60.9.1253
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Maeda T, 2012, J NEUROGENET, V26, P245, DOI 10.3109/01677063.2011.651665
   Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002
   Martínez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   Maruszak A, 2012, J ALZHEIMERS DIS, V28, P309, DOI 10.3233/JAD-2011-110743
   Maruszak A, 2011, J ALZHEIMERS DIS, V27, P197, DOI 10.3233/JAD-2011-110710
   Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043
   Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Mueller EE, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0052367
   Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007
   Noack H, 2006, BBA-GEN SUBJECTS, V1760, P141, DOI 10.1016/j.bbagen.2005.12.007
   Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Pacelli C, 2011, BBA-MOL BASIS DIS, V1812, P1041, DOI 10.1016/j.bbadis.2010.12.022
   Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9
   Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Peplonska B, 2013, NEUROBIOL AGING, V34, P0, DOI 10.1016/j.neurobiolaging.2013.02.018
   Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pihlstrom L, 2013, NEUROBIOL AGING, V34, P0, DOI 10.1016/j.neurobiolaging.2012.10.019
   Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3
   Prabhakar S, 2010, NEUROEPIDEMIOLOGY, V35, P152, DOI 10.1159/000313855
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Rakovic A, 2011, PARKINSONS DIS-US, V2011, P0, DOI 10.4061/2011/153979
   Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254
   Rego-Pérez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659
   Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x
   Rideout HJ, 2013, NEUROCHEM RES, V0, P0
   Rosa A, 2008, BMC MED GENET, V9, P0, DOI 10.1186/1471-2350-9-57
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
   Sai Y, 2012, NEUROSCI BIOBEHAV R, V36, P2034, DOI 10.1016/j.neubiorev.2012.06.007
   Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8
   Sánchez-Ferrero E, 2009, PARKINSONISM RELAT D, V15, P468, DOI 10.1016/j.parkreldis.2008.09.004
   Sangar V, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00404
   Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schoeler S, 2007, CLIN NEUROPATHOL, V26, P164
   Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234
   Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353
   Sherer TB, 2002, J NEUROSCI, V22, P7006
   Shi M, 2008, J NEUROPATH EXP NEUR, V67, P117, DOI 10.1097/nen.0b013e318163354a
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571
   Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358
   Simon DK, 2010, BMC MED GENET, V11, P0, DOI 10.1186/1471-2350-11-53
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Simón-Sánchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254
   Simón-Sánchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Suissa S, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000474
   Sun C, 2007, GENOMICS, V89, P338, DOI 10.1016/j.ygeno.2006.11.005
   Surh Young-Joon, 2010, EXP NEUROBIOL, V19, P63, DOI 10.5607/en.2010.19.2.63
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Takasaki S, 2009, J BIOENERG BIOMEMBR, V41, P407, DOI 10.1007/s10863-009-9240-8
   Takasaki S, 2009, J GENET GENOMICS, V36, P425, DOI 10.1016/S1673-8527(08)60132-0
   Tan EK, 2010, NEUROLOGY, V75, P508, DOI 10.1212/WNL.0b013e3181eccfcd
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105
   Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430
   Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789
   Torroni A, 1996, GENETICS, V144, P1835
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014
   Tsuboi Yoshio, 2012, EXP NEUROBIOL, V21, P123, DOI 10.5607/en.2012.21.3.123
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Umeda S, 2000, EUR J BIOCHEM, V267, P200, DOI 10.1046/j.1432-1327.2000.00990.x
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van Nuenen BFL, 2009, MOVEMENT DISORD, V24, PS703, DOI 10.1002/mds.22635
   Vimaleswaran KS, 2008, J APPL PHYSIOL, V105, P1352, DOI 10.1152/japplphysiol.90423.2008
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867
   Warner TT, 2003, ANN NEUROL, V53, PS16, DOI 10.1002/ana.10487
   Watfa G, 2011, J NUTR HEALTH AGING, V15, P277, DOI 10.1007/s12603-010-0275-7
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Wittkopp S, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064444
   Wooten GF, 1997, ANN NEUROL, V41, P265, DOI 10.1002/ana.410410218
   Wu YR, 2010, AM J MED GENET B, V153B, P229, DOI 10.1002/ajmg.b.30977
   Zheng B, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001059
NR 238
TC 21
Z9 24
U1 0
U2 19
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1389-2029
EI 1875-5488
J9 CURR GENOMICS
JI Curr. Genomics
PD DEC 15
PY 2013
VL 14
IS 8
BP 543
EP 559
DI 
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AB6LW
UT WOS:000331901000006
PM 24532986
DA 2024-11-01
ER

PT J
AU Haack, TB
   Kopajtich, R
   Freisinger, P
   Wieland, T
   Rorbach, J
   Nicholls, TJ
   Baruffini, E
   Walther, A
   Danhauser, K
   Zimmermann, FA
   Husain, RA
   Schum, J
   Mundy, H
   Ferrero, I
   Strom, TM
   Meitinger, T
   Taylor, RW
   Minczuk, M
   Mayr, JA
   Prokisch, H
AF Haack, Tobias B.
   Kopajtich, Robert
   Freisinger, Peter
   Wieland, Thomas
   Rorbach, Joanna
   Nicholls, Thomas J.
   Baruffini, Enrico
   Walther, Anett
   Danhauser, Katharina
   Zimmermann, Franz A.
   Husain, Ralf A.
   Schum, Jessica
   Mundy, Helen
   Ferrero, Ileana
   Strom, Tim M.
   Meitinger, Thomas
   Taylor, Robert W.
   Minczuk, Michal
   Mayr, Johannes A.
   Prokisch, Holger
TI <i>ELAC2</i> Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID complex i deficiency; susceptibility gene elac2; missense mutations; lactic-acidosis; product; disease; dna; translation; metabolism; variants
AB The human mitochondrial genome encodes RNA components of its own translational machinery to produce the 13 mitochondrial-encoded subunits of the respiratory chain. Nuclear-encoded gene products are essential for all processes within the organelle, including RNA processing. Transcription of the mitochondrial genome generates large polycistronic transcripts punctuated by the 22 mitochondrial (mt) tRNAs that are conventionally cleaved by the RNase P-complex and the RNase Z activity of ELAC2 at 5' and 3' ends, respectively. We report the identification of mutations in ELAC2 in five individuals with infantile hypertrophic cardiomyopathy and complex I deficiency. We observed accumulated mtRNA precursors in affected individuals muscle and fibroblasts. Although mature mt-tRNA, mt-mRNA, and mt-rRNA levels were not decreased in fibroblasts, the processing defect was associated with impaired mitochondrial translation. Complementation experiments in mutant cell lines restored RNA processing and a yeast model provided additional evidence for the disease-causal role of defective ELAC2, thereby linking mtRNA processing to human disease.
C1 [Haack, Tobias B.; Wieland, Thomas; Walther, Anett; Danhauser, Katharina; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Haack, Tobias B.; Kopajtich, Robert; Wieland, Thomas; Walther, Anett; Schum, Jessica; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.
   [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany.
   [Rorbach, Joanna; Nicholls, Thomas J.; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge CB2 OXY, England.
   [Baruffini, Enrico; Ferrero, Ileana] Univ Parma, Dept Life Sci, I-43124 Parma, Italy.
   [Zimmermann, Franz A.; Mayr, Johannes A.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
   [Husain, Ralf A.] Jena Univ Hosp, Dept Neuropediatr, D-07740 Jena, Germany.
   [Mundy, Helen] Evelina Childrens Hosp, Guys & St Thomas NHS Fdn Trust, Ctr Inherited Metab Dis, London SE1 7EH, England.
   [Meitinger, Thomas] German Ctr Cardiovasc Res, DZHK, D-81675 Munich, Germany.
   [Meitinger, Thomas] Munich Heart Alliance, D-80802 Munich, Germany.
   [Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Parma; Paracelsus Private Medical University; Friedrich Schiller University of Jena; Guy's & St Thomas' NHS Foundation Trust; German Centre for Cardiovascular Research; Munich Heart Alliance; Newcastle University - UK
RP Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 OXY, England.
EM michal.minczuk@mrc-mbu.cam.ac.uk; prokisch@helmholtz-muenchen.de
FU UK Medical Research Council; German Bundesministerium fur Bildung und Forschung (BMBF) [SysMBo 0315494A]; E-Rare project GENOMIT [01GM1207, FWF I 920-B13]; German Network for mitochondrial disorders (mitoNET) [mitoNET 01GM1113C]; Wellcome Trust [096919/Z/11/Z]; Fondazione Telethon [GGP11011]; MRC [MC_U105697135, MR/K000608/1] Funding Source: UKRI
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393
   Christian BE, 2010, J BIOL CHEM, V285, P28379, DOI 10.1074/jbc.M110.149054
   Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004
   Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5
   Feichtinger RG, 2010, BMC CANCER, V10, P0, DOI 10.1186/1471-2407-10-149
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025
   Minagawa A, 2005, CANCER LETT, V222, P211, DOI 10.1016/j.canlet.2004.09.013
   Mineri R, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005713
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013
   Rorbach J, 2012, NUCLEIC ACIDS RES, V40, P4097, DOI 10.1093/nar/gkr1282
   Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   Rossmanith W, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0019152
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Smith MM, 2004, DEV BIOL, V266, P151, DOI 10.1016/j.ydbio.2003.10.016
   Tomari Y, 2003, J BIOL CHEM, V278, P16828, DOI 10.1074/jbc.M213216200
   Xu B, 2010, PROSTATE CANCER P D, V13, P270, DOI 10.1038/pcan.2010.6
NR 29
TC 99
Z9 109
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD AUG 8
PY 2013
VL 93
IS 2
BP 211
EP 223
DI 10.1016/j.ajhg.2013.06.006
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA 202AP
UT WOS:000323186200002
PM 23849775
DA 2024-11-01
ER

PT J
AU Milone, M
   Wong, LJ
AF Milone, Margherita
   Wong, Lee-Jun
TI Diagnosis of mitochondrial myopathies
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Review
DE Mitochondrial DNA; Mitochondrial myopathy; Progressive external ophthalmoplegia; Oxidative phosphorylation; NGS diagnosis of mitochondrial disorders; Molecular diagnosis
ID cytochrome-c-oxidase; progressive external ophthalmoplegia; comparative genomic hybridization; dna depletion; molecular diagnosis; leigh-syndrome; exercise intolerance; lactic-acidosis; skeletal-muscle; disease genes
AB Mitochondria are ubiquitous organelles and play crucial roles in vital functions, most importantly, the oxidative phosphorylation and energy metabolism. Therefore, mitochondrial dysfunction can affect multiple tissues, with muscle and nerve preferentially affected. Mitochondrial myopathy is a common clinical phenotype, which is characterized by early fatigue and/or fixed muscle weakness; rhabdomyolysis can seldom occur. Muscle biopsy often identifies signs of diseased mitochondria by morphological studies, while biochemical analysis may identify respiratory chain deficiencies. The clinical, morphological and biochemical data guide molecular analysis. Being the mitochondrial function under the control of both mitochondrial DNA and nuclear DNA, the search for mitochondrial DNA mutations and mitochondrial DNA quantitation, may not be sufficient for the molecular diagnosis of mitochondrial myopathies. Approximately 1500 nuclear genes can affect mitochondrial structure and function and the targeting of such genes may be necessary to reach the diagnosis. The identification of causative molecular defects in nuclear or mitochondrial genome leads to the definite diagnosis of mitochondrial myopathy. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Milone, Margherita] Mayo Clin, Neuromuscular Div, Dept Neurol, Rochester, MN USA.
   [Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Mayo Clinic; Baylor College of Medicine
RP Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
FU MDA
CR Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Darras BT, 2000, PEDIATR NEUROL, V22, P87, DOI 10.1016/S0887-8994(99)00133-2
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI 10.1042/bse0470115
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Emmanuele V, 2011, J NEUROL SCI, V303, P39, DOI 10.1016/j.jns.2011.01.018
   Engel AG, 2004, ULTRASTRUCTURAL CHAN, V0, P0
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   FELIG P, 1975, NEW ENGL J MED, V293, P1078
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Haller RG, 2004, NEUROLOGY, V62, P82, DOI 10.1212/WNL.62.1.82
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee IC, 2012, HUM MUTAT, V33, P1192, DOI 10.1002/humu.22095
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Massie R, 2012, J NEUROL SCI, V319, P158, DOI 10.1016/j.jns.2012.05.003
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Mastaglia FL, 2012, CURR NEUROL NEUROSCI, V12, P54, DOI 10.1007/s11910-011-0232-9
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   MITA S, 1995, MUSCLE NERVE, V0, PS113
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Nouws J, 2012, BRAIN, V135, P12, DOI 10.1093/brain/awr261
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pecina P, 2003, BBA-MOL BASIS DIS, V1639, P53, DOI 10.1016/S0925-4439(03)00127-3
   Pestronk A, 2011, CURR OPIN RHEUMATOL, V23, P595, DOI 10.1097/BOR.0b013e32834bab42
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Scharfe C, 2009, PLOS COMPUT BIOL, V5, P0, DOI 10.1371/journal.pcbi.1000374
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Talim B, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws197
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Techritz S, 2013, PROTEOMICS, V13, P179, DOI 10.1002/pmic.201100539
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Venhoff N, 2007, ANTIVIR THER, V12, P1075
   Von Kleist-Retzow JC, 2001, J MED GENET, V38, P109, DOI 10.1136/jmg.38.2.109
   Wallace DC, 2001, THE METABOLIC AND MOLECULAR BASIS OF INHERITED DISEASE, V0, P2425
   Wang J, 2011, CURR. PROTOC. HUM. GENET., V0, P0
   Wang J, 2013, GENET MED, V15, P106, DOI 10.1038/gim.2012.104
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Wong LJC, 2003, J MED GENET, V40, P0
   Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awq288
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 96
TC 55
Z9 65
U1 0
U2 33
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT 15
PY 2013
VL 110
IS 1-2
BP 35
EP 41
DI 10.1016/j.ymgme.2013.07.007
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 209ZP
UT WOS:000323799400004
PM 23911206
DA 2024-11-01
ER

PT J
AU Yasuzaki, Y
   Yamada, Y
   Kanefuji, T
   Harashima, H
AF Yasuzaki, Yukari
   Yamada, Yuma
   Kanefuji, Tsutomu
   Harashima, Hideyoshi
TI Localization of exogenous DNA to mitochondria in skeletal muscle following hydrodynamic limb vein injection
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Mitochondria disease; Mitochondrial gene delivery; Hydrodynamic limb vein injection; Mitochondrial gene therapy
ID nonviral gene delivery; naked plasmid dna; nano device mend; in-vivo; polyplex micelles; membrane-fusion; human-cells; rna import; expression; mutation
AB Mitochondrial genetic disorders are a major cause of mitochondrial diseases. It is therefore likely that mitochondrial gene therapy will be useful for the treatment of such diseases. Here, we report on the possibility of mitochondrial gene delivery in skeletal muscle using hydrodynamic limb vein (HLV) injection. The HLV injection procedure, a useful method for transgene expression in skeletal muscle, involves the rapid injection of a large volume of naked plasmid DNA (pDNA) into the distal vein of a limb. We hypothesized that the technique could be used to deliver pDNA not only to nuclei but also to mitochondria, since cytosolic pDNA that is internalized by the method may be able to overcome mitochondrial membrane. We determined if pDNA could be delivered to myofibrillar mitochondria by HLV injection by PCR analysis. Mitochondrial toxicity assays showed that the HLV injection had no influence on mitochondrial function. These findings indicate that HLV injection promises to be a useful technique for in vivo mitochondrial gene delivery. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Yasuzaki, Yukari; Yamada, Yuma; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 060, Japan.
   [Kanefuji, Tsutomu] Niigata Univ, Div Gastroenterol & Hepatol, Niigata, Japan.
C3 Hokkaido University; Niigata University
RP Harashima, H (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Kita 12, Sapporo, Hokkaido 060, Japan.
EM harasima@pharm.hokudai.ac.jp
FU Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology; Japanese Government (MEXT); Grants-in-Aid for Scientific Research [23680053] Funding Source: KAKEN
CR Akita H, 2011, J CONTROL RELEASE, V149, P58, DOI 10.1016/j.jconrel.2010.08.023
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Biswas S, 2012, J CONTROL RELEASE, V159, P393, DOI 10.1016/j.jconrel.2012.01.009
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Endo T, 2010, CELL, V142, P362, DOI 10.1016/j.cell.2010.07.024
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hagstrom JE, 2004, MOL THER, V10, P386, DOI 10.1016/j.ymthe.2004.05.004
   Hegge JO, 2010, HUM GENE THER, V21, P829, DOI 10.1089/hum.2009.172
   Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Ibrahim N, 2011, PHARM RES-DORDR, V28, P2871, DOI 10.1007/s11095-011-0516-4
   Itaka K, 2010, J CONTROL RELEASE, V143, P112, DOI 10.1016/j.jconrel.2009.12.014
   Itaka K, 2009, EUR J PHARM BIOPHARM, V71, P475, DOI 10.1016/j.ejpb.2008.09.019
   Kogure K, 2008, ADV DRUG DELIVER REV, V60, P559, DOI 10.1016/j.addr.2007.10.007
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Koulintchenko M, 2006, HUM MOL GENET, V15, P143, DOI 10.1093/hmg/ddi435
   Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128
   Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Osada K, 2012, BIOMATERIALS, V33, P325, DOI 10.1016/j.biomaterials.2011.09.046
   Owen R, 2000, HUM GENE THER, V11, P2067, DOI 10.1089/104303400750001381
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shinohara Y, 2002, EUR J BIOCHEM, V269, P5224, DOI 10.1046/j.1432-1033.2002.03229.x
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Toumi H, 2006, MOL THER, V13, P229, DOI 10.1016/j.ymthe.2005.07.699
   TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257
   Uchida S, 2011, J CONTROL RELEASE, V155, P296, DOI 10.1016/j.jconrel.2011.04.026
   Vigen KK, 2007, HUM GENE THER, V18, P257, DOI 10.1089/hum.2006.115
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109
   Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035
   Weber-Lotfi F, 2009, BBA-BIOENERGETICS, V1787, P320, DOI 10.1016/j.bbabio.2008.11.001
   Weissig V, 2011, PHARM RES-DORDR, V28, P2657, DOI 10.1007/s11095-011-0556-9
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Won YW, 2011, J CONTROL RELEASE, V152, P99, DOI 10.1016/j.jconrel.2011.01.013
   Wooddell CI, 2011, HUM GENE THER, V22, P889, DOI 10.1089/hum.2010.160
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2012, METHOD ENZYMOL, V509, P301, DOI 10.1016/B978-0-12-391858-1.00015-0
   Yan SD, 2012, J CONTROL RELEASE, V161, P763, DOI 10.1016/j.jconrel.2012.05.018
   Yu HJ, 2009, CURR OPIN MOL THER, V11, P165
   Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734
   Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79
NR 43
TC 24
Z9 24
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD DEC 28
PY 2013
VL 172
IS 3
BP 805
EP 811
DI 10.1016/j.jconrel.2013.09.029
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 272WH
UT WOS:000328492800023
PM 24100263
DA 2024-11-01
ER

PT J
AU Liu, H
   Ma, YN
   Fang, F
   Zhang, Y
   Zou, LP
   Yang, YL
   Zhu, SN
   Wang, ST
   Zheng, XF
   Pei, P
   Li, L
   Wu, HR
   Xiao, Y
   Xu, YF
   Wang, LW
   Cao, YY
   Pan, H
   Qi, Y
AF Liu, Hui
   Ma, Yinan
   Fang, Fang
   Zhang, Ying
   Zou, Liping
   Yang, Yanling
   Zhu, Sainan
   Wang, Songtao
   Zheng, Xuefei
   Pei, Pei
   Li, Lin
   Wu, Hairong
   Xiao, Yang
   Xu, Yufeng
   Wang, Liwen
   Cao, Yanyan
   Pan, Hong
   Qi, Yu
TI Wild-Type Mitochondrial DNA Copy Number in Urinary Cells as a Useful Marker for Diagnosing Severity of the Mitochondrial Diseases
SO PLOS ONE
LA English
DT Article
ID saccharomyces-cerevisiae; a3243g mutation; mtdna; melas; phenotype; population; deafness; gene; load
AB The genotype-phenotype relationship in diseases with mtDNA point mutations is still elusive. The maintenance of wild-type mtDNA copy number is essential to the normal mitochondrial oxidative function. This study examined the relationship between mtDNA copy number in blood and urine and disease severity of the patients harboring A3243G mutation. We recruited 115 A3243G patients, in which 28 were asymptomatic, 42 were oligo-symptomatic, and 45 were poly-symptomatic. Increase of total mtDNA copy number without correlation to the proportion of mutant mtDNA was found in the A3243G patients. Correlation analyses revealed that wild-type mtDNA copy number in urine was the most important factor correlated to disease severity, followed by proportion of mutant mtDNA in urine and proportion of mutant mtDNA in blood. Wild-type copy number in urine negatively correlated to the frequencies of several major symptoms including seizures, myopathy, learning disability, headache and stroke, but positively correlated to the frequencies of hearing loss and diabetes. Besides proportion of mutant mtDNA in urine, wild-type copy number in urine is also an important marker for disease severity of A3243G patients.
C1 [Liu, Hui; Ma, Yinan; Zhang, Ying; Wang, Songtao; Zheng, Xuefei; Pei, Pei; Li, Lin; Wu, Hairong; Xiao, Yang; Xu, Yufeng; Pan, Hong; Qi, Yu] Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China.
   [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China.
   [Zou, Liping] Beijing 301 Hosp, Dept Pediat, Beijing, Peoples R China.
   [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.
   [Zhu, Sainan] Peking Univ, Hosp 1, Dept Biostat, Beijing 100871, Peoples R China.
   [Wang, Liwen; Cao, Yanyan] Capital Inst Pediat, Dept Neurol, Beijing, Peoples R China.
C3 Peking University; Capital Medical University; Peking University; Peking University; Capital Institute of Pediatrics (CIP)
RP Ma, YN (corresponding author), Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China.
EM mayinan1014@163.com; qiyu0724@163.com
FU National Natural Science Foundation of China [81271256]; Capital Medical Development Foundation of China [2009-2022]
CR Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Francisci S, 1998, CURR GENET, V33, P110, DOI 10.1007/s002940050315
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503
   Oka T, 1996, DIABETIC MED, V13, P0
   Rinaldi T, 2003, GENE, V303, P63, DOI 10.1016/S0378-1119(02)01154-X
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 21
TC 14
Z9 20
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2013
VL 8
IS 6
BP 
EP 
DI 10.1371/journal.pone.0067146
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 174IX
UT WOS:000321150000034
PM 23826218
DA 2024-11-01
ER

PT J
AU Nolte, KW
   Trepels-Kottek, S
   Honnef, D
   Weis, J
   Bien, CG
   van Baalen, A
   Ritter, K
   Czermin, B
   Rudnik-Schöneborn, S
   Wagner, N
   Häusler, M
AF Nolte, Kay W.
   Trepels-Kottek, Sonja
   Honnef, Dagmar
   Weis, Joachim
   Bien, Christian G.
   van Baalen, Andreas
   Ritter, Klaus
   Czermin, Birgit
   Rudnik-Schoeneborn, Sabine
   Wagner, Norbert
   Haeusler, Martin
TI Early muscle and brain ultrastructural changes in polymerase gamma 1-related encephalomyopathy
SO NEUROPATHOLOGY
LA English
DT Article
DE Alpers-Huttenlocher disease; electron microscopy; epilepsia partialis continua; mitochondrial disorder; polymerase gamma-1 mutations
ID progressive neuronal degeneration; mitochondrial-dna polymerase; epilepsia partialis continua; alpers-disease; mutations; encephalopathy; childhood; children; patient; polg
AB Mutations affecting the mitochondrial DNA-polymerase gamma 1 (POLG1) gene have been shown to cause Alpers-Huttenlocher disease. Ultrastructural data on brain and muscle tissue are rare. We report on ultrastructural changes in brain and muscle tissue of two sisters who were compound heterozygous for the c.2243G>C and c.1879C>T POLG1 mutations. Patient 1 (16 years) presented with epilepsia partialis continua that did not respond to antiepileptic treatment. Neuroimaging showed right occipital and bithalamic changes. Light microscopy from a brain biopsy performed after 3 weeks suggested chronic encephalitis showing astro- and microgliosis as well as perivascular CD8-positive T-cells. However, immunosuppressive therapy failed to improve her condition. When her 17-year-old sister (patient 2) also developed epilepsy, an intensified search for metabolic diseases led to the diagnosis. On electron microscopy mitochondrial abnormalities mainly affecting neurons were detected in the brain biopsy of patient 1, including an increase in number and size, structural changes and globoid inclusions. In patient 2, light and electron microscopy on a muscle biopsy confirmed a mitochondrial myopathy, also revealing an increase in mitochondrial size and number, as well as globoid inclusions. Neurons may be the primary target of mitochondrial dysfunction in brains of patients with Alpers disease related to POLG1 mutations. During early disease stages, brain histopathology may be misleading, showing reactive inflammatory changes.
C1 [Nolte, Kay W.; Weis, Joachim] Rhein Westfal TH Aachen, Inst Neuropathol, Fac Med, Aachen, Germany.
   [Trepels-Kottek, Sonja; Wagner, Norbert; Haeusler, Martin] Rhein Westfal TH Aachen, Dept Pediat, Fac Med, Aachen, Germany.
   [Honnef, Dagmar] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Fac Med, Aachen, Germany.
   [Ritter, Klaus] Rhein Westfal TH Aachen, Inst Med Microbiol, Div Virol, Fac Med, Aachen, Germany.
   [Rudnik-Schoeneborn, Sabine] Rhein Westfal TH Aachen, Inst Human Genet, Fac Med, Aachen, Germany.
   [Bien, Christian G.] Univ Bonn, Dept Epileptol, Med Ctr Bonn, Bonn, Germany.
   [van Baalen, Andreas] Univ Hosp Kiel, Dept Neuropediat, Kiel, Germany.
   [Czermin, Birgit] Ctr Med Genet, Munich, Germany.
C3 RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Bonn; University of Kiel; Schleswig Holstein University Hospital
RP Häusler, M (corresponding author), Rhein Westfal TH Aachen, Dept Pediat, Univ Hosp, Pauwels St 30, D-52074 Aachen, Germany.
EM haeusler@rwth-aachen.de; haeusler@rwth-aachen.de
CR Bao XH, 2008, BRAIN DEV-JPN, V30, P295, DOI 10.1016/j.braindev.2007.08.009
   Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x
   Boes M, 2009, SEIZURE-EUR J EPILEP, V18, P232, DOI 10.1016/j.seizure.2008.08.003
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Cardenas JF, 2010, SEMIN PEDIATR NEUROL, V17, P62, DOI 10.1016/j.spen.2010.02.012
   Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216
   de Vries MC, 2008, J INHERIT METAB DIS, V31, PS299, DOI 10.1007/s10545-008-0871-4
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fabene PF, 2010, J NEUROIMMUNOL, V224, P22, DOI 10.1016/j.jneuroim.2010.05.016
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Komulainen T, 2010, BMC NEUROL, V10, P0, DOI 10.1186/1471-2377-10-29
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Nishri D, 2010, EUR J PAEDIATR NEURO, V14, P456, DOI 10.1016/j.ejpn.2010.03.002
   SANDBANK U, 1972, J NEUROL NEUROSUR PS, V35, P749, DOI 10.1136/jnnp.35.6.749
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   SCHRODER JM, 1985, J NEUROL, V232, P83, DOI 10.1007/BF00313906
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Takahashi Y, 2003, NEUROLOGY, V61, P891, DOI 10.1212/01.WNL.0000086819.53078.70
   Tezer FI, 2008, EPILEPTIC DISORD, V10, P306, DOI 10.1684/epd.2008.0220
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   van Baalen A, 2010, EPILEPSIA, V51, P1323, DOI 10.1111/j.1528-1167.2010.02535.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   WEIS J, 1995, MUSCLE NERVE, V18, P175, DOI 10.1002/mus.880180205
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
NR 32
TC 6
Z9 8
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD FEB 15
PY 2013
VL 33
IS 1
BP 59
EP 67
DI 10.1111/j.1440-1789.2012.01317.x
PG 9
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 083NT
UT WOS:000314472000007
PM 22537151
DA 2024-11-01
ER

PT J
AU Tschampa, HJ
   Urbach, H
   Greschus, S
   Kunz, WS
   Kornblum, C
AF Tschampa, Henriette J.
   Urbach, Horst
   Greschus, Susanne
   Kunz, Wolfram S.
   Kornblum, Cornelia
TI Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A&gt;G <i>MTTL1</i> mutation
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE MELAS; Mitochondrial myopathy; MRI; Basal ganglia; Stroke-like episodes
ID stroke-like episodes; delayed ischemic hyperintensity; melas syndrome; blood; mri; dna; ct; caudoputamen; features
AB Stroke-like lesions (SLL) are common radiological findings in patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (SLE; MELAS) harboring the m.3243A > G MTTL1 mutation. Imaging patterns in the m.3243A > G mutation carriers with encephalopathies lacking SLE have not been systematically examined to date. The aim of this study was to analyze brain imaging findings in encephalopathies associated with the m.3243A > G mutation irrespective of the presence or absence of SLE. Brain MRI and cranial CT scans from 11 m.3243A > G mutation carriers with encephalopathies were analyzed by two neuroradiologists in consensus. We evaluated stroke-like lesions (SLL), deep grey matter (DGM) changes on T1- and T2-weighted MR images, calcification on CT, brain atrophy, and white matter (WM) changes. SLL were present in all patients showing the full MELAS phenotype with SLE (4/11). Seven patients did not show SLE. DGM changes with T1 hyperintensity and T2 hypointensity were a distinctive finding in most patients (7/11) and present in the majority of m.3243A > G mutation carriers lacking SLE (5/7). DGM changes were also seen in half of our MELAS patients with SLL (2/4), though less pronounced. Brain atrophy was a prominent finding in general and accentuated in the cerebellum. In contrast, WM changes were rather mild and more prevalent and pronounced in MELAS. Our data stress that the distinction between MELAS with SLE and m.3243A > G mutation carriers lacking SLE is rather artificial. In clinical practice, mitochondrial disorders associated with the m.3243A > G mutation should be taken into consideration in encephalopathies with DGM changes, even when SLE and SLL are lacking.
C1 [Tschampa, Henriette J.; Urbach, Horst; Greschus, Susanne] Univ Bonn, Dept Radiol Neuroradiol, Bonn, Germany.
   [Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Kornblum, Cornelia] Univ Bonn, Dept Neurol, Bonn, Germany.
C3 University of Bonn; University of Bonn; University of Bonn
RP Tschampa, HJ (corresponding author), Univ Bonn, Dept Radiol Neuroradiol, Bonn, Germany.
EM henriette.tschampa@ukb.uni-bonn.de
CR BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   BOYKO OB, 1992, AM J NEURORADIOL, V13, P1439
   Chung SH, 2005, NEUROLOGY, V65, PE19, DOI 10.1212/01.wnl.0000184112.34211.d1
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Fujioka M, 2003, ANN NEUROL, V54, P732, DOI 10.1002/ana.10751
   Fujioka M, 1999, STROKE, V30, P1043, DOI 10.1161/01.STR.30.5.1043
   Fujioka M, 1999, STROKE, V30, P1038, DOI 10.1161/01.STR.30.5.1038
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gutierrez LG, 2010, NEURORADIOLOGY, V52, P949, DOI 10.1007/s00234-010-0728-z
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   VANDERKNAAP MS, 1993, NEUROPEDIATRICS, V24, P143, DOI 10.1055/s-2008-1071532
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
NR 32
TC 27
Z9 29
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD APR 15
PY 2013
VL 260
IS 4
BP 1071
EP 1080
DI 10.1007/s00415-012-6763-4
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA 122XM
UT WOS:000317351900016
PM 23196335
DA 2024-11-01
ER

PT J
AU Roos, S
   Darin, N
   Kollberg, G
   Grönlund, MA
   Tulinius, M
   Holme, E
   Moslemi, AR
   Oldfors, A
AF Roos, Sara
   Darin, Niklas
   Kollberg, Gittan
   Gronlund, Marita Andersson
   Tulinius, Mar
   Holme, Elisabeth
   Moslemi, Ali-Reza
   Oldfors, Anders
TI A novel mitochondrial tRNA Arg mutation resulting in an anticodon swap in a patient with mitochondrial encephalomyopathy
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mitochondrial diseases; mtDNA; PCR-RFLP; retinal dystrophy
ID childhood; trna(arg); myopathy; genes; mtdna
AB We report a mutation in the anticodon of the tRNA(Arg) gene (m.10437G>A),resulting in an anticodon swap from GCU to ACU, which is the anticodon of tRNA(Trp), in a boy with mitochondrial encephalomyopathy. Enzyme histochemical analysis of muscle tissue and biochemical analysis of isolated muscle mitochondria demonstrated cytochrome c oxidase (COX) deficiency. Restriction fragment length polymorphism analysis showed that 90% of muscle and 82% of urinary epithelium mtDNA harbored the mutation. The mutation was not identified in blood, fibroblasts, hair roots, or buccal epithelial cells and it was absent in the asymptomatic mother, suggesting that it was a de novo mutation. Single-fiber PCR analysis showed that the proportion of mutated mtDNA correlated with enzyme histochemical COX deficiency. This mutation adds to the three previously described disease-causing mutations in tRNA(Arg), but it is the first mutation occurring in the anticodon of tRNA(Arg). European Journal of Human Genetics (2013) 21, 571-573; doi:10.1038/ejhg.2012.153; published online 11 July 2012
C1 [Roos, Sara; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Darin, Niklas; Tulinius, Mar] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, SE-41345 Gothenburg, Sweden.
   [Kollberg, Gittan; Holme, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem, SE-41345 Gothenburg, Sweden.
   [Gronlund, Marita Andersson] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol Ophthalmol, Dept Pediat Ophthalmol, SE-41345 Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, Gula Straket 8, SE-41345 Gothenburg, Sweden.
EM sara.roos@gu.se
FU Swedish Research Council [07122]
CR Abu-Amero EK, 2006, J CHILD NEUROL, V21, P971, DOI 10.2310/7010.2006.00208
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Oldfors Anders, 2007, HANDB CLIN NEUROL, V86, P125, DOI 10.1016/S0072-9752(07)86006-4
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zanssen S, 1997, MOL CELL BIOCHEM, V174, P231, DOI 10.1023/A:1006864709515
NR 13
TC 7
Z9 7
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAY 15
PY 2013
VL 21
IS 5
BP 571
EP 573
DI 10.1038/ejhg.2012.153
PG 3
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 127VQ
UT WOS:000317727300016
PM 22781096
DA 2024-11-01
ER

PT J
AU Tzoufi, M
   Makis, A
   Chaliasos, N
   Nakou, I
   Siomou, E
   Tsatsoulis, A
   Zikou, A
   Argyropoulou, M
   Bonnefont, JP
   Siamopoulou, A
AF Tzoufi, Meropi
   Makis, Alexandros
   Chaliasos, Nikolaos
   Nakou, Iliada
   Siomou, Ekaterini
   Tsatsoulis, Agathoklis
   Zikou, Anastasia
   Argyropoulou, Maria
   Bonnefont, Jean Paul
   Siamopoulou, Antigone
TI A rare case report of simultaneous presentation of myopathy, Addison's disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE Kearns-Sayre syndrome; Fanconi syndrome; Addison's disease; Primary hypoparathyroidism
ID mitochondrial-dna; pediatric-patients; deletion
AB Kearns-Sayre syndrome (KSS) is a rare mitochondrial DNA deletion syndrome defined as the presence of ophthalmoplegia, pigmentary retinopathy, onset less than age 20 years, and one of the following: cardiac conduction defects, cerebellar syndrome, or cerebrospinal fluid protein above 100 mg/dl. KSS may affect many organ systems causing endocrinopathies, encephalomyopathy, sensorineural hearing loss, and renal tubulopathy. Clinical presentation at diagnosis is quite heterogeneous and, usually, few organs are affected with progression to generalized disease early in adulthood. We present the case of a boy with KSS presenting at the age of 5 years with myopathy, Addison's disease, primary hypoparathyroidism, and Fanconi syndrome. The proper replacement treatment along with the administration of mitochondrial metabolism-improving agents had a brief ameliorating effect, but gradual severe multisystemic deterioration was inevitable over the next 5 years. Conclusion This report highlights the fact that in case of simultaneous presentation of polyendocrinopathies and renal disease early in childhood, KSS should be considered.
C1 [Tzoufi, Meropi; Makis, Alexandros; Chaliasos, Nikolaos; Nakou, Iliada; Siomou, Ekaterini; Siamopoulou, Antigone] Univ Ioannina, Sch Med, Dept Child Hlth, GR-45110 Ioannina, Greece.
   [Tsatsoulis, Agathoklis] Univ Ioannina, Sch Med, Dept Endocrinol, GR-45110 Ioannina, Greece.
   [Zikou, Anastasia; Argyropoulou, Maria] Univ Ioannina, Sch Med, Dept Radiol, GR-45110 Ioannina, Greece.
   [Bonnefont, Jean Paul] Univ Paris 05, INSERM U781, Paris, France.
   [Bonnefont, Jean Paul] Hosp Necker Enfants Malad, Serv Genet Med, Paris, France.
C3 University of Ioannina; University of Ioannina; University of Ioannina; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP
RP Makis, A (corresponding author), Univ Ioannina, Sch Med, Dept Child Hlth, POB 1187, GR-45110 Ioannina, Greece.
EM amakis@cc.uoi.gr
CR Artuch R, 1998, HORM RES, V50, P99, DOI 10.1159/000023243
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   DeCoo IFM, 1997, J NEUROL SCI, V149, P37, DOI 10.1016/S0022-510X(97)05366-5
   Katsanos KH, 2001, AM J NEPHROL, V21, P150, DOI 10.1159/000046239
   Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40
   Mihai Cristina Maria, 2009, J MED CASE REP, V3, P101, DOI 10.1186/1752-1947-3-101
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   Wilichowski E, 1997, PEDIATR RES, V41, P193, DOI 10.1203/00006450-199702000-00007
   Wilmer MJ, 2011, PEDIATR NEPHROL, V26, P205, DOI 10.1007/s00467-010-1627-6
   Zaffanello M, 2005, MINERVA PEDIATR, V57, P143
NR 14
TC 21
Z9 25
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6199
EI 
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD APR 15
PY 2013
VL 172
IS 4
BP 557
EP 561
DI 10.1007/s00431-012-1798-1
PG 5
WC Pediatrics
SC Pediatrics
GA 113QM
UT WOS:000316682700018
PM 22875312
DA 2024-11-01
ER

PT J
AU Hagen, CM
   Aidt, FH
   Hedley, PL
   Jensen, MK
   Havndrup, O
   Kanters, JK
   Moolman-Smook, JC
   Larsen, SO
   Bundgaard, H
   Christiansen, M
AF Hagen, Christian M.
   Aidt, Frederik H.
   Hedley, Paula L.
   Jensen, Morten K.
   Havndrup, Ole
   Kanters, Jorgen K.
   Moolman-Smook, Johanna C.
   Larsen, Severin O.
   Bundgaard, Henning
   Christiansen, Michael
TI Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population
SO PLOS ONE
LA English
DT Article
ID oxidative stress; dna haplogroups; heart-failure; mutations; disease; superoxide; longevity; organization; radicals; genes
AB Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by mutations in genes coding for proteins involved in sarcomere function. The disease is associated with mitochondrial dysfunction. Evolutionarily developed variation in mitochondrial DNA (mtDNA), defining mtDNA haplogroups and haplogroup clusters, is associated with functional differences in mitochondrial function and susceptibility to various diseases, including ischemic cardiomyopathy. We hypothesized that mtDNA haplogroups, in particular H, J and K, might modify disease susceptibility to HCM. Mitochondrial DNA, isolated from blood, was sequenced and haplogroups identified in 91 probands with HCM. The association with HCM was ascertained using two Danish control populations. Haplogroup H was more prevalent in HCM patients, 60% versus 46% (p = 0.006) and 41% (p = 0.003), in the two control populations. Haplogroup J was less prevalent, 3% vs. 12.4% (p = 0.017) and 9.1%, (p = 0.06). Likewise, the UK haplogroup cluster was less prevalent in HCM, 11% vs. 22.1% (p = 0.02) and 22.8% (p = 0.04). These results indicate that haplogroup H constitutes a susceptibility factor and that haplogroup J and haplogroup cluster UK are protective factors in the development of HCM. Thus, constitutive differences in mitochondrial function may influence the occurrence and clinical presentation of HCM. This could explain some of the phenotypic variability in HCM. The fact that haplogroup H and J are also modifying factors in ischemic cardiomyopathy suggests that mtDNA haplotypes may be of significance in determining whether a physiological hypertrophy develops into myopathy. mtDNA haplotypes may have the potential of becoming significant biomarkers in cardiomyopathy.
C1 [Hagen, Christian M.; Aidt, Frederik H.; Hedley, Paula L.; Larsen, Severin O.; Christiansen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.
   [Hagen, Christian M.; Kanters, Jorgen K.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.
   [Hedley, Paula L.; Moolman-Smook, Johanna C.] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa.
   [Jensen, Morten K.; Bundgaard, Henning] Rigshosp, Dept Med B, Ctr Heart, DK-2100 Copenhagen, Denmark.
   [Havndrup, Ole] Roskilde Hosp, Dept Cardiol, Roskilde, Denmark.
   [Kanters, Jorgen K.] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark.
C3 Statens Serum Institut; University of Copenhagen; Stellenbosch University; University of Copenhagen; Rigshospitalet; University of Copenhagen; Herlev & Gentofte Hospital
RP Christiansen, M (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.
EM mic@ssi.dk
FU Statens Serum Institut; LUNDBECKFONDEN [R67-A6552]; Danish Strategic Research Council
CR Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015
   Andersen PS, 2009, HUM MUTAT, V30, P363, DOI 10.1002/humu.20862
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Beckstead WA, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005836
   Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fernández-Caggiano M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044128
   Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4
   Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Grieve DJ, 2003, EUR HEART J, V24, P2161, DOI 10.1016/j.ehj.2003.10.015
   Havndrup O, 2010, EUR J HEART FAIL, V12, P535, DOI 10.1093/eurjhf/hfq073
   Hedley PL, 2011, J NEGAT RESULTS BIOM, V10, P0, DOI 10.1186/1477-5751-10-12
   Ide T, 2000, CIRC RES, V86, P152, DOI 10.1161/01.RES.86.2.152
   Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002
   Kalman B, 1999, ACTA NEUROL SCAND, V99, P16
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536
   Marcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007
   MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305
   Martínez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005
   Mikkelsen M, 2010, FORENSIC SCI INT-GEN, V4, PE87, DOI 10.1016/j.fsigen.2009.07.007
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   PINOS T, 2011, AGE DORDR, V0, P0
   Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841
   Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240
   Rosca MG, 2009, J BIOENERG BIOMEMBR, V41, P107, DOI 10.1007/s10863-009-9215-9
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Seelert H, 2009, BBA-BIOENERGETICS, V1787, P657, DOI 10.1016/j.bbabio.2009.02.028
   TENCATE FJ, 1979, AM J CARDIOL, V43, P731, DOI 10.1016/0002-9149(79)90071-7
   Towbin JA, 2009, PACE, V32, PS23, DOI 10.1111/j.1540-8159.2009.02381.x
   Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280
   Valenti L, 2004, J MED GENET, V41, P946, DOI 10.1136/jmg.2004.019588
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019
   Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005
   Zielonka J, 2008, FREE RADICAL BIO MED, V45, P1217, DOI 10.1016/j.freeradbiomed.2008.07.025
NR 45
TC 28
Z9 31
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD AUG 5
PY 2013
VL 8
IS 8
BP 
EP 
DI 10.1371/journal.pone.0071904
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 218XC
UT WOS:000324465000231
PM 23940792
DA 2024-11-01
ER

PT J
AU Katsetos, CD
   Koutzaki, S
   Melvin, JJ
AF Katsetos, Christos D.
   Koutzaki, Sirma
   Melvin, Joseph J.
TI Mitochondrial Dysfunction in Neuromuscular Disorders
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID congenital muscular-dystrophy; amyotrophic-lateral-sclerosis; respiratory-chain dysfunction; skeletal-muscle fibers; mdx mouse model; inflammatory myopathy; oxidative stress; centronuclear myopathy; peripheral neuropathy; lipid-metabolism
AB This review deciphers aspects of mitochondrial (mt) dysfunction among nosologically, pathologically, and genetically diverse diseases of the skeletal muscle, lower motor neuron, and peripheral nerve, which fall outside the traditional realm of mt cytopathies. Special emphasis is given to well-characterized mt abnormalities in collagen VI myopathies (Ullrich congenital muscular dystrophy and Bethlem myopathy), megaconial congenital muscular dystrophy, limb-girdle muscular dystrophy type 2 (calpainopathy), centronuclear myopathies, core myopathies, inflammatory myopathies, spinal muscular atrophy, Charcot-Marie-Tooth neuropathy type 2, and drug-induced peripheral neuropathies. Among inflammatory myopathies, mt abnormalities are more prominent in inclusion body myositis and a subset of polymyositis with mt pathology, both of which are refractory to corticosteroid treatment. Awareness is raised about instances of phenotypic mimicry between cases harboring primary mtDNA depletion, in the context of mtDNA depletion syndrome, and established neuromuscular disorders such as spinal muscular atrophy. A substantial body of experimental work, derived from animal models, attests to a major role of mitochondria (mt) in the early process of muscle degeneration. Common mechanisms of mt-related cell injury include dysregulation of the mt permeability transition pore opening and defective autophagy. The therapeutic use of mt permeability transition pore modifiers holds promise in various neuromuscular disorders, including muscular dystrophies. (C) 2013 Published by Elsevier Inc.
C1 [Katsetos, Christos D.; Melvin, Joseph J.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pediat, Philadelphia, PA 19104 USA.
   [Katsetos, Christos D.; Koutzaki, Sirma] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Katsetos, Christos D.; Melvin, Joseph J.] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.
C3 Drexel University; Drexel University; Drexel University
RP Katsetos, CD (corresponding author), St Christophers Hosp Children, Neurol Sect, 3601 A St, Philadelphia, PA 19134 USA.
EM Christos.Katsetos@drexelmed.edu
FU St. Christophers Foundation for Children
CR AFIFI AK, 1973, J NEUROL NEUROSUR PS, V36, P643, DOI 10.1136/jnnp.36.4.643
   Allison WS, 2009, METHODS ENZYMOLOGY A, V456, P0
   Angelin A, 2008, BBA-BIOENERGETICS, V1777, P893, DOI 10.1016/j.bbabio.2008.03.026
   Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104
   [Anonymous], 1999, GENEREVIEWS, V0, P0
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Baloh RH, 2008, NEUROSCIENTIST, V14, P12, DOI 10.1177/1073858407307354
   Baron D, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026952
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058
   Bennett GJ, 2010, ONCOLOGIST, V15, P9, DOI 10.1634/theoncologist.2009-S503
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386
   Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395
   Bernardi P, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011387
   Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009
   Bevilacqua JA, 2009, ACTA NEUROPATHOL, V117, P283, DOI 10.1007/s00401-008-0472-1
   Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588
   Broglio L, 2010, NEUROLOGIST, V16, P340, DOI 10.1097/NRL.0b013e3181d35b39
   Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112
   Burelle Y, 2010, J MOL CELL CARDIOL, V48, P310, DOI 10.1016/j.yjmcc.2009.09.004
   Calore EE, 1994, PATHOLOGICA (GENOA), V86, P649
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chowdhury SKR, 2013, NEUROBIOL DIS, V51, P56, DOI 10.1016/j.nbd.2012.03.016
   Chowdhury SKR, 2011, MITOCHONDRION, V11, P845, DOI 10.1016/j.mito.2011.06.007
   Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199
   Constantin B, 2006, J MUSCLE RES CELL M, V27, P375, DOI 10.1007/s10974-006-9085-2
   Corti S, 2009, J NEUROL SCI, V276, P170, DOI 10.1016/j.jns.2008.09.030
   Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Dalton JC, 2006, GENEREVIEWS, V0, P0
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   DOBKIN BH, 1976, NEUROLOGY, V26, P754, DOI 10.1212/WNL.26.8.754
   Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413
   Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261
   Eschbach J, 2013, NEUROBIOL DIS, V58, P220, DOI 10.1016/j.nbd.2013.05.015
   EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649
   Ferrier J, 2013, CURR PAIN HEADACHE R, V17, P0, DOI 10.1007/s11916-013-0364-5
   Fidzianska A, 2012, MUSCLE NERVE, V46, P125, DOI 10.1002/mus.23365
   Frank S, 2006, ACTA NEUROPATHOL, V111, P93, DOI 10.1007/s00401-005-0002-3
   GANNOUNZAKI L, 1995, FEBS LETT, V375, P268, DOI 10.1016/0014-5793(95)01225-4
   Gardner K, 2013, TOXICOL PATHOL, V0, P0
   Gayathri N, 2011, INDIAN J PATHOL MICR, V54, P350, DOI 10.4103/0377-4929.81636
   Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147
   Giacomotto J, 2013, HUM MOL GENET, V22, P4562, DOI 10.1093/hmg/ddt302
   GIMENO A, 1973, J NEUROL NEUROSUR PS, V36, P806, DOI 10.1136/jnnp.36.5.806
   Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013
   GOBERNADO JM, 1980, J NEUROL NEUROSUR PS, V43, P546, DOI 10.1136/jnnp.43.6.546
   Godin Richard, 2012, J PHYSIOL, V590, P5487, DOI 10.1113/jphysiol.2012.240390
   González-Cabo P, 2013, J NEUROCHEM, V126, P53, DOI 10.1111/jnc.12303
   Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247
   Herasse M, 2007, J NEUROPATH EXP NEUR, V66, P57, DOI 10.1097/NEN.0b013e31802d47ce
   Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489
   Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625
   Hicks D, 2009, BRAIN, V132, P147, DOI 10.1093/brain/awn289
   Hirano M, 2008, ARCH NEUROL-CHICAGO, V65, P403, DOI 10.1001/archneurol.2007.65
   Hnia K, 2011, J CLIN INVEST, V121, P70, DOI 10.1172/JCI44021
   Huber N, 2013, EMBO REP, V14, P545, DOI 10.1038/embor.2013.56
   Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019
   Jahnke VE, 2012, SKELET MUSCLE, V2, P0, DOI 10.1186/2044-5040-2-16
   Janes K, 2013, PAIN, V13, P0
   Jongpiputvanich S, 2005, J CLIN NEUROSCI, V12, P426, DOI 10.1016/j.jocn.2004.06.014
   Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005
   Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P216, DOI 10.1016/j.spen.2013.09.003
   Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002
   Kramerova I, 2009, HUM MOL GENET, V18, P3194, DOI 10.1093/hmg/ddp257
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320
   Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267
   Mancuso M, 2003, ACTA NEUROPATHOL, V105, P621, DOI 10.1007/s00401-003-0699-9
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mason KE, 2005, ARCH BIOCHEM BIOPHYS, V437, P138, DOI 10.1016/j.abb.2005.03.004
   Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339
   Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105
   MHIRI C, 1991, ANN NEUROL, V29, P606, DOI 10.1002/ana.410290607
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Molnar M, 1998, ACTA NEUROPATHOL, V96, P41, DOI 10.1007/s004010050858
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Moyle G, 2005, ANTIVIR THER S2, V10, P0
   Moyle Graeme, 2004, J HIV THER, V9, P45
   Nasu S, 2013, CLIN NEUROPHYSIOL, V13, P0
   Nicolson GL, 2008, CLIN EXP METASTAS, V25, P161, DOI 10.1007/s10585-007-9129-z
   Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217
   Nomura H, 2001, NEUROPATHOLOGY, V21, P212, DOI 10.1046/j.1440-1789.2001.00388.x
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Oldfors A, 1999, CURR OPIN NEUROL, V12, P527, DOI 10.1097/00019052-199910000-00006
   Ouvrier R, 2010, DEV MED CHILD NEUROL, V52, P328, DOI 10.1111/j.1469-8749.2010.03613.x
   Palau F, 2009, ADV EXP MED BIOL, V652, P129, DOI 10.1007/978-90-481-2813-6_9
   Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004
   Pellegrini C, 2013, J CELL PHYSIOL, V228, P1323, DOI 10.1002/jcp.24290
   Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415
   Pestronk A, 2011, CURR OPIN RHEUMATOL, V23, P595, DOI 10.1097/BOR.0b013e32834bab42
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Ríos PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467
   Rubio-Gozalbo ME, 1999, NEUROLOGY, V52, P383, DOI 10.1212/WNL.52.2.383
   Rusconi F, 2010, NEUROBIOL DIS, V38, P273, DOI 10.1016/j.nbd.2010.01.017
   Sabatelli P, 2012, J CELL PHYSIOL, V227, P2927, DOI 10.1002/jcp.23039
   SCHOLTE HR, 1980, J NEUROL SCI, V45, P217, DOI 10.1016/0022-510X(80)90167-7
   Schroder JM, 1997, MOL CELL BIOCHEM, V174, P277, DOI 10.1023/A:1006829129079
   Sewry CA, 2008, CURR OPIN NEUROL, V21, P569, DOI 10.1097/WCO.0b013e32830f93c7
   Siepmann T, 2013, ANN DIAGN PATHOL, V17, P183, DOI 10.1016/j.anndiagpath.2012.10.004
   Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195
   Talwalkar SS, 2006, CLIN NEUROPATHOL, V25, P180
   Tecilazich F, 2013, J VASC SURG, V57, P997, DOI 10.1016/j.jvs.2012.10.011
   Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Tinelli E, 2013, HUM MOL GENET, V22, P4417, DOI 10.1093/hmg/ddt292
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041
   Verkhratsky A, 2008, CELL CALCIUM, V44, P112, DOI 10.1016/j.ceca.2007.11.010
   Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012
   Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1
   Wanschitz J, 2002, CLIN NEUROPATHOL, V21, P220
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   Zenker J, 2013, TRENDS NEUROSCI, V36, P439, DOI 10.1016/j.tins.2013.04.008
   Zorzano A, 2009, CURR OPIN DRUG DISC, V12, P597
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 132
TC 55
Z9 64
U1 0
U2 16
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD SEP 15
PY 2013
VL 20
IS 3
BP 202
EP 215
DI 10.1016/j.spen.2013.10.010
PG 14
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 269SK
UT WOS:000328262000006
PM 24331362
DA 2024-11-01
ER

PT J
AU Bonnen, PE
   Yarham, JW
   Besse, A
   Wu, P
   Faqeih, EA
   Al-Asmari, AM
   Saleh, MAM
   Eyaid, W
   Hadee, A
   He, LP
   Smith, F
   Yau, S
   Simcox, EM
   Miwa, S
   Donti, T
   Abu-Amero, KK
   Wong, LJ
   Craigen, WJ
   Graham, BH
   Scott, KL
   McFarland, R
   Taylor, RW
AF Bonnen, Penelope E.
   Yarham, John W.
   Besse, Arnaud
   Wu, Ping
   Faqeih, Eissa A.
   Al-Asmari, Ali Mohammad
   Saleh, Mohammad A. M.
   Eyaid, Wafaa
   Hadee, Alrukban
   He, Langping
   Smith, Frances
   Yau, Shu
   Simcox, Eve M.
   Miwa, Satomi
   Donti, Taraka
   Abu-Amero, Khaled K.
   Wong, Lee-Jun
   Craigen, William J.
   Graham, Brett H.
   Scott, Kenneth L.
   McFarland, Robert
   Taylor, Robert W.
TI Mutations in <i>FBXL4</i> Cause Mitochondrial Encephalopathy and a Disorder of Mitochondrial DNA Maintenance
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID protein; framework; depletion; disease; family
AB Nuclear genetic disorders causing mitochondrial DNA (mtDNA) depletion are clinically and genetically heterogeneous, and the molecular etiology remains undiagnosed in the majority of cases. Through whole-exome sequencing, we identified recessive nonsense and splicing mutations in FBXL4 segregating in three unrelated consanguineous kindreds in which affected children present with a fatal encephalopathy, lactic acidosis, and severe mtDNA depletion in muscle. We show that FBXL4 is an F-box protein that colocalizes with mitochondria and that loss-of-function and splice mutations in this protein result in a severe respiratory chain deficiency, loss of mitochondrial membrane potential, and a disturbance of the dynamic mitochondrial network and nucleoid distribution in fibroblasts from affected individuals. Expression of the wild-type FBXL4 transcript in cell lines from two subjects fully rescued the levels of mtDNA copy number, leading to a correction of the mitochondrial biochemical deficit. Together our data demonstrate that mutations in FBXL4 are disease causing and establish FBXL4 as a mitochondrial protein with a possible role in maintaining mtDNA integrity and stability.
C1 [Bonnen, Penelope E.; Besse, Arnaud; Wu, Ping; Donti, Taraka; Wong, Lee-Jun; Craigen, William J.; Graham, Brett H.; Scott, Kenneth L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Bonnen, Penelope E.; Besse, Arnaud] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Yarham, John W.; He, Langping; Simcox, Eve M.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Faqeih, Eissa A.; Al-Asmari, Ali Mohammad; Saleh, Mohammad A. M.] King Fahad Med City, Childrens Hosp, Sect Med Genet, Riyadh 11525, Saudi Arabia.
   [Eyaid, Wafaa; Hadee, Alrukban] King Saud Bin Abdulaziz Univ Hlth & Sci, King Abdulaziz Med City, Dept Pediat, Riyadh 11426, Saudi Arabia.
   [Smith, Frances; Yau, Shu] Guys Hosp, Guys & St Thomas Serco Pathol, DNA Lab, London SE1 9RT, England.
   [Miwa, Satomi] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Abu-Amero, Khaled K.] King Saud Univ, Coll Med, Dept Ophthalmol, Ophthalm Genet Lab, Riyadh 11411, Saudi Arabia.
C3 Baylor College of Medicine; Baylor College of Medicine; Newcastle University - UK; King Fahad Medical City; King Saud Bin Abdulaziz University for Health Sciences; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK; King Saud University
RP Bonnen, PE (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
EM pbonnen@bcm.edu; robert.taylor@ncl.ac.uk
FU Texas Norman Hackerman Advanced Research Program [[THECB] 02006]; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health [AI036211, CA125123, RR024574]; NHARP [0049-0041-2009]; Medical Research Council (UK) Centenary Early Career Award; HEFCE/DoH Clinical Senior Lecturer Award; Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Specialist Commissioners; MRC [G0601943, MR/K000608/1, G0800674] Funding Source: UKRI; Wellcome Trust [096919/Z/11/Z] Funding Source: Wellcome Trust
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bainbridge MN, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-7-r68
   BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073
   Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Davydov EV, 2010, PLOS COMPUT BIOL, V6, P0, DOI 10.1371/journal.pcbi.1001025
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, PD225, DOI 10.1093/nar/gkq1189
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4
   Wong LJC, 2003, J MED GENET, V40, P0
NR 37
TC 121
Z9 128
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD SEP 5
PY 2013
VL 93
IS 3
BP 471
EP 481
DI 10.1016/j.ajhg.2013.07.017
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA 297QB
UT WOS:000330268900006
PM 23993193
DA 2024-11-01
ER

PT J
AU Riley, LG
   Menezes, MJ
   Rudinger-Thirion, J
   Duff, R
   de Lonlay, P
   Rotig, A
   Tchan, MC
   Davis, M
   Cooper, ST
   Christodoulou, J
AF Riley, Lisa G.
   Menezes, Minal J.
   Rudinger-Thirion, Joelle
   Duff, Rachael
   de Lonlay, Pascale
   Rotig, Agnes
   Tchan, Michel C.
   Davis, Mark
   Cooper, Sandra T.
   Christodoulou, John
TI Phenotypic variability and identification of novel <i>YARS2</i> mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Mitochondrial respiratory chain; Myopathy with lactic acidosis and sideroblastic anemia; Aminoacyl tRNA-synthetase; Mitochondrial myopathies; Muscle diseases; Lactic acidaemia; Inborn error of metabolism; Mutation
ID transfer-rna-synthetase; respiratory-chain disorders; perrault syndrome; dna haplogroups; hearing-loss; transcription; cardiomyopathy; deficiency; initiation; diseases
AB Background: Mutations in the mitochondrial tyrosyl-tRNA synthetase (YARS2) gene have previously been identified as a cause of the tissue specific mitochondrial respiratory chain (RC) disorder, Myopathy, Lactic Acidosis, Sideroblastic Anaemia (MLASA). In this study, a cohort of patients with a mitochondrial RC disorder for who anaemia was a feature, were screened for mutations in YARS2. Methods: Twelve patients were screened for YARS2 mutations by Sanger sequencing. Clinical data were compared. Functional assays were performed to confirm the pathogenicity of the novel mutations and to investigate tissue specific effects. Results: PathogenicYARS2 mutations were identified in three of twelve patients screened. Two patients were found to be homozygous for the previously reported p.Phe52Leu mutation, one severely and one mildly affected. These patients had different mtDNA haplogroups which may contribute to the observed phenotypic variability. A mildly affected patient was a compound heterozygote for two novel YARS2 mutations, p.Gly191Asp and p.Arg360X. The p.Gly191Asp mutation resulted in a 38-fold loss in YARS2 catalytic efficiency and the p.Arg360X mutation did not produce a stable protein. The p.Phe52Leu and p.Gly191Asp/p.Arg360X mutations resulted in more severe RC deficiency of complexes I, III and IV in muscle cells compared to fibroblasts, but had relatively normal YARS2 protein levels. The muscle-specific RC deficiency can be related to the increased requirement for RC complexes in muscle. There was also a failure of mtDNA proliferation upon myogenesis in patient cells which may compound the RC defect. Patient muscle had increased levels of PGC1-alpha and TFAM suggesting mitochondrial biogenesis was activated as a potential compensatory mechanism. Conclusion: In this study we have identified novel YARS2 mutations and noted marked phenotypic variability among YARS2 MLASA patients, with phenotypes ranging from mild to lethal, and we suggest that the background mtDNA haplotype may be contributing to the phenotypic variability. These findings have implications for diagnosis and prognostication of the MLASA and related phenotypes.
C1 [Riley, Lisa G.; Menezes, Minal J.; Christodoulou, John] Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW 2145, Australia.
   [Riley, Lisa G.; Menezes, Minal J.; Cooper, Sandra T.; Christodoulou, John] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.
   [Tchan, Michel C.; Christodoulou, John] Univ Sydney, Discipline Genet Med, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Rudinger-Thirion, Joelle] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, F-67084 Strasbourg, France.
   [Duff, Rachael] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia.
   [Duff, Rachael] Western Australian Inst Med Res, Perth, WA 6009, Australia.
   [de Lonlay, Pascale; Rotig, Agnes] Univ Paris 05, F-75015 Paris, France.
   [de Lonlay, Pascale; Rotig, Agnes] Hop Necker Enfants Malad, INSERM U781, F-75015 Paris, France.
   [Tchan, Michel C.] Westmead Hosp, Dept Med Genet, Sydney, NSW, Australia.
   [Davis, Mark] QEII Med Ctr, PathWest Lab Med, Nedlands, WA 6009, Australia.
   [Cooper, Sandra T.] Childrens Hosp Westmead, Kids Res Inst, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia.
   [Christodoulou, John] Childrens Hosp Westmead, Western Sydney Genet Program, Westmead, NSW 2145, Australia.
C3 NSW Health; The Children's Hospital at Westmead; University of Sydney; University of Sydney; University of Sydney; Centre National de la Recherche Scientifique (CNRS); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Western Australia; University of Western Australia; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Sydney; NSW Health; Westmead Hospital; Pathwest Laboratory Medicine; University of Western Australia; Queen Elizabeth II Medical Centre; University of Sydney; NSW Health; The Children's Hospital at Westmead; NSW Health; Sydney Childrens Hospitals Network; The Children's Hospital at Westmead; University of Sydney
RP Christodoulou, J (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW 2145, Australia.
EM john.christodoulou@health.nsw.gov.au
FU March of Dimes Research Grant; National Health and Medical Research Council of Australia [1026891]; AMDF; Crane family; Perkins family
CR Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031
   Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bayat V, 2012, PLOS BIOL, V10, P1
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Castro MG, 2007, MITOCHONDRION, V7, P354, DOI 10.1016/j.mito.2007.06.002
   Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008
   Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Messmer M, 2011, BIOCHEM J, V433, P441, DOI 10.1042/BJ20101902
   Moyes CD, 2003, ANNU REV PHYSIOL, V65, P177, DOI 10.1146/annurev.physiol.65.092101.142705
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029
   Riley L, 2010, AM J HUM GENET, V97, P1
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rötig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Thorburn D R, 2000, HUM REPROD, V15 Suppl 2, P57
   Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356
NR 36
TC 48
Z9 49
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-1172
EI 
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD DEC 17
PY 2013
VL 8
IS 
BP 
EP 
DI 10.1186/1750-1172-8-193
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA AB8CH
UT WOS:000332017200003
PM 24344687
DA 2024-11-01
ER

PT J
AU Xiao, F
   Li, J
   Zhang, XG
   Wang, XF
AF Xiao, Fei
   Li, Jia
   Zhang, Xiaogang
   Wang, Xuefeng
TI Antiepileptic treatment and blood lactate level alteration in patients with myoclonic epilepsy with ragged-red fibers (MERRF) syndrome in a Chinese family
SO NEUROLOGY ASIA
LA English
DT Article
ID mitochondrial-dna; valproic acid; defects; melas; levetiracetam; metabolism; myopathy; mutation; protein
AB Background: Myoclonic epilepsy with ragged-red fibers (MERRF) is a type of mitochondrial encephalomyopathy, clinical experience with the antiepileptic treatment for myoclonus in MERRF is still limited. Myoclonus appears to be intractable, and some antiepileptic drugs may change the blood lactate level. Objective: In this study, we report on two patients, a girl and her mother, both with MERRF in a Chinese family. We aimed to study their myoclonus attack, response to AEDs and blood lactate level. Methods: The diagnosis was based on muscle biopsies and a genetic test. We recorded their myoclonus and detected alterations of blood lactate when the patients received antiepileptic drugs. Results: The patients displayed substantial differences in their responses to antiepileptic drugs. The mother exhibited a good response to valproic acid, although valproic acid is not recommended for mitochondrial disease; however, her daughter was refractory to many antiepileptic drugs until she received a combination treatment of levetiracetam and topiramate. We did not find valproic acid, levetiracetam or topiramate affected the blood lactate levels. Conclusion: These findings imply that not all MERRF patients are resistant to antiepileptic drugs, and for those who are intractable, combination treatment involving levetiracetam and topiramate may be effective for treating myoclonus in MERRF and does not worsen lactic acidosis.
C1 [Xiao, Fei; Li, Jia; Zhang, Xiaogang; Wang, Xuefeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Key Lab Neurol, Chongqing 400016, Peoples R China.
C3 Chongqing Medical University
RP Wang, XF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing Key Lab Neurol, 1 You Yi Rd, Chongqing 400016, Peoples R China.
EM xfyp@163.com
CR Alluin A, 2011, ANN FR ANESTH, V30, P752, DOI 10.1016/j.annfar.2011.05.019
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Close BR, 2010, ANN PHARMACOTHER, V44, P1112, DOI 10.1345/aph.1M617
   Crest C, 2004, NEUROLOGY, V62, P640, DOI 10.1212/01.WNL.0000110193.78872.DD
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2010, DRUG CHEM TOXICOL, V33, P138, DOI 10.3109/01480540903207076
   Finsterer J, 2010, EUR J PAEDIATR NEURO, V14, P29, DOI 10.1016/j.ejpn.2009.07.005
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Gropman A L, 2001, CURR NEUROL NEUROSCI REP, V1, P185
   GUELDRY S, 1987, EPILEPSIA, V28, P160, DOI 10.1111/j.1528-1157.1987.tb03642.x
   Jiménez-Caballero PE, 2006, REV NEUROLOGIA, V43, P724, DOI 10.33588/rn.4312.2006440
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   MACMILLAN V, 1987, BRAIN RES, V420, P268, DOI 10.1016/0006-8993(87)91247-9
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mikol J, 2005, ANN PATHOL, V25, P282, DOI 10.1016/S0242-6498(05)80132-4
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Price KE, 2011, CLIN PHARMACOL THER, V89, P867, DOI 10.1038/clpt.2011.47
   Rathman SC, 2003, J NUTR, V133, P2119, DOI 10.1093/jn/133.7.2119
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zhang Zai-qiang, 2009, ZHONGHUA YI XUE ZA ZHI, V89, P1185
NR 26
TC 0
Z9 0
U1 0
U2 6
PU ASEAN NEUROLOGICAL ASSOC
PI KUALA LUMPUR
PA UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100, MALAYSIA
SN 1823-6138
EI 
J9 NEUROL ASIA
JI Neurol. Asia
PD MAR 15
PY 2013
VL 18
IS 1
BP 47
EP 51
DI 
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA 115BP
UT WOS:000316787600007
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   Tomlinson, SE
   Hargreaves, I
   Bhardwaj, N
   Holton, JL
   Morrow, JM
   Evans, J
   Smith, C
   Fratter, C
   Woodward, CE
   Sweeney, MG
   Rahman, S
   Hanna, MG
AF Pitceathly, Robert D. S.
   Tomlinson, Susan E.
   Hargreaves, Iain
   Bhardwaj, Nisha
   Holton, Janice L.
   Morrow, Jasper M.
   Evans, Julie
   Smith, Conrad
   Fratter, Carl
   Woodward, Cathy E.
   Sweeney, Mary G.
   Rahman, Shamima
   Hanna, Michael G.
TI Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase γ mutations
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID dna-polymerase; accessory subunit; polg; disorders; depletion; binding
AB Background The myopathy associated with mutations in the nuclear-encoded mitochondrial DNA maintenance gene POLG, coding for the catalytic subunit of DNA polymerase, is typically proximal with early ophthalmoplegia. Results We report two unrelated patients in whom a distal, mainly upper limb, myopathy was the predominant and early clinical feature. One patient also suffered with marked cachexia. DNA genomic sequence analysis identified novel dominant heterozygous missense POLG mutations (Leu896Arg and Tyr951His) located within the conserved catalytic polymerase domain of the protein in both cases. Conclusions Distal upper limb myopathy/cachexia is not previously described with dominant POLG mutations and our observations further highlight the diverse clinical spectrum of POLG-related mitochondrial disorders. These data indicate that dominant POLG mutations should be considered in the differential diagnosis of distal upper limb predominant myopathy.
C1 [Rahman, Shamima] Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.; Tomlinson, Susan E.; Holton, Janice L.; Morrow, Jasper M.; Rahman, Shamima; Hanna, Michael G.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Tomlinson, Susan E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Bhardwaj, Nisha] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.
   [Holton, Janice L.; Hanna, Michael G.] UCL Inst Neurol, Dept Mol Neurosci, London, England.
   [Evans, Julie; Smith, Conrad; Fratter, Carl] Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford, England.
   [Woodward, Cathy E.; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
C3 University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Sydney; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London
RP Rahman, S (corresponding author), Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, 8-11 Queen Sq, London WC1N 3BG, England.
EM shamima.rahman@ucl.ac.uk
FU MRC [G0800674, G0601943]; Great Ormond Street Hospital Children's Charity; Myositis Support Group; UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children; NIHR UCLH/UCL Comprehensive Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres; MRC [G0200335, MR/K000608/1, G0800674, G0601943] Funding Source: UKRI
CR Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chinnery PF, 2010, BRAIN, V133, P1865, DOI 10.1093/brain/awq161
   Cohen BH, 2010, POLG RELATED DISORDE, V0, P0
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 16
TC 15
Z9 15
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD JAN 15
PY 2013
VL 84
IS 1
BP 107
EP 110
DI 10.1136/jnnp-2012-303232
PG 4
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA 055WD
UT WOS:000312447600021
PM 22933815
DA 2024-11-01
ER

PT J
AU Adeva, M
   González-Lucán, M
   Seco, M
   Donapetry, C
AF Adeva, M.
   Gonzalez-Lucan, M.
   Seco, M.
   Donapetry, C.
TI Enzymes involved in L-lactate metabolism in humans
SO MITOCHONDRION
LA English
DT Review
DE Lactate dehydrogenase; Alanine aminotransferase; Pyruvate dehydrogenase; Tricarboxylic acid cycle; Mitochondrial respiratory chain; Gluconeogenesis
ID pyruvate-carboxylase deficiency; serum alanine aminotransferase; glycogen-storage-disease; human skeletal-muscle; human liver fructose-1,6-bisphosphatase; tricarboxylic-acid cycle; m-subunit deficiency; phosphoenolpyruvate carboxykinase; lactic-acidosis; dehydrogenase complex
AB L-lactate formation occurs via the reduction of pyruvate catalyzed by lactate dehydrogenase. L-lactate removal takes place via its oxidation into pyruvate, which may be oxidized or converted into glucose. Pyruvate oxidation involves the cooperative effort of pyruvate dehydrogenase, the tricarboxylic acid cycle, and the mitochondrial respiratory chain. Enzymes of the gluconeogenesis pathway sequentially convert pyruvate into glucose. In addition, pyruvate may undergo reversible transamination to alanine by alanine aminotransferase. Enzymes involved in L-lactate metabolism are crucial to diabetes pathophysiology and therapy. Elevated plasma alanine aminotransferase concentration has been associated with insulin resistance. Polymorphisms in the G6PC2 gene have been associated with fasting glucose concentration and insulin secretion. In diabetes patients, pyruvate dehydrogenase is down-regulated and the activity of pyruvate carboxylase is diminished in the pancreatic islets. Inhibitors of fructose 1,6-bisphosphatase are being investigated as potential therapy for type 2 diabetes. In addition, enzymes implicated in L-lactate metabolism have revealed to be important in cancer cell homeostasis. Many human tumors have higher LDH5 levels than normal tissues. The LDHC gene is expressed in a broad range of tumors. The activation of PDH is a potential mediator in the body response that protects against cancer and PDH activation has been observed to reduce glioblastoma growth. The expression of PDK1 may serve as a biomarker of poor prognosis in gastric cancer. Mitochondrial DNA mutations have been detected in a number of human cancers. Genes encoding succinate dehydrogenase have tumor suppressor functions and consequently mutations in these genes may cause a variety of tumors. (C) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Adeva, M.; Gonzalez-Lucan, M.; Seco, M.; Donapetry, C.] Hosp Gen Juan Cardona, Div Nephrol, La Coruna 15406, Spain.
RP Adeva, M (corresponding author), Hosp Gen Juan Cardona, Div Nephrol, Ave Pardo Bazan S-N, La Coruna 15406, Spain.
EM madevaa@yahoo.com
CR Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x
   ADAMS A, 1990, J INHERIT METAB DIS, V13, P829, DOI 10.1007/BF01800207
   Adina-Zada A, 2012, ARCH BIOCHEM BIOPHYS, V519, P118, DOI 10.1016/j.abb.2011.11.015
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002
   ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009
   Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3
   Banka S, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-84
   Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575
   Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57
   Berthold HK, 2006, DRUG SAFETY, V29, P703, DOI 10.2165/00002018-200629080-00007
   Bigl M, 2008, BIOCHEM BIOPH RES CO, V377, P720, DOI 10.1016/j.bbrc.2008.10.045
   Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001
   BLASS JP, 1972, J CLIN INVEST, V51, P1845, DOI 10.1172/JCI106986
   BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0
   Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806
   Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099
   Brière JJ, 2006, AM J PHYSIOL-CELL PH, V291, PC1114, DOI 10.1152/ajpcell.00216.2006
   BROWN GK, 1987, J INHERIT METAB DIS, V10, P359, DOI 10.1007/BF01799978
   Cameron JM, 2009, HUM GENET, V125, P319, DOI 10.1007/s00439-009-0629-6
   Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361
   Chen PH, 2009, WORLD J GASTROENTERO, V15, P5598, DOI 10.3748/wjg.15.5598
   Chen XY, 2009, MOL BIOL REP, V36, P669, DOI 10.1007/s11033-008-9227-2
   CHEN YT, 1990, NEW ENGL J MED, V323, P590, DOI 10.1056/NEJM199008303230907
   Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772
   COOKER LA, 1993, BIOL REPROD, V48, P1309, DOI 10.1095/biolreprod48.6.1309
   Däublin G, 2002, EUR J PEDIATR, V161, PS40, DOI 10.1007/s00431-002-1001-1
   De Bari L, 2010, INT J ONCOL, V37, P1607, DOI 10.3892/ijo_00000815
   Debray FG, 2006, EUR J PEDIATR, V165, P462, DOI 10.1007/s00431-006-0104-5
   DeBrosse SD, 2012, MOL GENET METAB, V107, P394, DOI 10.1016/j.ymgme.2012.09.001
   Delanghe J, 1997, CLIN CHEM, V43, P1665
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, PE571, DOI 10.1152/ajpendo.2000.278.4.E571
   DZUGAJ A, 1980, BIOCHIM BIOPHYS ACTA, V614, P407, DOI 10.1016/0005-2744(80)90230-2
   EDWARDS Y, 1989, ANN HUM GENET, V53, P215, DOI 10.1111/j.1469-1809.1989.tb01787.x
   ELMAGHRABI MR, 1995, GENOMICS, V27, P520, DOI 10.1006/geno.1995.1085
   ELMAGHRABI MR, 1993, J BIOL CHEM, V268, P9466
   FERNANDES J, 1982, LANCET, V1, P113
   Ferriero R, 2013, ONCOTARGET, V0, P0
   Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008
   Ford I, 2011, INT J EPIDEMIOL, V40, P1530, DOI 10.1093/ije/dyr172
   Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870
   Fujisawa K, 2000, J BIOCHEM-TOKYO, V127, P373, DOI 10.1093/oxfordjournals.jbchem.a022618
   Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202
   GIDHJAIN M, 1994, J BIOL CHEM, V269, P27732
   Gizak A, 2003, HISTOL HISTOPATHOL, V18, P135, DOI 10.14670/HH-18.135
   Gizak A, 2001, HISTOL HISTOPATHOL, V16, P53, DOI 10.14670/HH-16.53
   Glinghammar B, 2009, INT J MOL MED, V23, P621, DOI 10.3892/ijmm_00000173
   Glushakova LG, 2011, MOL GENET METAB, V104, P255, DOI 10.1016/j.ymgme.2011.07.023
   Gouni-Berthold I, 2006, DIABETIC MED, V23, P419, DOI 10.1111/j.1464-5491.2006.01819.x
   Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989
   Gunji T, 2010, DIGEST LIVER DIS, V42, P882, DOI 10.1016/j.dld.2010.04.001
   Güven AG, 2006, PEDIATR NEPHROL, V21, P761, DOI 10.1007/s00467-006-0077-7
   Hanley AJG, 2007, DIABETES CARE, V30, P1819, DOI 10.2337/dc07-0086
   HAWORTH JC, 1981, J INHERIT METAB DIS, V4, P57, DOI 10.1007/BF02263589
   Heard KJ, 2010, PHARMACOTHERAPY, V30, P818, DOI 10.1592/phco.30.8.818
   Herzog B, 2000, BIOCHEM J, V351, P385, DOI 10.1042/0264-6021:3510385
   Hidaka K, 1999, J HUM GENET, V44, P69, DOI 10.1007/s100380050111
   Hoekstra AS, 2012, BIOCHIM BIOPHYS ACTA, V0, P0
   HOMMES FA, 1976, ACTA PAEDIATR SCAND, V65, P233, DOI 10.1111/j.1651-2227.1976.tb16543.x
   Hur H, 2013, INT J ONCOL, V42, P44, DOI 10.3892/ijo.2012.1687
   Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010
   Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544
   Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008
   ISHIGURO M, 1991, BIOCHEMISTRY-US, V30, P10451, DOI 10.1021/bi00107a013
   Jacobs RA, 2013, AM J PHYSIOL-ENDOC M, V304, PE686, DOI 10.1152/ajpendo.00476.2012
   Jitrapakdee S, 1996, BIOCHEM BIOPH RES CO, V223, P695, DOI 10.1006/bbrc.1996.0958
   Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001
   Jitrapakdee S, 1999, BIOCHEM BIOPH RES CO, V266, P512, DOI 10.1006/bbrc.1999.1846
   Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709
   JOUKYUU R, 1989, CLIN CHEM, V35, P687
   KANNO T, 1988, CLIN CHIM ACTA, V173, P89, DOI 10.1016/0009-8981(88)90359-2
   KAO FT, 1988, SOMAT CELL MOLEC GEN, V14, P515, DOI 10.1007/BF01534717
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Kato J, 2010, ACTA CRYSTALLOGR F, V66, P342, DOI 10.1107/S1744309110003131
   Kayser G, 2010, DIAGN PATHOL, V5, P0, DOI 10.1186/1746-1596-5-22
   Kerr D, 2012, METHODS MOL BIOL, V837, P93, DOI 10.1007/978-1-61779-504-6_7
   Kiilerich K, 2011, J APPL PHYSIOL, V111, P751, DOI 10.1152/japplphysiol.00063.2011
   KIKAWA Y, 1994, BIOCHEM BIOPH RES CO, V199, P687, DOI 10.1006/bbrc.1994.1283
   Kikawa Y, 2002, J INHERIT METAB DIS, V25, P41, DOI 10.1023/A:1015129616599
   KITAMURA M, 1971, CLIN CHIM ACTA, V34, P419
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   KREISBERG RA, 1980, ANN INTERN MED, V92, P227, DOI 10.7326/0003-4819-92-2-227
   Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6
   Laughton JD, 2007, BMC NEUROSCI, V8, P0, DOI 10.1186/1471-2202-8-35
   Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107
   Lemire J, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001550
   Lindblom P, 2007, ARCH BIOCHEM BIOPHYS, V466, P66, DOI 10.1016/j.abb.2007.07.023
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6
   MACKAY N, 1994, BIOCHEM BIOPH RES CO, V202, P1009, DOI 10.1006/bbrc.1994.2029
   Mak CM, 2010, PATHOLOGY, V42, P94, DOI 10.3109/00313020903434678
   Mamczur P, 2012, HISTOCHEM CELL BIOL, V137, P121, DOI 10.1007/s00418-011-0884-1
   Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205
   MAYEDA K, 1974, AM J HUM GENET, V26, P59
   MCCORMICK K, 1985, AM J MED GENET, V22, P291, DOI 10.1002/ajmg.1320220211
   Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P196, DOI 10.1016/j.bbrc.2010.08.102
   MIYAJIMA H, 1993, NEUROLOGY, V43, P1414, DOI 10.1212/WNL.43.7.1414
   Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359
   Moon S, 2011, METABOLISM, V60, P107, DOI 10.1016/j.metabol.2009.12.021
   NAITO E, 1994, PEDIATR RES, V36, P340, DOI 10.1203/00006450-199409000-00013
   PAGLIARA AS, 1972, J CLIN INVEST, V51, P2115, DOI 10.1172/JCI107018
   Paksu MS, 2011, PEDIATR EMERG CARE, V27, P1180, DOI 10.1097/PEC.0b013e31823b412d
   Patel DA, 2011, METAB SYNDR RELAT D, V9, P211, DOI 10.1089/met.2010.0086
   Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016
   Patel MS, 2009, J MOL CATAL B-ENZYM, V61, P2, DOI 10.1016/j.molcatb.2009.05.001
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   PILZ AJ, 1992, ANN HUM GENET, V56, P289, DOI 10.1111/j.1469-1809.1992.tb01155.x
   Pizzuto R, 2012, BBA-BIOENERGETICS, V1817, P1679, DOI 10.1016/j.bbabio.2012.05.010
   POPINIGIS J, 1991, ACTA BIOCHIM POL, V38, P169
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003
   Quinonez SC, 2013, PEDIATR NEUROL, V48, P67, DOI 10.1016/j.pediatrneurol.2012.09.013
   Rafter I, 2012, INT J MOL MED, V30, P1241, DOI 10.3892/ijmm.2012.1106
   Rasmussen HN, 2002, J PHYSIOL-LONDON, V541, P575, DOI 10.1113/jphysiol.2002.019216
   Renault S, 2010, TOXICOL APPL PHARM, V242, P9, DOI 10.1016/j.taap.2009.09.002
   ROBINSON BH, 1987, AM J HUM GENET, V40, P50
   Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015
   Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376
   Rumack B, 2012, PHARMACOTHERAPY, V32, P784, DOI 10.1002/j.1875-9114.2012.01122.x
   RUTLEDGE SL, 1989, PEDIATR NEUROL, V5, P249
   Sanda S, 2013, ACTA DIABETOL, V50, P459, DOI 10.1007/s00592-012-0389-y
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sato T, 2002, PANCREAS, V25, P130, DOI 10.1097/00006676-200208000-00003
   SAUDUBRAY JM, 1976, ACTA PAEDIATR SCAND, V65, P717, DOI 10.1111/j.1651-2227.1976.tb18009.x
   Saunders AC, 2005, J INHERIT METAB DIS, V28, P695, DOI 10.1007/s10545-005-0090-1
   Shangraw RE, 1998, AM J PHYSIOL-GASTR L, V274, PG569, DOI 10.1152/ajpgi.1998.274.3.G569
   Shieh JJ, 2002, J BIOL CHEM, V277, P5047, DOI 10.1074/jbc.M110486200
   Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smith AC, 2011, BMC SYST BIOL, V5, P0, DOI 10.1186/1752-0509-5-102
   Sohocki MM, 1997, GENOMICS, V40, P247, DOI 10.1006/geno.1996.4604
   Soini Heidi K, 2012, BMC RES NOTES, V5, P350, DOI 10.1186/1756-0500-5-350
   Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003
   Spriet LL, 2002, EXERC SPORT SCI REV, V30, P91, DOI 10.1097/00003677-200204000-00009
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stallknecht B, 1998, SCAND J MED SCI SPOR, V8, P127
   Steller J, 2013, NEUROPEDIATRICS, V0, P0
   STERN HJ, 1995, CLIN BIOCHEM, V28, P85, DOI 10.1016/0009-9120(94)00059-5
   Sue CM, 2000, BRAIN PATHOL, V10, P442
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Sutendra G, 2013, FRONT ONCOL, V3, P0, DOI 10.3389/fonc.2013.00038
   Swiderek K, 2011, ARCH BIOCHEM BIOPHYS, V505, P33, DOI 10.1016/j.abb.2010.10.010
   Sybirna N, 2006, CELL BIOL INT, V30, P624, DOI 10.1016/j.cellbi.2006.03.008
   TAKANO T, 1989, BIOCHEM BIOPH RES CO, V159, P579, DOI 10.1016/0006-291X(89)90033-8
   Takatani T, 2001, MOL GENET METAB, V73, P344, DOI 10.1006/mgme.2001.3203
   TAKAYASU S, 1991, J AM ACAD DERMATOL, V24, P339, DOI 10.1016/0190-9622(91)70047-6
   Tang HH, 2009, J ANDROL, V30, P157, DOI 10.2164/jandrol.108.005785
   Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067
   Tillmann H, 1998, GENE, V212, P295, DOI 10.1016/S0378-1119(98)00181-4
   Tillmann H, 2000, GENE, V247, P241, DOI 10.1016/S0378-1119(00)00079-2
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   van Poelje PD, 2011, HANDB EXP PHARMACOL, V203, P279, DOI 10.1007/978-3-642-17214-4_12
   VANCOSTER RN, 1991, NEUROLOGY, V41, P1815, DOI 10.1212/WNL.41.11.1815
   vandenBerghe G, 1996, J INHERIT METAB DIS, V19, P470, DOI 10.1007/BF01799108
   VESELL ES, 1961, J CLIN INVEST, V40, P586, DOI 10.1172/JCI104287
   VIDNES J, 1976, ACTA PAEDIATR SCAND, V65, P307, DOI 10.1111/j.1651-2227.1976.tb04890.x
   Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889
   WALKER ME, 1995, CYTOGENET CELL GENET, V69, P187, DOI 10.1159/000133958
   Wang D, 2008, MOL GENET METAB, V95, P31, DOI 10.1016/j.ymgme.2008.06.006
   Wang H, 2005, INT J MOL MED, V15, P949
   Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   WEXLER ID, 1994, BBA-MOL BASIS DIS, V1227, P46, DOI 10.1016/0925-4439(94)90105-8
   Wolfsdorf JI, 1997, J INHERIT METAB DIS, V20, P559, DOI 10.1023/A:1005346824368
   WROBLEWSKI F, 1960, NEW ENGL J MED, V263, P531, DOI 10.1056/NEJM196009152631102
   Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393
   Yánez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337
   Yang RZ, 2002, GENOMICS, V79, P445, DOI 10.1006/geno.2002.6722
   Yen TY, 2008, EUR J PEDIATR, V167, P941, DOI 10.1007/s00431-007-0592-y
   Zhu DW, 2001, ACTA CRYSTALLOGR D, V57, P847, DOI 10.1107/S0907444901004371
NR 175
TC 62
Z9 71
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2013
VL 13
IS 6
BP 615
EP 629
DI 10.1016/j.mito.2013.08.011
PG 15
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 255ZY
UT WOS:000327280500007
PM 24029012
DA 2024-11-01
ER

PT J
AU Piantino, CB
   Reis, ST
   Viana, NI
   Silva, IA
   Morais, DR
   Antunes, AA
   Dip, N
   Srougi, M
   Leite, KR
AF Piantino, Camila B.
   Reis, Sabrina T.
   Viana, Nayara I.
   Silva, Iran A.
   Morais, Denis R.
   Antunes, Alberto A.
   Dip, Nelson
   Srougi, Miguel
   Leite, Katia R.
TI Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
SO CLINICS
LA English
DT Article
DE Bladder cancer; p53; Apoptosis; Prima-1
ID bh3-only proteins puma; molecular alterations; caspase family; specificity; pathway
AB OBJECTIVES: Bladder cancer represents 3% of all carcinomas in the Brazilian population and ranks second in incidence among urological tumors, after prostate cancer. The loss of p53 function is the main genetic alteration related to the development of high-grade muscle-invasive disease. Prima-1 is a small molecule that restores tumor suppressor function to mutant p53 and induces cancer cell death in various cancer types. Our aim was to investigate the ability of Prima-1 to induce apoptosis after DNA damage in bladder cancer cell lines. METHOD: The therapeutic effect of Prima-1 was studied in two bladder cancer cell lines: T24, which is characterized by a p53 mutation, and RT4, which is the wild-type for the p53 gene. Morphological features of apoptosis induced by p53, including mitochondrial membrane potential changes and the expression of thirteen genes involved in apoptosis, were assessed by microscopic observation and quantitative real-time PCR (qRT-PCR). RESULTS: Prima-1 was able to reactivate p53 function in the T24 (p53 mt) bladder cancer cell line and promote apoptosis via the induction of Bax and Puma expression, activation of the caspase cascade and disruption of the mitochondrial membrane in a BAK-independent manner. CONCLUSION: Prima-1 is able to restore the transcriptional activity of p53. Experimental studies in vivo may be conducted to test this molecule as a new therapeutic agent for urothelial carcinomas of the bladder, which characteristically harbor p53 mutations.
C1 [Piantino, Camila B.; Reis, Sabrina T.; Viana, Nayara I.; Silva, Iran A.; Morais, Denis R.; Antunes, Alberto A.; Dip, Nelson; Srougi, Miguel; Leite, Katia R.] Univ Sao Paulo, Fac Med, Dept Urol, Lab Med Investigat,LIM55, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo
RP Piantino, CB (corresponding author), Univ Sao Paulo, Fac Med, Dept Urol, Lab Med Investigat,LIM55, Sao Paulo, Brazil.
EM camilapiantino@hotmail.com
FU State of Sao Paulo Research Foundation (FAPESP)
CR Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001
   Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006
   Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
   Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282
   Clavería C, 2004, J BIOL CHEM, V279, P1368, DOI 10.1074/jbc.M309819200
   Cordon-Cardo C, 1998, CANCER SURV, V32, P115
   Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915
   Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883
   Cote RJ, 2003, CRIT REV ONCOL HEMAT, V46, PS67, DOI 10.1016/S1040-8428(03)00066-0
   Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595
   Feng ZH, 2002, CARCINOGENESIS, V23, P1721, DOI 10.1093/carcin/23.10.1721
   Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019
   Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200
   Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7
   Konstantakou EG, 2009, INT J ONCOL, V35, P401, DOI 10.3892/ijo_00000353
   Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989
   Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Lomonosova E, 2009, MOL CANCER RES, V7, P1268, DOI 10.1158/1541-7786.MCR-08-0183
   Lu ML, 2002, CLIN CANCER RES, V8, P171
   Messina RL, 2012, INT J CANCER, V130, P2259, DOI 10.1002/ijc.26228
   Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3
   Shen J, 2008, ONCOGENE, V27, P6571, DOI 10.1038/onc.2008.249
   Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603
   Siegel RL, 2019, ANTI-CANCER DRUG, V69, P7, DOI 10.3322/caac.20115
   Silverman DT, 2006, CANCER EPIDEMIOLOGY AND PREVENTION, V0, P1101
   Szliszka E, 2011, INT J ONCOL, V38, P941, DOI 10.3892/ijo.2011.930
   Szliszka E, 2010, MOLECULES, V15, P5336, DOI 10.3390/molecules15085336
   Talanian RV, 1997, J BIOL CHEM, V272, P9677
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907
   Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072
   Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232
   Watanabe FT, 2011, CLINICS, V66, P2121, DOI 10.1590/S1807-59322011001200019
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
NR 36
TC 12
Z9 15
U1 0
U2 2
PU ELSEVIER ESPANA
PI MADRID
PA CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PD JUN 15
PY 2013
VL 68
IS 3
BP 297
EP 303
DI 10.6061/clinics/2013(03)OA03
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 158VC
UT WOS:000320000800004
PM 23644847
DA 2024-11-01
ER

PT J
AU Mastaglia, FL
   Rojana-Udomsart, A
   James, I
   Needham, M
   Day, TJ
   Kiers, L
   Corbett, JA
   Saunders, AM
   Lutz, MW
   Roses, AD
AF Mastaglia, F. L.
   Rojana-udomsart, A.
   James, I.
   Needham, M.
   Day, T. J.
   Kiers, L.
   Corbett, J. A.
   Saunders, A. M.
   Lutz, M. W.
   Roses, A. D.
TI Polymorphism in the <i>TOMM40</i> gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Sporadic IBM; TOMM40; APOE; Susceptibility; Age of onset
ID amyloid precursor protein; mitochondrial-dna deletions; alzheimers-disease; apolipoprotein-e; abnormality; alleles; muscle; beta
AB A polyT repeat in an intronic polymorphism (rs10524523) in the TOMM40 gene, which encodes an outer mitochondrial membrane translocase involved in the transport of amyloid-beta and other proteins into mitochondria, has been implicated in Alzheimer's disease and APOE-TOMM40 genotypes have been shown to modify disease risk and age at onset of symptoms. Because of the similarities between Alzheimer's disease and sporadic inclusion body myositis (s-IBM), and the importance of amyloid-beta and mitochondrial changes in s-IBM, we investigated whether variation in poly-T repeat lengths in rs10524523 also influence susceptibility and age at onset in a cohort of 90 Caucasian s-IBM patients (55 males; age 69.1 +/- 9.6). In carriers of APOE epsilon 3/epsilon 3 or epsilon 3/epsilon 4, genotypes with a very long (VL) poly-T repeat were under-represented in s-IBM compared to controls and were associated with a later age at symptom onset, suggesting that these genotypes may be protective. Our study is the first to suggest that polymorphisms in genes controlling mitochondrial function can influence susceptibility to s-IBM and have disease modifying effects. However, further studies in other s-IBM populations are needed to confirm these findings, as well as expression studies of different TOMM40 alleles in muscle tissue. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Mastaglia, F. L.; Rojana-udomsart, A.; Needham, M.] Univ Western Australia, Queen Elizabeth II Med Ctr, Ctr Neuromuscular & Neurol Disorders, Australian Neuromuscular Res Inst, Perth, WA 6009, Australia.
   [Mastaglia, F. L.; James, I.; Needham, M.] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia.
   [Day, T. J.; Kiers, L.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia.
   [Day, T. J.; Kiers, L.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurophysiol, Parkville, Vic, Australia.
   [Day, T. J.; Kiers, L.] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia.
   [Corbett, J. A.] Concord Hosp, Dept Neurol, Concord, NSW, Australia.
   [Saunders, A. M.; Lutz, M. W.; Roses, A. D.] Duke Univ, Durham, NC 27705 USA.
   [Roses, A. D.] Zinfandel Pharmaceut, Durham, NC 27705 USA.
C3 University of Western Australia; Murdoch University; Melbourne Health; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Melbourne Health; Royal Melbourne Hospital; University of Melbourne; Concord Repatriation General Hospital; Duke University
RP Mastaglia, FL (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Ctr Neuromuscular & Neurol Disorders, Australian Neuromuscular Res Inst, Perth, WA 6009, Australia.
EM francis.mastaglia@anri.uwa.edu.au
FU Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Enid and Arthur Home Memorial Scholarship; University of Western Australia Scholarship for International Research Fees (SIRF); Zinfandel; Neuromuscular Foundation of Western Australi
CR Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030
   Askanas V, 2006, NEUROLOGY, V66, PS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1996, ANN NEUROL, V40, P264, DOI 10.1002/ana.410400223
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   Crenshaw DG, 2013, CLIN PHARMACOL THER, V93, P177, DOI 10.1038/clpt.2012.222
   Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005
   Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155
   Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Linnertz C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030994
   Maruszak A, 2012, J ALZHEIMERS DIS, V28, P309, DOI 10.3233/JAD-2011-110743
   Mastaglia FL, 2009, NEUROMUSCULAR DISORD, V19, P763, DOI 10.1016/j.nmd.2009.07.015
   Mirabella M, 1996, ANN NEUROL, V40, P864, DOI 10.1002/ana.410400608
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P6, DOI 10.1016/j.nmd.2007.11.001
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P150, DOI 10.1016/j.nmd.2007.09.005
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105
   Rojana-udomsart A, 2013, J NEUROIMMUNOL, V254, P174, DOI 10.1016/j.jneuroim.2012.09.003
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Schmidt J, 2012, BRAIN, V135, P1102
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
NR 31
TC 16
Z9 18
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC 15
PY 2013
VL 23
IS 12
BP 969
EP 974
DI 10.1016/j.nmd.2013.09.008
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 293FP
UT WOS:000329957100003
PM 24103330
DA 2024-11-01
ER

PT J
AU Samuels, DC
   Li, C
   Li, BS
   Song, Z
   Torstenson, E
   Clay, HB
   Rokas, A
   Thornton-Wells, TA
   Moore, JH
   Hughes, TM
   Hoffman, RD
   Haines, JL
   Murdock, DG
   Mortlock, DP
   Williams, SM
AF Samuels, David C.
   Li, Chun
   Li, Bingshan
   Song, Zhuo
   Torstenson, Eric
   Clay, Hayley Boyd
   Rokas, Antonis
   Thornton-Wells, Tricia A.
   Moore, Jason H.
   Hughes, Tia M.
   Hoffman, Robert D.
   Haines, Jonathan L.
   Murdock, Deborah G.
   Mortlock, Douglas P.
   Williams, Scott M.
TI Recurrent Tissue-Specific mtDNA Mutations Are Common in Humans
SO PLOS GENETICS
LA English
DT Article
ID human mitochondrial-dna; control region sequences; major noncoding region; point mutations; heteroplasmic mice; healthy-subjects; high-frequency; data set; age; replication
AB Mitochondrial DNA (mtDNA) variation can affect phenotypic variation; therefore, knowing its distribution within and among individuals is of importance to understanding many human diseases. Intra-individual mtDNA variation (heteroplasmy) has been generally assumed to be random. We used massively parallel sequencing to assess heteroplasmy across ten tissues and demonstrate that in unrelated individuals there are tissue-specific, recurrent mutations. Certain tissues, notably kidney, liver and skeletal muscle, displayed the identical recurrent mutations that were undetectable in other tissues in the same individuals. Using RFLP analyses we validated one of the tissue-specific mutations in the two sequenced individuals and replicated the patterns in two additional individuals. These recurrent mutations all occur within or in very close proximity to sites that regulate mtDNA replication, strongly implying that these variations alter the replication dynamics of the mutated mtDNA genome. These recurrent variants are all independent of each other and do not occur in the mtDNA coding regions. The most parsimonious explanation of the data is that these frequently repeated mutations experience tissue-specific positive selection, probably through replication advantage.
C1 [Samuels, David C.; Li, Bingshan; Clay, Hayley Boyd; Thornton-Wells, Tricia A.; Haines, Jonathan L.; Murdock, Deborah G.; Mortlock, Douglas P.; Williams, Scott M.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA.
   [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Ctr Human Genet Res, Nashville, TN 37212 USA.
   [Song, Zhuo; Torstenson, Eric; Hughes, Tia M.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA.
   [Rokas, Antonis] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37212 USA.
   [Moore, Jason H.; Williams, Scott M.] Dartmouth Med Sch, Dept Genet, Computat Genet Lab, Lebanon, NH USA.
   [Hoffman, Robert D.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA.
C3 Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Dartmouth College; Vanderbilt University
RP Samuels, DC (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA.
EM scott.williams@dartmouth.edu
FU NIH [R01HG004517, R01GM073744, AG019085, AG027944]; Recruitment for Genetic Aging Research [1P30AG036445];  [LM010098];  [GM103534]; Division Of Environmental Biology; Direct For Biological Sciences [0844968] Funding Source: National Science Foundation
CR Allard MW, 2006, J FORENSIC SCI, V51, P566, DOI 10.1111/j.1556-4029.2006.00136.x
   Allard MW, 2005, FORENSIC SCI INT, V148, P169, DOI 10.1016/j.forsciint.2004.06.001
   Andrew T, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022332
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Barthélémy C, 2002, HUM GENET, V110, P479, DOI 10.1007/s00439-002-0708-4
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Beeton Christine, 2007, J VIS EXP, V0, PP402, DOI 10.3791/402
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Cormio A, 2005, NEUROBIOL AGING, V26, P655, DOI 10.1016/j.neurobiolaging.2004.06.014
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   da Costa CK, 2007, J NEUROL SCI, V263, P139, DOI 10.1016/j.jns.2007.07.006
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Janssen GMC, 2006, EXP CLIN ENDOCR DIAB, V114, P168, DOI 10.1055/s-2006-924066
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Malyarchuk BA, 2001, RUSS J GENET+, V37, P823, DOI 10.1023/A:1016707228425
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Pai CY, 2006, FORENSIC SCI INT, V156, P124, DOI 10.1016/j.forsciint.2004.12.021
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225
   Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013
   Picornell A, 2006, INT J LEGAL MED, V120, P271, DOI 10.1007/s00414-006-0083-0
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shu L, 2012, INT J OPHTHALMOL-CHI, V5, P28, DOI 10.3980/j.issn.2222-3959.2012.01.06
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suspène R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108
   Tully G, 2004, FORENSIC SCI INT, V140, P1, DOI 10.1016/S0379-0738(03)00181-6
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Yamasoba T, 2002, NEUROMUSCULAR DISORD, V12, P506, DOI 10.1016/S0960-8966(01)00329-7
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
NR 49
TC 108
Z9 123
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD NOV 15
PY 2013
VL 9
IS 11
BP 
EP 
DI 10.1371/journal.pgen.1003929
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 299BG
UT WOS:000330369000022
PM 24244193
DA 2024-11-01
ER

PT J
AU He, Q
   Wang, M
   Harris, N
   Han, XL
AF He, Quan
   Wang, Miao
   Harris, Nicole
   Han, Xianlin
TI Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE cardiolipin; mitogen-activated protein kinase; reactive oxygen species; cell cycle
ID p70 s6 kinase; linked cardioskeletal myopathy; neutropenia barth-syndrome; activated protein-kinase; nuclear antigen pcna; cardiac fibroblasts; induced proliferation; signaling mechanisms; shotgun lipidomics; mass-spectrometry
AB Mutation of the mitochondrial protein tafazzin causes dilated cardiomyopathy in Barth syndrome. Previous studies have shown that tafazzin knockdown promotes hypertrophy of neonatal cardiac myocytes. The current investigation was designed to show whether tafazzin knockdown affects cardiac fibroblast proliferation and collagen secretion, which contribute to fibrosis in dilated cardiomyopathy. In primary cultures of neonatal ventricular fibroblasts (NVFs) transduced with a tafazzin short hairpin RNA adenovirus, tafazzin knockdown increased production of reactive oxygen species and activation of mitogen- activated protein kinases and induced protein and DNA synthesis via cell cycle regulators. It also reduced intracellular ATP, activated AMPK, and caused multinucleation, hypertrophy, and enhanced collagen secretion. We concluded that tafazzin knockdown interrupts the NVF cell cycle and this in turn may contribute to fibrosis and dilated cardiomyopathy in Barth syndrome.
C1 [He, Quan; Wang, Miao; Harris, Nicole; Han, Xianlin] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA.
   [He, Quan] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA.
C3 Sanford Burnham Prebys Medical Discovery Institute; Henry Ford Health System; Henry Ford Hospital
RP He, Q (corresponding author), Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, 6400 Sanger Rd, Orlando, FL 32827 USA.
EM qhe@sanfordburnham.org
FU Barth Syndrome Foundation; American Heart Association
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Agocha AE, 1997, MOL CELL BIOCHEM, V172, P195, DOI 10.1023/A:1006848512174
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005
   Banks MF, 2005, J APPL PHYSIOL, V98, P732, DOI 10.1152/japplphysiol.00821.2004
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418
   Berrebi D, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002216
   BOOZ GW, 1995, CARDIOVASC RES, V30, P537, DOI 10.1016/S0008-6363(96)88507-5
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200
   Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, PC33, DOI 10.1152/ajpcell.00243.2006
   Chou MM, 2003, J BIOL CHEM, V278, P35241, DOI 10.1074/jbc.M305246200
   Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177
   Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896
   Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, PH3356, DOI 10.1152/ajpheart.00928.2007
   Cui Hang, 2012, J SIGNAL TRANSDUCT, V2012, P646354, DOI 10.1155/2012/646354
   Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010
   Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189
   DIETRICH DR, 1993, CRIT REV TOXICOL, V23, P77, DOI 10.3109/10408449309104075
   Freed DH, 2003, MOL CELL BIOCHEM, V254, P247, DOI 10.1023/A:1027332504861
   Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214
   Garnovskaya MN, 2004, J BIOL CHEM, V279, P24899, DOI 10.1074/jbc.M311622200
   Gerasimovskaya EV, 2005, J BIOL CHEM, V280, P1838, DOI 10.1074/jbc.M409466200
   Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837
   Grim JE, 2003, TRENDS CELL BIOL, V13, P396, DOI 10.1016/S0962-8924(03)00148-X
   Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Han MJ, 2003, MOL CELLS, V15, P94
   Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200
   Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200
   Hauff K, 2009, BIOCHEM J, V417, P573, DOI 10.1042/BJ20080650
   He QA, 2010, AM J PHYSIOL-HEART C, V299, PH210, DOI 10.1152/ajpheart.00098.2010
   Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Kanazawa Shinichiro, 1994, KOBE JOURNAL OF MEDICAL SCIENCES, V40, P165
   Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347
   Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce
   Kiebish MA, 2012, J BIOL CHEM, V287, P25086, DOI 10.1074/jbc.M112.340521
   KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288
   Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322
   Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711
   Li PF, 1999, FEBS LETT, V448, P206, DOI 10.1016/S0014-5793(99)00370-1
   Liang YL, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012860
   Ling MT, 2002, ONCOGENE, V21, P8498, DOI 10.1038/sj.onc.1206007
   Liu L, 2009, BIOCHEM BIOPH RES CO, V382, P385, DOI 10.1016/j.bbrc.2009.03.031
   Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237
   Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653
   Manso AM, 2009, J INVEST MED, V57, P856, DOI 10.2310/JIM.0b013e3181c5e61f
   Marziliano N, 2007, AM J MED GENET A, V143A, P907, DOI 10.1002/ajmg.a.31653
   Matthiesen S, 2007, LIFE SCI, V80, P2259, DOI 10.1016/j.lfs.2007.02.027
   Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173
   Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x
   NEUSTEIN HB, 1979, ARCH PATHOL LAB MED, V103, P214
   Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268
   Preeta R, 1999, J MOL CELL CARDIOL, V31, P1573, DOI 10.1006/jmcc.1999.0994
   Ravens U, 1996, CARDIOVASC RES, V32, P613, DOI 10.1016/0008-6363(96)00121-6
   Reynolds CM, 2002, HYPERTENSION, V39, P525, DOI 10.1161/hy0202.103076
   Seo M, 2006, NEUROSCI LETT, V404, P87, DOI 10.1016/j.neulet.2006.05.061
   Son Yong, 2011, J SIGNAL TRANSDUCT, V2011, P792639, DOI 10.1155/2011/792639
   Spencer CT, 2006, PEDIATRICS, V118, PE337, DOI 10.1542/peds.2005-2667
   Stockand JD, 2003, AM J PHYSIOL-HEART C, V284, PH176, DOI 10.1152/ajpheart.00421.2002
   SUTHERLAND RL, 1993, J STEROID BIOCHEM, V47, P99, DOI 10.1016/0960-0760(93)90062-2
   Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, PH2181, DOI 10.1152/ajpheart.00554.2011
   Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Wang M, 2012, ANAL CHEM, V84, P4580, DOI 10.1021/ac300695p
   Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085
   Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103
   Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200
   Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u
   Yu HW, 2010, BIOCHEM BIOPH RES CO, V396, P451, DOI 10.1016/j.bbrc.2010.04.115
   Zhu LA, 2005, EUR J CANCER, V41, P2415, DOI 10.1016/j.ejca.2005.08.009
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
NR 77
TC 26
Z9 32
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6135
EI 1522-1539
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD NOV 15
PY 2013
VL 305
IS 9
BP H1332
EP H1343
DI 10.1152/ajpheart.00084.2013
PG 12
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Physiology
GA 246XG
UT WOS:000326574100007
PM 23997105
DA 2024-11-01
ER

